data_2kdy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kdy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.691 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.7 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.609 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.592 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.677 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.696 ' CD2' ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.696 ' OG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.698 ' CG2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.548 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.649 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.698 ' ND2' ' CG2' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 49' ' ' ASN . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.804 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.665 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.691 ' O ' ' CG2' ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.653 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.665 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CE1' ' CD ' ' A' ' 61' ' ' LYS . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.677 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 3.1 t-20 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.679 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 13.6 m120 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.764 ' CG2' ' CD1' ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.764 ' CD1' ' CG2' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.807 ' CG1' ' CE2' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.839 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.62 ' O ' ' OG1' ' A' ' 51' ' ' THR . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.749 ' CD1' ' N ' ' A' ' 88' ' ' ILE . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.61 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.661 ' CB ' HG23 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.608 ' N ' ' CG2' ' A' ' 96' ' ' THR . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 80' ' ' SER . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.807 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.689 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HA ' ' O ' ' A' ' 139' ' ' ASP . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.683 ' O ' ' N ' ' A' ' 138' ' ' GLY . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.538 ' N ' HG21 ' A' ' 113' ' ' THR . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.607 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.662 HG21 ' N ' ' A' ' 118' ' ' GLU . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.662 ' N ' HG21 ' A' ' 117' ' ' THR . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.698 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 21.5 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.507 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.698 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 1.6 ptm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.196 0.522 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.725 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.668 ' C ' ' CD1' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 144' ' ' HIS . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB2' ' CG ' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.689 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.591 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.765 ' CD2' ' CG ' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.736 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.683 HG11 ' CB ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.812 ' CB ' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.818 ' CE2' ' CG2' ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.607 ' HB2' ' OG1' ' A' ' 173' ' ' THR . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 258' ' ' ALA . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.739 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.736 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.584 ' CG ' HD12 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.801 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.725 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.731 ' CE1' HD22 ' A' ' 199' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CZ ' ' O ' ' A' ' 152' ' ' LYS . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.605 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.763 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.801 ' CD2' ' N ' ' A' ' 170' ' ' GLY . 2.2 t60 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.581 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 1.4 mp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.763 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.2 m120 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 220' ' ' TYR . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.616 ' N ' HG12 ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.624 ' O ' HD13 ' A' ' 199' ' ' LEU . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.677 ' CG1' HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.737 ' HB3' ' CZ ' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.691 ' CG1' ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.675 HG23 ' CG1' ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.602 ' O ' HG11 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD1' HG22 ' A' ' 197' ' ' VAL . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.707 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.589 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.736 ' CG ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.736 ' CD1' ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.614 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.818 ' CG2' ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.791 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.765 ' CG ' ' CD2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.683 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.613 ' O ' ' OE1' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.791 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.704 ' HB2' ' CE2' ' A' ' 233' ' ' PHE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.683 ' CG2' HG12 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.459 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.678 ' N ' ' CD2' ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.594 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.772 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.57 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 250' ' ' ASN . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 2.7 m-80 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.466 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.636 ' CD2' ' N ' ' A' ' 253' ' ' HIS . 1.3 m170 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.736 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.772 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.736 ' CD1' ' CD1' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.63 ' HA ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CG ' ' A' ' 158' ' ' TYR . 27.7 mm-40 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.694 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.682 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.672 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.673 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.665 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.665 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.561 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.61 ' O ' ' O ' ' A' ' 42' ' ' LEU . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.657 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.68 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.609 ' N ' HG21 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.682 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' N ' ' HB3' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.666 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.691 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.687 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.701 ' CG ' HD22 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.482 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 6.2 t-20 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.679 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.683 ' CG2' HD12 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.683 HD12 ' CG2' ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' CG ' ' H ' ' A' ' 76' ' ' ASN . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.696 ' CB ' ' O ' ' A' ' 53' ' ' THR . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.7 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.68 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.693 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.671 ' HB ' ' CD1' ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.693 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.654 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 80' ' ' SER . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.621 ' NE2' ' HB2' ' A' ' 108' ' ' SER . 0.3 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.658 ' CB ' ' HB1' ' A' ' 237' ' ' ALA . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.676 ' CD2' ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.654 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.66 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.684 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.658 HG21 ' N ' ' A' ' 118' ' ' GLU . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.658 ' N ' HG21 ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.688 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.688 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.66 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.571 ' CG2' ' OD1' ' A' ' 139' ' ' ASP . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.519 ' CD ' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.728 ' CG ' ' HB2' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 211' ' ' HIS . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.738 ' CD2' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.623 ' N ' ' HD3' ' A' ' 151' ' ' PRO . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.735 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.741 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.6 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.696 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.55 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.684 ' HB1' ' CG ' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.687 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.705 ' CD1' ' O ' ' A' ' 172' ' ' LEU . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.729 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.685 ' CG2' ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.75 HG23 ' CE2' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.713 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.566 ' CB ' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.713 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.713 ' O ' ' CG2' ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.735 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.652 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.724 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 3.9 t-160 -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.506 ' H ' ' CD2' ' A' ' 190' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.802 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.592 0.711 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.802 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.627 HG12 ' CG1' ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 228' ' ' TYR . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.623 ' O ' HG21 ' A' ' 201' ' ' VAL . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.72 HG23 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.75 ' CE2' HG23 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.586 ' CG ' HG23 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.724 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.738 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.712 HG12 ' CE1' ' A' ' 203' ' ' TYR . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 219' ' ' LEU . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.711 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 225' ' ' LYS . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.624 ' OE1' ' CG2' ' A' ' 197' ' ' VAL . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.662 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.6 ' O ' HD13 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 245' ' ' GLU . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.734 ' CD1' HD23 ' A' ' 199' ' ' LEU . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.681 ' CD2' HD13 ' A' ' 257' ' ' LEU . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.647 ' O ' ' CG2' ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.74 HG22 ' CE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.689 ' CB ' ' HA ' ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.728 ' HB2' ' CG ' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.739 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.67 HG23 ' CA ' ' A' ' 232' ' ' ILE . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.498 ' N ' HG21 ' A' ' 240' ' ' VAL . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.667 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.704 ' O ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.73 HG13 ' CD2' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.73 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.704 ' CD1' ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.441 ' H ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.696 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.688 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.589 ' O ' HD22 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.611 ' CB ' HG23 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.774 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.697 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.609 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.687 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.586 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.694 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA3' HG13 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.62 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.824 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.662 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.601 ' O ' HG23 ' A' ' 20' ' ' THR . 46.3 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.697 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.662 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.605 ' C ' ' CD1' ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.743 ' OD2' ' CE2' ' A' ' 63' ' ' TYR . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.535 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.673 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.673 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.591 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.662 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.698 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.649 ' NE2' HG23 ' A' ' 85' ' ' ILE . 1.1 mt-30 -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 ' CD1' ' A' ' 95' ' ' ILE . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.726 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.732 ' CD1' HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.736 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.698 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.646 ' CB ' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.9 tp60 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG23 HG22 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 75' ' ' LYS . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.667 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.681 ' CA ' HD12 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.681 HD23 ' CD1' ' A' ' 140' ' ' ILE . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.584 ' HB ' ' HA3' ' A' ' 138' ' ' GLY . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.659 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.601 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 96' ' ' THR . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.582 ' C ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.683 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 144' ' ' HIS . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.748 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.734 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.637 HG23 ' N ' ' A' ' 235' ' ' GLU . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CG ' ' HB1' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.705 ' O ' ' CG ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.95 ' O ' ' N ' ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.95 ' N ' ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.611 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CZ ' ' HB3' ' A' ' 238' ' ' GLN . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.551 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 HG23 ' CD ' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.755 ' CE2' ' CD1' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.442 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.717 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.692 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.697 ' CA ' ' HB ' ' A' ' 187' ' ' ILE . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.694 ' CE1' HD11 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.7 ' CB ' ' HA3' ' A' ' 183' ' ' GLY . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.585 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.762 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.656 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.597 ' HA3' HD22 ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.703 ' CD1' ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 189' ' ' HIS . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.715 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.686 ' CD2' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.724 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.54 0.686 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.636 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.683 HG23 ' CG1' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 219' ' ' LEU . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.822 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.716 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.696 ' CG2' HG21 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.689 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 211' ' ' HIS . 28.8 p-80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 147' ' ' PHE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.689 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.696 HG21 ' CG2' ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.668 ' N ' HG21 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.586 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.612 ' O ' HD11 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.682 HG22 ' CB ' ' A' ' 199' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.617 ' CD1' ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 2.2 t30 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.602 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 245' ' ' GLU . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.822 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.677 ' CD2' HD13 ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.723 HG12 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.736 ' CG ' ' HB3' ' A' ' 143' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.637 ' N ' HG23 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.73 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.681 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.505 ' HB3' ' OD2' ' A' ' 139' ' ' ASP . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.572 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.685 ' O ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.827 ' CG1' ' CD2' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 250' ' ' ASN . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.606 ' OD1' ' O ' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.827 ' CD2' ' CG1' ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.838 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.698 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.662 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.6 mm-40 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.693 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.693 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.691 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 26' ' ' LEU . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HB3' ' HG ' ' A' ' 39' ' ' SER . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.652 ' CD1' ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.701 ' CE ' ' CD ' ' A' ' 78' ' ' LYS . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.699 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.68 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.611 ' O ' ' C ' ' A' ' 43' ' ' GLU . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.612 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.675 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.662 ' O ' ' CG2' ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.673 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.569 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' GLY . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.68 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.67 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.699 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.676 ' CD2' ' HB ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 106' ' ' LYS . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.682 ' HB3' ' CD ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.701 ' CD ' ' CE ' ' A' ' 38' ' ' LYS . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.731 HG12 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.447 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.73 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.678 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.687 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.583 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.688 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.686 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.578 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 118' ' ' GLU . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.72 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CD2' HG12 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.685 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.679 ' CG ' ' OE2' ' A' ' 239' ' ' GLU . 1.9 mm100 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.401 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.698 ' CD2' ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.68 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.585 ' C ' ' HG3' ' A' ' 118' ' ' GLU . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.622 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.357 0.599 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.519 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.757 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.68 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.524 ' HB1' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 144' ' ' HIS . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.661 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 5.0 m170 -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.756 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 149' ' ' LYS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.823 ' CD1' ' CB ' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.635 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.693 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.685 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.743 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.679 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 257' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.72 ' CD1' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.403 ' CG ' ' HD2' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.581 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 257' ' ' LEU . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.789 ' CE2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.584 HG21 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.825 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CZ ' ' O ' ' A' ' 152' ' ' LYS . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.685 ' CB ' ' HB3' ' A' ' 151' ' ' PRO . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.774 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.713 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.809 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.809 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.728 ' CG2' ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.61 ' O ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.681 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.681 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.329 0.585 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.4 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.73 ' HA ' ' CD1' ' A' ' 220' ' ' TYR . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.665 ' N ' HG11 ' A' ' 197' ' ' VAL . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.789 ' CD2' ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.681 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.757 ' CG1' ' N ' ' A' ' 215' ' ' SER . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.825 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.676 ' CG1' ' HB ' ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.653 ' CB ' HG21 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.756 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.823 ' CB ' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.676 ' HB ' ' CG1' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.677 ' CG2' HG12 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.757 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.61 ' O ' HD11 ' A' ' 199' ' ' LEU . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.728 ' CG1' ' CG2' ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.589 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.73 ' CD1' ' HA ' ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.58 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.686 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.586 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.585 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.602 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.688 ' HB2' ' CG2' ' A' ' 218' ' ' VAL . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.78 ' CD1' ' CA ' ' A' ' 242' ' ' GLY . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.743 ' CD1' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.804 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 234' ' ' GLY . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.743 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.698 ' OE2' ' CD2' ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.566 ' HB1' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.563 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.69 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.67 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.735 HG21 ' CE1' ' A' ' 253' ' ' HIS . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.604 ' O ' HG21 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.735 ' CE1' HG21 ' A' ' 248' ' ' THR . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.642 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.69 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.679 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.682 ' CD ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.736 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.691 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.691 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.692 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.59 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' HD22 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.689 ' OG1' ' CB ' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.66 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.676 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.734 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.679 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.674 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HB3' HG22 ' A' ' 20' ' ' THR . 49.2 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.679 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.678 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.734 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.681 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.689 ' CB ' ' OG1' ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 71' ' ' THR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.604 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.676 HD22 ' CB ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.589 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' CB ' HD22 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.659 HG12 ' CG ' ' A' ' 87' ' ' GLN . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.676 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.606 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.726 ' CD1' ' CG ' ' A' ' 89' ' ' GLU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.62 ' CB ' HD13 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.652 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.732 ' CE2' HG23 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.671 ' CD ' HD23 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.595 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.598 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.677 ' CG ' ' HB3' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.533 HG21 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.533 ' N ' HG21 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.566 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.708 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.482 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.708 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.561 HD11 ' O ' ' A' ' 113' ' ' THR . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.612 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.722 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.77 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.851 ' CD2' ' CE2' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.619 ' O ' ' CE ' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.732 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.75 ' HB2' ' CG ' ' A' ' 178' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.615 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.62 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.818 ' CG ' ' CD1' ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.605 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 162' ' ' ALA . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.722 ' CB ' ' HA ' ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.56 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.603 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.424 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.692 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.579 ' O ' HD13 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.589 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.698 ' CB ' ' HA3' ' A' ' 185' ' ' GLY . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.818 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 155' ' ' MET . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CG ' ' HB2' ' A' ' 151' ' ' PRO . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.674 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.796 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.4 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.796 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' CG ' ' A' ' 196' ' ' ASN . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.745 ' NE2' ' CG2' ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.687 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.674 ' CG1' ' HB2' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.689 ' CD1' ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.689 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.756 ' O ' ' CE2' ' A' ' 203' ' ' TYR . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.686 ' OD1' ' CG1' ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.734 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.686 ' CG1' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.673 HG22 ' CG2' ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 187' ' ' ILE . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.606 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.738 ' CD1' ' O ' ' A' ' 196' ' ' ASN . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.725 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.617 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.575 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.58 ' C ' ' CG1' ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 245' ' ' GLU . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.585 ' HA ' ' HB1' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.598 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.689 ' CD2' HD11 ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.736 HG12 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.77 ' N ' ' CG2' ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.691 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.412 ' HB1' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.582 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.682 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.745 ' CG2' ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.602 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 249' ' ' ALA . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.417 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.602 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.735 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.56 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.682 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.722 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.7 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.614 ' O ' ' O ' ' A' ' 261' ' ' GLN . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.661 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.609 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.754 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.666 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' LEU . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.745 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.658 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.68 HD23 ' CB ' ' A' ' 38' ' ' LYS . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.664 ' HB3' ' CB ' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.74 ' CD1' ' CG ' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.74 ' CG ' ' CD1' ' A' ' 37' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.675 ' CB ' HD22 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.629 ' CD1' ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.685 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.685 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.65 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.67 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.671 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.673 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.695 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' OH ' ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.661 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.433 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.636 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.608 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.563 ' O ' ' C ' ' A' ' 72' ' ' GLY . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.584 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.668 HD11 ' CB ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 80' ' ' SER . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.623 HG12 ' CB ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 97' ' ' LEU . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.67 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.685 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.688 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.626 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.686 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.623 ' CB ' HG12 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.679 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.67 ' CD ' ' HB1' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.6 ' HG3' ' N ' ' A' ' 108' ' ' SER . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.6 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.432 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.7 ' O ' ' CD1' ' A' ' 140' ' ' ILE . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.679 ' HG ' ' CB ' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.665 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.559 HD22 ' CE1' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.58 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.651 ' NE2' ' SD ' ' A' ' 129' ' ' MET . 22.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.68 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.651 ' SD ' ' NE2' ' A' ' 119' ' ' GLN . 9.3 mmt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.33 0.586 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CD1' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.624 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.666 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.7 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.766 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.743 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.688 HD21 ' CG ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.78 ' CB ' ' CD1' ' A' ' 178' ' ' PHE . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.68 ' HB2' ' CB ' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.723 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.661 ' N ' ' HB3' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.574 ' CG2' ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.665 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.675 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.737 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.621 ' CB ' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.692 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.676 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.728 ' CD2' ' CB ' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.734 ' CD1' ' HA3' ' A' ' 185' ' ' GLY . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.587 ' C ' HD11 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.827 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.609 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.69 ' CA ' HG13 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.613 ' O ' ' HB3' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.734 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.678 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.676 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.549 ' HB3' ' ND2' ' A' ' 196' ' ' ASN . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.615 ' CB ' ' HA3' ' A' ' 170' ' ' GLY . 3.4 pp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.621 ' HB2' ' CB ' ' A' ' 168' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.684 ' HB ' ' CG2' ' A' ' 187' ' ' ILE . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.678 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.758 ' CD2' ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.653 ' N ' HD11 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.676 ' CG1' ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.827 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.597 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.679 ' CG ' ' CG1' ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.723 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.737 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.679 ' CG1' ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.655 HD11 ' CG2' ' A' ' 232' ' ' ILE . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.676 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.666 ' N ' HG12 ' A' ' 201' ' ' VAL . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.734 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.748 ' CE1' ' O ' ' A' ' 196' ' ' ASN . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.667 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.584 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.758 ' CE1' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.627 HD23 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 237' ' ' ALA . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.766 ' N ' ' CG2' ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.664 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.569 HG21 ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.58 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.587 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.777 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.674 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.614 ' CG ' ' O ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.469 ' C ' ' CD1' ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 252' ' ' ILE . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.737 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.2 m170 -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.777 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.725 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.649 ' CD2' ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.609 ' O ' HD22 ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.728 ' CB ' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 239' ' ' GLU . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' HD22 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.676 ' CG2' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.588 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.697 ' CA ' ' O ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.689 ' CD1' ' O ' ' A' ' 22' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.615 ' OG1' ' O ' ' A' ' 60' ' ' GLU . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.697 ' O ' ' CA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HB3' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 6.2 t60 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' HA2' ' HZ2' ' A' ' 38' ' ' LYS . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HZ2' ' HA2' ' A' ' 36' ' ' GLY . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.678 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 42' ' ' LEU . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' GLU . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.584 HD13 ' OD1' ' A' ' 67' ' ' ASP . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.674 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.639 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.729 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' HG22 ' A' ' 20' ' ' THR . 33.1 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.676 ' HA3' ' CG2' ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.675 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.729 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 3.5 t-20 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.681 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.5 OUTLIER -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 71' ' ' THR . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.742 ' N ' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.728 ' CD1' HD12 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.591 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.583 ' C ' ' HG3' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.674 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.453 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 5.0 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.699 ' O ' ' CG ' ' A' ' 121' ' ' GLN . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.591 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.569 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.742 ' CE1' ' N ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.68 ' NE2' ' OE1' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.68 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 140' ' ' ILE . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.65 ' CD2' ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.666 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.82 ' CD2' ' CE2' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.731 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.664 HG21 ' N ' ' A' ' 118' ' ' GLU . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' HG21 ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.704 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.503 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.704 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 2.9 tpp . . . . . 0 C--O 1.215 -0.728 0 CA-C-O 121.194 0.521 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.727 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.731 ' CE2' ' HG3' ' A' ' 116' ' ' GLN . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.553 ' CG1' ' OD2' ' A' ' 139' ' ' ASP . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.618 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.744 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.627 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 39.7 m-70 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.699 ' OG1' ' CE ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' A' ' 203' ' ' TYR . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.704 ' NZ ' ' CG ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.682 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.691 ' CA ' ' HB1' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.589 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 203' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.706 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 170' ' ' GLY . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CD2' ' HA3' ' A' ' 256' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.531 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.715 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.817 ' CD1' ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.817 ' CE1' ' CD1' ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.763 ' CD1' ' CG1' ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.641 ' N ' HG22 ' A' ' 176' ' ' ILE . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.691 ' HB1' ' CA ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.676 ' HD2' ' CB ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.739 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.3 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.739 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.715 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.677 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.677 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.648 ' ND2' HD13 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.728 HG23 ' CD1' ' A' ' 220' ' ' TYR . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.572 ' N ' HG13 ' A' ' 197' ' ' VAL . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.804 ' N ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.763 ' CG1' ' CD1' ' A' ' 176' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.676 ' CB ' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.864 ' CE1' ' CE2' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.676 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.67 ' HB3' ' CD2' ' A' ' 211' ' ' HIS . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.595 ' HB2' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.812 ' CB ' ' CE1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.676 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.618 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.684 HG13 ' CG1' ' A' ' 197' ' ' VAL . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.729 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.747 ' CE2' ' OH ' ' A' ' 174' ' ' TYR . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.76 ' CD1' ' CA ' ' A' ' 242' ' ' GLY . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.594 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.797 ' CD1' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.733 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.704 ' CG ' ' NZ ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.742 ' HB3' ' O ' ' A' ' 233' ' ' PHE . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.796 ' CG ' ' CE2' ' A' ' 233' ' ' PHE . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.68 HG23 ' CA ' ' A' ' 232' ' ' ILE . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.624 ' N ' HD11 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.774 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.502 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.67 ' HG3' ' CG2' ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.741 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 30.1 t-20 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.675 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.67 ' CG2' ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.3 m170 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.735 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.774 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CD2' ' A' ' 163' ' ' PHE . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.733 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.706 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.733 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 2.1 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.684 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.684 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.676 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.642 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.604 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.68 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 50' ' ' GLY . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.628 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 63' ' ' TYR . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.675 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.664 ' OE1' ' NH1' ' A' ' 81' ' ' ARG . 33.2 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.676 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.728 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.628 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 5.9 t-20 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.696 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.614 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.682 ' CD2' ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.68 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.639 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.516 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.731 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.664 ' NH1' ' OE1' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.695 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.675 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.693 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.694 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.686 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.687 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.695 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.68 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.674 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.636 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HD2' HD21 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.658 ' CG ' ' HB3' ' A' ' 105' ' ' TYR . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.679 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.581 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.674 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 117' ' ' THR . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.682 ' CE ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.041 0.448 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.57 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.679 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.69 ' O ' ' CD1' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CD1' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.651 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.737 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 6.7 m-70 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.604 ' C ' ' O ' ' A' ' 147' ' ' PHE . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.721 ' CD ' ' O ' ' A' ' 147' ' ' PHE . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.744 ' N ' ' CD ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.598 ' O ' ' CE ' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.737 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.725 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.68 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 257' ' ' LEU . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.734 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.409 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.692 ' CA ' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.685 ' CD2' ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.735 ' CE2' ' CD1' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.824 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.757 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.737 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.694 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.757 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.599 ' O ' HG23 ' A' ' 176' ' ' ILE . 3.5 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.7 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 17.1 p-80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.698 ' CG2' ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.588 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.636 ' CD2' ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.75 ' CG1' ' N ' ' A' ' 219' ' ' LEU . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.741 ' CD2' ' CG2' ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 201' ' ' VAL . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.824 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.69 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.683 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.732 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.69 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.674 ' CG2' HG12 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.741 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.75 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.745 ' CG ' ' O ' ' A' ' 196' ' ' ASN . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.7 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 218' ' ' VAL . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.736 ' CE2' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.656 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.741 HG22 ' CE1' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.694 ' CD1' ' OE1' ' A' ' 239' ' ' GLU . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.651 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.725 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.689 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.509 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.714 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.552 HG13 ' OE2' ' A' ' 224' ' ' GLU . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.744 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.514 ' H ' ' CG2' ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.652 ' C ' ' CD1' ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.652 ' CD1' ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.714 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.67 ' CD1' HD22 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.68 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.73 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.689 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.692 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.693 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.568 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.678 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.594 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.657 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.675 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.522 ' C ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.714 ' HG ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.689 ' O ' ' CG2' ' A' ' 20' ' ' THR . 31.2 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.595 ' O ' ' CG2' ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.743 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 42' ' ' LEU . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.678 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.684 HG23 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' LYS . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.683 ' CD1' ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' LYS . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.683 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.726 HG23 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.618 ' O ' ' OG1' ' A' ' 51' ' ' THR . 60.4 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.697 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.7 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.699 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.699 ' CD1' ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.69 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.675 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.66 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.493 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.682 ' CG2' HG22 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.684 ' CE ' HG23 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 238' ' ' GLN . 11.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.418 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.664 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.682 HG22 ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.685 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.579 ' O ' ' CA ' ' A' ' 100' ' ' GLY . 5.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.616 HG21 ' N ' ' A' ' 118' ' ' GLU . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.616 ' N ' HG21 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.601 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 65.1 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' OE2' ' NZ ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.683 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.594 ' OD1' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.4 0.619 . . . . 0.0 110.594 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.669 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.669 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.584 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.614 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.732 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.733 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.727 ' HA2' ' CE1' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.67 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 6.0 m170 -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.604 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.69 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.741 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.683 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.672 ' CB ' ' CD ' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.759 ' CE1' ' CG1' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.715 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB3' HD23 ' A' ' 172' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.727 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.532 ' HB2' ' CD2' ' A' ' 254' ' ' HIS . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.447 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.456 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.748 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.593 ' C ' HG22 ' A' ' 176' ' ' ILE . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.825 ' CD1' ' CE2' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.727 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.674 ' CB ' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.727 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.684 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.741 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 6.0 t60 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.571 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.77 ' CG2' ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.754 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.716 ' CD2' ' C ' ' A' ' 169' ' ' GLY . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.529 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 1.2 mp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.754 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.5 m120 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.692 ' CG2' ' OE2' ' A' ' 224' ' ' GLU . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.741 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.676 ' CG1' ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.825 ' CE2' ' CD1' ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.7 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 208' ' ' GLU . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.655 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.871 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.871 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 31.0 m80 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.674 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.732 HG23 ' CZ ' ' A' ' 203' ' ' TYR . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.676 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.77 ' CG1' ' CG2' ' A' ' 187' ' ' ILE . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.671 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.692 ' OE2' ' CG2' ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.602 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.726 HD11 ' CE2' ' A' ' 228' ' ' TYR . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 214' ' ' ILE . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' A' ' 214' ' ' ILE . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.733 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.711 ' C ' ' O ' ' A' ' 233' ' ' PHE . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.713 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 107' ' ' GLN . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.759 ' CG1' ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.688 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.662 ' N ' HD21 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.659 ' N ' HD23 ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.725 ' HB2' ' CD1' ' A' ' 228' ' ' TYR . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.525 HG12 ' ND1' ' A' ' 253' ' ' HIS . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.602 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.625 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.447 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.677 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 1.5 m170 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.687 ' N ' ' CD2' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.685 ' CD1' ' HB1' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.727 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.688 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.715 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.689 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.615 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.58 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 12.7 t60 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' C ' ' O ' ' A' ' 36' ' ' GLY . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.642 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.679 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 63' ' ' TYR . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.667 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.689 ' O ' ' CG2' ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.667 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.703 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.682 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.593 ' O ' HD11 ' A' ' 42' ' ' LEU . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.679 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.681 ' CG2' HD23 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 71' ' ' THR . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.644 ' O ' ' CA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.671 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.686 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.675 ' HG2' ' CG ' ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.689 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 4.2 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.651 ' CD1' HD13 ' A' ' 88' ' ' ILE . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.721 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.689 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.702 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.752 ' CZ ' ' CD2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 104' ' ' VAL . 9.0 mm-40 -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 80' ' ' SER . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 76' ' ' ASN . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.688 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.692 ' CD2' ' OE1' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.62 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.752 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.725 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.652 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.652 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.485 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.414 0.626 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.615 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.66 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.683 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.712 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.725 ' HB3' ' CG ' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.688 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.765 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.732 ' CD1' ' HB3' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.674 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.683 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.718 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.7 ' CB ' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.7 ' OH ' ' CB ' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.706 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.587 ' C ' ' HA3' ' A' ' 170' ' ' GLY . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.58 ' OG ' ' HB3' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.673 ' CD2' HD21 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.822 ' CE2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.822 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 153' ' ' ASP . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.678 ' HG3' ' CE1' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.699 ' CA ' HG12 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.678 ' CE1' ' HG3' ' A' ' 182' ' ' GLN . 38.6 p-80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.706 ' CG2' ' O ' ' A' ' 197' ' ' VAL . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 189' ' ' HIS . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.671 ' O ' ' N ' ' A' ' 171' ' ' LYS . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.763 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.507 0.67 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.702 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 3.3 m120 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.706 ' O ' ' CG2' ' A' ' 187' ' ' ILE . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.822 ' CD2' ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.7 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.685 HG11 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.447 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.822 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.683 ' CD1' HG23 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.745 ' OD2' ' CD2' ' A' ' 211' ' ' HIS . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.554 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.745 ' CD2' ' OD2' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.77 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.646 ' N ' HG12 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.655 HG11 ' N ' ' A' ' 227' ' ' SER . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.685 ' CA ' HG11 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.735 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.411 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.579 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.57 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.678 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.63 ' C ' ' CG1' ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.655 ' N ' HG11 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.733 ' CD2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.681 ' CD2' HD13 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.589 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.709 HG22 ' CE1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.714 ' HG2' ' CE2' ' A' ' 233' ' ' PHE . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.436 ' CG1' ' HB1' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.623 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.784 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.681 ' HG3' ' CG2' ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.591 HG21 ' CE1' ' A' ' 253' ' ' HIS . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.496 ' H ' ' CG2' ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 7.9 p30 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.681 ' CG2' ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.58 ' HB3' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.784 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.598 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 230' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.706 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.672 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.709 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.645 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HA ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.605 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 40' ' ' LEU . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.755 ' CD2' ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.607 ' O ' ' O ' ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.65 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.668 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.822 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.678 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 59' ' ' ALA . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.698 ' O ' ' CG2' ' A' ' 20' ' ' THR . 5.2 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.672 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.678 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.595 ' CE ' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.594 ' O ' HG21 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.822 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.755 ' CB ' ' CD2' ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.595 ' O ' ' CE ' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.547 HD11 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.697 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.6 m120 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.696 ' CG2' ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.674 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.824 ' CG1' ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.478 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 102' ' ' PHE . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.731 ' CE2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.657 ' CG2' ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.657 ' CD ' ' CG2' ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.668 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.784 ' HB ' ' CG ' ' A' ' 93' ' ' GLN . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.594 ' N ' HG12 ' A' ' 90' ' ' VAL . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.841 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.841 ' N ' ' HG3' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.698 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.731 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.824 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.682 ' HB2' ' CB ' ' A' ' 78' ' ' LYS . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.582 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.702 ' O ' ' CG1' ' A' ' 140' ' ' ILE . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.582 HD23 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 118' ' ' GLU . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.663 ' NE2' ' HB2' ' A' ' 97' ' ' LEU . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.685 ' CE ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.16 0.505 . . . . 0.0 110.073 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.584 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.544 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' ' N ' ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.73 ' CD1' ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.73 ' N ' ' CD1' ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.602 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 11.5 m170 -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.754 ' OG1' ' CD2' ' A' ' 211' ' ' HIS . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.75 ' CG ' ' HB3' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.703 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.736 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.743 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.695 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.619 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.59 ' C ' ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.705 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.633 ' HB2' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.675 ' CD1' ' C ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.739 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.531 ' HB2' ' CA ' ' A' ' 164' ' ' GLY . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.697 ' CD2' ' O ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.736 ' CG ' ' HA3' ' A' ' 185' ' ' GLY . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.497 ' C ' HD11 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.817 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.713 ' CB ' ' CB ' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.743 ' CD2' ' HA ' ' A' ' 153' ' ' ASP . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.692 ' O ' ' CE ' ' A' ' 181' ' ' LYS . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.733 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.599 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.734 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.736 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.679 HG23 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.682 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.831 ' CE1' ' CG2' ' A' ' 255' ' ' ILE . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.645 ' O ' ' O ' ' A' ' 189' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.692 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.688 ' CG2' ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.526 ' N ' HG11 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.766 ' CD2' ' CG2' ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 201' ' ' VAL . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 214' ' ' ILE . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CE1' ' CG2' ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.681 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.81 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.81 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.75 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.759 ' CG2' ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.605 ' C ' HG11 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.766 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.708 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 220' ' ' TYR . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.725 ' CE1' HD12 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 243' ' ' SER . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 242' ' ' GLY . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.734 ' CG1' ' CE1' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.7 ' O ' ' C ' ' A' ' 234' ' ' GLY . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.7 ' C ' ' O ' ' A' ' 233' ' ' PHE . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.693 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.662 ' HB ' ' CD1' ' A' ' 232' ' ' ILE . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.665 ' N ' HD22 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.77 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.516 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.731 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 250' ' ' ASN . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 11.0 p30 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.671 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.561 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.731 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.831 ' CG2' ' CE1' ' A' ' 189' ' ' HIS . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.725 HD12 ' CE1' ' A' ' 228' ' ' TYR . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.705 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.674 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.588 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.644 ' CB ' HG21 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.692 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.621 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.595 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.597 ' C ' ' CD1' ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.7 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.768 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.658 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 64.5 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.658 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.699 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.745 ' OD2' ' CE2' ' A' ' 63' ' ' TYR . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.67 ' CB ' ' HA ' ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.574 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' O ' HD11 ' A' ' 74' ' ' LEU . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' CD2' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.692 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.677 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.624 ' CG ' HG13 ' A' ' 95' ' ' ILE . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.684 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.704 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.627 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.692 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.68 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.474 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.815 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.677 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.735 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.595 ' OE1' ' CD ' ' A' ' 239' ' ' GLU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.668 ' N ' ' OG ' ' A' ' 110' ' ' SER . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.68 HD11 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.584 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.677 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.721 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 118' ' ' GLU . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.644 ' N ' HG23 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.68 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.694 ' HA ' ' CE ' ' A' ' 129' ' ' MET . 6.1 mmt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.19 0.519 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.678 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.584 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.712 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.788 ' CB ' ' CD2' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.788 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 7.1 p80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.753 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.709 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.701 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.701 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.698 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.416 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.498 ' CB ' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.698 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.747 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.481 HG21 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.736 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' A' ' 177' ' ' ASP . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.69 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.476 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 11.0 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.736 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.618 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 196' ' ' ASN . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.585 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.508 ' CD2' ' HD1' ' A' ' 189' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.514 ' CD1' ' H ' ' A' ' 196' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.677 ' CG ' ' CB ' ' A' ' 188' ' ' GLU . 1.6 m120 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.827 ' CG2' ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.618 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.775 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.691 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.697 ' CB ' ' O ' ' A' ' 183' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.753 ' OH ' ' CD2' ' A' ' 147' ' ' PHE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.695 ' OD1' ' CG1' ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.744 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.695 ' CG1' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.667 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.683 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.678 ' N ' ' CG2' ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.641 HG21 ' CA ' ' A' ' 199' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 224' ' ' GLU . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.827 ' CG ' ' CG2' ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.596 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 245' ' ' GLU . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.775 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.608 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.643 ' CG ' ' HA3' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.684 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.616 ' OE2' ' OG1' ' A' ' 145' ' ' THR . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.651 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.69 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.66 HG12 ' ND1' ' A' ' 253' ' ' HIS . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 21.1 t-20 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.668 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.1 m170 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.69 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 105' ' ' TYR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.701 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.752 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.637 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.582 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.631 ' N ' ' OG1' ' A' ' 27' ' ' THR . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.46 HD22 HG22 ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.663 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' N ' ' OG ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.693 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.678 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.653 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.657 ' N ' HG21 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 ' CG ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.675 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.637 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.675 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.681 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.733 ' CG ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.653 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t-20 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.678 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.693 ' OG ' ' CG2' ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.695 ' O ' ' CG2' ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.695 ' CG2' ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.672 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.791 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.547 ' HA ' HD13 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.593 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.646 ' NE2' ' CD1' ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.475 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.687 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.604 ' O ' HD11 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.655 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' CD2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.589 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.791 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HA ' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.697 ' OE1' ' CG ' ' A' ' 239' ' ' GLU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.448 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.666 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.642 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.673 HD23 ' CG ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.78 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 135' ' ' PHE . 32.7 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.543 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.573 ' HG2' ' HA2' ' A' ' 100' ' ' GLY . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.471 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.686 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.327 0.584 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.686 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.561 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.69 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.738 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.666 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.679 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.719 ' CZ ' ' HG2' ' A' ' 205' ' ' LYS . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.71 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.71 ' HD3' ' CD2' ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 177' ' ' ASP . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CE2' HD13 ' A' ' 232' ' ' ILE . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.714 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.68 HG23 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.453 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.83 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.61 ' CE2' HG21 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.765 ' CD1' ' CD1' ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.725 ' O ' ' O ' ' A' ' 177' ' ' ASP . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.711 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 25.6 p-80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.668 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.728 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.605 ' O ' ' HA2' ' A' ' 170' ' ' GLY . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.661 ' CD1' HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.704 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 2.7 mp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.407 0.622 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.685 HG11 ' CG1' ' A' ' 218' ' ' VAL . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 197' ' ' VAL . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 228' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.61 ' O ' HG21 ' A' ' 201' ' ' VAL . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.692 ' CG1' ' N ' ' A' ' 215' ' ' SER . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.692 ' OH ' ' CB ' ' A' ' 147' ' ' PHE . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.671 ' CA ' HG23 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 6.1 p-80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.623 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.671 HG23 ' CA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.704 ' CG1' ' CG2' ' A' ' 232' ' ' ILE . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.692 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.675 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.685 ' CG1' HG11 ' A' ' 197' ' ' VAL . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.585 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.755 ' CD2' ' HB3' ' A' ' 222' ' ' GLN . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.755 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.682 ' HG2' ' CG2' ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.512 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.728 ' CD2' HD21 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.695 ' CD1' ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.582 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.765 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.715 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.708 ' CG2' ' CD1' ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.602 ' O ' ' HG ' ' A' ' 230' ' ' LEU . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.695 ' N ' ' CD1' ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.767 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.549 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.687 ' CB ' ' HA3' ' A' ' 226' ' ' GLY . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.452 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.657 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.524 ' OD1' ' O ' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.628 ' O ' ' CD1' ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.628 ' CD1' ' O ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.657 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.0 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.83 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.767 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CD2' ' A' ' 163' ' ' PHE . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 172' ' ' LEU . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.714 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.702 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.687 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.694 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.774 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.607 ' O ' ' O ' ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.681 ' CD1' ' OD1' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.59 ' C ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.615 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.774 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.668 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.694 ' O ' ' CG2' ' A' ' 20' ' ' THR . 4.1 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.679 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.668 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.682 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.3 t-20 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.59 ' CG2' HD22 ' A' ' 69' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.609 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.62 ' O ' ' CA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.671 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.694 ' CD1' ' OE1' ' A' ' 87' ' ' GLN . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.696 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 5.3 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' A' ' 88' ' ' ILE . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.696 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.611 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.692 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.583 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.672 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.671 ' HB ' ' CB ' ' A' ' 80' ' ' SER . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.724 ' CD2' HG12 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.62 ' CA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.614 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.685 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.682 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 15.8 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.681 ' HG2' ' CG2' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.697 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.632 ' OD2' ' CG2' ' A' ' 130' ' ' VAL . 24.3 m-20 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.697 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.681 ' CG2' ' HG2' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.743 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.585 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.693 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.726 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.662 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 8.2 m170 -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.73 HG22 ' CG ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.75 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.67 ' CD ' HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.686 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.686 ' CA ' ' HB3' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.731 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.657 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.627 ' C ' ' CD2' ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.701 ' CB ' ' HA ' ' A' ' 257' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.635 ' O ' ' N ' ' A' ' 167' ' ' ASP . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.682 ' CB ' ' OE1' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.654 ' O ' ' N ' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.593 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.68 ' CD2' ' HB2' ' A' ' 162' ' ' ALA . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.746 ' CD1' ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.696 ' HB3' ' CB ' ' A' ' 182' ' ' GLN . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.731 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' CA ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.742 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.746 ' CA ' ' CD1' ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.685 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.68 HG22 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 195' ' ' LEU . 2.9 m-80 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.68 ' CG2' HG22 ' A' ' 187' ' ' ILE . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 228' ' ' TYR . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.649 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.725 HG22 ' CD2' ' A' ' 228' ' ' TYR . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.75 ' OH ' ' CD2' ' A' ' 147' ' ' PHE . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 205' ' ' LYS . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.676 ' HA ' ' CG1' ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.728 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.796 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 6.0 p80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.796 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 60.0 m170 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 201' ' ' VAL . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.67 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.545 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.665 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.665 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.594 ' OE1' HG12 ' A' ' 197' ' ' VAL . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.582 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.683 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.606 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 257' ' ' LEU . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.726 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.558 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.679 ' O ' ' CD1' ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.576 ' N ' ' CD2' ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.647 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.693 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.6 HG23 ' CG1' ' A' ' 255' ' ' ILE . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.738 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.693 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.673 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.701 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.538 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.657 ' HA ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.694 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.659 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.684 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.664 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 27' ' ' THR . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.584 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.581 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' C ' HD21 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.688 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.632 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.665 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.702 ' CD2' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CB ' ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.664 ' N ' ' HB2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.566 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.725 HD23 ' CD1' ' A' ' 63' ' ' TYR . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.65 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.636 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.63 ' O ' ' CG2' ' A' ' 20' ' ' THR . 54.3 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.684 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.65 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HB2' ' N ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.73 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.671 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.785 ' CG2' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.673 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.65 ' HD2' ' NE2' ' A' ' 103' ' ' GLN . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.676 HG23 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.641 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.68 ' OE1' ' CA ' ' A' ' 97' ' ' LEU . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.63 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' ILE . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.591 ' OG1' ' OD1' ' A' ' 122' ' ' ASP . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.641 ' HB3' ' NE ' ' A' ' 86' ' ' ARG . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.59 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.65 ' NE2' ' HD2' ' A' ' 81' ' ' ARG . 1.6 mm-40 -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.705 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.785 ' CE1' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.671 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.656 ' NE2' ' HB3' ' A' ' 110' ' ' SER . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.594 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.67 ' CB ' ' HE2' ' A' ' 106' ' ' LYS . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.681 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.667 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 36.9 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.6 ' CG2' ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.605 ' O ' ' CG ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 6.2 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.591 ' OD1' ' OG1' ' A' ' 96' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.847 0.832 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.549 ' CG2' ' C ' ' A' ' 129' ' ' MET . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.694 ' O ' ' CZ ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.614 ' O ' HG22 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.681 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.718 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.793 ' CB ' ' CD2' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.793 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 7.1 p80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' OH ' ' A' ' 203' ' ' TYR . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.604 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.7 ' O ' ' CG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.584 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.646 ' N ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.597 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.676 ' C ' ' CD2' ' A' ' 172' ' ' LEU . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.693 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.695 ' CB ' ' HB3' ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.673 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.763 ' HA3' ' CG ' ' A' ' 189' ' ' HIS . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.717 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.693 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.726 ' CD1' HD12 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 174' ' ' TYR . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.684 ' CB ' ' HB3' ' A' ' 182' ' ' GLN . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.742 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.618 ' C ' ' O ' ' A' ' 180' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 201' ' ' VAL . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 2.8 t-160 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.64 ' CD1' ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.678 ' HB3' ' CB ' ' A' ' 196' ' ' ASN . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.763 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.705 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.705 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.678 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.687 ' CG1' ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.826 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.648 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.805 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.688 ' HA ' ' CG1' ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.569 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.733 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 147' ' ' PHE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.688 ' CG1' ' HA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.695 ' CG2' HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.572 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 201' ' ' VAL . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 228' ' ' TYR . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.687 ' O ' ' CG1' ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.826 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.674 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.686 HD23 ' CD1' ' A' ' 257' ' ' LEU . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.724 ' CG1' ' CG2' ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 261' ' ' GLN . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.684 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.724 ' CG2' ' CG1' ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.783 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.736 ' CG1' ' CD2' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 250' ' ' ASN . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 248' ' ' THR . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.736 ' CD2' ' CG1' ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.783 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.726 HD23 ' CZ ' ' A' ' 228' ' ' TYR . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 13.9 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.599 ' O ' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.749 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.682 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.698 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.571 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.579 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.579 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' SER . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.601 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.599 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.632 ' CG2' ' HA3' ' A' ' 50' ' ' GLY . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.667 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.654 ' CA ' HG13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.632 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.723 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.648 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.682 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.488 HE22 ' NH1' ' A' ' 81' ' ' ARG . 30.5 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.698 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.648 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.645 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.667 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.6 t-20 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.593 ' O ' HD11 ' A' ' 42' ' ' LEU . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.618 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.676 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.68 ' CG2' HD23 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.68 HD23 ' CG2' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.592 ' O ' ' C ' ' A' ' 107' ' ' GLN . 7.9 m-80 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.672 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.683 ' CD1' HD21 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.43 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.697 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.701 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.696 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.696 ' CD1' ' O ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.59 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.805 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.725 ' HG3' ' CE1' ' A' ' 163' ' ' PHE . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.685 ' CB ' HD11 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.608 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.788 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.654 ' N ' HG22 ' A' ' 117' ' ' THR . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HG3' ' HA ' ' A' ' 129' ' ' MET . 1.5 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.58 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.219 0.533 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.686 ' O ' ' CD1' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.568 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.714 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 144' ' ' HIS . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.547 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.763 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CG ' ' CB ' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.589 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.61 ' C ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.687 HD21 ' CG ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.687 ' CG ' HD21 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.703 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 180' ' ' ALA . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.655 ' N ' HG12 ' A' ' 154' ' ' VAL . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE1' ' O ' ' A' ' 238' ' ' GLN . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.602 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.551 ' CA ' HD23 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.568 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.725 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.41 ' HB2' ' HE2' ' A' ' 135' ' ' PHE . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.695 ' CB ' ' OH ' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.823 ' CE1' ' CD2' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.821 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.645 ' O ' ' O ' ' A' ' 178' ' ' PHE . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.703 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.753 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.65 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.69 ' CD1' ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.609 ' NE2' HG21 ' A' ' 246' ' ' VAL . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.378 0.609 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.715 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.732 HG12 ' CD1' ' A' ' 220' ' ' TYR . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.823 ' CD2' ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.65 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.639 HG11 ' CG2' ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 215' ' ' SER . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.821 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.676 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.762 ' CB ' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.639 ' CG2' HG11 ' A' ' 201' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.564 ' O ' ' HB1' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' A' ' 197' ' ' VAL . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.732 ' CD1' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.74 ' CE2' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 257' ' ' LEU . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 213' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.723 HD11 ' CZ ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.7 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 237' ' ' ALA . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.763 ' N ' ' CG2' ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.689 HG11 ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 240' ' ' VAL . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.653 ' N ' HD21 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.634 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.609 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.718 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.59 ' O ' ' OD1' ' A' ' 250' ' ' ASN . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.542 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.718 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.9 OUTLIER -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.634 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.691 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 39.2 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.694 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.688 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.691 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.69 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.668 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.628 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.611 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.499 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.428 ' NE2' HD13 ' A' ' 22' ' ' LEU . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.5 t-20 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.687 ' O ' ' CZ ' ' A' ' 63' ' ' TYR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.447 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 5.0 m120 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.67 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.67 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.634 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.679 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HD2' ' HA ' ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.651 ' N ' ' HD3' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.708 ' CG2' ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.589 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.708 ' NE2' ' CG2' ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.699 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.613 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HD12 ' A' ' 88' ' ' ILE . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.696 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.612 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.679 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.587 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.67 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' NE2' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.693 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.769 ' CD1' ' CB ' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.577 HD12 ' NE ' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.689 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.603 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 5.0 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.599 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 3.7 ttp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' A' ' 135' ' ' PHE . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.577 ' NE ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.701 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.729 ' HB3' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.727 ' CE1' ' HB2' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.711 HG23 ' CD2' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 148' ' ' ASP . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 147' ' ' PHE . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.675 ' CB ' ' HB3' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.732 ' HB1' ' CZ ' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CZ ' ' HB3' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.699 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.713 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.657 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.4 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.601 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.742 ' OD2' ' CD2' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.657 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.713 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.692 ' CD1' ' O ' ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.741 ' CD2' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 214' ' ' ILE . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.732 ' CZ ' ' HB1' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.629 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB3' ' CB ' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.678 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.741 ' O ' ' CD2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.74 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.742 ' CD2' ' OD2' ' A' ' 167' ' ' ASP . 10.8 m-70 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.747 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.747 ' CD2' ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.692 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.694 HG11 ' CA ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.737 HD21 ' CD1' ' A' ' 228' ' ' TYR . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.711 HG22 ' CD2' ' A' ' 228' ' ' TYR . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 206' ' ' PRO . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 211' ' ' HIS . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.711 ' CD2' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.736 ' HB3' ' CE1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 214' ' ' ILE . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.697 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.67 ' N ' HG21 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.691 ' CG2' ' O ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.584 ' C ' HG11 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.691 ' O ' ' CG2' ' A' ' 218' ' ' VAL . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.738 ' CE2' ' OH ' ' A' ' 174' ' ' TYR . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.539 ' C ' HD11 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.678 ' CG2' ' CD1' ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.729 ' CE2' ' HB3' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.727 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.563 ' HB1' ' NE2' ' A' ' 261' ' ' GLN . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.675 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.585 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.492 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.633 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 253' ' ' HIS . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.456 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.724 HG22 ' CE1' ' A' ' 253' ' ' HIS . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.599 ' O ' ' ND2' ' A' ' 250' ' ' ASN . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 3.5 m-80 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.676 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.456 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.724 ' CE1' HG22 ' A' ' 248' ' ' THR . 1.9 m170 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.601 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.633 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . 0.769 ' CB ' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.699 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.563 ' NE2' ' HB1' ' A' ' 237' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.258 0.552 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -47.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -94.35 -33.86 13.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -1.174 . . . . 0.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.3 m -101.34 119.38 38.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.55 130.81 3.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.38 70.24 0.24 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.2 103.06 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.44 -106.97 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.1 p -90.44 54.48 2.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -1.153 . . . . 0.0 110.177 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.02 24.87 11.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.31 -23.95 68.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.79 -114.58 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.32 -106.69 0.54 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' A' ' 18' ' ' ILE . 2.3 m -58.91 136.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.259 -1.142 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.517 ' H ' ' CG1' ' A' ' 18' ' ' ILE . 14.5 t -116.23 -160.98 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.4 6.74 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 15' ' ' THR . 1.5 t70 -162.29 47.43 0.17 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.091 -1.006 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.687 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -106.29 -78.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.149 -0.969 . . . . 0.0 109.914 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.687 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -97.1 69.08 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.691 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.7 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.679 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.609 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.592 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.582 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.677 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.696 ' CD2' ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.696 ' OG ' ' CD2' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.698 ' CG2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.548 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.649 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.698 ' ND2' ' CG2' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.566 ' C ' ' O ' ' A' ' 49' ' ' ASN . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.804 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.665 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.691 ' O ' ' CG2' ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.653 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.665 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CE1' ' CD ' ' A' ' 61' ' ' LYS . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.674 ' N ' ' OD1' ' A' ' 67' ' ' ASP . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.677 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 3.1 t-20 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD12 ' CZ ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.679 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 13.6 m120 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.764 ' CG2' ' CD1' ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.764 ' CD1' ' CG2' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.807 ' CG1' ' CE2' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.839 ' CE1' ' CD2' ' A' ' 102' ' ' PHE . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.62 ' O ' ' OG1' ' A' ' 51' ' ' THR . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.749 ' CD1' ' N ' ' A' ' 88' ' ' ILE . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.61 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.661 ' CB ' HG23 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.608 ' N ' ' CG2' ' A' ' 96' ' ' THR . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 80' ' ' SER . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.807 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.689 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HA ' ' O ' ' A' ' 139' ' ' ASP . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.683 ' O ' ' N ' ' A' ' 138' ' ' GLY . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.538 ' N ' HG21 ' A' ' 113' ' ' THR . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.607 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.662 HG21 ' N ' ' A' ' 118' ' ' GLU . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.662 ' N ' HG21 ' A' ' 117' ' ' THR . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.698 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 21.5 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.737 ' O ' ' N ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -126.16 103.6 26.36 Favored Pre-proline 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 48.4 Cg_endo -74.73 48.83 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.265 1.666 . . . . 0.0 111.707 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.752 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 8.3 mm-40 -90.99 -28.57 17.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.381 1.086 . . . . 0.0 108.435 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.752 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -75.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.82 17.43 10.21 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.706 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -103.02 5.46 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 111.113 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.737 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.62 36.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.209 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.706 ' N ' ' O ' ' A' ' 127' ' ' GLU . 1.6 ptm -157.58 141.89 16.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.155 -0.966 . . . . 0.0 110.083 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.725 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.668 ' C ' ' CD1' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.664 HD12 ' NE2' ' A' ' 144' ' ' HIS . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB2' ' CG ' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.689 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.591 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.599 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.765 ' CD2' ' CG ' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.736 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.683 HG11 ' CB ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.812 ' CB ' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.818 ' CE2' ' CG2' ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.607 ' HB2' ' OG1' ' A' ' 173' ' ' THR . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 258' ' ' ALA . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.739 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.736 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.584 ' CG ' HD12 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.801 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.725 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.731 ' CE1' HD22 ' A' ' 199' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.678 HG21 ' CD1' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CZ ' ' O ' ' A' ' 152' ' ' LYS . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.673 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.605 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.641 ' CG2' HG22 ' A' ' 218' ' ' VAL . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.763 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.801 ' CD2' ' N ' ' A' ' 170' ' ' GLY . 2.2 t60 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER -95.82 -160.28 0.78 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.676 ' CA ' HD23 ' A' ' 195' ' ' LEU . 8.5 mmmt -125.89 7.56 7.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.416 -0.802 . . . . 0.0 110.147 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.728 ' CB ' ' HD2' ' A' ' 193' ' ' PRO . 0.1 OUTLIER -48.31 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.728 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.6 Cg_endo -67.65 -0.64 5.49 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.345 1.182 . . . . 0.0 109.705 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 195' ' ' LEU . 8.6 pt-20 -135.76 41.5 2.7 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.676 HD23 ' CA ' ' A' ' 191' ' ' LYS . 1.4 mp -37.11 -68.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.763 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.2 m120 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 220' ' ' TYR . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.616 ' N ' HG12 ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.736 HD11 ' CG ' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.624 ' O ' HD13 ' A' ' 199' ' ' LEU . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.677 ' CG1' HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.682 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.737 ' HB3' ' CZ ' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.691 ' CG1' ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.675 HG23 ' CG1' ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.602 ' O ' HG11 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD1' HG22 ' A' ' 197' ' ' VAL . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.707 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.589 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.587 ' CA ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.736 ' CG ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.736 ' CD1' ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.614 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.818 ' CG2' ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.728 ' CG ' ' HB2' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.791 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.765 ' CG ' ' CD2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.683 ' CB ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.613 ' O ' ' OE1' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.791 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.704 ' HB2' ' CE2' ' A' ' 233' ' ' PHE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.683 ' CG2' HG12 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.459 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.678 ' N ' ' CD2' ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.594 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.772 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.57 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 250' ' ' ASN . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 2.7 m-80 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.466 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.636 ' CD2' ' N ' ' A' ' 253' ' ' HIS . 1.3 m170 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.736 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.772 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.736 ' CD1' ' CD1' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.63 ' HA ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CG ' ' A' ' 158' ' ' TYR . 27.7 mm-40 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.97 97.8 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -101.2 118.7 37.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -1.177 . . . . 0.0 110.113 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 p -154.87 166.59 33.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.04 111.46 3.29 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.26 -133.41 2.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.42 83.56 1.5 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.66 164.13 32.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -157.26 153.32 27.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -1.096 . . . . 0.0 110.229 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.95 -72.36 1.21 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.29 90.26 0.44 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.35 -136.3 0.21 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.08 -56.36 1.07 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.683 ' CG1' HD12 ' A' ' 18' ' ' ILE . 2.8 t -58.84 -164.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -1.214 . . . . 0.0 110.257 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.502 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 2.9 t -79.83 168.04 19.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.249 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' CG ' ' A' ' 17' ' ' ASP . . . -64.31 -1.1 1.49 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 8.5 m-20 -162.29 67.51 0.24 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.244 -0.91 . . . . 0.0 110.227 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.683 HD12 ' CG1' ' A' ' 14' ' ' VAL . 1.1 mt -39.5 -29.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.694 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . -71.85 -80.59 0.36 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.682 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.673 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.665 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.665 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.561 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.679 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.61 ' O ' ' O ' ' A' ' 42' ' ' LEU . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.657 ' HA ' ' ND2' ' A' ' 65' ' ' ASN . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.68 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.609 ' N ' HG21 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.682 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' N ' ' HB3' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.666 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.691 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.687 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.701 ' CG ' HD22 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.482 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 6.2 t-20 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.679 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.683 ' CG2' HD12 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.683 HD12 ' CG2' ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' CG ' ' H ' ' A' ' 76' ' ' ASN . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HE3' HG23 ' A' ' 18' ' ' ILE . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.696 ' CB ' ' O ' ' A' ' 53' ' ' THR . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.7 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.68 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.611 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 92' ' ' GLY . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.693 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.671 ' HB ' ' CD1' ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.693 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.654 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 80' ' ' SER . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.621 ' NE2' ' HB2' ' A' ' 108' ' ' SER . 0.3 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.658 ' CB ' ' HB1' ' A' ' 237' ' ' ALA . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.676 ' CD2' ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.654 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.66 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.684 ' CG ' ' HB1' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.658 HG21 ' N ' ' A' ' 118' ' ' GLU . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.658 ' N ' HG21 ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.688 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -117.16 175.28 2.05 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.683 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.0 Cg_endo -96.42 -73.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.95 2.434 . . . . 0.0 110.73 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.683 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -11.2 -59.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.869 1.319 . . . . 0.0 109.281 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.839 ' O ' ' N ' ' A' ' 127' ' ' GLU . 63.8 m80 -130.14 80.19 1.94 Allowed 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 2.0 p -21.27 -31.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.247 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -80.77 7.14 11.01 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 110.485 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 20.2 mttt -71.9 -157.49 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.644 -1.285 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -156.06 145.35 20.72 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.688 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.55 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.744 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.66 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.571 ' CG2' ' OD1' ' A' ' 139' ' ' ASP . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.519 ' CD ' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.728 ' CG ' ' HB2' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.724 ' HB ' ' CG ' ' A' ' 211' ' ' HIS . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.626 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.738 ' CD2' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.46 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.623 ' N ' ' HD3' ' A' ' 151' ' ' PRO . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.735 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.741 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.6 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.696 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.55 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.684 ' HB1' ' CG ' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.687 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.705 ' CD1' ' O ' ' A' ' 172' ' ' LEU . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.729 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.685 ' CG2' ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.75 HG23 ' CE2' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.713 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.566 ' CB ' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.713 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.713 ' O ' ' CG2' ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.735 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.652 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.814 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 3.9 t-160 -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.507 ' CG ' ' H ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -49.67 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.756 ' O ' ' O ' ' A' ' 192' ' ' SER . 14.3 mttt -71.73 15.28 0.15 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.892 -0.505 . . . . 0.0 111.735 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.814 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -45.02 -162.02 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.577 -0.702 . . . . 0.0 110.053 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.733 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 41.4 Cg_endo -69.16 12.39 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 122.516 0.745 . . . . 0.0 110.72 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CG ' ' O ' ' A' ' 193' ' ' PRO . 0.2 OUTLIER 179.84 -52.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.967 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.802 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.3 OUTLIER 176.04 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.346 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.802 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.627 HG12 ' CG1' ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 228' ' ' TYR . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.623 ' O ' HG21 ' A' ' 201' ' ' VAL . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.72 HG23 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.75 ' CE2' HG23 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.755 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.586 ' CG ' HG23 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.724 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.738 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.712 HG12 ' CE1' ' A' ' 203' ' ' TYR . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.606 ' O ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 219' ' ' LEU . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.711 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 225' ' ' LYS . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.681 ' HG3' ' CG ' ' A' ' 193' ' ' PRO . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.662 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.6 ' O ' HD13 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 245' ' ' GLU . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.734 ' CD1' HD23 ' A' ' 199' ' ' LEU . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.681 ' CD2' HD13 ' A' ' 257' ' ' LEU . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.647 ' O ' ' CG2' ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.74 HG22 ' CE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.689 ' CB ' ' HA ' ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.596 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.728 ' HB2' ' CG ' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.739 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.67 HG23 ' CA ' ' A' ' 232' ' ' ILE . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.498 ' N ' HG21 ' A' ' 240' ' ' VAL . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.667 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.704 ' O ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.73 HG13 ' CD2' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 193' ' ' PRO . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.73 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.704 ' CD1' ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.441 ' H ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.696 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.688 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.168 0.509 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.81 85.83 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.6 p -101.93 -169.42 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.215 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -102.35 -33.07 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.7 178.96 38.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.71 171.09 55.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.84 -132.23 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 -130.55 6.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -151.87 167.08 29.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.79 -175.93 31.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.25 -100.64 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.65 -148.17 5.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.96 59.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.682 ' CG1' HD11 ' A' ' 18' ' ' ILE . 2.8 t -58.86 -162.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.167 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.505 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 8.8 t -70.66 168.6 16.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' O ' ' OD1' ' A' ' 17' ' ' ASP . . . -64.22 -1.16 1.47 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.613 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 4.9 m-20 -162.39 67.12 0.23 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.307 -0.87 . . . . 0.0 110.252 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.682 HD11 ' CG1' ' A' ' 14' ' ' VAL . 1.1 mt -39.27 -29.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.589 ' O ' HD22 ' A' ' 22' ' ' LEU . . . -68.4 -78.59 0.3 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.6 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.611 ' CB ' HG23 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.774 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.697 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' CE ' ' HA ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.687 ' O ' ' CD2' ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.586 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.694 ' CD1' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.49 ' N ' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.588 ' HA3' HG13 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.62 ' O ' ' CD1' ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.824 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.662 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.601 ' O ' HG23 ' A' ' 20' ' ' THR . 46.3 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.697 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.662 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.605 ' C ' ' CD1' ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.743 ' OD2' ' CE2' ' A' ' 63' ' ' TYR . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.586 ' OG ' ' HA ' ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.535 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.673 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.673 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.591 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.662 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.698 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.649 ' NE2' HG23 ' A' ' 85' ' ' ILE . 1.1 mt-30 -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG21 ' CD1' ' A' ' 95' ' ' ILE . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.726 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.732 ' CD1' HG21 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.736 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.698 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.646 ' CB ' HG22 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.659 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 1.9 tp60 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG23 HG22 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 75' ' ' LYS . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.667 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.463 ' HB3' HD13 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.681 ' CA ' HD12 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.681 HD23 ' CD1' ' A' ' 140' ' ' ILE . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.584 ' HB ' ' HA3' ' A' ' 138' ' ' GLY . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.659 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.601 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 96' ' ' THR . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.704 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.3 t0 -117.22 -179.28 0.62 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.68 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.7 Cg_endo -95.56 -1.31 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.985 1.79 . . . . 0.0 111.692 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.37 -104.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.756 -1.215 . . . . 0.0 110.925 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.602 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 8.0 p-80 -158.77 -33.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.558 0.694 . . . . 0.0 110.27 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 9.7 t -77.32 -36.9 53.52 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 109.357 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mm-40 -115.32 4.67 14.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.477 -0.764 . . . . 0.0 109.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.69 -7.15 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.037 0.922 . . . . 0.0 110.63 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.671 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -157.26 133.19 9.46 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.544 178.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.683 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.681 ' CD1' HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.663 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 144' ' ' HIS . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.748 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.734 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.637 HG23 ' N ' ' A' ' 235' ' ' GLU . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CG ' ' HB1' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.705 ' O ' ' CG ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.95 ' O ' ' N ' ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.585 ' OD1' ' HB3' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.95 ' N ' ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.611 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CZ ' ' HB3' ' A' ' 238' ' ' GLN . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.551 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 HG23 ' CD ' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.755 ' CE2' ' CD1' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.442 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.717 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.692 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.697 ' CA ' ' HB ' ' A' ' 187' ' ' ILE . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.694 ' CE1' HD11 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.7 ' CB ' ' HA3' ' A' ' 183' ' ' GLY . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.585 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.762 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.656 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.597 ' HA3' HD22 ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.703 ' CD1' ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.581 ' O ' ' C ' ' A' ' 189' ' ' HIS . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.715 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.686 ' CD2' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.5 -110.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HG2' ' NZ ' ' A' ' 171' ' ' LYS . 8.5 mttt -145.41 -31.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.363 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.678 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 1.5 t -64.38 134.54 96.02 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.664 -0.648 . . . . 0.0 110.08 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.39 46.16 0.72 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.071 1.564 . . . . 0.0 110.102 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.644 ' CB ' HD13 ' A' ' 195' ' ' LEU . 5.4 mt-10 -145.29 -34.2 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 110.355 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.724 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 2.9 mp -104.4 25.51 10.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.056 -1.027 . . . . 0.0 110.287 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 192' ' ' SER . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.683 HG23 ' CG1' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 219' ' ' LEU . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.822 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.716 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.696 ' CG2' HG21 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.599 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.689 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 211' ' ' HIS . 28.8 p-80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.742 ' HB1' ' CG ' ' A' ' 147' ' ' PHE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.689 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.696 HG21 ' CG2' ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.668 ' N ' HG21 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.586 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.612 ' O ' HD11 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.682 HG22 ' CB ' ' A' ' 199' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.617 ' CD1' ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 2.2 t30 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.602 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 245' ' ' GLU . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.822 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.677 ' CD2' HD13 ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.723 HG12 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.736 ' CG ' ' HB3' ' A' ' 143' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.637 ' N ' HG23 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.73 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.681 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.505 ' HB3' ' OD2' ' A' ' 139' ' ' ASP . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.572 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.685 ' O ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.827 ' CG1' ' CD2' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 250' ' ' ASN . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.606 ' OD1' ' O ' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.827 ' CD2' ' CG1' ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.838 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.685 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.698 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.662 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.6 mm-40 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.207 0.527 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.14 -145.1 4.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -100.58 170.64 8.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.115 . . . . 0.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 p -100.54 109.6 21.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.242 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.57 126.23 1.8 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.5 -131.66 1.91 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.09 113.27 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.06 -52.52 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t -102.86 -37.25 7.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 110.284 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 85.69 0.13 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.8 -88.8 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.39 -129.75 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.65 -70.88 1.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 m -58.97 168.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.165 -1.197 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -87.5 -51.09 6.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 110.205 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 15' ' ' THR . . . 179.76 -115.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -92.8 39.45 1.04 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.69 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -106.35 -79.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.862 0.839 . . . . 0.0 110.116 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.693 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . -64.88 -72.85 0.65 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.662 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.693 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.675 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.667 ' HB2' ' CG2' ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.691 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 26' ' ' LEU . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.411 ' HB3' ' HG ' ' A' ' 39' ' ' SER . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' HA2' HD21 ' A' ' 40' ' ' LEU . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.652 ' CD1' ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.701 ' CE ' ' CD ' ' A' ' 78' ' ' LYS . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.699 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.645 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.68 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.611 ' O ' ' C ' ' A' ' 43' ' ' GLU . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.612 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.734 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.675 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.662 ' O ' ' CG2' ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.673 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.569 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.609 ' O ' ' O ' ' A' ' 66' ' ' GLY . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.68 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.699 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.676 ' CD2' ' HB ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 106' ' ' LYS . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.682 ' HB3' ' CD ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.701 ' CD ' ' CE ' ' A' ' 38' ' ' LYS . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.731 HG12 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.447 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.73 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.72 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.678 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.687 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.583 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.688 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.686 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.578 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 118' ' ' GLU . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.72 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CD2' HG12 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.685 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.679 ' CG ' ' OE2' ' A' ' 239' ' ' GLU . 1.9 mm100 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.401 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.698 ' CD2' ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.68 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 101' ' ' GLU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.585 ' C ' ' HG3' ' A' ' 118' ' ' GLU . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.622 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.68 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.26 170.44 6.36 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.656 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.5 Cg_endo -96.08 -73.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.869 2.379 . . . . 0.0 110.23 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 123' ' ' PRO . 10.2 mt-10 -13.42 -58.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.92 1.343 . . . . 0.0 109.501 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.846 ' O ' ' N ' ' A' ' 127' ' ' GLU . 59.6 m80 -130.3 79.72 1.92 Allowed 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.6 t -21.13 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.493 . . . . 0.0 110.963 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.846 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.3 mt-10 -73.96 1.02 11.74 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -81.99 146.18 29.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.461 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.637 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.3 133.18 47.34 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 110.556 -179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.519 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.757 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.68 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.66 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.524 ' HB1' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 144' ' ' HIS . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.661 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 5.0 m170 -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.756 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 149' ' ' LYS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.823 ' CD1' ' CB ' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.635 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.64 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.693 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.685 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.743 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.679 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 257' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.72 ' CD1' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.403 ' CG ' ' HD2' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.581 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.678 ' CD2' HD21 ' A' ' 257' ' ' LEU . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.789 ' CE2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.584 HG21 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.825 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CZ ' ' O ' ' A' ' 152' ' ' LYS . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.685 ' CB ' ' HB3' ' A' ' 151' ' ' PRO . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.774 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.713 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.809 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.809 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.728 ' CG2' ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.61 ' O ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.681 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -94.25 -110.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 8.1 mttt -163.68 -30.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.765 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.678 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 36.1 t -51.82 139.97 30.31 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.507 -0.745 . . . . 0.0 110.092 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.448 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.7 Cg_endo -71.7 50.58 1.39 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.022 1.538 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.508 ' CB ' HD12 ' A' ' 195' ' ' LEU . 2.9 mt-10 -152.64 -33.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.862 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.681 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 4.0 mp -98.01 13.92 29.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 110.311 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.68 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.4 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.73 ' HA ' ' CD1' ' A' ' 220' ' ' TYR . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.665 ' N ' HG11 ' A' ' 197' ' ' VAL . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.789 ' CD2' ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.681 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.757 ' CG1' ' N ' ' A' ' 215' ' ' SER . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.825 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.676 ' CG1' ' HB ' ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.653 ' CB ' HG21 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.56 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.756 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.823 ' CB ' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.676 ' HB ' ' CG1' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.677 ' CG2' HG12 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.757 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.681 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.61 ' O ' HD11 ' A' ' 199' ' ' LEU . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.728 ' CG1' ' CG2' ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.589 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.73 ' CD1' ' HA ' ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.58 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.686 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.586 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.585 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.497 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.602 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.688 ' HB2' ' CG2' ' A' ' 218' ' ' VAL . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.78 ' CD1' ' CA ' ' A' ' 242' ' ' GLY . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.743 ' CD1' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.804 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.743 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 234' ' ' GLY . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.743 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.698 ' OE2' ' CD2' ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.566 ' HB1' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.563 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.69 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.67 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.735 HG21 ' CE1' ' A' ' 253' ' ' HIS . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.604 ' O ' HG21 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.735 ' CE1' HG21 ' A' ' 248' ' ' THR . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.642 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.69 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.679 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.682 ' CD ' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.736 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.229 0.538 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.77 155.18 17.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -161.21 33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -129.81 145.61 51.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.81 -88.48 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.96 -126.53 0.86 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.87 108.73 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.74 -109.37 0.74 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -149.31 177.9 9.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.247 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.57 -155.39 31.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.15 -153.88 15.13 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.88 144.78 15.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.43 -100.57 0.14 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.679 ' CB ' HD12 ' A' ' 18' ' ' ILE . 2.0 m -58.91 155.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.271 -1.134 . . . . 0.0 110.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.5 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 14.9 t -96.71 174.05 7.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 0.0 110.155 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.07 6.22 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.94 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -133.21 44.17 2.85 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.14 -0.975 . . . . 0.0 110.601 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.716 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.67 -79.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.229 -0.919 . . . . 0.0 110.001 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.716 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -109.21 -56.95 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.691 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.692 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.59 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' HD22 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.689 ' OG1' ' CB ' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.66 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.676 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.734 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.679 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.674 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HB3' HG22 ' A' ' 20' ' ' THR . 49.2 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.679 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.678 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.734 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.681 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.689 ' CB ' ' OG1' ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 HD22 HG22 ' A' ' 71' ' ' THR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.604 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.676 HD22 ' CB ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.589 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' CB ' HD22 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.732 HG23 ' CE2' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.659 HG12 ' CG ' ' A' ' 87' ' ' GLN . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.675 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.676 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.606 ' HB2' ' HB ' ' A' ' 90' ' ' VAL . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.726 ' CD1' ' CG ' ' A' ' 89' ' ' GLU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.62 ' CB ' HD13 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.652 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.732 ' CE2' HG23 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.671 ' CD ' HD23 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.595 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.598 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.677 ' CG ' ' HB3' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.533 HG21 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.533 ' N ' HG21 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.566 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.708 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.731 ' O ' ' N ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -124.65 103.96 31.14 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.3 49.99 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.268 1.667 . . . . 0.0 111.556 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.747 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 5.7 mm-40 -94.62 -27.86 15.68 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.346 1.07 . . . . 0.0 108.626 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.747 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 t -122.68 17.34 10.33 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.2 OUTLIER -104.34 5.45 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 111.174 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.069 -1.019 . . . . 0.0 111.448 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.708 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER -157.89 139.23 13.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.385 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.561 HD11 ' O ' ' A' ' 113' ' ' THR . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.612 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.722 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.77 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.851 ' CD2' ' CE2' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.619 ' O ' ' CE ' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.732 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.75 ' HB2' ' CG ' ' A' ' 178' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.615 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.62 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.818 ' CG ' ' CD1' ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.605 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 162' ' ' ALA . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.722 ' CB ' ' HA ' ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.56 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.603 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.424 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.692 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.579 ' O ' HD13 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.589 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.698 ' CB ' ' HA3' ' A' ' 185' ' ' GLY . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.818 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 155' ' ' MET . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.75 ' CG ' ' HB2' ' A' ' 151' ' ' PRO . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.674 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.796 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.4 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.796 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.448 ' HG2' ' CG ' ' A' ' 196' ' ' ASN . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.745 ' NE2' ' CG2' ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.687 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -93.97 -112.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 190' ' ' LEU . 18.2 mtpt -151.72 -33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 110.498 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.671 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -61.68 132.71 93.26 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.667 -0.646 . . . . 0.0 110.073 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.82 45.11 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.002 1.527 . . . . 0.0 110.099 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.618 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -145.91 -30.85 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.687 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 4.7 mp -92.83 13.75 19.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.112 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.674 ' CG1' ' HB2' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.689 ' CD1' ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.689 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.756 ' O ' ' CE2' ' A' ' 203' ' ' TYR . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.686 ' OD1' ' CG1' ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.734 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.686 ' CG1' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.673 HG22 ' CG2' ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.584 HG23 HG21 ' A' ' 187' ' ' ILE . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.606 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.738 ' CD1' ' O ' ' A' ' 196' ' ' ASN . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.725 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.617 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.575 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.58 ' C ' ' CG1' ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 245' ' ' GLU . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.585 ' HA ' ' HB1' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.598 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.689 ' CD2' HD11 ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.591 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.736 HG12 ' CZ ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.539 ' C ' HG22 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.77 ' N ' ' CG2' ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.691 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.412 ' HB1' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.582 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.682 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.745 ' CG2' ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.602 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 249' ' ' ALA . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.417 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.599 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.602 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.735 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.56 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.2 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.682 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.722 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.7 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.614 ' O ' ' O ' ' A' ' 261' ' ' GLN . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.661 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 mtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.513 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.4 -97.41 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -155.67 101.66 2.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.0 p -101.41 34.12 2.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.04 -167.4 29.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.0 -107.39 1.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.15 -158.36 14.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.99 -77.76 0.88 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.0 m -100.78 111.04 23.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -1.168 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.29 75.04 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.95 175.0 28.39 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.23 -12.86 20.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.53 136.81 21.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 14' ' ' VAL . 2.5 m -58.83 138.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.278 -1.131 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 16' ' ' ALA . 1.4 t -48.46 -35.59 13.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.477 ' N ' HG22 ' A' ' 15' ' ' THR . . . 179.77 -24.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.605 ' HA ' ' OE1' ' A' ' 57' ' ' GLN . 4.3 p-10 -162.51 39.37 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 110.177 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.594 ' HB ' ' HB ' ' A' ' 14' ' ' VAL . 15.7 mm -69.7 -23.99 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.609 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -79.26 36.18 1.97 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.754 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.666 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 22' ' ' LEU . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.745 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.658 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.68 HD23 ' CB ' ' A' ' 38' ' ' LYS . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.664 ' HB3' ' CB ' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' CD1' ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.74 ' CD1' ' CG ' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.74 ' CG ' ' CD1' ' A' ' 37' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.675 ' CB ' HD22 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.629 ' CD1' ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.685 ' CD1' ' O ' ' A' ' 43' ' ' GLU . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.685 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.65 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.67 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.671 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.605 ' OE1' ' HA ' ' A' ' 17' ' ' ASP . 2.6 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.673 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.695 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' OH ' ' CD1' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.661 ' HB2' ' CD2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.433 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.636 ' CD1' ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.608 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.563 ' O ' ' C ' ' A' ' 72' ' ' GLY . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.584 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.54 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.668 HD11 ' CB ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.672 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 80' ' ' SER . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.623 HG12 ' CB ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 97' ' ' LEU . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.67 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.685 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.688 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.626 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.686 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.623 ' CB ' HG12 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.651 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.601 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.679 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.67 ' CD ' ' HB1' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.6 ' HG3' ' N ' ' A' ' 108' ' ' SER . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.6 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.432 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.7 ' O ' ' CD1' ' A' ' 140' ' ' ILE . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.679 ' HG ' ' CB ' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.665 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.559 HD22 ' CE1' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.58 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.651 ' NE2' ' SD ' ' A' ' 129' ' ' MET . 22.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.68 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -117.57 175.6 1.95 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.691 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.2 Cg_endo -96.69 -73.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.958 2.439 . . . . 0.0 110.925 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.724 ' CD ' ' CE1' ' A' ' 125' ' ' HIS . 22.2 tt0 -11.01 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.791 1.281 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.829 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.8 m80 -132.0 81.04 1.94 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.39 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.829 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.99 4.11 4.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 110.591 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' A' ' 125' ' ' HIS . 5.2 mmtt -73.57 179.92 3.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.518 -1.364 . . . . 0.0 109.528 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.695 ' CE ' ' O ' ' A' ' 128' ' ' LYS . 9.3 mmt -141.16 125.36 17.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CD1' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.624 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.666 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.7 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.432 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.766 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.743 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.688 HD21 ' CG ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.78 ' CB ' ' CD1' ' A' ' 178' ' ' PHE . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.622 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.68 ' HB2' ' CB ' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.513 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.723 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.661 ' N ' ' HB3' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.574 ' CG2' ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.665 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.675 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.737 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.621 ' CB ' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.692 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.676 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.728 ' CD2' ' CB ' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.734 ' CD1' ' HA3' ' A' ' 185' ' ' GLY . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.587 ' C ' HD11 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.827 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.68 ' CB ' ' HB2' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.609 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.69 ' CA ' HG13 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.613 ' O ' ' HB3' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.734 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.678 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.676 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 193' ' ' PRO . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.674 HD12 ' CB ' ' A' ' 191' ' ' LYS . 3.4 pp -94.02 -32.14 13.94 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.674 ' CB ' HD12 ' A' ' 190' ' ' LEU . 20.7 mttt -133.8 -7.98 2.77 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.392 0.615 . . . . 0.0 110.178 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 189' ' ' HIS . 0.6 OUTLIER 179.94 144.71 0.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.6 ' HA ' ' HB3' ' A' ' 189' ' ' HIS . 45.2 Cg_endo -72.17 80.27 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.042 1.549 . . . . 0.0 110.436 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.5 -42.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.477 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.621 ' HB2' ' CB ' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -110.42 22.6 15.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.969 . . . . 0.0 110.683 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.684 ' HB ' ' CG2' ' A' ' 187' ' ' ILE . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.678 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.758 ' CD2' ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.653 ' N ' HD11 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.676 ' CG1' ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.827 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.597 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.679 ' CG ' ' CG1' ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.723 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.737 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.679 ' CG1' ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.655 HD11 ' CG2' ' A' ' 232' ' ' ILE . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.676 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.666 ' N ' HG12 ' A' ' 201' ' ' VAL . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.734 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.748 ' CE1' ' O ' ' A' ' 196' ' ' ASN . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.667 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.584 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.758 ' CE1' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.627 HD23 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.735 HD11 ' CE2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 237' ' ' ALA . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.766 ' N ' ' CG2' ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.664 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.569 HG21 ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.58 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.587 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.777 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.674 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.499 ' N ' ' CG2' ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.614 ' CG ' ' O ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.469 ' C ' ' CD1' ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 252' ' ' ILE . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.737 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.2 m170 -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.777 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.725 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.649 ' CD2' ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.609 ' O ' HD22 ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.728 ' CB ' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.676 ' HA ' ' CG ' ' A' ' 239' ' ' GLU . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.664 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.25 -82.69 0.33 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.4 p -147.25 88.08 1.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.4 m -162.07 116.33 1.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.98 121.14 1.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.16 24.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.58 101.45 2.36 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.7 -102.09 0.18 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -151.43 101.17 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -1.138 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.51 -126.98 0.86 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 134.87 12.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.45 64.03 3.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 128.13 2.97 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.93 173.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 110.242 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.696 ' HB ' ' CG1' ' A' ' 18' ' ' ILE . 53.6 m -84.7 161.49 20.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.893 . . . . 0.0 110.171 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . -71.29 2.1 5.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' OD2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -162.43 44.71 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.007 -1.058 . . . . 0.0 110.704 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.722 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -107.81 -77.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.926 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.722 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -63.19 62.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.676 ' CG2' ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.588 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.697 ' CA ' ' O ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.689 ' CD1' ' O ' ' A' ' 22' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.615 ' OG1' ' O ' ' A' ' 60' ' ' GLU . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.697 ' O ' ' CA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HB3' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 6.2 t60 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' HA2' ' HZ2' ' A' ' 38' ' ' LYS . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HZ2' ' HA2' ' A' ' 36' ' ' GLY . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.678 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.681 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 42' ' ' LEU . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' GLU . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.584 HD13 ' OD1' ' A' ' 67' ' ' ASP . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.674 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.639 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.729 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' HG22 ' A' ' 20' ' ' THR . 33.1 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.676 ' HA3' ' CG2' ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.675 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.729 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 3.5 t-20 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.681 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.678 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.5 OUTLIER -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.514 HD22 ' HB ' ' A' ' 71' ' ' THR . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.619 ' O ' ' O ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.742 ' N ' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.728 ' CD1' HD12 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.591 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' C ' ' HG3' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.674 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 5.0 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.699 ' O ' ' CG ' ' A' ' 121' ' ' GLN . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.604 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.591 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.569 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CE2' ' CD2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.666 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.742 ' CE1' ' N ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.68 ' NE2' ' OE1' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.68 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 140' ' ' ILE . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.65 ' CD2' ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.666 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.82 ' CD2' ' CE2' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.731 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.664 HG21 ' N ' ' A' ' 118' ' ' GLU . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' HG21 ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.704 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.722 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.7 OUTLIER -125.32 103.96 28.99 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.41 50.13 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.25 1.658 . . . . 0.0 111.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.751 ' C ' ' CG ' ' A' ' 125' ' ' HIS . 6.7 mt-10 -95.14 -27.66 15.45 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.356 1.074 . . . . 0.0 108.656 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.751 ' CG ' ' C ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -76.89 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.73 17.36 10.29 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.698 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.8 OUTLIER -104.38 5.4 34.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.1 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.722 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.76 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.109 -0.994 . . . . 0.0 111.468 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.704 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 2.9 tpp -157.02 138.92 14.33 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.975 . . . . 0.0 110.161 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.727 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.731 ' CE2' ' HG3' ' A' ' 116' ' ' GLN . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.553 ' CG1' ' OD2' ' A' ' 139' ' ' ASP . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.618 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.744 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.627 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 39.7 m-70 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.699 ' OG1' ' CE ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.864 ' CE2' ' CE1' ' A' ' 203' ' ' TYR . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.541 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.704 ' NZ ' ' CG ' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.682 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.691 ' CA ' ' HB1' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.589 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.619 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 203' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.706 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 170' ' ' GLY . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CD2' ' HA3' ' A' ' 256' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.531 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.715 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.817 ' CD1' ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.817 ' CE1' ' CD1' ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.763 ' CD1' ' CG1' ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.641 ' N ' HG22 ' A' ' 176' ' ' ILE . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.691 ' HB1' ' CA ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.676 ' HD2' ' CB ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.739 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.3 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.739 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.715 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.683 ' CD1' ' O ' ' A' ' 192' ' ' SER . 0.2 OUTLIER -39.8 175.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -4.84 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.568 -0.708 . . . . 0.0 111.976 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.686 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 7.0 t -145.74 124.54 6.6 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.87 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.608 ' C ' ' OD1' ' A' ' 196' ' ' ASN . 48.2 Cg_endo -75.38 13.27 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.21 1.637 . . . . 0.0 110.013 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.615 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 3.2 tt0 -105.01 -27.83 11.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.686 ' CD1' ' OG ' ' A' ' 192' ' ' SER . 5.7 mp -84.81 8.26 17.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.648 ' ND2' HD13 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.728 HG23 ' CD1' ' A' ' 220' ' ' TYR . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.572 ' N ' HG13 ' A' ' 197' ' ' VAL . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.804 ' N ' ' CD1' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.763 ' CG1' ' CD1' ' A' ' 176' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.676 ' CB ' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.864 ' CE1' ' CE2' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.676 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.67 ' HB3' ' CD2' ' A' ' 211' ' ' HIS . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.595 ' HB2' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.717 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.812 ' CB ' ' CE1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.676 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.618 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.684 HG13 ' CG1' ' A' ' 197' ' ' VAL . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.729 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.747 ' CE2' ' OH ' ' A' ' 174' ' ' TYR . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.76 ' CD1' ' CA ' ' A' ' 242' ' ' GLY . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.594 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.797 ' CD1' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.733 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.704 ' CG ' ' NZ ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.742 ' HB3' ' O ' ' A' ' 233' ' ' PHE . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.796 ' CG ' ' CE2' ' A' ' 233' ' ' PHE . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.68 HG23 ' CA ' ' A' ' 232' ' ' ILE . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.624 ' N ' HD11 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.774 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.502 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.67 ' HG3' ' CG2' ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.741 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 30.1 t-20 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.675 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.67 ' CG2' ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.3 m170 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.735 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.774 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CD2' ' A' ' 163' ' ' PHE . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.733 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.706 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.733 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 2.1 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.259 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.99 -130.86 1.5 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -154.04 131.39 11.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.4 m -153.7 121.58 6.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.62 -96.77 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.35 -103.65 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.71 160.85 30.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.3 -145.57 4.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -153.22 -171.32 3.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.19 61.26 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.52 67.43 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.5 -165.9 3.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.93 143.25 17.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.685 ' CA ' HD12 ' A' ' 18' ' ' ILE . 2.1 m -58.97 155.04 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.261 -1.14 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.508 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 14.8 t -95.01 173.83 7.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 6.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 0.0 110.674 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' THR . 1.0 OUTLIER -133.51 43.92 2.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.089 -1.007 . . . . 0.0 110.637 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.719 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.66 -78.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.719 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -118.4 -44.35 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.684 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.676 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.642 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.604 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.68 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 50' ' ' GLY . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.628 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.589 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 63' ' ' TYR . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.675 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.664 ' OE1' ' NH1' ' A' ' 81' ' ' ARG . 33.2 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.676 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.728 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.628 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 5.9 t-20 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.696 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.614 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.682 ' CD2' ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.68 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.639 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.685 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.731 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.664 ' NH1' ' OE1' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD1' ' O ' ' A' ' 84' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.695 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.675 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.6 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.693 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.694 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.686 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.687 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.695 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.68 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.674 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.636 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.564 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HD2' HD21 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 140' ' ' ILE . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.658 ' CG ' ' HB3' ' A' ' 105' ' ' TYR . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.636 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.679 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.581 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.674 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 117' ' ' THR . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.4 t0 -117.55 179.14 0.86 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.1 Cg_endo -95.08 12.04 1.5 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.823 1.682 . . . . 0.0 111.49 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -111.39 -105.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.784 -1.198 . . . . 0.0 110.911 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.717 ' ND1' ' N ' ' A' ' 126' ' ' SER . 4.7 p80 -156.62 -31.8 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.562 -0.711 . . . . 0.0 110.416 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.717 ' N ' ' ND1' ' A' ' 125' ' ' HIS . 22.3 t -81.62 -34.14 31.04 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.442 -0.786 . . . . 0.0 109.247 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.688 ' O ' ' N ' ' A' ' 122' ' ' ASP . 6.6 mt-10 -116.02 0.45 13.02 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.516 0.674 . . . . 0.0 109.311 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.708 ' CE ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -57.04 -4.34 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.685 ' N ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -157.42 127.49 6.26 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.952 178.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.57 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.679 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.69 ' O ' ' CD1' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.65 ' CD1' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.651 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.737 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 6.7 m-70 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.742 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.604 ' C ' ' O ' ' A' ' 147' ' ' PHE . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD22 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.721 ' CD ' ' O ' ' A' ' 147' ' ' PHE . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.744 ' N ' ' CD ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.598 ' O ' ' CE ' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.737 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.725 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.68 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 257' ' ' LEU . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.734 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.409 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.718 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.692 ' CA ' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.685 ' CD2' ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.735 ' CE2' ' CD1' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.824 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.757 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.737 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.694 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.757 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.599 ' O ' HG23 ' A' ' 176' ' ' ILE . 3.5 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.7 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 17.1 p-80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.698 ' CG2' ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.588 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -95.2 -99.82 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.537 ' HA ' ' CD ' ' A' ' 188' ' ' GLU . 5.8 mtmt -168.3 -28.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.668 ' CB ' HD13 ' A' ' 195' ' ' LEU . 1.3 m -42.04 136.25 2.21 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.457 -0.777 . . . . 0.0 110.084 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.529 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 45.1 Cg_endo -72.38 44.75 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.036 1.545 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 193' ' ' PRO . 8.7 mp0 -154.4 -30.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.668 HD13 ' CB ' ' A' ' 192' ' ' SER . 5.7 mp -86.48 2.05 49.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.75 ' CG1' ' N ' ' A' ' 219' ' ' LEU . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.741 ' CD2' ' CG2' ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 201' ' ' VAL . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.674 HG12 ' CG2' ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.824 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.69 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.683 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.732 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.69 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.674 ' CG2' HG12 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.741 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.75 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.745 ' CG ' ' O ' ' A' ' 196' ' ' ASN . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.7 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 218' ' ' VAL . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.736 ' CE2' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.656 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.741 HG22 ' CE1' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.694 ' CD1' ' OE1' ' A' ' 239' ' ' GLU . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.651 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.725 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.689 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.509 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.714 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.552 HG13 ' OE2' ' A' ' 224' ' ' GLU . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.744 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.514 ' H ' ' CG2' ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.652 ' C ' ' CD1' ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.652 ' CD1' ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.714 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.67 ' CD1' HD22 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.68 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.73 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.242 0.544 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.48 137.18 4.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.2 m -148.75 103.25 3.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -1.143 . . . . 0.0 110.227 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 p -156.02 -59.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.36 -178.64 44.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.76 143.19 19.74 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 138.64 21.14 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.43 -168.84 20.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 p -103.59 116.74 32.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.82 111.27 3.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.37 52.41 0.53 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.75 93.11 0.09 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.18 20.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.68 ' CG1' HG12 ' A' ' 18' ' ' ILE . 5.5 t -58.81 -176.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.409 HG21 HG13 ' A' ' 18' ' ' ILE . 8.0 t -59.06 162.87 3.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.28 -1.1 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 15' ' ' THR . 5.1 p-10 -162.34 72.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.213 -0.93 . . . . 0.0 110.253 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.68 HG12 ' CG1' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -59.88 -40.87 84.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . -50.08 -73.28 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.689 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.692 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.598 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.693 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.568 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.678 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.594 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.613 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.657 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.675 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.522 ' C ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.714 ' HG ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 60' ' ' GLU . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.689 ' O ' ' CG2' ' A' ' 20' ' ' THR . 31.2 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.595 ' O ' ' CG2' ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.743 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 42' ' ' LEU . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.678 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.684 HG23 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' LYS . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.683 ' CD1' ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' LYS . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.683 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.726 HG23 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.618 ' O ' ' OG1' ' A' ' 51' ' ' THR . 60.4 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.612 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.697 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.7 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.699 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.699 ' CD1' ' O ' ' A' ' 96' ' ' THR . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.69 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.675 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.66 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.493 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.682 ' CG2' HG22 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.726 ' CE2' HG23 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.684 ' CE ' HG23 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 238' ' ' GLN . 11.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.418 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.407 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.664 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 139' ' ' ASP . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.682 HG22 ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.685 ' HG ' ' CB ' ' A' ' 136' ' ' ARG . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.579 ' O ' ' CA ' ' A' ' 100' ' ' GLY . 5.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.616 HG21 ' N ' ' A' ' 118' ' ' GLU . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.616 ' N ' HG21 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.601 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 65.1 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' OE2' ' NZ ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.683 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.36 170.51 6.29 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.667 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.3 Cg_endo -96.19 -72.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.826 2.351 . . . . 0.0 110.276 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.667 ' C ' ' O ' ' A' ' 123' ' ' PRO . 2.5 mt-10 -13.93 -60.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.818 1.294 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.842 ' O ' ' N ' ' A' ' 127' ' ' GLU . 7.0 m80 -128.72 79.6 1.92 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.6 t -20.74 -33.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.117 0.484 . . . . 0.0 110.871 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.842 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -72.34 2.28 6.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.408 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.732 ' HE2' ' CG ' ' A' ' 125' ' ' HIS . 1.0 OUTLIER -84.25 146.2 27.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.583 -1.323 . . . . 0.0 109.494 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -127.92 137.05 52.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 110.594 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.669 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.592 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.669 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.584 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.614 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.732 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.733 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.727 ' HA2' ' CE1' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.67 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 6.0 m170 -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.604 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.741 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.69 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.741 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.683 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.672 ' CB ' ' CD ' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.759 ' CE1' ' CG1' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.715 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.577 ' HB3' HD23 ' A' ' 172' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.727 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.532 ' HB2' ' CD2' ' A' ' 254' ' ' HIS . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.447 ' HB2' ' CD ' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.456 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.748 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.593 ' C ' HG22 ' A' ' 176' ' ' ILE . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.825 ' CD1' ' CE2' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.727 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.674 ' CB ' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.727 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.684 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.741 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 6.0 t60 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.571 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.77 ' CG2' ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.754 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.716 ' CD2' ' C ' ' A' ' 169' ' ' GLY . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.574 ' CD2' ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER -95.97 -161.11 0.84 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.684 ' HA ' ' CD2' ' A' ' 195' ' ' LEU . 24.0 mmtt -122.6 8.09 9.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.569 -0.707 . . . . 0.0 110.011 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.721 ' CB ' ' HD2' ' A' ' 193' ' ' PRO . 0.1 OUTLIER -47.21 -167.93 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.452 -0.78 . . . . 0.0 110.191 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.721 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.0 Cg_endo -67.03 -1.07 5.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.321 1.169 . . . . 0.0 109.711 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.741 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.7 OUTLIER -137.1 41.31 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.684 ' CD2' ' HA ' ' A' ' 191' ' ' LYS . 1.2 mp -34.97 -69.65 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.754 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.5 m120 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.692 ' CG2' ' OE2' ' A' ' 224' ' ' GLU . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.741 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.676 ' CG1' ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.825 ' CE2' ' CD1' ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.7 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 208' ' ' GLU . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.655 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.871 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.871 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 31.0 m80 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.674 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.732 HG23 ' CZ ' ' A' ' 203' ' ' TYR . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.676 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.77 ' CG1' ' CG2' ' A' ' 187' ' ' ILE . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.671 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.563 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.692 ' OE2' ' CG2' ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.602 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.61 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.726 HD11 ' CE2' ' A' ' 228' ' ' TYR . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.471 ' C ' HD12 ' A' ' 214' ' ' ILE . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' A' ' 214' ' ' ILE . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.733 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.711 ' C ' ' O ' ' A' ' 233' ' ' PHE . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.713 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 107' ' ' GLN . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.759 ' CG1' ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.688 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.662 ' N ' HD21 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.659 ' N ' HD23 ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.725 ' HB2' ' CD1' ' A' ' 228' ' ' TYR . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.525 HG12 ' ND1' ' A' ' 253' ' ' HIS . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.602 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.625 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.447 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OE2' ' A' ' 194' ' ' GLU . 1.5 m170 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.687 ' N ' ' CD2' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.685 ' CD1' ' HB1' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.727 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 172' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.688 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.715 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.626 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.89 142.72 17.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 m -102.83 -173.35 2.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -1.127 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -155.23 138.88 16.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.56 81.83 1.67 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.34 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.89 -110.97 0.32 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.69 -167.41 17.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -104.51 -173.15 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.06 -165.7 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.86 101.74 1.96 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.48 -113.54 1.85 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.86 27.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' ' H ' ' A' ' 15' ' ' THR . 3.9 t -58.91 -176.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.682 ' HB ' ' CG1' ' A' ' 18' ' ' ILE . 6.9 m -101.39 150.79 22.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.01 1.93 19.32 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.247 -0.908 . . . . 0.0 110.665 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.39 46.59 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.708 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.85 -79.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.16 -0.963 . . . . 0.0 109.965 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.708 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -102.53 -45.8 1.62 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.689 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.597 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.615 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.58 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 12.7 t60 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' C ' ' O ' ' A' ' 36' ' ' GLY . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.642 ' HB2' ' CB ' ' A' ' 70' ' ' ASN . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.679 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.608 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 63' ' ' TYR . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.667 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.689 ' O ' ' CG2' ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.667 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.703 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.682 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' O ' HD11 ' A' ' 42' ' ' LEU . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.679 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.681 ' CG2' HD23 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 71' ' ' THR . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.644 ' O ' ' CA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.671 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.686 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.675 ' HG2' ' CG ' ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.689 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 4.2 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.651 ' CD1' HD13 ' A' ' 88' ' ' ILE . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.721 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.689 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.702 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.752 ' CZ ' ' CD2' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 104' ' ' VAL . 9.0 mm-40 -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 80' ' ' SER . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' O ' ' O ' ' A' ' 76' ' ' ASN . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.688 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.692 ' CD2' ' OE1' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.62 ' HB ' ' CG2' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.752 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.725 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.652 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.652 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.485 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.68 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.58 169.66 7.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.673 ' O ' ' C ' ' A' ' 124' ' ' GLU . 53.4 Cg_endo -96.03 -72.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.783 2.322 . . . . 0.0 110.25 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.708 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 1.3 mm-40 -14.63 -60.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.785 1.279 . . . . 0.0 109.557 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.848 ' O ' ' N ' ' A' ' 127' ' ' GLU . 4.2 m80 -128.05 79.65 1.91 Allowed 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.7 p -20.85 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.941 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.848 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -73.08 2.83 6.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.098 -1.001 . . . . 0.0 110.492 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -84.37 144.8 28.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.654 -1.279 . . . . 0.0 109.451 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -125.03 132.71 53.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 110.662 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.615 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.66 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.683 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.712 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.725 ' HB3' ' CG ' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.688 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.765 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.732 ' CD1' ' HB3' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.674 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.683 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.718 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.7 ' CB ' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.7 ' OH ' ' CB ' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.706 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.587 ' C ' ' HA3' ' A' ' 170' ' ' GLY . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.58 ' OG ' ' HB3' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.673 ' CD2' HD21 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.822 ' CE2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.822 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 153' ' ' ASP . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.678 ' HG3' ' CE1' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.699 ' CA ' HG12 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.678 ' CE1' ' HG3' ' A' ' 182' ' ' GLN . 38.6 p-80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.706 ' CG2' ' O ' ' A' ' 197' ' ' VAL . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 189' ' ' HIS . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.671 ' O ' ' N ' ' A' ' 171' ' ' LYS . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.563 ' HG ' ' OG ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -94.83 -159.82 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 193' ' ' PRO . 30.0 mtpt -54.19 -15.11 1.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.029 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.698 ' CB ' ' HB2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -28.15 88.2 0.04 OUTLIER Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.726 -0.609 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.686 ' N ' ' O ' ' A' ' 191' ' ' LYS . 43.9 Cg_endo -71.29 -2.73 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 109.806 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.747 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 9.5 mt-10 -142.64 0.65 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.539 -0.726 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.763 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 1.3 mp -111.44 29.69 7.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.702 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 3.3 m120 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.706 ' O ' ' CG2' ' A' ' 187' ' ' ILE . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.822 ' CD2' ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.7 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.685 HG11 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.447 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.822 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.683 ' CD1' HG23 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.745 ' OD2' ' CD2' ' A' ' 211' ' ' HIS . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.554 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.745 ' CD2' ' OD2' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.732 ' HB3' ' CD1' ' A' ' 147' ' ' PHE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.683 HG23 ' CD1' ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.77 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.646 ' N ' HG12 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.655 HG11 ' N ' ' A' ' 227' ' ' SER . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.685 ' CA ' HG11 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.747 ' CE2' ' O ' ' A' ' 194' ' ' GLU . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.411 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.735 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.579 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.57 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.678 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.63 ' C ' ' CG1' ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.655 ' N ' HG11 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.733 ' CD2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.681 ' CD2' HD13 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.589 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.709 HG22 ' CE1' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.714 ' HG2' ' CE2' ' A' ' 233' ' ' PHE . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.436 ' CG1' ' HB1' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.623 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.784 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.681 ' HG3' ' CG2' ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.591 HG21 ' CE1' ' A' ' 253' ' ' HIS . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.496 ' H ' ' CG2' ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 7.9 p30 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.681 ' CG2' ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.58 ' HB3' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.784 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.598 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 230' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.706 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.195 0.521 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.36 64.86 0.31 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 t -155.99 -45.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -134.92 136.01 41.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.65 120.84 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.63 -143.74 4.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.79 -145.71 4.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.09 24.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -155.85 -50.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -1.142 . . . . 0.0 110.167 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.64 67.18 3.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.07 -146.01 19.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.44 -103.56 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.64 146.45 49.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.86 172.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.491 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 14.2 t -112.78 -21.76 11.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 15' ' ' THR . . . 179.79 -115.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.877 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB2' HD21 ' A' ' 74' ' ' LEU . 16.1 t70 -103.39 41.75 1.24 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.272 -0.893 . . . . 0.0 109.931 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.71 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -100.68 -80.21 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.87 0.843 . . . . 0.0 110.151 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.71 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -57.8 -160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.698 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.672 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.709 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.645 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HA ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.605 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.559 ' O ' HD22 ' A' ' 40' ' ' LEU . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.755 ' CD2' ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.607 ' O ' ' O ' ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.573 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.65 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.668 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.822 ' CD2' ' CD1' ' A' ' 63' ' ' TYR . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.678 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 59' ' ' ALA . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.698 ' O ' ' CG2' ' A' ' 20' ' ' THR . 5.2 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.672 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.678 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.595 ' CE ' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.594 ' O ' HG21 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.822 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.755 ' CB ' ' CD2' ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.595 ' O ' ' CE ' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD11 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.697 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.6 m120 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.696 ' CG2' ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.674 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.824 ' CG1' ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.478 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.731 ' CE1' ' HB3' ' A' ' 102' ' ' PHE . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.731 ' CE2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.657 ' CG2' ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.657 ' CD ' ' CG2' ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.668 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.784 ' HB ' ' CG ' ' A' ' 93' ' ' GLN . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.594 ' N ' HG12 ' A' ' 90' ' ' VAL . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.841 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.841 ' N ' ' HG3' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.698 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.731 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.824 ' CE2' ' CG1' ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.682 ' HB2' ' CB ' ' A' ' 78' ' ' LYS . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.582 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.702 ' O ' ' CG1' ' A' ' 140' ' ' ILE . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.582 HD23 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 118' ' ' GLU . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG23 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 127' ' ' GLU . 3.4 m-20 -140.97 104.65 6.19 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 46.7 Cg_endo -73.59 51.03 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.201 1.632 . . . . 0.0 111.327 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.753 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 6.3 mm-40 -95.35 -25.66 16.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.264 1.03 . . . . 0.0 108.801 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.753 ' CE1' ' CB ' ' A' ' 124' ' ' GLU . 0.6 OUTLIER 179.4 -76.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.574 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 1.3 t -122.87 17.09 10.17 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.746 ' CG ' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -106.63 6.34 29.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 111.132 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.53 8.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.171 -0.956 . . . . 0.0 111.807 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.685 ' CE ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.17 114.16 3.04 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.488 -0.758 . . . . 0.0 110.073 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.584 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.544 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' ' N ' ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.73 ' CD1' ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.73 ' N ' ' CD1' ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.525 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.602 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 11.5 m170 -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.754 ' OG1' ' CD2' ' A' ' 211' ' ' HIS . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.75 ' CG ' ' HB3' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.703 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.736 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.743 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.695 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.619 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.59 ' C ' ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.705 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.633 ' HB2' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.675 ' CD1' ' C ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.739 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.598 ' OD2' ' CD ' ' A' ' 193' ' ' PRO . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.587 ' C ' ' HB2' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.697 ' CD2' ' O ' ' A' ' 161' ' ' THR . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.736 ' CG ' ' HA3' ' A' ' 185' ' ' GLY . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.497 ' C ' HD11 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.817 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.713 ' CB ' ' CB ' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.743 ' CD2' ' HA ' ' A' ' 153' ' ' ASP . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.692 ' O ' ' CE ' ' A' ' 181' ' ' LYS . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.733 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.599 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.734 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.736 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.679 HG23 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.682 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.832 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.645 ' O ' ' O ' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -32.79 -107.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -79.69 -0.97 36.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 110.768 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.832 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 1.0 OUTLIER -60.7 173.66 0.62 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.618 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 46.9 Cg_endo -74.05 36.65 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.972 1.512 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.688 ' OE2' ' CG2' ' A' ' 246' ' ' VAL . 4.3 mt-10 -168.93 43.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.179 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.692 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.0 OUTLIER -5.32 -69.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.688 ' CG2' ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.526 ' N ' HG11 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.766 ' CD2' ' CG2' ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 201' ' ' VAL . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 214' ' ' ILE . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CE1' ' CG2' ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.595 ' HB ' HG21 ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.681 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.81 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.81 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.75 ' HB3' ' CG ' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.681 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.759 ' CG2' ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.605 ' C ' HG11 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.766 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.708 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 220' ' ' TYR . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.725 ' CE1' HD12 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 243' ' ' SER . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 242' ' ' GLY . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.734 ' CG1' ' CE1' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.7 ' O ' ' C ' ' A' ' 234' ' ' GLY . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.7 ' C ' ' O ' ' A' ' 233' ' ' PHE . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.693 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.662 ' HB ' ' CD1' ' A' ' 232' ' ' ILE . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.665 ' N ' HD22 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.77 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.688 ' CG2' ' OE2' ' A' ' 194' ' ' GLU . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.483 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.731 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 250' ' ' ASN . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 11.0 p30 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.671 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.561 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.731 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.831 ' CG2' ' CE1' ' A' ' 189' ' ' HIS . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.625 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.725 HD12 ' CE1' ' A' ' 228' ' ' TYR . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.705 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.674 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.246 0.546 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.76 -47.59 3.14 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -161.91 122.95 2.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -1.181 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -135.11 34.88 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -38.89 63.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.79 152.03 23.93 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.84 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.81 -129.72 1.4 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -153.79 146.53 24.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -1.132 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.47 -106.82 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.06 90.85 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.89 3.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.699 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -107.43 84.48 0.38 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.699 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 46.1 t -161.96 -178.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.08 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.508 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 11.5 t -102.39 169.12 8.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -1.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.407 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 15' ' ' THR . 1.1 m-20 -162.33 83.22 0.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.657 ' O ' ' N ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -55.16 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.588 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -36.88 -66.67 0.48 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.644 HG21 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.644 ' CB ' HG21 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.692 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.621 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.595 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.597 ' C ' ' CD1' ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.597 ' CD1' ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.67 ' HA ' ' CB ' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.7 ' O ' ' CB ' ' A' ' 65' ' ' ASN . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.616 HD21 ' N ' ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.768 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.658 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 26' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 64.5 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.454 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.658 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.699 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.745 ' OD2' ' CE2' ' A' ' 63' ' ' TYR . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.67 ' CB ' ' HA ' ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.595 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.574 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' O ' HD11 ' A' ' 74' ' ' LEU . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' CD2' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.692 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.677 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.624 ' CG ' HG13 ' A' ' 95' ' ' ILE . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.684 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.704 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.627 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.692 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.68 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.474 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.815 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.677 ' CB ' ' HB2' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.735 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.595 ' OE1' ' CD ' ' A' ' 239' ' ' GLU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.668 ' N ' ' OG ' ' A' ' 110' ' ' SER . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.68 HD11 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.584 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.677 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.697 HD22 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.721 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 118' ' ' GLU . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.644 ' N ' HG23 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.68 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' A' ' 127' ' ' GLU . 2.5 m-20 -145.17 104.18 4.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 47.9 Cg_endo -74.49 51.17 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.123 1.591 . . . . 0.0 111.25 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.76 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 7.9 mm-40 -97.86 -24.91 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 108.918 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.76 ' CE1' ' CB ' ' A' ' 124' ' ' GLU . 0.6 OUTLIER 179.48 -77.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.569 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 0.5 OUTLIER -122.63 17.1 10.37 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.755 ' CG ' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -105.98 4.05 29.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 111.105 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.76 -1.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.95 . . . . 0.0 110.84 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.694 ' HA ' ' CE ' ' A' ' 129' ' ' MET . 6.1 mmt -157.07 112.94 2.91 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.085 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.678 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.607 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.584 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.712 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.788 ' CB ' ' CD2' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.788 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 7.1 p80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.753 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.434 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.709 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.701 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.701 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.698 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.416 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.498 ' CB ' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.698 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.747 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.481 HG21 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.736 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.745 ' O ' ' O ' ' A' ' 177' ' ' ASP . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.69 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.476 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 11.0 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.736 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.618 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 196' ' ' ASN . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.585 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.508 ' CD2' ' HD1' ' A' ' 189' ' ' HIS . 0.4 OUTLIER -94.55 -156.96 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.599 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 17.1 mmmt -137.69 4.97 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.192 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.716 ' CB ' ' HD2' ' A' ' 193' ' ' PRO . 0.1 OUTLIER -56.61 -167.03 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.899 . . . . 0.0 109.962 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.716 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 42.3 Cg_endo -70.47 -0.77 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.587 1.309 . . . . 0.0 109.81 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.627 ' OE2' ' CZ ' ' A' ' 220' ' ' TYR . 13.4 mt-10 -131.75 25.74 4.69 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.646 0.736 . . . . 0.0 109.135 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.695 ' CD2' ' O ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -35.42 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.677 ' CG ' ' CB ' ' A' ' 188' ' ' GLU . 1.6 m120 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.827 ' CG2' ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.618 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.775 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.691 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.697 ' CB ' ' O ' ' A' ' 183' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.753 ' OH ' ' CD2' ' A' ' 147' ' ' PHE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.695 ' OD1' ' CG1' ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.744 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.695 ' CG1' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.667 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.683 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.678 ' N ' ' CG2' ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.641 HG21 ' CA ' ' A' ' 199' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 224' ' ' GLU . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.827 ' CG ' ' CG2' ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.596 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 245' ' ' GLU . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.775 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.608 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.643 ' CG ' ' HA3' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.684 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.616 ' OE2' ' OG1' ' A' ' 145' ' ' THR . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.651 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.643 ' HA3' ' CG ' ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.447 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.69 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.66 HG12 ' ND1' ' A' ' 253' ' ' HIS . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.73 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 21.1 t-20 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.668 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.1 m170 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.69 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 105' ' ' TYR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.701 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.251 0.548 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.32 -143.46 5.9 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -100.36 115.69 30.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 t -154.92 -179.93 8.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.258 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.06 -162.21 11.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.21 104.46 2.48 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.96 113.14 0.55 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.06 102.18 2.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -102.05 124.1 47.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -1.109 . . . . 0.0 110.231 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.0 -134.1 1.59 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.65 54.34 2.48 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.88 91.81 0.44 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.2 -139.07 0.84 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 t -58.84 174.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.683 ' HB ' ' CG1' ' A' ' 18' ' ' ILE . 19.5 m -84.35 161.75 20.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.76 39.59 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -162.54 45.44 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.11 -0.994 . . . . 0.0 110.698 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.721 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -98.77 -79.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.721 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -128.22 7.02 6.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.752 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.637 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.582 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.631 ' N ' ' OG1' ' A' ' 27' ' ' THR . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.46 HD22 HG22 ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.589 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.663 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' N ' ' OG ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.693 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.678 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.636 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.653 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.657 ' N ' HG21 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 ' CG ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.675 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.637 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.675 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.681 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.733 ' CG ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.653 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t-20 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.678 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.693 ' OG ' ' CG2' ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.695 ' O ' ' CG2' ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.695 ' CG2' ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.672 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.791 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.547 ' HA ' HD13 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.593 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.646 ' NE2' ' CD1' ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.475 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.687 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.697 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.604 ' O ' HD11 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.655 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.78 ' CZ ' ' CD2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.589 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.791 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HA ' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.697 ' OE1' ' CG ' ' A' ' 239' ' ' GLU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.448 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.666 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.642 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.673 HD23 ' CG ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.78 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.527 ' HA ' ' CB ' ' A' ' 135' ' ' PHE . 32.7 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.543 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.573 ' HG2' ' HA2' ' A' ' 100' ' ' GLY . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.471 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.685 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.28 177.72 1.23 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.684 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.6 Cg_endo -97.7 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.91 2.407 . . . . 0.0 110.834 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.5 mm-40 -11.56 -59.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.834 1.302 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.825 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.6 m80 -132.68 80.77 1.91 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.57 -35.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.175 0.512 . . . . 0.0 110.827 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.825 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -71.1 2.91 3.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.541 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 125' ' ' HIS . 4.5 mmtt -71.84 -172.79 0.88 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.584 -1.322 . . . . 0.0 109.533 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -155.61 124.15 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.751 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.686 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.561 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.665 ' HD3' ' CD1' ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.69 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.738 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.666 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.679 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.719 ' CZ ' ' HG2' ' A' ' 205' ' ' LYS . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.71 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.71 ' HD3' ' CD2' ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 177' ' ' ASP . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CE2' HD13 ' A' ' 232' ' ' ILE . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.714 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.68 HG23 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB3' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.453 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.83 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.638 ' CD2' HD21 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.61 ' CE2' HG21 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.765 ' CD1' ' CD1' ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.725 ' O ' ' O ' ' A' ' 177' ' ' ASP . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.711 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 25.6 p-80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.604 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.668 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.728 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.605 ' O ' ' HA2' ' A' ' 170' ' ' GLY . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.661 ' CD1' HD21 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.81 -103.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 5.6 mtmt -162.68 -30.2 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.608 -0.683 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.45 ' HB3' HD13 ' A' ' 195' ' ' LEU . 27.9 t -45.07 139.79 3.87 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 110.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.424 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 46.3 Cg_endo -72.51 43.79 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.929 1.489 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.69 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 8.0 tt0 -142.14 -27.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 110.555 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.704 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 2.7 mp -104.94 20.65 18.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.337 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.685 HG11 ' CG1' ' A' ' 218' ' ' VAL . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 197' ' ' VAL . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 228' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.61 ' O ' HG21 ' A' ' 201' ' ' VAL . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.692 ' CG1' ' N ' ' A' ' 215' ' ' SER . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.692 ' OH ' ' CB ' ' A' ' 147' ' ' PHE . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.671 ' CA ' HG23 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 6.1 p-80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.623 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.671 HG23 ' CA ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.704 ' CG1' ' CG2' ' A' ' 232' ' ' ILE . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.692 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.675 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.685 ' CG1' HG11 ' A' ' 197' ' ' VAL . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.585 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.755 ' CD2' ' HB3' ' A' ' 222' ' ' GLN . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.755 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.682 ' HG2' ' CG2' ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.512 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.687 ' HA3' ' CB ' ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.728 ' CD2' HD21 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.695 ' CD1' ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.582 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.765 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.715 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.708 ' CG2' ' CD1' ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.602 ' O ' ' HG ' ' A' ' 230' ' ' LEU . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.695 ' N ' ' CD1' ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.767 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.549 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.687 ' CB ' ' HA3' ' A' ' 226' ' ' GLY . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.452 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.657 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.524 ' OD1' ' O ' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.628 ' O ' ' CD1' ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.628 ' CD1' ' O ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.657 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.0 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.83 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.767 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CD2' ' A' ' 163' ' ' PHE . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 172' ' ' LEU . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.714 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.702 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.212 0.53 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.28 68.71 0.33 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -151.66 100.91 2.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 110.263 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 t -158.23 33.41 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.92 -154.48 6.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.29 137.75 6.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.95 21.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.19 90.33 1.31 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.1 p -153.26 154.39 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -1.114 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.86 -144.62 3.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.77 60.25 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.11 49.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.59 -42.56 0.87 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.93 169.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.225 -1.162 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.689 ' HB ' ' CG1' ' A' ' 18' ' ' ILE . 8.5 m -69.99 153.58 43.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.336 -0.852 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.57 1.01 24.0 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.261 -0.9 . . . . 0.0 110.623 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.5 46.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.111 -0.993 . . . . 0.0 110.641 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.58 -79.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.151 -0.968 . . . . 0.0 109.942 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.699 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -120.25 -46.54 0.37 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.694 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.774 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.592 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.607 ' O ' ' O ' ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.681 ' CD1' ' OD1' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.59 ' C ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.615 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.774 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.668 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.588 ' CB ' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.694 ' O ' ' CG2' ' A' ' 20' ' ' THR . 4.1 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.679 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.668 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.682 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.3 t-20 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.682 ' HB2' ' CG ' ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.595 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.59 ' CG2' HD22 ' A' ' 69' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.609 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.62 ' O ' ' CA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.671 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.694 ' CD1' ' OE1' ' A' ' 87' ' ' GLN . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.696 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 5.3 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD1' HD11 ' A' ' 88' ' ' ILE . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.696 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.611 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.692 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.583 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.672 ' HB3' ' CB ' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.671 ' HB ' ' CB ' ' A' ' 80' ' ' SER . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.724 ' CD2' HG12 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.62 ' CA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.614 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.685 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.672 ' CB ' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.682 ' OE1' ' CB ' ' A' ' 168' ' ' ALA . 15.8 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.681 ' HG2' ' CG2' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.697 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.739 ' O ' ' N ' ' A' ' 128' ' ' LYS . 24.3 m-20 -122.34 104.37 37.63 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.689 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 42.8 Cg_endo -70.11 104.06 1.32 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.197 1.63 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.744 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 35.7 mt-10 -163.24 -34.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.071 0.938 . . . . 0.0 108.945 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.744 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -178.27 -77.46 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.858 0.837 . . . . 0.0 108.795 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.571 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 7.9 t -122.64 17.66 10.36 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.727 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -103.26 -6.99 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.402 -0.811 . . . . 0.0 111.068 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.739 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.49 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.333 -0.854 . . . . 0.0 111.71 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.697 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER -157.0 137.54 13.09 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 110.246 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.681 ' CG2' ' HG2' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.743 ' CG ' ' O ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.585 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.693 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.726 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.662 ' CD2' ' N ' ' A' ' 144' ' ' HIS . 8.2 m170 -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.73 HG22 ' CG ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.75 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.67 ' CD ' HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.686 ' O ' ' CD1' ' A' ' 150' ' ' LEU . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.686 ' CA ' ' HB3' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.731 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.657 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.627 ' C ' ' CD2' ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.701 ' CB ' ' HA ' ' A' ' 257' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.635 ' O ' ' N ' ' A' ' 167' ' ' ASP . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.658 ' HB3' ' CB ' ' A' ' 191' ' ' LYS . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.682 ' CB ' ' OE1' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.655 ' N ' ' HD2' ' A' ' 191' ' ' LYS . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.654 ' O ' ' N ' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.593 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.68 ' CD2' ' HB2' ' A' ' 162' ' ' ALA . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.699 ' N ' ' CD1' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.746 ' CD1' ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.696 ' HB3' ' CB ' ' A' ' 182' ' ' GLN . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.731 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' CA ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.742 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.746 ' CA ' ' CD1' ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.685 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.574 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.68 HG22 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -95.23 150.41 20.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.678 ' N ' HD12 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -45.83 -72.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.633 ' O ' ' O ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -37.85 171.57 0.02 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.918 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.589 ' HG2' ' OE2' ' A' ' 194' ' ' GLU . 44.9 Cg_endo -71.79 -14.48 29.85 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.98 1.516 . . . . 0.0 110.199 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 194' ' ' GLU . 56.1 mp0 -87.88 30.69 0.82 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 109.244 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.727 ' N ' ' CD1' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -46.89 -13.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 111.364 -179.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 195' ' ' LEU . 2.9 m-80 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.68 ' CG2' HG22 ' A' ' 187' ' ' ILE . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.634 ' N ' ' OD1' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 228' ' ' TYR . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.649 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.725 HG22 ' CD2' ' A' ' 228' ' ' TYR . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.75 ' OH ' ' CD2' ' A' ' 147' ' ' PHE . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.615 HG22 ' N ' ' A' ' 205' ' ' LYS . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.676 ' HA ' ' CG1' ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.728 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.796 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 6.0 p80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.796 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 60.0 m170 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.729 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.58 HG21 HG11 ' A' ' 201' ' ' VAL . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.67 ' C ' ' CG1' ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.545 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.665 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.665 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.601 ' OE1' ' HB3' ' A' ' 194' ' ' GLU . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.582 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.683 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.725 ' CD2' HG22 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.606 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 257' ' ' LEU . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.733 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.726 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.558 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.604 ' HG3' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.679 ' O ' ' CD1' ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.576 ' N ' ' CD2' ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.647 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.693 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.6 HG23 ' CG1' ' A' ' 255' ' ' ILE . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.738 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.693 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.673 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.701 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.538 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.657 ' HA ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.63 -115.15 0.51 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -99.52 94.29 6.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.172 . . . . 0.0 110.171 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -120.65 -170.18 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.32 -130.05 1.14 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.24 -172.73 49.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 67.07 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.16 78.63 1.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -94.52 151.72 19.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -1.14 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.42 94.4 1.55 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.77 145.23 20.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.17 178.71 20.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.48 -169.99 3.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 m -58.97 -179.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.685 ' HB ' ' CG1' ' A' ' 18' ' ' ILE . 11.1 m -72.2 156.28 39.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.12 0.14 29.3 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 110.621 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 16.4 t70 -162.47 46.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.063 -1.023 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.711 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.01 -79.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.147 -0.971 . . . . 0.0 109.982 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.711 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -107.46 -45.71 1.12 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.659 ' CD2' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.684 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.664 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 27' ' ' THR . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.581 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' C ' HD21 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.688 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.632 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.671 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.665 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.702 ' CD2' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CB ' ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.59 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.664 ' N ' ' HB2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.566 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.725 HD23 ' CD1' ' A' ' 63' ' ' TYR . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.65 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.636 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.63 ' O ' ' CG2' ' A' ' 20' ' ' THR . 54.3 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.684 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.65 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.73 ' CD2' ' HB3' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.664 ' HB2' ' N ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.73 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.671 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.785 ' CG2' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.673 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.65 ' HD2' ' NE2' ' A' ' 103' ' ' GLN . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.56 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.676 HG23 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.641 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.68 ' OE1' ' CA ' ' A' ' 97' ' ' LEU . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.63 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' N ' ' CG1' ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 95' ' ' ILE . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.702 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.591 ' OG1' ' OD1' ' A' ' 122' ' ' ASP . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.698 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.641 ' HB3' ' NE ' ' A' ' 86' ' ' ARG . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.59 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.65 ' NE2' ' HD2' ' A' ' 81' ' ' ARG . 1.6 mm-40 -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.705 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.785 ' CE1' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.671 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.656 ' NE2' ' HB3' ' A' ' 110' ' ' SER . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.594 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.67 ' CB ' ' HE2' ' A' ' 106' ' ' LYS . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.681 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.667 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 36.9 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.6 ' CG2' ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.605 ' O ' ' CG ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 6.2 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -119.96 -171.84 0.22 Allowed Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.619 ' CD ' ' HB3' ' A' ' 122' ' ' ASP . 53.2 Cg_endo -92.94 23.11 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.593 1.529 . . . . 0.0 114.376 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.73 ' HB3' ' CD2' ' A' ' 125' ' ' HIS . 6.2 mt-10 -150.63 -102.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.652 -1.905 . . . . 0.0 112.16 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.73 ' CD2' ' HB3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -131.28 -97.02 0.33 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.65 ' C ' ' O ' ' A' ' 125' ' ' HIS . 3.7 m -36.32 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' C ' ' CB ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -115.36 74.14 0.87 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.039 176.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 122' ' ' ASP . 7.2 pttt -135.39 -149.17 0.33 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.448 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -121.77 110.74 16.29 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.043 -1.035 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.673 HG21 ' CE ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.694 ' O ' ' CZ ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.614 ' O ' HG22 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.681 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.718 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.793 ' CB ' ' CD2' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.793 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 7.1 p80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' OH ' ' A' ' 203' ' ' TYR . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.604 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.7 ' O ' ' CG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.584 ' HA ' ' HB1' ' A' ' 180' ' ' ALA . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.646 ' N ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.597 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.676 ' C ' ' CD2' ' A' ' 172' ' ' LEU . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.693 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.486 ' HB3' ' CB ' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.695 ' CB ' ' HB3' ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.673 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.763 ' HA3' ' CG ' ' A' ' 189' ' ' HIS . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.717 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.693 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.726 ' CD1' HD12 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 174' ' ' TYR . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.684 ' CB ' ' HB3' ' A' ' 182' ' ' GLN . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.742 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.618 ' C ' ' O ' ' A' ' 180' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 201' ' ' VAL . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 2.8 t-160 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.64 ' CD1' ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.678 ' HB3' ' CB ' ' A' ' 196' ' ' ASN . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.763 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.71 ' CD1' ' O ' ' A' ' 192' ' ' SER . 0.2 OUTLIER -41.23 178.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -60.6 0.57 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.464 -0.773 . . . . 0.0 111.953 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.71 ' O ' ' CD1' ' A' ' 190' ' ' LEU . 3.2 m -151.16 125.74 4.59 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.801 -1.187 . . . . 0.0 110.967 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.598 ' C ' ' OD1' ' A' ' 196' ' ' ASN . 48.9 Cg_endo -74.47 11.59 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.947 1.498 . . . . 0.0 110.16 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 192' ' ' SER . 0.9 OUTLIER -104.98 -26.79 12.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.369 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.705 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 5.5 mp -86.12 10.62 13.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.849 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.678 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.687 ' CG1' ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.826 ' CD2' ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.648 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.695 HG11 ' CG2' ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.805 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.688 ' HA ' ' CG1' ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.569 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.733 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 147' ' ' PHE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.688 ' CG1' ' HA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.695 ' CG2' HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.572 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.656 ' N ' HG22 ' A' ' 201' ' ' VAL . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.735 HG21 ' CD1' ' A' ' 228' ' ' TYR . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.687 ' O ' ' CG1' ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.826 ' CD2' ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.674 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.686 HD23 ' CD1' ' A' ' 257' ' ' LEU . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.724 ' CG1' ' CG2' ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 261' ' ' GLN . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.684 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.724 ' CG2' ' CG1' ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.783 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.736 ' CG1' ' CD2' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 250' ' ' ASN . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 248' ' ' THR . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.736 ' CD2' ' CG1' ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.783 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.726 HD23 ' CZ ' ' A' ' 228' ' ' TYR . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 13.9 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.3 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.296 0.569 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.22 121.15 5.34 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -153.79 174.03 15.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -153.97 105.05 2.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.34 -144.54 10.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.43 149.61 20.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.39 154.13 27.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.23 -107.86 0.33 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.8 p -149.59 -60.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -1.132 . . . . 0.0 110.21 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.41 70.24 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.16 56.21 0.31 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.53 176.71 0.63 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.94 165.03 38.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.674 ' CB ' HD13 ' A' ' 18' ' ' ILE . 2.3 m -58.94 153.93 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.313 -1.11 . . . . 0.0 110.338 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.499 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 14.8 t -84.03 174.25 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.08 6.38 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 110.69 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 15' ' ' THR . 12.7 m-20 -133.47 42.94 2.95 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.116 -0.99 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.699 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 1.2 mt -115.62 -79.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 0.0 109.996 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.699 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -140.64 16.09 2.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 19' ' ' GLY . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.749 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.682 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.698 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.579 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 39' ' ' SER . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.601 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.599 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.632 ' CG2' ' HA3' ' A' ' 50' ' ' GLY . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.667 ' CA ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.654 ' CA ' HG13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.632 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.723 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.648 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.682 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.488 HE22 ' NH1' ' A' ' 81' ' ' ARG . 30.5 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.649 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.698 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.648 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.645 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.717 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.667 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.6 t-20 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' O ' HD11 ' A' ' 42' ' ' LEU . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.618 ' O ' ' OH ' ' A' ' 63' ' ' TYR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.676 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.68 ' CG2' HD23 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.68 HD23 ' CG2' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.592 ' O ' ' C ' ' A' ' 107' ' ' GLN . 7.9 m-80 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.568 HG21 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.672 ' CG2' ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' HB3' ' HG ' ' A' ' 97' ' ' LEU . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.683 ' CD1' HD21 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.611 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.43 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.596 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.697 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.701 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.696 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.696 ' CD1' ' O ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' A' ' 119' ' ' GLN . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.59 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.805 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.725 ' HG3' ' CE1' ' A' ' 163' ' ' PHE . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.685 ' CB ' HD11 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.608 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.622 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.602 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.788 ' CD2' ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.654 ' N ' HG22 ' A' ' 117' ' ' THR . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.5 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.741 ' N ' ' O ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -142.11 104.69 5.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.7 48.08 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.238 1.652 . . . . 0.0 111.414 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.757 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -88.0 -40.27 14.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.384 1.088 . . . . 0.0 108.353 178.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.757 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 13.0 m80 -164.35 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.24 17.07 9.11 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.741 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mt-10 -106.2 9.57 32.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 111.595 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -57.14 -0.57 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.121 -0.987 . . . . 0.0 111.17 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.58 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -156.77 125.44 5.82 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.233 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.588 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.686 ' O ' ' CD1' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.568 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.714 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.622 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 144' ' ' HIS . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.547 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.763 ' CG2' ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.762 ' CG ' ' CB ' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.589 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.61 ' C ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.687 HD21 ' CG ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.687 ' CG ' HD21 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.703 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 180' ' ' ALA . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.655 ' N ' HG12 ' A' ' 154' ' ' VAL . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE1' ' O ' ' A' ' 238' ' ' GLN . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.602 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.551 ' CA ' HD23 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.568 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.725 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.41 ' HB2' ' HE2' ' A' ' 135' ' ' PHE . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 189' ' ' HIS . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.695 ' CB ' ' OH ' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.823 ' CE1' ' CD2' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.821 ' CG2' ' CD1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.645 ' O ' ' O ' ' A' ' 178' ' ' PHE . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.703 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.753 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.65 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.538 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.69 ' CD1' ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.609 ' NE2' HG21 ' A' ' 246' ' ' VAL . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.68 HD11 ' CD2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.16 -103.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -164.88 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 110.74 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.627 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -53.02 132.88 49.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 110.045 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.412 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.0 Cg_endo -71.37 46.12 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.958 1.504 . . . . 0.0 110.004 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.625 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -149.86 -32.3 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 110.334 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.68 ' CD2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp -91.08 6.93 42.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.313 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.715 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.732 HG12 ' CD1' ' A' ' 220' ' ' TYR . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.823 ' CD2' ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.65 ' N ' ' CD1' ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.639 HG11 ' CG2' ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 215' ' ' SER . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.821 ' CD1' ' CG2' ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.676 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.762 ' CB ' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.684 ' CG2' ' HA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.639 ' CG2' HG11 ' A' ' 201' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.564 ' O ' ' HB1' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.686 ' CG1' HG21 ' A' ' 197' ' ' VAL . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.732 ' CD1' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.431 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.607 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.607 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.74 ' CE2' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.687 ' CD2' HD11 ' A' ' 257' ' ' LEU . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 213' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.723 HD11 ' CZ ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.7 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 237' ' ' ALA . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.763 ' N ' ' CG2' ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.689 HG11 ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 240' ' ' VAL . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.653 ' N ' HD21 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.634 ' CB ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.609 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.718 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.59 ' O ' ' OD1' ' A' ' 250' ' ' ASN . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.542 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.718 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.9 OUTLIER -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.634 ' CD1' ' CB ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.687 HD11 ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.691 ' HB2' ' CD1' ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 39.2 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.238 0.542 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.03 -128.93 2.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 t -153.31 115.2 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -1.104 . . . . 0.0 110.205 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -101.04 148.33 25.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.05 -94.66 0.1 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.81 5.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.96 -54.48 3.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.39 -69.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -102.26 -51.11 3.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 43.07 0.26 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.94 140.93 4.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.43 112.35 0.52 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.16 157.66 35.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 15' ' ' THR . 6.1 t -58.91 -172.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -1.167 . . . . 0.0 110.21 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.68 ' CB ' ' CG1' ' A' ' 18' ' ' ILE . 9.1 m -105.15 154.34 20.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.8 0.74 25.78 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.308 -0.87 . . . . 0.0 110.577 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -162.4 46.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -0.999 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.702 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.3 -79.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.946 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.702 ' N ' ' CG2' ' A' ' 18' ' ' ILE . . . -91.44 -60.82 1.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.654 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.688 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.691 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.69 ' CB ' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.668 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.596 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.628 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.682 ' CG2' ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.586 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.683 ' CB ' HD13 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.611 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.499 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.669 ' O ' ' CB ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.654 ' CB ' ' HA ' ' A' ' 23' ' ' ALA . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.428 ' NE2' HD13 ' A' ' 22' ' ' LEU . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.549 ' O ' ' CG2' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.59 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.5 t-20 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.687 ' O ' ' CZ ' ' A' ' 63' ' ' TYR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.447 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.628 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 5.0 m120 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.67 ' HB ' ' CD1' ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.67 ' CD1' ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.634 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.679 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HD2' ' HA ' ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.651 ' N ' ' HD3' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.732 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.708 ' CG2' ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.708 ' NE2' ' CG2' ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.699 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.613 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' CD1' HD12 ' A' ' 88' ' ' ILE . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.696 ' CG2' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.612 ' O ' ' CG ' ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.679 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.587 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.67 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' NE2' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.693 ' O ' ' CG2' ' A' ' 140' ' ' ILE . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.769 ' CD1' ' CB ' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.577 HD12 ' NE ' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.689 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.603 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 5.0 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.704 ' CB ' ' HG2' ' A' ' 127' ' ' GLU . 0.5 OUTLIER -117.27 -171.36 0.2 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.711 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 53.1 Cg_endo -89.93 35.98 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.67 1.58 . . . . 0.0 110.917 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.713 ' O ' ' N ' ' A' ' 127' ' ' GLU . 35.1 mt-10 -164.09 96.86 0.81 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.114 -0.991 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.738 ' N ' ' HB3' ' A' ' 128' ' ' LYS . 70.3 m-70 -12.78 -52.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.744 0.783 . . . . 0.0 111.158 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 124' ' ' GLU . 34.2 t -51.59 -41.51 61.26 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.394 -0.817 . . . . 0.0 109.51 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.713 ' N ' ' O ' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -117.09 -3.8 11.51 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.984 0.897 . . . . 0.0 109.272 179.43 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.738 ' HB3' ' N ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -56.99 8.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.712 . . . . 0.0 112.244 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.699 ' CB ' ' HD3' ' A' ' 128' ' ' LYS . 3.7 ttp -155.89 152.54 28.43 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.578 -0.701 . . . . 0.0 109.584 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' A' ' 135' ' ' PHE . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.577 ' NE ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.56 ' O ' HG22 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.701 ' O ' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.729 ' HB3' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.727 ' CE1' ' HB2' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.711 HG23 ' CD2' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 148' ' ' ASP . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.722 HD23 ' CD1' ' A' ' 147' ' ' PHE . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.675 ' CB ' ' HB3' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.732 ' HB1' ' CZ ' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CZ ' ' HB3' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.448 ' CG ' ' O ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.699 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.713 ' CB ' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.657 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.4 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.601 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.742 ' OD2' ' CD2' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.657 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.713 ' O ' ' CB ' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.692 ' CD1' ' O ' ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.741 ' CD2' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.556 ' HB ' ' NE2' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 214' ' ' ILE . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.732 ' CZ ' ' HB1' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.629 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HB3' ' CB ' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.678 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.741 ' O ' ' CD2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.74 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CG2' ' HB ' ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.742 ' CD2' ' OD2' ' A' ' 167' ' ' ASP . 10.8 m-70 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.747 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.62 -106.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.523 ' CG ' ' HE2' ' A' ' 171' ' ' LYS . 1.6 mtpt -155.52 -30.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.652 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 0.9 OUTLIER -45.93 134.41 6.74 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 121.52 -0.737 . . . . 0.0 110.043 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.54 46.2 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.171 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.607 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.5 mt-10 -153.79 -31.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.747 ' CD2' ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp -84.84 2.79 40.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.225 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.692 ' ND2' ' N ' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.694 HG11 ' CA ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.737 HD21 ' CD1' ' A' ' 228' ' ' TYR . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.711 HG22 ' CD2' ' A' ' 228' ' ' TYR . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 206' ' ' PRO . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 211' ' ' HIS . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.711 ' CD2' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.736 ' HB3' ' CE1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 214' ' ' ILE . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 176' ' ' ILE . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.697 ' N ' ' CG1' ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.67 ' N ' HG21 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.691 ' CG2' ' O ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.584 ' C ' HG11 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.691 ' O ' ' CG2' ' A' ' 218' ' ' VAL . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.738 ' CE2' ' OH ' ' A' ' 174' ' ' TYR . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.539 ' C ' HD11 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.678 ' CG2' ' CD1' ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.729 ' CE2' ' HB3' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.727 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.563 ' HB1' ' NE2' ' A' ' 261' ' ' GLN . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.724 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.675 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.585 ' C ' HD21 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.492 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.633 ' C ' ' CD1' ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 253' ' ' HIS . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.456 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.724 HG22 ' CE1' ' A' ' 253' ' ' HIS . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.599 ' O ' ' ND2' ' A' ' 250' ' ' ASN . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 3.5 m-80 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.676 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.456 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.724 ' CE1' HG22 ' A' ' 248' ' ' THR . 1.9 m170 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.601 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.633 ' CD1' ' C ' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.684 HD11 ' CD2' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.769 ' CB ' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.699 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.563 ' NE2' ' HB1' ' A' ' 237' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' HD22 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.94 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.037 HD23 HD11 ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.997 ' O ' HD12 ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.69 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD23 ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.749 ' OG ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.139 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.928 ' ND2' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.656 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.074 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.037 HD11 HD23 ' A' ' 26' ' ' LEU . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.933 ' O ' HG22 ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.651 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 1.081 ' OH ' HD12 ' A' ' 69' ' ' LEU . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 1.139 ' C ' HD12 ' A' ' 46' ' ' ILE . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.664 ' N ' HD12 ' A' ' 46' ' ' ILE . 61.9 t30 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 43' ' ' GLU . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.081 HD12 ' OH ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.705 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 19.8 m-80 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.787 ' HB ' HD13 ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.802 HD23 ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.802 ' HB2' HD23 ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.078 HG22 ' CE1' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 1.074 ' CD2' HD13 ' A' ' 52' ' ' LEU . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.709 HG22 ' CG ' ' A' ' 87' ' ' GLN . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.709 ' CG ' HG22 ' A' ' 85' ' ' ILE . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 94' ' ' LEU . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.677 HG11 ' CD ' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.092 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.092 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 87' ' ' GLN . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.911 HG22 HG23 ' A' ' 113' ' ' THR . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.078 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.703 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.686 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.946 ' N ' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 104' ' ' VAL . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.616 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.561 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.696 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 70.2 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.498 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.696 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 1.6 ptm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.196 0.522 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.725 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.976 HD12 ' C ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 141' ' ' ALA . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.274 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.686 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.6 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.614 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.997 HD22 ' HG2' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.846 HG11 ' CD ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.891 ' CE2' HG21 ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.887 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 170' ' ' GLY . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.737 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.775 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 1.054 ' OD2' HD11 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.601 ' N ' ' ND1' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.124 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.124 ' CE2' HD13 ' A' ' 172' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.491 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.978 HG12 HG11 ' A' ' 201' ' ' VAL . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.773 ' CE1' ' HA ' ' A' ' 153' ' ' ASP . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.682 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.573 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 187' ' ' ILE . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.957 ' HB3' HD23 ' A' ' 190' ' ' LEU . 4.9 t-160 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.054 HD11 ' OD2' ' A' ' 167' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.443 ' O ' ' OD1' ' A' ' 196' ' ' ASN . 1.4 mp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 1.087 ' O ' HG23 ' A' ' 197' ' ' VAL . 32.1 m-20 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.087 HG23 ' O ' ' A' ' 196' ' ' ASN . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.612 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.791 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.629 ' C ' HG23 ' A' ' 201' ' ' VAL . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.978 HG11 HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.991 ' CE1' ' HB1' ' A' ' 212' ' ' ALA . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.971 ' CA ' HG22 ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.991 ' HB1' ' CE1' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.971 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.604 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.756 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.614 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.238 HD11 ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.624 ' HA3' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.891 HG21 ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 1.274 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.811 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.997 ' HG2' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.846 ' CD ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.768 ' O ' ' NE2' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.811 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.796 ' O ' HG23 ' A' ' 232' ' ' ILE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.881 HG23 HG13 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.596 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 1.132 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.713 HG22 ' N ' ' A' ' 249' ' ' ALA . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 248' ' ' THR . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 1.6 m120 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 253' ' ' HIS . 1.2 m-70 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.775 ' CE1' ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.737 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.238 ' CD1' HD11 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.887 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.768 ' NE2' ' O ' ' A' ' 237' ' ' ALA . 6.1 mm100 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.959 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.793 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.137 HD22 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 1.007 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.662 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.66 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 45' ' ' SER . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 47' ' ' SER . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 46' ' ' ILE . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 22.0 p-10 -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.137 ' CD1' HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.624 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.874 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.761 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.687 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.705 ' CG ' HD23 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.614 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 15.5 t30 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.007 ' CB ' ' HB3' ' A' ' 28' ' ' ALA . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.896 HG22 HD13 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.896 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.689 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.63 ' NH2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.82 ' O ' HG23 ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.72 ' OE1' HD23 ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.088 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.71 ' CD ' HG11 ' A' ' 90' ' ' VAL . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.047 ' O ' HD12 ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.088 ' HB ' HD12 ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.047 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 1.136 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 113' ' ' THR . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.652 ' NE2' ' OE1' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.465 ' HB2' ' OE1' ' A' ' 107' ' ' GLN . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.81 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.907 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 104' ' ' VAL . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.136 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.982 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG2' ' C ' ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.698 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.744 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.665 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 163' ' ' PHE . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.652 ' OE1' ' NE2' ' A' ' 107' ' ' GLN . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.749 ' CE1' ' HG3' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.085 ' CD1' HD11 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.085 HD11 ' CD1' ' A' ' 147' ' ' PHE . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 178' ' ' PHE . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CB ' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.807 ' CD1' HD12 ' A' ' 176' ' ' ILE . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 172' ' ' LEU . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.664 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.982 ' HB2' ' HG2' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.009 HD11 ' CB ' ' A' ' 259' ' ' ALA . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.018 ' CE1' HD13 ' A' ' 199' ' ' LEU . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.951 HG21 ' CZ ' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.747 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.73 ' CB ' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.052 ' HB1' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.747 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.66 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 187' ' ' ILE . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.574 ' N ' ' OD1' ' A' ' 196' ' ' ASN . 0.6 OUTLIER -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.652 ' O ' ' OD1' ' A' ' 196' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.592 0.711 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.652 ' OD1' ' O ' ' A' ' 195' ' ' LEU . 4.7 m-20 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.129 ' CG1' HG12 ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.1 ' CD2' HG22 ' A' ' 218' ' ' VAL . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.138 HG21 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.951 ' CZ ' HG21 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.777 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 1.052 ' HG3' ' HB1' ' A' ' 179' ' ' ALA . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.639 ' CG ' HG22 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.736 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.757 HG22 HG11 ' A' ' 201' ' ' VAL . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.98 ' C ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.875 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.129 HG12 ' CG1' ' A' ' 197' ' ' VAL . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.826 HD12 ' C ' ' A' ' 218' ' ' VAL . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.848 ' CD ' HG21 ' A' ' 197' ' ' VAL . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.684 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.541 ' O ' HD11 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.771 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.138 ' CD2' HG21 ' A' ' 201' ' ' VAL . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.498 ' C ' HD12 ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.001 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 1.044 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.978 ' HB3' HG23 ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 237' ' ' ALA . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HG3' ' CE1' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.907 ' OE2' HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 1.044 HG23 ' O ' ' A' ' 231' ' ' GLY . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.489 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 1.001 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.951 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.843 HG12 ' CE1' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 252' ' ' ILE . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.625 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.539 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.401 HG23 ' HG3' ' A' ' 247' ' ' GLU . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.843 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.2 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.798 HD12 HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 1.009 ' CB ' HD11 ' A' ' 172' ' ' LEU . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 2.1 pt20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.677 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.736 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.116 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.808 ' O ' HD22 ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.808 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 69' ' ' LEU . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.114 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.603 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 ' HA2' ' A' ' 64' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 20' ' ' THR . 57.8 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.627 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 1.114 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 33.5 t-20 -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 42' ' ' LEU . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.793 ' HB2' HG23 ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 42' ' ' LEU . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.834 ' HB ' HD13 ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.834 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.656 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.084 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.758 ' C ' HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' CG2' ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 94' ' ' LEU . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.053 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.966 ' CG2' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.969 HD12 ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.828 ' O ' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.992 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 1.3 tp-100 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.885 HG22 HG23 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.084 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.436 ' H ' ' CD ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.509 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.037 HD12 ' HB1' ' A' ' 258' ' ' ALA . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.885 HG23 HG22 ' A' ' 104' ' ' VAL . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.992 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.704 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.583 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 129' ' ' MET . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 1.3 t0 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.589 ' HA ' ' HG2' ' A' ' 121' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.995 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.704 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.0 HD12 HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.622 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 140' ' ' ILE . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.752 ' HB3' ' CG ' ' A' ' 233' ' ' PHE . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.802 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.045 HG21 ' C ' ' A' ' 234' ' ' GLY . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.595 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.804 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 1.048 ' O ' HG12 ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.039 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 1.048 HG12 ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.634 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.774 ' HE1' ' HB1' ' A' ' 156' ' ' ALA . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.586 HG22 ' NE2' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.786 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 189' ' ' HIS . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.941 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.622 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.039 HD12 ' CE1' ' A' ' 174' ' ' TYR . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 158' ' ' TYR . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.039 ' CE1' HD12 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 184' ' ' HIS . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.761 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 1.039 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.792 ' HA3' HG22 ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.951 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.417 ' H ' ' HG ' ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.858 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 196' ' ' ASN . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.988 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.54 0.686 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.636 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.721 ' HA ' ' HB2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.615 ' C ' HG23 ' A' ' 218' ' ' VAL . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.249 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.063 HG21 HG23 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.684 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 1.029 ' CG ' HG13 ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 1.166 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 30.0 p80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 1.166 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.017 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.029 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.063 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.585 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.979 ' C ' HD12 ' A' ' 219' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.979 HD12 ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.721 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 1.4 t-20 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD23 ' A' ' 219' ' ' LEU . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.841 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.739 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.249 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.569 ' C ' HD12 ' A' ' 230' ' ' LEU . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.017 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.758 ' CE2' ' HG3' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 1.045 ' C ' HG21 ' A' ' 145' ' ' THR . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.748 ' N ' HG21 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.758 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.786 ' HB ' HD12 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.015 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 1.151 HG12 ' CE1' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.57 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.606 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 1.151 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.995 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.726 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.033 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 1.037 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.656 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.3 mm100 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.071 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.977 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.938 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 37' ' ' LEU . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.758 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 68' ' ' SER . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 47.2 p-10 -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.621 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.409 ' C ' HD23 ' A' ' 52' ' ' LEU . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' CD2' ' A' ' 26' ' ' LEU . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.671 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 1.071 ' O ' HG22 ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.938 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD2' HD13 ' A' ' 42' ' ' LEU . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.864 ' HA ' HD12 ' A' ' 42' ' ' LEU . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.728 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.95 ' HB ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.094 HD21 ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.094 ' HG2' HD21 ' A' ' 74' ' ' LEU . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.082 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.687 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.657 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.721 HG11 ' CD ' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.134 ' O ' HD12 ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.134 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.783 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.58 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.728 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.926 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.082 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.762 ' NE2' ' OE2' ' A' ' 239' ' ' GLU . 9.6 mm-40 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.02 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.159 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.906 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.77 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.603 ' HG3' ' C ' ' A' ' 117' ' ' THR . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.652 ' HE2' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.357 0.599 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.525 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.757 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 144' ' ' HIS . 0.1 OUTLIER -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.372 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.902 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.082 ' O ' HD12 ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.717 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.774 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.687 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.678 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.924 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CG ' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.555 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.077 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.14 HG21 ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.945 ' CZ ' ' HB2' ' A' ' 180' ' ' ALA . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.752 ' HB1' ' HE2' ' A' ' 205' ' ' LYS . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.945 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.958 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.74 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.883 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.713 ' N ' ' CG ' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.168 HG21 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.659 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.058 HD21 ' CB ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.058 ' CB ' HD21 ' A' ' 190' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.329 0.585 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 196' ' ' ASN . 0.7 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.017 ' HB ' HG23 ' A' ' 187' ' ' ILE . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.077 HD21 ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.066 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 214' ' ' ILE . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.14 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.865 ' CG ' HG22 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.712 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.848 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.372 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.919 ' CG2' HG11 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.783 ' N ' HG13 ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.857 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.168 ' CG1' HG21 ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.86 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.831 ' HB2' HG22 ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.596 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.789 ' CB ' HG22 ' A' ' 197' ' ' VAL . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.597 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.826 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.889 ' CD2' HD22 ' A' ' 199' ' ' LEU . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.94 HD23 HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.824 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.822 ' CB ' HG21 ' A' ' 145' ' ' THR . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.796 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 1.159 ' OE2' HD21 ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.94 HG22 HD23 ' A' ' 230' ' ' LEU . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.641 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 251' ' ' GLY . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.837 ' H ' HG23 ' A' ' 248' ' ' THR . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.979 ' O ' HG22 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.671 ' HB2' ' CG1' ' A' ' 246' ' ' VAL . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.442 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 2.4 p-80 -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.687 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.686 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.753 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.951 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.041 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.084 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 1.041 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.692 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.823 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.823 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.697 ' C ' HG21 ' A' ' 88' ' ' ILE . 5.5 p-10 -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.084 HD11 HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.657 ' HB3' HG22 ' A' ' 20' ' ' THR . 54.0 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.678 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 1.056 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.602 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 31.2 t30 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.813 ' HB3' HG23 ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD12 ' OH ' ' A' ' 63' ' ' TYR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.936 HG22 HD13 ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HD23 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.77 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.878 HE22 HD23 ' A' ' 97' ' ' LEU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.023 HD12 ' CB ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 90' ' ' VAL . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CD ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.039 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.023 ' CB ' HD12 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.643 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.827 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.81 ' HA ' HG13 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.695 ' CD ' HD22 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.709 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.827 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.643 ' N ' HG22 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.575 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 163' ' ' PHE . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.951 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.214 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.09 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.632 ' O ' ' HE2' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.731 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.765 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.623 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.655 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.206 ' CG ' HD11 ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.43 HG22 ' OE1' ' A' ' 103' ' ' GLN . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.022 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.614 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.687 ' HB2' ' CE1' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.954 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.865 HD12 ' HE1' ' A' ' 174' ' ' TYR . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.865 ' HE1' HD12 ' A' ' 172' ' ' LEU . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.206 HD11 ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.682 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.98 ' HD3' HD13 ' A' ' 204' ' ' ILE . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 185' ' ' GLY . 0.2 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 1.141 ' NE2' HG21 ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 195' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.923 HG12 ' CB ' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.061 HD12 ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.061 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.98 HD13 ' HD3' ' A' ' 181' ' ' LYS . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 1.063 ' OD1' HG13 ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.907 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.907 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.09 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.063 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.822 HG12 ' C ' ' A' ' 226' ' ' GLY . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.923 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.746 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.822 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.732 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.507 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.652 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 1.214 ' N ' HG21 ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.827 ' OE2' HD11 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.699 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.778 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 1.141 HG21 ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.71 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.467 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.76 ' H ' HG23 ' A' ' 248' ' ' THR . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.71 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.956 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 165' ' ' SER . 0.3 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.076 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.08 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.703 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.682 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 1.2 pt20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.754 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.913 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.805 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.064 HD12 ' N ' ' A' ' 31' ' ' ASP . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 1.064 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.68 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.007 ' O ' HD11 ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' HG2' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.02 ' CB ' HD22 ' A' ' 30' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 1.049 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.007 HD11 ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.149 HD21 ' CB ' ' A' ' 67' ' ' ASP . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 1.085 ' O ' HD12 ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.684 ' O ' HG21 ' A' ' 88' ' ' ILE . 10.1 p-10 -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.696 HD13 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.823 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.913 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 31.1 t30 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.149 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.676 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 39' ' ' SER . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.697 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.619 HG21 ' CE1' ' A' ' 105' ' ' TYR . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.61 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.964 HG23 ' OG ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.907 ' HG3' HG22 ' A' ' 85' ' ' ILE . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.99 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.688 HG11 ' CD ' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.577 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.105 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.105 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.99 ' HB ' HD12 ' A' ' 88' ' ' ILE . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 96' ' ' THR . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.964 ' OG ' HG23 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.664 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.62 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.982 ' HD2' ' HB2' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.448 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.982 ' HB2' ' HD2' ' A' ' 106' ' ' LYS . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.824 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.669 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 118' ' ' GLU . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.691 ' N ' HG22 ' A' ' 117' ' ' THR . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.543 ' HB2' ' OE2' ' A' ' 118' ' ' GLU . 36.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 9.3 mmt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.33 0.586 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.78 ' O ' HG23 ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.669 ' HA ' ' N ' ' A' ' 113' ' ' THR . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.888 HD12 ' C ' ' A' ' 140' ' ' ILE . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.264 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.117 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 1.117 ' CD ' HD23 ' A' ' 150' ' ' LEU . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.904 ' HA ' ' HB3' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 1.003 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.963 HG23 ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.653 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.681 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.764 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.85 ' HB2' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.711 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.963 ' O ' HG23 ' A' ' 161' ' ' THR . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.214 ' CD2' ' HB2' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.974 ' OH ' HD22 ' A' ' 257' ' ' LEU . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.071 HG21 ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.626 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.98 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.858 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.698 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.846 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.673 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 196' ' ' ASN . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 168' ' ' ALA . 3.4 pp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.85 ' HB2' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.5 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.855 HG13 ' CA ' ' A' ' 220' ' ' TYR . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.698 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.272 HD22 ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.963 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.101 HG12 ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.071 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.663 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 1.139 ' CG ' HG13 ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.988 ' CD2' ' HE2' ' A' ' 211' ' ' HIS . 0.9 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.988 ' HE2' ' CD2' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.83 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.139 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.855 ' CG2' HD21 ' A' ' 230' ' ' LEU . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 1.101 ' C ' HG12 ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.855 ' CA ' HG13 ' A' ' 197' ' ' VAL . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.689 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.694 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.272 ' CE1' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.855 HD21 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.83 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.732 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 1.264 ' N ' HG21 ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.824 ' CD ' HD21 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.073 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.661 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.709 HG22 ' N ' ' A' ' 249' ' ' ALA . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.709 ' N ' HG22 ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.903 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.903 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.764 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.0 OUTLIER -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.073 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.724 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.974 HD22 ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.49 ' C ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 1.214 ' HB2' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.677 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.865 HG22 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.668 ' HB ' ' HB1' ' A' ' 59' ' ' ALA . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.754 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.805 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.597 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 48.4 t-80 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD13 ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.01 HD13 ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.594 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.789 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.789 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.693 ' C ' HG21 ' A' ' 88' ' ' ILE . 37.6 p-10 -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 20' ' ' THR . 83.9 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' HG22 ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.666 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.834 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 13.6 t30 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.01 ' HB3' HD13 ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.754 ' ND2' ' HB3' ' A' ' 29' ' ' PRO . 17.8 t-20 -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.751 ' HB ' ' CE2' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.923 ' CD1' HD13 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.612 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.756 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.135 ' O ' HD12 ' A' ' 95' ' ' ILE . 18.5 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.756 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.86 HD12 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.612 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.934 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 1.049 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 113' ' ' THR . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.794 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.76 ' NE2' ' OE2' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.685 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.142 HD21 ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.865 HG23 HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.934 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.72 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.644 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.699 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.47 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.697 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 2.9 tpp . . . . . 0 C--O 1.215 -0.728 0 CA-C-O 121.194 0.521 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.749 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.451 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 133' ' ' ARG . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.659 HD13 ' CE2' ' A' ' 163' ' ' PHE . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.58 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.963 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.685 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 41.6 m80 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.793 HG21 ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.208 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.841 ' CG ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.803 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.578 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.767 ' HB1' ' HE1' ' A' ' 158' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 258' ' ' ALA . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.425 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.557 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.618 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.725 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.862 HD13 ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.862 ' CE1' HD13 ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.963 ' CD1' HG11 ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.803 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.997 ' HD2' ' HB1' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.858 ' CE1' ' O ' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 1.064 ' O ' HD22 ' A' ' 199' ' ' LEU . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.725 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.69 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.772 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.991 ' CG1' HG12 ' A' ' 218' ' ' VAL . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.687 ' C ' HD13 ' A' ' 199' ' ' LEU . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.018 ' CG1' HG23 ' A' ' 214' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.006 ' OH ' HD13 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.683 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.756 ' CA ' HG22 ' A' ' 213' ' ' VAL . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.629 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.208 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.756 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.018 HG23 ' CG1' ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.029 HG13 HD12 ' A' ' 199' ' ' LEU . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.787 ' CB ' HG22 ' A' ' 197' ' ' VAL . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.751 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.748 ' C ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.809 ' CE2' HD13 ' A' ' 257' ' ' LEU . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.006 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.793 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 145' ' ' THR . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.782 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 1.142 ' CD ' HD21 ' A' ' 112' ' ' LEU . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 230' ' ' LEU . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.153 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.516 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 1.011 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.765 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.765 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 0.1 OUTLIER 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.875 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.875 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.8 m-70 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.153 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.826 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.772 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 5.3 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 1.067 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.038 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.643 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.617 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.622 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.665 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HG ' ' C ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.746 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 7.2 p-10 -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.739 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.822 ' NE2' ' NH1' ' A' ' 81' ' ' ARG . 78.8 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 1.038 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.739 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.624 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 18.9 t30 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 41' ' ' THR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.686 HD23 ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.665 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.676 ' HB ' HD13 ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.676 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.704 ' HA ' ' CD ' ' A' ' 260' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.822 ' NH1' ' NE2' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.746 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.702 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG11 ' CD ' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.62 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.141 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.141 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.755 ' O ' HD12 ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.686 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.698 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.832 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HD2' HD22 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.006 HD23 HD12 ' A' ' 140' ' ' ILE . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.832 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.593 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.698 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.947 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.041 0.448 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.594 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.701 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.006 HD12 HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.635 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 211' ' ' HIS . 3.5 m80 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.613 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.103 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 1.103 ' CD ' HD23 ' A' ' 150' ' ' LEU . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.935 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.624 ' HA ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.747 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 176' ' ' ILE . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.695 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB3' ' HA3' ' A' ' 170' ' ' GLY . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.742 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.474 ' CA ' HG22 ' A' ' 255' ' ' ILE . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.727 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.858 HD22 ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.049 ' CE2' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.795 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.747 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.795 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 176' ' ' ILE . 11.6 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.721 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 31.5 p80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.733 HG22 ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.708 ' HB2' HD23 ' A' ' 190' ' ' LEU . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.133 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.133 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.959 HG11 HG12 ' A' ' 218' ' ' VAL . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.221 ' CD2' HG22 ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.02 HG11 HG23 ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.072 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.7 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.743 ' OD1' HG13 ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.884 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.743 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.02 HG23 HG11 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.724 ' N ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.865 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.221 HG22 ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.785 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.829 ' N ' HG13 ' A' ' 197' ' ' VAL . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.731 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.646 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.029 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . 1.009 ' C ' HD12 ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.107 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.884 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.702 ' CE1' HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.678 ' HA2' ' CG ' ' A' ' 239' ' ' GLU . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.635 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.716 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.864 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.841 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 249' ' ' ALA . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 1.091 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 1.091 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.2 m-70 -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.107 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.695 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 1.6 pm0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.102 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.658 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.137 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.402 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.945 HG23 ' HB2' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.736 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 5.1 p-10 -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.483 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.771 HD13 ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 1.102 ' O ' HG22 ' A' ' 20' ' ' THR . 82.6 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 1.137 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 17.3 t30 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.945 ' HB2' HG23 ' A' ' 41' ' ' THR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.696 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.677 HG21 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.991 ' HB2' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.137 HG22 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.767 ' OE1' HD23 ' A' ' 97' ' ' LEU . 16.9 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.736 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.737 HG11 ' CD ' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.113 ' O ' HD12 ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.113 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.009 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.696 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.658 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.494 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.765 HG22 HG23 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.137 ' CE2' HG22 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' CE ' HG21 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 5.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.649 ' OG ' ' HA ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.633 ' O ' HD23 ' A' ' 112' ' ' LEU . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 105' ' ' TYR . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.765 HG23 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.694 ' N ' HD12 ' A' ' 115' ' ' LEU . 6.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.569 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.56 ' N ' HG22 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 22.5 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.623 ' OD1' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.4 0.619 . . . . 0.0 110.594 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.676 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.646 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.69 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.571 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.92 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.956 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.817 ' C ' ' HE1' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.799 ' O ' ' CE1' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 144' ' ' HIS . 0.2 OUTLIER -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.671 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CD1' ' HG3' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.846 ' HB3' ' OE2' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.968 ' CE1' HG12 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.73 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 164' ' ' GLY . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.77 HD22 HD22 ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.738 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.993 HG21 ' CE1' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.758 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.758 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.984 ' H ' HG22 ' A' ' 176' ' ' ILE . 29.8 t-80 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.581 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.164 HG21 ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.698 ' HB3' ' CB ' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.859 ' HB3' HD23 ' A' ' 190' ' ' LEU . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.859 HD23 ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 195' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.698 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 45.7 m-20 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.176 ' CG1' HG12 ' A' ' 218' ' ' VAL . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.015 HD11 ' CZ ' ' A' ' 228' ' ' TYR . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.054 HG13 ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.993 ' CE1' HG21 ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.982 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.878 ' CG ' HG13 ' A' ' 213' ' ' VAL . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 1.006 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 1.006 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 72.1 m-70 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.098 ' HB3' HG23 ' A' ' 232' ' ' ILE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.878 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.959 HD11 HG23 ' A' ' 240' ' ' VAL . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 1.054 ' C ' HG13 ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.842 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.176 HG12 ' CG1' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.69 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.534 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.733 ' OE2' HG21 ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.643 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.015 ' CZ ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.981 HD21 ' CD1' ' A' ' 257' ' ' LEU . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.098 HG23 ' HB3' ' A' ' 212' ' ' ALA . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.956 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.713 ' CA ' ' HB3' ' A' ' 238' ' ' GLN . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.846 ' OE2' ' HB3' ' A' ' 156' ' ' ALA . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 261' ' ' GLN . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.713 ' HB3' ' CA ' ' A' ' 234' ' ' GLY . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.968 HG12 ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.705 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.93 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.157 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.643 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.555 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.873 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.873 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.5 m-70 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.157 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.981 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.705 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.73 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 60.5 t-80 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.877 ' O ' HD23 ' A' ' 40' ' ' LEU . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.651 HG22 ' H ' ' A' ' 47' ' ' SER . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 11.8 p-10 -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.059 HD11 HD22 ' A' ' 26' ' ' LEU . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.632 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.895 ' O ' HG22 ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' THR . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.632 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.701 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.823 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 47.5 t30 -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 66' ' ' GLY . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.834 ' HB2' HG23 ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.924 HG22 HD21 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HB2' HD12 ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.697 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 1.182 ' OE1' HD23 ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.001 HG11 ' CD ' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.107 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.107 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.798 ' O ' HD12 ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.182 HD23 ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.771 ' OE1' HG22 ' A' ' 96' ' ' THR . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HA ' ' CB ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HB ' ' A' ' 113' ' ' THR . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.886 ' CB ' HD11 ' A' ' 74' ' ' LEU . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.684 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.931 ' HB ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.799 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.665 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.496 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.661 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.414 0.626 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 130' ' ' VAL . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' HB1' ' A' ' 114' ' ' ALA . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.678 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.877 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.914 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.914 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.901 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.666 ' CG ' ' CD ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.583 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.72 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 154' ' ' VAL . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 1.11 ' HB1' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.11 ' OH ' ' HB1' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.625 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.005 ' CD2' HD22 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.19 ' CZ ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.122 HG21 ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.941 ' CD2' ' HB3' ' A' ' 180' ' ' ALA . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.941 ' HB3' ' CD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.657 ' HG3' ' CD2' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.903 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.657 ' CD2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 p80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.929 HD13 ' OH ' ' A' ' 228' ' ' TYR . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 196' ' ' ASN . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.7 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 195' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.507 0.67 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.702 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 3.3 m120 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.105 HG13 ' C ' ' A' ' 219' ' ' LEU . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.19 HD21 ' CZ ' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.072 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.122 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 1.103 HD12 HG21 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.754 ' CA ' HG12 ' A' ' 213' ' ' VAL . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.565 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.956 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.103 HG21 HD12 ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.057 HG23 HG11 ' A' ' 201' ' ' VAL . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.597 ' CA ' HG22 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.957 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 1.105 ' C ' HG13 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 1.017 ' HB2' HG22 ' A' ' 197' ' ' VAL . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HG2' ' CE2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.579 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.676 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.801 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.127 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.731 ' C ' HD12 ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.936 ' OE2' HD11 ' A' ' 112' ' ' LEU . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.832 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.129 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.952 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.62 HG23 ' H ' ' A' ' 250' ' ' ASN . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.589 ' N ' HG23 ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.62 ' H ' HG23 ' A' ' 248' ' ' THR . 2.5 p-10 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.952 HG23 ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.578 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.129 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.6 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.005 HD22 ' CD2' ' A' ' 172' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 2.6 pm0 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.061 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.948 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.767 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.628 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.247 HD21 ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.984 ' O ' HD12 ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' H ' ' A' ' 47' ' ' SER . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.672 ' C ' HG21 ' A' ' 88' ' ' ILE . 28.4 p-10 -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.641 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.034 HD11 HD23 ' A' ' 26' ' ' LEU . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.629 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 20' ' ' THR . 39.3 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.671 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.948 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.924 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.645 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 9.8 t30 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.247 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.6 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.924 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.05 ' O ' HG23 ' A' ' 71' ' ' THR . 5.9 m-80 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.05 HG23 ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.191 HG13 ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.749 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.823 HG22 ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.823 ' CD ' HG22 ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.672 HG21 ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.885 HG12 ' H ' ' A' ' 92' ' ' GLY . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.885 ' H ' HG12 ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.921 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.913 HD12 ' OE1' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.921 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.728 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.627 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 80' ' ' SER . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.191 ' CE2' HG13 ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.716 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.584 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 106' ' ' LYS . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' A' ' 137' ' ' ILE . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.627 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' A' ' 132' ' ' LYS . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.685 ' NE2' ' HB2' ' A' ' 97' ' ' LEU . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 1.005 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.16 0.505 . . . . 0.0 110.073 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.545 ' CG2' ' C ' ' A' ' 129' ' ' MET . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.6 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.568 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.609 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.14 HD12 ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.541 ' O ' ' HE2' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.88 HG21 ' CD2' ' A' ' 233' ' ' PHE . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.011 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HD2' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.772 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.775 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.709 ' HB1' ' CG ' ' A' ' 235' ' ' GLU . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 174' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.688 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.71 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.768 ' HZ ' ' HE2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.76 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.538 ' HB2' ' CA ' ' A' ' 164' ' ' GLY . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.678 ' C ' ' HB3' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.813 ' N ' ' HB3' ' A' ' 162' ' ' ALA . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.942 ' O ' HG23 ' A' ' 157' ' ' THR . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.718 ' C ' HD13 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.006 HD12 ' CA ' ' A' ' 183' ' ' GLY . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.738 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.972 ' CE2' ' HB3' ' A' ' 180' ' ' ALA . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 178' ' ' PHE . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.972 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.755 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 1.006 ' CA ' HD12 ' A' ' 176' ' ' ILE . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.89 HG21 HG11 ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.703 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.831 ' CE1' ' CG2' ' A' ' 255' ' ' ILE . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.692 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.185 HG21 ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.289 ' CD2' HG22 ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.877 HG22 ' HA3' ' A' ' 216' ' ' GLY . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 1.144 ' CE1' HG23 ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.576 HG13 ' HB ' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.903 ' CA ' HG22 ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.951 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.951 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.011 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.903 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.144 HG23 ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.784 ' C ' HG13 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.877 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.289 HG22 ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.734 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 1.185 ' OE1' HG21 ' A' ' 197' ' ' VAL . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.875 ' OH ' HD13 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.004 HD21 HD12 ' A' ' 257' ' ' LEU . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.933 ' HB ' HD11 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.88 ' CD2' HG21 ' A' ' 145' ' ' THR . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 145' ' ' THR . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.688 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.681 ' CD ' HD21 ' A' ' 112' ' ' LEU . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 158' ' ' TYR . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.94 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.191 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 1.6 p-10 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.87 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 247' ' ' GLU . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.87 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.6 m-70 -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.191 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.004 HD12 HD21 ' A' ' 230' ' ' LEU . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 172' ' ' LEU . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.079 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.899 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 1.079 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD22 ' C ' ' A' ' 36' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 1.094 ' C ' HD12 ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.957 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 47.4 p-10 -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.957 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 39.2 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.62 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.699 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.059 ' O ' HD12 ' A' ' 42' ' ' LEU . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.781 ' HB3' HG23 ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.588 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 74' ' ' LEU . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.686 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.708 HG11 ' CD ' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.618 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.136 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.136 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.987 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.704 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.943 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.814 ' CB ' HD12 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.75 ' NE2' HD21 ' A' ' 112' ' ' LEU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' HD22 ' A' ' 76' ' ' ASN . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.814 HD12 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.6 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.822 HE22 ' HB2' ' A' ' 168' ' ' ALA . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 134' ' ' ARG . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.706 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.706 ' CE ' ' HB3' ' A' ' 121' ' ' GLN . 6.1 mmt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.19 0.519 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.692 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.6 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.905 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.12 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 1.12 ' ND1' ' HB3' ' A' ' 141' ' ' ALA . 22.0 p-80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.791 ' O ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.761 ' CB ' ' HB2' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.713 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.002 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.729 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB2' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 1.002 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.925 HD22 ' HB3' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.742 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.749 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 1.008 ' CE1' HD21 ' A' ' 150' ' ' LEU . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.761 ' HB2' ' CB ' ' A' ' 153' ' ' ASP . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.493 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 34.7 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.749 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.64 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.691 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.501 ' N ' ' ND1' ' A' ' 189' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.749 HD12 ' H ' ' A' ' 196' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.749 ' H ' HD12 ' A' ' 195' ' ' LEU . 18.3 m-20 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.211 HG22 ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.64 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.085 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.183 HG22 ' N ' ' A' ' 216' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.957 ' HE2' HD13 ' A' ' 232' ' ' ILE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 1.189 ' OD1' HG13 ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.95 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.189 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.788 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . 1.011 ' C ' HG22 ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 1.183 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.806 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 218' ' ' VAL . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 1.211 ' CG ' HG22 ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.617 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.74 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.933 ' C ' HD12 ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.957 HD13 ' HE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 143' ' ' GLU . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.517 HG12 ' HD2' ' A' ' 158' ' ' TYR . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.989 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.639 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.408 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.784 ' H ' HG22 ' A' ' 248' ' ' THR . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.665 ' ND2' ' O ' ' A' ' 250' ' ' ASN . 0.6 OUTLIER 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.863 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.863 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.4 m-70 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.989 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.925 ' HB3' HD22 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.713 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.616 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.773 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.831 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.116 HD13 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 1.196 HG23 ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' SER . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.755 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.745 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 23.9 p-10 -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.583 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.975 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t30 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.777 ' O ' HD13 ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.196 ' OG ' HG23 ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 1.064 ' O ' HG23 ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.678 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.18 HG22 ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.816 ' O ' HG23 ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' C ' ' HG2' ' A' ' 87' ' ' GLN . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.702 ' NE2' HD13 ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.681 HG11 ' CD ' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.573 ' N ' HG12 ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.091 ' O ' HD12 ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.091 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.802 ' O ' HD12 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.666 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.897 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.18 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG3' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.916 ' NE2' HD21 ' A' ' 112' ' ' LEU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.671 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.897 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 3.4 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 117' ' ' THR . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.49 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.693 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.327 0.584 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.567 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.877 ' HD3' HD12 ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.62 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 113' ' ' THR . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.671 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.663 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.731 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.731 ' N ' HD23 ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.483 ' CA ' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 155' ' ' MET . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.928 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.722 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.016 HG21 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.672 ' CB ' ' CE1' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.794 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.891 ' HE1' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.891 HD12 HD13 ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.928 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.722 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 24.0 p80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.702 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.848 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.7 mp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.407 0.622 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 1.1 m-20 -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.891 HG13 ' N ' ' A' ' 220' ' ' TYR . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.891 HD13 ' HE1' ' A' ' 174' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.05 HG22 ' N ' ' A' ' 216' ' ' GLY . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.902 ' CE2' ' HB1' ' A' ' 212' ' ' ALA . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.601 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 17.8 p80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.681 ' HE1' ' CE1' ' A' ' 210' ' ' HIS . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.889 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.794 ' N ' HG13 ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 1.05 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 228' ' ' TYR . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.891 ' N ' HG13 ' A' ' 197' ' ' VAL . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 1.01 ' HG2' HG21 ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.64 ' C ' HG23 ' A' ' 246' ' ' VAL . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.85 ' N ' HG23 ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.964 ' HB2' HG23 ' A' ' 218' ' ' VAL . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.545 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.165 HD12 ' CG2' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.716 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 1.165 ' CG2' HD12 ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.669 ' HB3' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.799 ' N ' HD12 ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.56 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 224' ' ' GLU . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.747 ' H ' HG22 ' A' ' 248' ' ' THR . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.932 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.729 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.672 ' CE1' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.855 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.721 HD13 ' HE2' ' A' ' 228' ' ' TYR . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.722 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.709 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.617 ' O ' ' HE2' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.687 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.076 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.728 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.305 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.87 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.611 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.76 ' O ' HD12 ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.691 HD11 ' OD2' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.688 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.899 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.305 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.656 ' HB2' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 1.076 ' O ' HG22 ' A' ' 20' ' ' THR . 34.8 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.87 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' HD11 ' A' ' 54' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 11.7 t30 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 1.052 ' CB ' HD21 ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.832 ' HB ' HD12 ' A' ' 74' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.832 HD12 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.151 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.68 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.984 HG11 ' NE2' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 90' ' ' VAL . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 95' ' ' ILE . 25.4 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.105 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.649 ' O ' HD12 ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.105 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.596 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.962 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.808 HG22 HG23 ' A' ' 113' ' ' THR . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.151 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.584 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.508 ' H ' ' HG ' ' A' ' 108' ' ' SER . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.707 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.808 HG23 HG22 ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.425 HD12 ' HE ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 1.036 ' NE2' ' HB1' ' A' ' 168' ' ' ALA . 40.5 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.632 ' OD2' ' CG2' ' A' ' 130' ' ' VAL . 24.3 m-20 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.466 ' H ' ' HB ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.743 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HE ' HD12 ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.827 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.061 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.804 HG23 ' CB ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.069 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 1.061 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.061 HD23 ' CD ' ' A' ' 149' ' ' LYS . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 1.005 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.581 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 1.057 ' CE2' HD13 ' A' ' 232' ' ' ILE . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.894 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.714 ' C ' HD21 ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.65 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 1.036 ' HB1' ' NE2' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 190' ' ' LEU . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.827 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.616 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.06 HD13 ' HB3' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.12 HD13 ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.858 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.005 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.858 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 1.12 ' CA ' HD13 ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.695 HG21 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.94 HD12 ' N ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.514 ' H ' HD12 ' A' ' 195' ' ' LEU . 4.8 m120 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 220' ' ' TYR . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 220' ' ' TYR . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.087 ' CD2' HG22 ' A' ' 218' ' ' VAL . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.631 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.119 HG13 ' C ' ' A' ' 215' ' ' SER . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.91 ' HE1' ' HB1' ' A' ' 212' ' ' ALA . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 1.011 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 5.6 p-80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 1.011 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 5.9 m-70 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . 1.119 ' C ' HG13 ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.954 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.087 HG22 ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.666 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.989 ' HB2' HG13 ' A' ' 197' ' ' VAL . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.686 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.597 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.597 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.708 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.066 ' CD2' HG21 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.042 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.057 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 1.061 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.551 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 1.042 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.059 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 253' ' ' HIS . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.691 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.86 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.059 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.67 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.06 ' HB3' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.894 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 2.3 pt20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.096 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.1 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.744 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' CG ' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.704 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.69 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.847 ' O ' HD22 ' A' ' 40' ' ' LEU . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.549 ' HB2' ' N ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 1.001 ' HA ' HD21 ' A' ' 65' ' ' ASN . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 88' ' ' ILE . 25.2 p-10 -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.1 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.789 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 1.096 ' O ' HG22 ' A' ' 20' ' ' THR . 45.0 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.588 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.772 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 1.001 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.4 t30 -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.704 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.678 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.118 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.679 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.874 ' CG ' HD13 ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 1.018 HG22 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.657 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 1.018 ' CG ' HG22 ' A' ' 85' ' ' ILE . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG21 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.122 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.122 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 97' ' ' LEU . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 96' ' ' THR . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.607 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.581 ' OE1' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.955 ' O ' HG12 ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.678 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.851 ' OE1' ' HB1' ' A' ' 237' ' ' ALA . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.621 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.018 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.745 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.506 HE21 ' HE2' ' A' ' 135' ' ' PHE . 21.7 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.681 HG22 ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.681 ' N ' HG22 ' A' ' 117' ' ' THR . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 121' ' ' GLN . 1.1 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.629 ' OD2' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.847 0.832 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.549 ' CG2' ' C ' ' A' ' 129' ' ' MET . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.018 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.121 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 1.121 ' ND1' ' HB3' ' A' ' 141' ' ' ALA . 22.2 p-80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.977 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.626 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.783 ' O ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 152' ' ' LYS . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.858 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.606 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 170' ' ' GLY . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.679 ' HB3' ' CD2' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 1.069 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.912 ' HA2' HD11 ' A' ' 187' ' ' ILE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 161' ' ' THR . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.711 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.938 HD13 ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.994 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 1.056 HG23 ' O ' ' A' ' 182' ' ' GLN . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.946 ' OD1' ' HB3' ' A' ' 180' ' ' ALA . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.858 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.946 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 179' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 1.056 ' O ' HG23 ' A' ' 176' ' ' ILE . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.692 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 2.5 t-80 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.144 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 1.144 ' N ' HD12 ' A' ' 187' ' ' ILE . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.761 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.069 HD23 ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.774 ' ND2' ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.997 HG13 ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.056 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.989 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.826 HG22 HG21 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.788 ' CA ' HG22 ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.584 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.005 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 204' ' ' ILE . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.942 HG23 HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.698 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 199' ' ' LEU . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.997 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.947 ' HB2' HG22 ' A' ' 197' ' ' VAL . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.056 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . 1.189 ' C ' HD12 ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.189 HD12 ' C ' ' A' ' 229' ' ' SER . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 1.013 HG13 HG23 ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.851 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 156' ' ' ALA . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 1.11 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.909 HG12 ' CE1' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.575 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.909 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 1.11 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.051 ' CD1' HD11 ' A' ' 230' ' ' LEU . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.2 mm100 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.749 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.919 ' HB1' ' N ' ' A' ' 59' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.899 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.796 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 38' ' ' LYS . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.593 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HB3' HD12 ' A' ' 30' ' ' LEU . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.753 ' O ' HD22 ' A' ' 40' ' ' LEU . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.753 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.9 HG23 ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.787 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.666 ' CA ' HG13 ' A' ' 88' ' ' ILE . 11.9 p-10 -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 26' ' ' LEU . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.599 ' CA ' ' CB ' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.919 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.612 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.74 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.662 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 15.8 t30 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.586 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.9 ' HB2' HG23 ' A' ' 41' ' ' THR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.64 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.073 ' CB ' HD21 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.073 HD21 ' CB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 2.3 m120 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.7 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.737 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 1.061 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' A' ' 85' ' ' ILE . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.91 ' CD1' HD22 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.673 HG11 ' CD ' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.145 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.91 HD22 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.145 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.061 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.608 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.925 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.91 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.707 ' NE2' HD21 ' A' ' 112' ' ' LEU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.653 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' HG3' ' A' ' 119' ' ' GLN . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 129' ' ' MET . 2.8 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.601 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.219 0.533 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 1.045 HD12 ' O ' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.906 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.653 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.6 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.237 HG21 ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 1.02 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.61 ' CD ' ' C ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.098 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 1.098 ' CD ' HD23 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 1.21 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.746 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.981 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.924 ' C ' HD21 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.895 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.731 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.71 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' C ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 1.249 ' CE1' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.996 HG21 ' CE1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.753 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.981 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 1.21 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.753 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.652 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.542 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.142 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.645 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.126 HD11 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HB2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.378 0.609 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.577 ' HB3' ' CG ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.943 ' CG2' HG23 ' A' ' 187' ' ' ILE . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.249 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.013 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.934 ' CG1' HG23 ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.996 ' CE1' HG21 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.685 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.665 ' CB ' HG22 ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.593 ' HA ' ' OE1' ' A' ' 208' ' ' GLU . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 1.02 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.685 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 240' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 1.051 HG22 ' HB2' ' A' ' 199' ' ' LEU . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 218' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.777 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.432 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.142 ' OH ' HD13 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.926 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.059 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLY . . . . . 0.79 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 1.237 ' N ' HG21 ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 1.059 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.992 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.599 HG22 ' N ' ' A' ' 249' ' ' ALA . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.599 ' N ' HG22 ' A' ' 248' ' ' THR . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 251' ' ' GLY . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.513 ' NE2' ' OG1' ' A' ' 248' ' ' THR . 1.2 m-70 -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.992 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.814 HD23 ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.791 ' HB2' HD12 ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 9.1 mm100 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.122 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.998 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 1.122 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.617 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.619 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 1.008 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.603 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.774 ' HB3' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' THR . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 14.6 t30 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.843 ' HB2' HG23 ' A' ' 41' ' ' THR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.7 m-80 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.83 ' HB ' HD13 ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.669 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' HD23 ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.008 HD11 ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.902 HG11 ' CD ' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.522 ' N ' HG12 ' A' ' 90' ' ' VAL . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 1.067 ' O ' HD12 ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.095 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.631 ' O ' HD12 ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.095 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.688 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.58 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.68 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 1.004 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.843 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.03 ' CD1' ' HB1' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.557 HD12 ' NH1' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.713 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 37.1 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 1.9 pt20 -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.606 ' HG2' ' N ' ' A' ' 130' ' ' VAL . 3.7 ttp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.498 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.713 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.557 ' NH1' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 163' ' ' PHE . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.837 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.944 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 1.004 ' HE1' ' HB2' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.044 HG23 ' CG ' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 1.115 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' HG2' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.711 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.989 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.663 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.41 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.728 ' CG ' ' CG ' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.989 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 1.118 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.832 ' HD1' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.765 ' HB ' ' CE1' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.858 HG23 ' CA ' ' A' ' 183' ' ' GLY . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 1.115 ' CE2' ' HB2' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.67 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.858 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.765 ' CE1' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.742 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.089 HG23 HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.728 ' CG ' ' CG ' ' A' ' 167' ' ' ASP . 44.3 m170 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.251 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.251 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 1.089 HG23 HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.951 ' CD2' HG13 ' A' ' 218' ' ' VAL . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.002 HG11 ' CG2' ' A' ' 214' ' ' ILE . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ILE . . . . . 0.652 HD13 ' HB ' ' A' ' 213' ' ' VAL . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASP . . . . . 0.707 ' CG ' HG22 ' A' ' 213' ' ' VAL . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 1.044 ' CG ' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.707 HG22 ' CG ' ' A' ' 207' ' ' ASP . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.002 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.877 ' C ' HG13 ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.951 HG13 ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.917 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.747 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.743 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 1.199 ' CE2' HD13 ' A' ' 230' ' ' LEU . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.899 ' C ' HD12 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.199 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.819 HG22 HD12 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.944 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.869 ' HB3' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.733 ' HG2' ' CE1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.688 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.857 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.964 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.47 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.65 ' N ' HG23 ' A' ' 248' ' ' THR . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.752 ' H ' HG23 ' A' ' 248' ' ' THR . 0.8 OUTLIER 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.878 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.47 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.878 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 2.6 m-70 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 165' ' ' SER . 0.3 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.964 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . 0.566 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 1.069 HD12 HD21 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 1.03 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.711 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 2.3 pm0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.258 0.552 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -47.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -94.35 -33.86 13.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -1.174 . . . . 0.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.3 m -101.34 119.38 38.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.55 130.81 3.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.38 70.24 0.24 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.2 103.06 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.44 -106.97 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.1 p -90.44 54.48 2.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -1.153 . . . . 0.0 110.177 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.02 24.87 11.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.31 -23.95 68.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.79 -114.58 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.32 -106.69 0.54 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.983 HG12 HG21 ' A' ' 18' ' ' ILE . 2.3 m -58.91 136.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.259 -1.142 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG12 ' A' ' 18' ' ' ILE . 14.5 t -116.23 -160.98 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.4 6.74 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.728 ' H ' HG23 ' A' ' 15' ' ' THR . 1.5 t70 -162.29 47.43 0.17 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.091 -1.006 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG12 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -106.29 -78.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.149 -0.969 . . . . 0.0 109.914 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.982 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -97.1 69.08 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.94 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.037 HD23 HD11 ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.997 ' O ' HD12 ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.69 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD23 ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.749 ' OG ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.139 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.928 ' ND2' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.656 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.074 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.037 HD11 HD23 ' A' ' 26' ' ' LEU . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.933 ' O ' HG22 ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.651 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.081 ' OH ' HD12 ' A' ' 69' ' ' LEU . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 1.139 ' C ' HD12 ' A' ' 46' ' ' ILE . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.664 ' N ' HD12 ' A' ' 46' ' ' ILE . 61.9 t30 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 43' ' ' GLU . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.081 HD12 ' OH ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.705 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 19.8 m-80 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.787 ' HB ' HD13 ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.802 HD23 ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.802 ' HB2' HD23 ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.078 HG22 ' CE1' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 1.074 ' CD2' HD13 ' A' ' 52' ' ' LEU . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.709 HG22 ' CG ' ' A' ' 87' ' ' GLN . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.709 ' CG ' HG22 ' A' ' 85' ' ' ILE . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 94' ' ' LEU . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.677 HG11 ' CD ' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.092 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.092 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 87' ' ' GLN . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.911 HG22 HG23 ' A' ' 113' ' ' THR . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.078 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.703 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.686 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.946 ' N ' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 104' ' ' VAL . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.616 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.561 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.696 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 70.2 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.761 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -126.16 103.6 26.36 Favored Pre-proline 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 48.4 Cg_endo -74.73 48.83 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.265 1.666 . . . . 0.0 111.707 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.752 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 8.3 mm-40 -90.99 -28.57 17.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.381 1.086 . . . . 0.0 108.435 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.752 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -75.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.82 17.43 10.21 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.706 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -103.02 5.46 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 111.113 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.761 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.62 36.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.209 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.706 ' N ' ' O ' ' A' ' 127' ' ' GLU . 1.6 ptm -157.58 141.89 16.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.155 -0.966 . . . . 0.0 110.083 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.725 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.976 HD12 ' C ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 141' ' ' ALA . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.274 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.686 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.6 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.614 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.997 HD22 ' HG2' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.846 HG11 ' CD ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.891 ' CE2' HG21 ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.887 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 170' ' ' GLY . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.737 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.775 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 1.054 ' OD2' HD11 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.601 ' N ' ' ND1' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.124 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.124 ' CE2' HD13 ' A' ' 172' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.491 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.978 HG12 HG11 ' A' ' 201' ' ' VAL . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.773 ' CE1' ' HA ' ' A' ' 153' ' ' ASP . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.682 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.573 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.7 ' N ' HD12 ' A' ' 187' ' ' ILE . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.957 ' HB3' HD23 ' A' ' 190' ' ' LEU . 4.9 t-160 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.054 HD11 ' OD2' ' A' ' 167' ' ' ASP . 0.1 OUTLIER -95.82 -160.28 0.78 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.942 ' HA ' HD23 ' A' ' 195' ' ' LEU . 8.5 mmmt -125.89 7.56 7.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.416 -0.802 . . . . 0.0 110.147 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.951 ' HB2' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -48.31 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.6 Cg_endo -67.65 -0.64 5.49 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.345 1.182 . . . . 0.0 109.705 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 195' ' ' LEU . 8.6 pt-20 -135.76 41.5 2.7 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.942 HD23 ' HA ' ' A' ' 191' ' ' LYS . 1.4 mp -37.11 -68.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 1.087 ' O ' HG23 ' A' ' 197' ' ' VAL . 32.1 m-20 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.087 HG23 ' O ' ' A' ' 196' ' ' ASN . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.612 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.791 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.629 ' C ' HG23 ' A' ' 201' ' ' VAL . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.978 HG11 HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.991 ' CE1' ' HB1' ' A' ' 212' ' ' ALA . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.971 ' CA ' HG22 ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.991 ' HB1' ' CE1' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.971 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.604 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.756 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.614 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.238 HD11 ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.624 ' HA3' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.891 HG21 ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 1.274 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.811 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.997 ' HG2' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.846 ' CD ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.768 ' O ' ' NE2' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.811 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.796 ' O ' HG23 ' A' ' 232' ' ' ILE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.881 HG23 HG13 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.596 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 1.132 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.713 HG22 ' N ' ' A' ' 249' ' ' ALA . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 248' ' ' THR . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 1.6 m120 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.401 ' ND1' ' N ' ' A' ' 253' ' ' HIS . 1.2 m-70 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.775 ' CE1' ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.737 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.238 ' CD1' HD11 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.887 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.768 ' NE2' ' O ' ' A' ' 237' ' ' ALA . 6.1 mm100 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.97 97.8 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -101.2 118.7 37.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -1.177 . . . . 0.0 110.113 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 p -154.87 166.59 33.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.04 111.46 3.29 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.26 -133.41 2.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.42 83.56 1.5 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.66 164.13 32.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -157.26 153.32 27.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -1.096 . . . . 0.0 110.229 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.95 -72.36 1.21 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.29 90.26 0.44 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.35 -136.3 0.21 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.08 -56.36 1.07 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.064 HG11 HD13 ' A' ' 18' ' ' ILE . 2.8 t -58.84 -164.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -1.214 . . . . 0.0 110.257 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.873 ' H ' HG12 ' A' ' 14' ' ' VAL . 2.9 t -79.83 168.04 19.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.249 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' CG ' ' A' ' 17' ' ' ASP . . . -64.31 -1.1 1.49 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 8.5 m-20 -162.29 67.51 0.24 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.244 -0.91 . . . . 0.0 110.227 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.064 HD13 HG11 ' A' ' 14' ' ' VAL . 1.1 mt -39.5 -29.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.959 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -71.85 -80.59 0.36 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.793 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.137 HD22 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 1.007 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.66 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 45' ' ' SER . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 47' ' ' SER . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 46' ' ' ILE . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 22.0 p-10 -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.137 ' CD1' HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.624 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.874 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.761 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.687 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.705 ' CG ' HD23 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.614 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 15.5 t30 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.007 ' CB ' ' HB3' ' A' ' 28' ' ' ALA . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.896 HG22 HD13 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.896 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.689 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 18' ' ' ILE . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.63 ' NH2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.82 ' O ' HG23 ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.72 ' OE1' HD23 ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.088 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.71 ' CD ' HG11 ' A' ' 90' ' ' VAL . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.047 ' O ' HD12 ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.088 ' HB ' HD12 ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.047 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 1.136 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 113' ' ' THR . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.652 ' NE2' ' OE1' ' A' ' 143' ' ' GLU . 0.1 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.465 ' HB2' ' OE1' ' A' ' 107' ' ' GLN . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.81 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.907 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 104' ' ' VAL . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.136 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.982 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG2' ' C ' ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.698 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -117.16 175.28 2.05 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.683 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.0 Cg_endo -96.42 -73.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.95 2.434 . . . . 0.0 110.73 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.683 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -11.2 -59.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.869 1.319 . . . . 0.0 109.281 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.839 ' O ' ' N ' ' A' ' 127' ' ' GLU . 63.8 m80 -130.14 80.19 1.94 Allowed 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 2.0 p -21.27 -31.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.247 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -80.77 7.14 11.01 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 110.485 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 20.2 mttt -71.9 -157.49 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.644 -1.285 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -156.06 145.35 20.72 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.744 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.665 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 163' ' ' PHE . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.652 ' OE1' ' NE2' ' A' ' 107' ' ' GLN . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.749 ' CE1' ' HG3' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.085 ' CD1' HD11 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.085 HD11 ' CD1' ' A' ' 147' ' ' PHE . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 178' ' ' PHE . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CB ' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.807 ' CD1' HD12 ' A' ' 176' ' ' ILE . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 172' ' ' LEU . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.664 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.982 ' HB2' ' HG2' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.009 HD11 ' CB ' ' A' ' 259' ' ' ALA . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.018 ' CE1' HD13 ' A' ' 199' ' ' LEU . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.951 HG21 ' CZ ' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.747 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.73 ' CB ' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.052 ' HB1' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.747 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.66 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 187' ' ' ILE . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.814 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 3.9 t-160 -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -49.67 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.756 ' O ' ' O ' ' A' ' 192' ' ' SER . 14.3 mttt -71.73 15.28 0.15 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.892 -0.505 . . . . 0.0 111.735 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.814 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -45.02 -162.02 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.577 -0.702 . . . . 0.0 110.053 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.756 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 41.4 Cg_endo -69.16 12.39 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 122.516 0.745 . . . . 0.0 110.72 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CG ' ' O ' ' A' ' 193' ' ' PRO . 0.2 OUTLIER 179.84 -52.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.967 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.652 ' O ' ' OD1' ' A' ' 196' ' ' ASN . 0.3 OUTLIER 176.04 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.346 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.652 ' OD1' ' O ' ' A' ' 195' ' ' LEU . 4.7 m-20 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.129 ' CG1' HG12 ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.1 ' CD2' HG22 ' A' ' 218' ' ' VAL . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.138 HG21 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.951 ' CZ ' HG21 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.777 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 1.052 ' HG3' ' HB1' ' A' ' 179' ' ' ALA . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.639 ' CG ' HG22 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.736 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.757 HG22 HG11 ' A' ' 201' ' ' VAL . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.98 ' C ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.875 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.129 HG12 ' CG1' ' A' ' 197' ' ' VAL . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.826 HD12 ' C ' ' A' ' 218' ' ' VAL . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.848 ' CD ' HG21 ' A' ' 197' ' ' VAL . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.684 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.541 ' O ' HD11 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.771 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.138 ' CD2' HG21 ' A' ' 201' ' ' VAL . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.498 ' C ' HD12 ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.001 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 1.044 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.978 ' HB3' HG23 ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 237' ' ' ALA . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HG3' ' CE1' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.907 ' OE2' HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 1.044 HG23 ' O ' ' A' ' 231' ' ' GLY . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.489 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 1.001 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.487 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.951 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.843 HG12 ' CE1' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 252' ' ' ILE . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.625 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.539 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.401 HG23 ' HG3' ' A' ' 247' ' ' GLU . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.843 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.2 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.53 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.798 HD12 HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 1.009 ' CB ' HD11 ' A' ' 172' ' ' LEU . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 2.1 pt20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.168 0.509 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.81 85.83 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.6 p -101.93 -169.42 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.215 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -102.35 -33.07 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.7 178.96 38.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.71 171.09 55.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.84 -132.23 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 -130.55 6.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -151.87 167.08 29.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.79 -175.93 31.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.25 -100.64 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.65 -148.17 5.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.96 59.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 18' ' ' ILE . 2.8 t -58.86 -162.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.167 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.862 ' H ' HG12 ' A' ' 14' ' ' VAL . 8.8 t -70.66 168.6 16.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' O ' ' OD1' ' A' ' 17' ' ' ASP . . . -64.22 -1.16 1.47 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 15' ' ' THR . 4.9 m-20 -162.39 67.12 0.23 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.307 -0.87 . . . . 0.0 110.252 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.863 HD13 HG11 ' A' ' 14' ' ' VAL . 1.1 mt -39.27 -29.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 22' ' ' LEU . . . -68.4 -78.59 0.3 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.677 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.736 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.116 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.808 ' O ' HD22 ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 69' ' ' LEU . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.114 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.603 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 ' HA2' ' A' ' 64' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 20' ' ' THR . 57.8 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.627 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 1.114 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 33.5 t-20 -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 42' ' ' LEU . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.793 ' HB2' HG23 ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 42' ' ' LEU . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.834 ' HB ' HD13 ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.834 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.656 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.084 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.758 ' C ' HD12 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' CG2' ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 94' ' ' LEU . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.053 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.966 ' CG2' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.969 HD12 ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.828 ' O ' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.992 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 1.3 tp-100 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.885 HG22 HG23 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.084 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.436 ' H ' ' CD ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.509 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.037 HD12 ' HB1' ' A' ' 258' ' ' ALA . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.885 HG23 HG22 ' A' ' 104' ' ' VAL . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.992 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.704 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.583 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 129' ' ' MET . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.3 t0 -117.22 -179.28 0.62 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.68 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.7 Cg_endo -95.56 -1.31 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.985 1.79 . . . . 0.0 111.692 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.37 -104.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.756 -1.215 . . . . 0.0 110.925 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.669 ' HA ' ' HG2' ' A' ' 128' ' ' LYS . 3.7 p80 -158.77 -33.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.558 0.694 . . . . 0.0 110.27 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 9.7 t -77.32 -36.9 53.52 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 109.357 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mm-40 -115.32 4.67 14.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.477 -0.764 . . . . 0.0 109.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.69 -7.15 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.037 0.922 . . . . 0.0 110.63 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.694 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -157.26 133.19 9.46 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.544 178.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.995 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.704 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.0 HD12 HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.622 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 140' ' ' ILE . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.752 ' HB3' ' CG ' ' A' ' 233' ' ' PHE . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.802 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.045 HG21 ' C ' ' A' ' 234' ' ' GLY . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.595 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.804 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 1.048 ' O ' HG12 ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.039 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.048 HG12 ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.634 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.774 ' HE1' ' HB1' ' A' ' 156' ' ' ALA . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.586 HG22 ' NE2' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.786 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 189' ' ' HIS . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.941 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.622 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.039 HD12 ' CE1' ' A' ' 174' ' ' TYR . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 158' ' ' TYR . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.039 ' CE1' HD12 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 184' ' ' HIS . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.761 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 1.039 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.792 ' HA3' HG22 ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.951 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.417 ' H ' ' HG ' ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.858 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 196' ' ' ASN . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.5 -110.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HG2' ' NZ ' ' A' ' 171' ' ' LYS . 8.5 mttt -145.41 -31.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.363 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.729 ' H ' HD12 ' A' ' 190' ' ' LEU . 1.5 t -64.38 134.54 96.02 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.664 -0.648 . . . . 0.0 110.08 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.39 46.16 0.72 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.071 1.564 . . . . 0.0 110.102 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.574 ' C ' HD12 ' A' ' 195' ' ' LEU . 5.4 mt-10 -145.29 -34.2 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 110.355 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.988 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.9 mp -104.4 25.51 10.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.056 -1.027 . . . . 0.0 110.287 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 192' ' ' SER . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.721 ' HA ' ' HB2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.615 ' C ' HG23 ' A' ' 218' ' ' VAL . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.249 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.063 HG21 HG23 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.684 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 1.029 ' CG ' HG13 ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 1.166 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 30.0 p80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 1.166 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.017 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.029 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.063 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.585 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.979 ' C ' HD12 ' A' ' 219' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.979 HD12 ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.721 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 1.4 t-20 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD23 ' A' ' 219' ' ' LEU . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.841 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.739 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.249 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.569 ' C ' HD12 ' A' ' 230' ' ' LEU . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.017 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.758 ' CE2' ' HG3' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 1.045 ' C ' HG21 ' A' ' 145' ' ' THR . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.748 ' N ' HG21 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.758 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.786 ' HB ' HD12 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.015 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 1.151 HG12 ' CE1' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.57 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.606 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 1.151 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.995 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.726 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.033 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 1.037 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.656 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.3 mm100 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.207 0.527 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.14 -145.1 4.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -100.58 170.64 8.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.115 . . . . 0.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 p -100.54 109.6 21.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.242 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.57 126.23 1.8 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.5 -131.66 1.91 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.09 113.27 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.06 -52.52 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t -102.86 -37.25 7.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 110.284 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 85.69 0.13 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.8 -88.8 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.39 -129.75 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.65 -70.88 1.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -58.97 168.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.165 -1.197 . . . . 0.0 110.303 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.822 HG21 HD12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -87.5 -51.09 6.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 110.205 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.631 ' N ' HG22 ' A' ' 15' ' ' THR . . . 179.76 -115.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -92.8 39.45 1.04 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.978 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -106.35 -79.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.862 0.839 . . . . 0.0 110.116 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.978 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -64.88 -72.85 0.65 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.071 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.977 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.938 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 37' ' ' LEU . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.758 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 68' ' ' SER . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 47.2 p-10 -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.621 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.409 ' C ' HD23 ' A' ' 52' ' ' LEU . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' CD2' ' A' ' 26' ' ' LEU . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.671 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 1.071 ' O ' HG22 ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.938 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD2' HD13 ' A' ' 42' ' ' LEU . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.864 ' HA ' HD12 ' A' ' 42' ' ' LEU . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.728 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.95 ' HB ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.094 HD21 ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.094 ' HG2' HD21 ' A' ' 74' ' ' LEU . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.082 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.687 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.657 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.721 HG11 ' CD ' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.134 ' O ' HD12 ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.134 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.783 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.58 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.728 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.926 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.082 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.709 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.762 ' NE2' ' OE2' ' A' ' 239' ' ' GLU . 9.6 mm-40 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.02 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.159 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.906 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.77 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.603 ' HG3' ' C ' ' A' ' 117' ' ' THR . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.749 ' NE2' ' O ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.26 170.44 6.36 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.656 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.5 Cg_endo -96.08 -73.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.869 2.379 . . . . 0.0 110.23 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 123' ' ' PRO . 10.2 mt-10 -13.42 -58.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.92 1.343 . . . . 0.0 109.501 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.846 ' O ' ' N ' ' A' ' 127' ' ' GLU . 59.6 m80 -130.3 79.72 1.92 Allowed 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.749 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 1.6 t -21.13 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.493 . . . . 0.0 110.963 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.846 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.3 mt-10 -73.96 1.02 11.74 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -81.99 146.18 29.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.461 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.652 ' HE2' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.3 133.18 47.34 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 110.556 -179.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.525 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.757 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.483 ' ND1' ' N ' ' A' ' 144' ' ' HIS . 0.1 OUTLIER -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.372 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.902 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.082 ' O ' HD12 ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.717 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.774 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.687 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.678 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.924 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CG ' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.555 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.077 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.14 HG21 ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.945 ' CZ ' ' HB2' ' A' ' 180' ' ' ALA . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.752 ' HB1' ' HE2' ' A' ' 205' ' ' LYS . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.945 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.958 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.74 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.883 ' CD2' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.713 ' N ' ' CG ' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.168 HG21 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.659 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.058 HD21 ' CB ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -94.25 -110.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 8.1 mttt -163.68 -30.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.765 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.678 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 36.1 t -51.82 139.97 30.31 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.507 -0.745 . . . . 0.0 110.092 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.48 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.7 Cg_endo -71.7 50.58 1.39 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.022 1.538 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.9 mt-10 -152.64 -33.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.862 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.058 ' CB ' HD21 ' A' ' 190' ' ' LEU . 4.0 mp -98.01 13.92 29.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 110.311 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.68 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.4 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.017 ' HB ' HG23 ' A' ' 187' ' ' ILE . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.077 HD21 ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.066 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 214' ' ' ILE . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.14 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.865 ' CG ' HG22 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.712 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.848 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.372 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.919 ' CG2' HG11 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.783 ' N ' HG13 ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.857 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.168 ' CG1' HG21 ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.86 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.831 ' HB2' HG22 ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.596 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.789 ' CB ' HG22 ' A' ' 197' ' ' VAL . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.597 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.826 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.889 ' CD2' HD22 ' A' ' 199' ' ' LEU . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.94 HD23 HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.824 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.822 ' CB ' HG21 ' A' ' 145' ' ' THR . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.796 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 1.159 ' OE2' HD21 ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.94 HG22 HD23 ' A' ' 230' ' ' LEU . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.641 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 251' ' ' GLY . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.837 ' H ' HG23 ' A' ' 248' ' ' THR . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.979 ' O ' HG22 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.671 ' HB2' ' CG1' ' A' ' 246' ' ' VAL . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.442 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 2.4 p-80 -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.687 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.686 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.753 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.229 0.538 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.77 155.18 17.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -161.21 33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -129.81 145.61 51.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.81 -88.48 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.96 -126.53 0.86 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.87 108.73 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.74 -109.37 0.74 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -149.31 177.9 9.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.247 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.57 -155.39 31.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.15 -153.88 15.13 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.88 144.78 15.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.43 -100.57 0.14 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG12 HD13 ' A' ' 18' ' ' ILE . 2.0 m -58.91 155.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.271 -1.134 . . . . 0.0 110.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.933 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.9 t -96.71 174.05 7.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 0.0 110.155 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.07 6.22 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.94 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.933 ' H ' HG23 ' A' ' 15' ' ' THR . 0.8 OUTLIER -133.21 44.17 2.85 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.14 -0.975 . . . . 0.0 110.601 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.67 -79.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.229 -0.919 . . . . 0.0 110.001 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -109.21 -56.95 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.041 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.084 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 1.041 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.692 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.823 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.823 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.697 ' C ' HG21 ' A' ' 88' ' ' ILE . 5.5 p-10 -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.084 HD11 HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.657 ' HB3' HG22 ' A' ' 20' ' ' THR . 54.0 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.678 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 1.056 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.602 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 31.2 t30 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.813 ' HB3' HG23 ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD12 ' OH ' ' A' ' 63' ' ' TYR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.936 HG22 HD13 ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HD23 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.77 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.878 HE22 HD23 ' A' ' 97' ' ' LEU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.023 HD12 ' CB ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 90' ' ' VAL . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CD ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.039 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.023 ' CB ' HD12 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.643 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.827 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.81 ' HA ' HG13 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.695 ' CD ' HD22 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.709 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.827 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.643 ' N ' HG22 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.575 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.789 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -124.65 103.96 31.14 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.3 49.99 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.268 1.667 . . . . 0.0 111.556 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.891 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 5.7 mm-40 -94.62 -27.86 15.68 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.346 1.07 . . . . 0.0 108.626 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.891 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 t -122.68 17.34 10.33 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.884 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -104.34 5.45 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 111.174 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.789 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.069 -1.019 . . . . 0.0 111.448 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.705 ' N ' ' O ' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -157.89 139.23 13.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.385 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 163' ' ' PHE . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.951 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.214 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.09 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.632 ' O ' ' HE2' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.731 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.765 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.623 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.655 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.206 ' CG ' HD11 ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.43 HG22 ' OE1' ' A' ' 103' ' ' GLN . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.022 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.614 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.687 ' HB2' ' CE1' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.954 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.865 HD12 ' HE1' ' A' ' 174' ' ' TYR . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.865 ' HE1' HD12 ' A' ' 172' ' ' LEU . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.206 HD11 ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.682 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.98 ' HD3' HD13 ' A' ' 204' ' ' ILE . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.587 ' ND1' ' N ' ' A' ' 185' ' ' GLY . 0.2 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 1.141 ' NE2' HG21 ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -93.97 -112.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.492 ' H ' HD12 ' A' ' 190' ' ' LEU . 18.2 mtpt -151.72 -33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 110.498 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.744 ' H ' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -61.68 132.71 93.26 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.667 -0.646 . . . . 0.0 110.073 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.82 45.11 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.002 1.527 . . . . 0.0 110.099 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -145.91 -30.85 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 195' ' ' LEU . 4.7 mp -92.83 13.75 19.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.112 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.923 HG12 ' CB ' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.061 HD12 ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.061 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.98 HD13 ' HD3' ' A' ' 181' ' ' LYS . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 1.063 ' OD1' HG13 ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.907 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.907 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.09 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.063 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.822 HG12 ' C ' ' A' ' 226' ' ' GLY . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.923 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.746 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.822 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.732 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.507 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.652 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 1.214 ' N ' HG21 ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.827 ' OE2' HD11 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.699 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.778 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 1.141 HG21 ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.71 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.467 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.76 ' H ' HG23 ' A' ' 248' ' ' THR . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.71 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.956 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 165' ' ' SER . 0.3 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.076 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.08 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.703 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.682 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 1.2 pt20 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 mtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.513 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.4 -97.41 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -155.67 101.66 2.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.0 p -101.41 34.12 2.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.04 -167.4 29.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.0 -107.39 1.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.15 -158.36 14.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.99 -77.76 0.88 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.0 m -100.78 111.04 23.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -1.168 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.29 75.04 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.95 175.0 28.39 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.23 -12.86 20.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.53 136.81 21.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 18' ' ' ILE . 2.5 m -58.83 138.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.278 -1.131 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.795 HG22 HD11 ' A' ' 18' ' ' ILE . 1.4 t -48.46 -35.59 13.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . 179.77 -24.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.61 ' HA ' ' OE1' ' A' ' 57' ' ' GLN . 4.3 p-10 -162.51 39.37 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 110.177 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.795 HD11 HG22 ' A' ' 15' ' ' THR . 15.7 mm -69.7 -23.99 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -79.26 36.18 1.97 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.754 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.913 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.805 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.064 HD12 ' N ' ' A' ' 31' ' ' ASP . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 1.064 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.68 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.007 ' O ' HD11 ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' HG2' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.02 ' CB ' HD22 ' A' ' 30' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 1.049 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.007 HD11 ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.149 HD21 ' CB ' ' A' ' 67' ' ' ASP . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 1.085 ' O ' HD12 ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.684 ' O ' HG21 ' A' ' 88' ' ' ILE . 10.1 p-10 -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.696 HD13 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.823 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' OE1' ' HA ' ' A' ' 17' ' ' ASP . 2.6 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.913 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 31.1 t30 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.149 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 39' ' ' SER . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.697 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.619 HG21 ' CE1' ' A' ' 105' ' ' TYR . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.61 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.964 HG23 ' OG ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.907 ' HG3' HG22 ' A' ' 85' ' ' ILE . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.99 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.688 HG11 ' CD ' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.577 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.105 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.105 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.99 ' HB ' HD12 ' A' ' 88' ' ' ILE . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 96' ' ' THR . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.964 ' OG ' HG23 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.664 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.62 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.982 ' HD2' ' HB2' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.448 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.982 ' HB2' ' HD2' ' A' ' 106' ' ' LYS . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.824 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.669 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 118' ' ' GLU . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.691 ' N ' HG22 ' A' ' 117' ' ' THR . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.543 ' HB2' ' OE2' ' A' ' 118' ' ' GLU . 36.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -117.57 175.6 1.95 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.691 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.2 Cg_endo -96.69 -73.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.958 2.439 . . . . 0.0 110.925 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.724 ' CD ' ' CE1' ' A' ' 125' ' ' HIS . 22.2 tt0 -11.01 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.791 1.281 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.829 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.8 m80 -132.0 81.04 1.94 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.39 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.829 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.99 4.11 4.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 110.591 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 1.065 ' O ' ' HE2' ' A' ' 129' ' ' MET . 5.2 mmtt -73.57 179.92 3.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.518 -1.364 . . . . 0.0 109.528 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 1.065 ' HE2' ' O ' ' A' ' 128' ' ' LYS . 9.3 mmt -141.16 125.36 17.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.78 ' O ' HG23 ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.669 ' HA ' ' N ' ' A' ' 113' ' ' THR . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.888 HD12 ' C ' ' A' ' 140' ' ' ILE . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.264 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.117 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 1.117 ' CD ' HD23 ' A' ' 150' ' ' LEU . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.904 ' HA ' ' HB3' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 1.003 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.963 HG23 ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.653 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.681 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.764 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.85 ' HB2' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.711 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.963 ' O ' HG23 ' A' ' 161' ' ' THR . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.214 ' CD2' ' HB2' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.974 ' OH ' HD22 ' A' ' 257' ' ' LEU . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.071 HG21 ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.626 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.98 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.858 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.698 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.846 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.673 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 192' ' ' SER . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 168' ' ' ALA . 3.4 pp -94.02 -32.14 13.94 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 20.7 mttt -133.8 -7.98 2.77 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.392 0.615 . . . . 0.0 110.178 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 189' ' ' HIS . 0.6 OUTLIER 179.94 144.71 0.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 189' ' ' HIS . 45.2 Cg_endo -72.17 80.27 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.042 1.549 . . . . 0.0 110.436 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.5 -42.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.477 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.85 ' HB2' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -110.42 22.6 15.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.969 . . . . 0.0 110.683 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.855 HG13 ' CA ' ' A' ' 220' ' ' TYR . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.698 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.272 HD22 ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.963 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.101 HG12 ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.071 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.663 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 1.139 ' CG ' HG13 ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.609 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.988 ' CD2' ' HE2' ' A' ' 211' ' ' HIS . 0.9 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.988 ' HE2' ' CD2' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.83 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.139 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.855 ' CG2' HD21 ' A' ' 230' ' ' LEU . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 1.101 ' C ' HG12 ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.855 ' CA ' HG13 ' A' ' 197' ' ' VAL . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.689 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.694 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.272 ' CE1' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.855 HD21 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.83 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.732 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 1.264 ' N ' HG21 ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.824 ' CD ' HD21 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.073 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.661 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.709 HG22 ' N ' ' A' ' 249' ' ' ALA . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.709 ' N ' HG22 ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.903 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.903 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.764 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.0 OUTLIER -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.073 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.724 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.974 HD22 ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.49 ' C ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 1.214 ' HB2' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.677 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.25 -82.69 0.33 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.4 p -147.25 88.08 1.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.4 m -162.07 116.33 1.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.98 121.14 1.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.16 24.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.58 101.45 2.36 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.7 -102.09 0.18 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -151.43 101.17 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -1.138 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.51 -126.98 0.86 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 134.87 12.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.45 64.03 3.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 128.13 2.97 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 14' ' ' VAL . 3.4 t -58.93 173.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 110.242 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.899 ' OG1' HD12 ' A' ' 18' ' ' ILE . 53.6 m -84.7 161.49 20.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.893 . . . . 0.0 110.171 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . -71.29 2.1 5.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -162.43 44.71 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.007 -1.058 . . . . 0.0 110.704 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -107.81 -77.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.926 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.983 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -63.19 62.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.865 HG22 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.668 ' HB ' ' HB1' ' A' ' 59' ' ' ALA . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.754 ' HB3' ' ND2' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.805 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.597 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 48.4 t-80 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD13 ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.01 HD13 ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.594 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.789 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.789 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.693 ' C ' HG21 ' A' ' 88' ' ' ILE . 37.6 p-10 -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' O ' HG23 ' A' ' 20' ' ' THR . 83.9 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' HG22 ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.666 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.834 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 13.6 t30 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.01 ' HB3' HD13 ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.754 ' ND2' ' HB3' ' A' ' 29' ' ' PRO . 17.8 t-20 -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.751 ' HB ' ' CE2' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.923 ' CD1' HD13 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.612 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.756 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.135 ' O ' HD12 ' A' ' 95' ' ' ILE . 18.5 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.756 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.86 HD12 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.612 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.934 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 1.049 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 113' ' ' THR . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.794 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.76 ' NE2' ' OE2' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.685 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.142 HD21 ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.865 HG23 HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.934 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.72 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.644 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.699 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.786 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.7 OUTLIER -125.32 103.96 28.99 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.41 50.13 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.25 1.658 . . . . 0.0 111.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.751 ' C ' ' CG ' ' A' ' 125' ' ' HIS . 6.7 mt-10 -95.14 -27.66 15.45 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.356 1.074 . . . . 0.0 108.656 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.751 ' CG ' ' C ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -76.89 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.402 ' HA ' ' NZ ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -122.73 17.36 10.29 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.698 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.8 OUTLIER -104.38 5.4 34.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.1 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.786 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.76 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.109 -0.994 . . . . 0.0 111.468 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.698 ' N ' ' O ' ' A' ' 127' ' ' GLU . 2.9 tpp -157.02 138.92 14.33 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.975 . . . . 0.0 110.161 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.749 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.451 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 133' ' ' ARG . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.659 HD13 ' CE2' ' A' ' 163' ' ' PHE . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.58 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.963 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.685 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 41.6 m80 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.793 HG21 ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.208 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.841 ' CG ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.803 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.578 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.767 ' HB1' ' HE1' ' A' ' 158' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 258' ' ' ALA . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.425 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.557 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.618 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.725 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.862 HD13 ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.862 ' CE1' HD13 ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.963 ' CD1' HG11 ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.803 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.997 ' HD2' ' HB1' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.858 ' CE1' ' O ' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 1.064 ' O ' HD22 ' A' ' 199' ' ' LEU . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.725 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.69 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -39.8 175.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -4.84 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.568 -0.708 . . . . 0.0 111.976 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.799 ' HB3' HD13 ' A' ' 195' ' ' LEU . 7.0 t -145.74 124.54 6.6 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.87 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.68 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 48.2 Cg_endo -75.38 13.27 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.21 1.637 . . . . 0.0 110.013 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.01 -27.83 11.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.7 mp -84.81 8.26 17.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.772 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.991 ' CG1' HG12 ' A' ' 218' ' ' VAL . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.687 ' C ' HD13 ' A' ' 199' ' ' LEU . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.018 ' CG1' HG23 ' A' ' 214' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.006 ' OH ' HD13 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.683 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.756 ' CA ' HG22 ' A' ' 213' ' ' VAL . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.629 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.208 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.756 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.018 HG23 ' CG1' ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.029 HG13 HD12 ' A' ' 199' ' ' LEU . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.787 ' CB ' HG22 ' A' ' 197' ' ' VAL . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.751 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.748 ' C ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.809 ' CE2' HD13 ' A' ' 257' ' ' LEU . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.006 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.793 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 145' ' ' THR . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.782 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 1.142 ' CD ' HD21 ' A' ' 112' ' ' LEU . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 230' ' ' LEU . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.153 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.516 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 1.011 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.765 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.765 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 0.1 OUTLIER 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.875 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.875 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.8 m-70 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.153 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.826 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.772 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 5.3 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.259 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.99 -130.86 1.5 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -154.04 131.39 11.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.4 m -153.7 121.58 6.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.62 -96.77 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.35 -103.65 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.71 160.85 30.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.3 -145.57 4.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -153.22 -171.32 3.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.19 61.26 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.52 67.43 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.5 -165.9 3.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.93 143.25 17.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 18' ' ' ILE . 2.1 m -58.97 155.04 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.261 -1.14 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.936 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.8 t -95.01 173.83 7.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 6.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 0.0 110.674 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.936 ' H ' HG23 ' A' ' 15' ' ' THR . 1.0 OUTLIER -133.51 43.92 2.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.089 -1.007 . . . . 0.0 110.637 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.956 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.66 -78.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 1.067 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -118.4 -44.35 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.038 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.643 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.617 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.622 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.665 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HG ' ' C ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.746 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 7.2 p-10 -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.739 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.822 ' NE2' ' NH1' ' A' ' 81' ' ' ARG . 78.8 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 1.038 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.739 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.624 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 18.9 t30 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 41' ' ' THR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.686 HD23 ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.665 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.676 ' HB ' HD13 ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.676 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.704 ' HA ' ' CD ' ' A' ' 260' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.822 ' NH1' ' NE2' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.746 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.702 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG11 ' CD ' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.62 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.141 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.141 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.755 ' O ' HD12 ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.686 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.698 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.832 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HD2' HD22 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.006 HD23 HD12 ' A' ' 140' ' ' ILE . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.832 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.593 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.698 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.751 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.4 t0 -117.55 179.14 0.86 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.1 Cg_endo -95.08 12.04 1.5 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.823 1.682 . . . . 0.0 111.49 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -111.39 -105.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.784 -1.198 . . . . 0.0 110.911 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.717 ' ND1' ' N ' ' A' ' 126' ' ' SER . 4.7 p80 -156.62 -31.8 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.562 -0.711 . . . . 0.0 110.416 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.717 ' N ' ' ND1' ' A' ' 125' ' ' HIS . 22.3 t -81.62 -34.14 31.04 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.442 -0.786 . . . . 0.0 109.247 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.688 ' O ' ' N ' ' A' ' 122' ' ' ASP . 6.6 mt-10 -116.02 0.45 13.02 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.516 0.674 . . . . 0.0 109.311 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.751 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.04 -4.34 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.947 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.42 127.49 6.26 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.952 178.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.594 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.701 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.006 HD12 HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.635 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 211' ' ' HIS . 3.5 m80 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.613 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.103 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 1.103 ' CD ' HD23 ' A' ' 150' ' ' LEU . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.935 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.624 ' HA ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.747 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 176' ' ' ILE . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.695 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB3' ' HA3' ' A' ' 170' ' ' GLY . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.742 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.474 ' CA ' HG22 ' A' ' 255' ' ' ILE . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.727 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.858 HD22 ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.049 ' CE2' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.795 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.747 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.795 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 176' ' ' ILE . 11.6 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.721 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 31.5 p80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.733 HG22 ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.708 ' HB2' HD23 ' A' ' 190' ' ' LEU . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.133 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -95.2 -99.82 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.578 ' HA ' ' CD ' ' A' ' 188' ' ' GLU . 5.8 mtmt -168.3 -28.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.767 ' CB ' HD13 ' A' ' 195' ' ' LEU . 1.3 m -42.04 136.25 2.21 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.457 -0.777 . . . . 0.0 110.084 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.516 ' HG2' ' OE2' ' A' ' 194' ' ' GLU . 45.1 Cg_endo -72.38 44.75 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.036 1.545 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.516 ' OE2' ' HG2' ' A' ' 193' ' ' PRO . 8.7 mp0 -154.4 -30.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.133 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp -86.48 2.05 49.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.959 HG11 HG12 ' A' ' 218' ' ' VAL . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.221 ' CD2' HG22 ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.02 HG11 HG23 ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.072 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.7 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.743 ' OD1' HG13 ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.884 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.743 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.02 HG23 HG11 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.724 ' N ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.865 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.221 HG22 ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.785 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.829 ' N ' HG13 ' A' ' 197' ' ' VAL . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.731 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.646 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.029 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . 1.009 ' C ' HD12 ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.107 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.884 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.702 ' CE1' HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.678 ' HA2' ' CG ' ' A' ' 239' ' ' GLU . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.635 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.716 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.864 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.841 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 249' ' ' ALA . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 1.091 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 1.091 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.2 m-70 -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.107 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.695 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 1.6 pm0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.242 0.544 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.48 137.18 4.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.2 m -148.75 103.25 3.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -1.143 . . . . 0.0 110.227 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 p -156.02 -59.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.36 -178.64 44.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.76 143.19 19.74 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 138.64 21.14 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.43 -168.84 20.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 p -103.59 116.74 32.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.82 111.27 3.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.37 52.41 0.53 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.75 93.11 0.09 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.18 20.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 15' ' ' THR . 5.5 t -58.81 -176.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.709 ' H ' HG12 ' A' ' 14' ' ' VAL . 8.0 t -59.06 162.87 3.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.28 -1.1 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' H ' HG23 ' A' ' 15' ' ' THR . 5.1 p-10 -162.34 72.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.213 -0.93 . . . . 0.0 110.253 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.702 HG12 ' CG1' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -59.88 -40.87 84.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -50.08 -73.28 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.102 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.658 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.137 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.402 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.945 HG23 ' HB2' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.736 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 5.1 p-10 -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.483 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.771 HD13 ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 1.102 ' O ' HG22 ' A' ' 20' ' ' THR . 82.6 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 1.137 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 17.3 t30 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.945 ' HB2' HG23 ' A' ' 41' ' ' THR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.696 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.677 HG21 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.991 ' HB2' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.137 HG22 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.767 ' OE1' HD23 ' A' ' 97' ' ' LEU . 16.9 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.736 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.737 HG11 ' CD ' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.113 ' O ' HD12 ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.113 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.009 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.696 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.658 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.494 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.765 HG22 HG23 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.137 ' CE2' HG22 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' CE ' HG21 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 5.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.649 ' OG ' ' HA ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.633 ' O ' HD23 ' A' ' 112' ' ' LEU . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 105' ' ' TYR . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.765 HG23 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.694 ' N ' HD12 ' A' ' 115' ' ' LEU . 6.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.569 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.56 ' N ' HG22 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 22.5 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.7 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.36 170.51 6.29 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.667 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.3 Cg_endo -96.19 -72.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.826 2.351 . . . . 0.0 110.276 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.667 ' C ' ' O ' ' A' ' 123' ' ' PRO . 2.5 mt-10 -13.93 -60.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.818 1.294 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.842 ' O ' ' N ' ' A' ' 127' ' ' GLU . 7.0 m80 -128.72 79.6 1.92 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.6 t -20.74 -33.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.117 0.484 . . . . 0.0 110.871 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.842 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -72.34 2.28 6.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.408 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.728 ' HE2' ' CG ' ' A' ' 125' ' ' HIS . 1.0 OUTLIER -84.25 146.2 27.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.583 -1.323 . . . . 0.0 109.494 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -127.92 137.05 52.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 110.594 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.676 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.646 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.69 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.571 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.92 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.956 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.817 ' C ' ' HE1' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.799 ' O ' ' CE1' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 144' ' ' HIS . 0.2 OUTLIER -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.671 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CD1' ' HG3' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.846 ' HB3' ' OE2' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.968 ' CE1' HG12 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.73 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 164' ' ' GLY . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.77 HD22 HD22 ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.738 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.993 HG21 ' CE1' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.758 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.758 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.984 ' H ' HG22 ' A' ' 176' ' ' ILE . 29.8 t-80 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.581 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.164 HG21 ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.698 ' HB3' ' CB ' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.859 ' HB3' HD23 ' A' ' 190' ' ' LEU . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.94 HD12 ' HB2' ' A' ' 192' ' ' SER . 0.1 OUTLIER -95.97 -161.11 0.84 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.96 ' HA ' HD23 ' A' ' 195' ' ' LEU . 24.0 mmtt -122.6 8.09 9.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.569 -0.707 . . . . 0.0 110.011 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.94 ' HB2' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -47.21 -167.93 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.452 -0.78 . . . . 0.0 110.191 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.736 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.0 Cg_endo -67.03 -1.07 5.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.321 1.169 . . . . 0.0 109.711 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.865 ' OE2' ' CD2' ' A' ' 253' ' ' HIS . 0.7 OUTLIER -137.1 41.31 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.96 HD23 ' HA ' ' A' ' 191' ' ' LYS . 1.2 mp -34.97 -69.65 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.698 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 45.7 m-20 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.176 ' CG1' HG12 ' A' ' 218' ' ' VAL . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.015 HD11 ' CZ ' ' A' ' 228' ' ' TYR . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.054 HG13 ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.993 ' CE1' HG21 ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.982 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.878 ' CG ' HG13 ' A' ' 213' ' ' VAL . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 1.006 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 1.006 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 72.1 m-70 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.098 ' HB3' HG23 ' A' ' 232' ' ' ILE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.878 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.959 HD11 HG23 ' A' ' 240' ' ' VAL . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 1.054 ' C ' HG13 ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.842 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.176 HG12 ' CG1' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.69 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.534 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.733 ' OE2' HG21 ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.643 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.015 ' CZ ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.981 HD21 ' CD1' ' A' ' 257' ' ' LEU . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.098 HG23 ' HB3' ' A' ' 212' ' ' ALA . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.956 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.713 ' CA ' ' HB3' ' A' ' 238' ' ' GLN . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.846 ' OE2' ' HB3' ' A' ' 156' ' ' ALA . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 261' ' ' GLN . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.713 ' HB3' ' CA ' ' A' ' 234' ' ' GLY . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.968 HG12 ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.705 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.93 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.157 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.643 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.555 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.873 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.873 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.5 m-70 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.157 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.981 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.705 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.73 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.89 142.72 17.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 m -102.83 -173.35 2.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -1.127 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -155.23 138.88 16.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.56 81.83 1.67 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.34 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.89 -110.97 0.32 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.69 -167.41 17.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -104.51 -173.15 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.06 -165.7 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.86 101.74 1.96 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.48 -113.54 1.85 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.86 27.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 15' ' ' THR . 3.9 t -58.91 -176.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.758 HG21 HG12 ' A' ' 18' ' ' ILE . 6.9 m -101.39 150.79 22.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.01 1.93 19.32 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.247 -0.908 . . . . 0.0 110.665 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.39 46.59 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.85 -79.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.16 -0.963 . . . . 0.0 109.965 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.951 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -102.53 -45.8 1.62 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 60.5 t-80 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.877 ' O ' HD23 ' A' ' 40' ' ' LEU . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.651 HG22 ' H ' ' A' ' 47' ' ' SER . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 11.8 p-10 -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.059 HD11 HD22 ' A' ' 26' ' ' LEU . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.632 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.895 ' O ' HG22 ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' THR . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.632 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.701 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.823 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 47.5 t30 -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 66' ' ' GLY . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.834 ' HB2' HG23 ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.924 HG22 HD21 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HB2' HD12 ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.697 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 1.182 ' OE1' HD23 ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.001 HG11 ' CD ' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.107 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.107 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.798 ' O ' HD12 ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.182 HD23 ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.771 ' OE1' HG22 ' A' ' 96' ' ' THR . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HA ' ' CB ' ' A' ' 81' ' ' ARG . 1.0 OUTLIER -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HB ' ' A' ' 113' ' ' THR . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.886 ' CB ' HD11 ' A' ' 74' ' ' LEU . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.684 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.931 ' HB ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.799 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.665 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.496 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.661 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.58 169.66 7.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.673 ' O ' ' C ' ' A' ' 124' ' ' GLU . 53.4 Cg_endo -96.03 -72.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.783 2.322 . . . . 0.0 110.25 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.73 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 1.3 mm-40 -14.63 -60.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.785 1.279 . . . . 0.0 109.557 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.848 ' O ' ' N ' ' A' ' 127' ' ' GLU . 4.2 m80 -128.05 79.65 1.91 Allowed 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.7 p -20.85 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.941 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.848 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -73.08 2.83 6.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.098 -1.001 . . . . 0.0 110.492 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -84.37 144.8 28.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.654 -1.279 . . . . 0.0 109.451 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -125.03 132.71 53.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 110.662 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 130' ' ' VAL . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' HB1' ' A' ' 114' ' ' ALA . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.678 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.877 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.914 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.914 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.901 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.666 ' CG ' ' CD ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.583 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.72 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 154' ' ' VAL . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.11 ' HB1' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.11 ' OH ' ' HB1' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.625 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.005 ' CD2' HD22 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.19 ' CZ ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.122 HG21 ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.941 ' CD2' ' HB3' ' A' ' 180' ' ' ALA . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.941 ' HB3' ' CD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.657 ' HG3' ' CD2' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.903 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.657 ' CD2' ' HG3' ' A' ' 182' ' ' GLN . 15.2 p80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.929 HD13 ' OH ' ' A' ' 228' ' ' TYR . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.85 ' HG2' HD21 ' A' ' 196' ' ' ASN . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.7 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.572 ' HG ' ' OG ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -94.83 -159.82 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 193' ' ' PRO . 30.0 mtpt -54.19 -15.11 1.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.029 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.752 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.1 OUTLIER -28.15 88.2 0.04 OUTLIER Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.726 -0.609 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.686 ' N ' ' O ' ' A' ' 191' ' ' LYS . 43.9 Cg_endo -71.29 -2.73 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 109.806 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.747 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 9.5 mt-10 -142.64 0.65 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.539 -0.726 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 195' ' ' LEU . 1.3 mp -111.44 29.69 7.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.85 HD21 ' HG2' ' A' ' 188' ' ' GLU . 11.1 m-20 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.105 HG13 ' C ' ' A' ' 219' ' ' LEU . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.19 HD21 ' CZ ' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.072 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.122 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 1.103 HD12 HG21 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.754 ' CA ' HG12 ' A' ' 213' ' ' VAL . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.565 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.956 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.103 HG21 HD12 ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.057 HG23 HG11 ' A' ' 201' ' ' VAL . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.597 ' CA ' HG22 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.957 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 1.105 ' C ' HG13 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 1.017 ' HB2' HG22 ' A' ' 197' ' ' VAL . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HG2' ' CE2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.579 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.676 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.801 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.127 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.731 ' C ' HD12 ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.936 ' OE2' HD11 ' A' ' 112' ' ' LEU . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.832 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.129 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.952 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.62 HG23 ' H ' ' A' ' 250' ' ' ASN . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.589 ' N ' HG23 ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.62 ' H ' HG23 ' A' ' 248' ' ' THR . 2.5 p-10 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.952 HG23 ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.578 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.129 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.6 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.005 HD22 ' CD2' ' A' ' 172' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 2.6 pm0 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.195 0.521 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.36 64.86 0.31 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 t -155.99 -45.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -134.92 136.01 41.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.65 120.84 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.63 -143.74 4.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.79 -145.71 4.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.09 24.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -155.85 -50.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -1.142 . . . . 0.0 110.167 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.64 67.18 3.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.07 -146.01 19.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.44 -103.56 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.64 146.45 49.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.8 t -58.86 172.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 14.2 t -112.78 -21.76 11.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . 179.79 -115.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.877 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.565 ' HB2' HD21 ' A' ' 74' ' ' LEU . 16.1 t70 -103.39 41.75 1.24 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.272 -0.893 . . . . 0.0 109.931 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.967 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -100.68 -80.21 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.87 0.843 . . . . 0.0 110.151 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.967 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -57.8 -160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.061 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.948 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.767 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.628 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.247 HD21 ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.984 ' O ' HD12 ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' H ' ' A' ' 47' ' ' SER . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.672 ' C ' HG21 ' A' ' 88' ' ' ILE . 28.4 p-10 -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.641 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.034 HD11 HD23 ' A' ' 26' ' ' LEU . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.629 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 20' ' ' THR . 39.3 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.671 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.948 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.924 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.645 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 9.8 t30 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.247 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.6 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.05 ' O ' HG23 ' A' ' 71' ' ' THR . 5.9 m-80 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.05 HG23 ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.191 HG13 ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.749 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.823 HG22 ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.823 ' CD ' HG22 ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.672 HG21 ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.885 HG12 ' H ' ' A' ' 92' ' ' GLY . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.885 ' H ' HG12 ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.921 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.913 HD12 ' OE1' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.921 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.728 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.627 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 80' ' ' SER . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.191 ' CE2' HG13 ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.716 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.584 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 106' ' ' LYS . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' A' ' 137' ' ' ILE . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.627 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' A' ' 132' ' ' LYS . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 127' ' ' GLU . 3.4 m-20 -140.97 104.65 6.19 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 46.7 Cg_endo -73.59 51.03 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.201 1.632 . . . . 0.0 111.327 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.753 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 6.3 mm-40 -95.35 -25.66 16.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.264 1.03 . . . . 0.0 108.801 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.756 ' CD2' ' HG3' ' A' ' 127' ' ' GLU . 0.6 OUTLIER 179.4 -76.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 1.3 t -122.87 17.09 10.17 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.756 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -106.63 6.34 29.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 111.132 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.53 8.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.171 -0.956 . . . . 0.0 111.807 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 1.005 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.17 114.16 3.04 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.488 -0.758 . . . . 0.0 110.073 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.545 ' CG2' ' C ' ' A' ' 129' ' ' MET . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.6 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.568 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.609 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.14 HD12 ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.541 ' O ' ' HE2' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.88 HG21 ' CD2' ' A' ' 233' ' ' PHE . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.011 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HD2' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.772 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.775 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.709 ' HB1' ' CG ' ' A' ' 235' ' ' GLU . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 174' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.688 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.71 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.768 ' HZ ' ' HE2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.76 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' CG ' ' HD3' ' A' ' 193' ' ' PRO . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.678 ' C ' ' HB3' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.813 ' N ' ' HB3' ' A' ' 162' ' ' ALA . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.942 ' O ' HG23 ' A' ' 157' ' ' THR . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.718 ' C ' HD13 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.006 HD12 ' CA ' ' A' ' 183' ' ' GLY . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.738 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.972 ' CE2' ' HB3' ' A' ' 180' ' ' ALA . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 178' ' ' PHE . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.972 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.755 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 1.006 ' CA ' HD12 ' A' ' 176' ' ' ILE . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.89 HG21 HG11 ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.703 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.832 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.2 OUTLIER -32.79 -107.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -79.69 -0.97 36.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 110.768 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.832 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 1.0 OUTLIER -60.7 173.66 0.62 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.623 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 46.9 Cg_endo -74.05 36.65 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.972 1.512 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 1.113 ' CD ' HG21 ' A' ' 246' ' ' VAL . 4.3 mt-10 -168.93 43.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.179 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -5.32 -69.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.185 HG21 ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.289 ' CD2' HG22 ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.877 HG22 ' HA3' ' A' ' 216' ' ' GLY . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 1.144 ' CE1' HG23 ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.576 HG13 ' HB ' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.903 ' CA ' HG22 ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.951 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.951 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.011 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.903 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.144 HG23 ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.784 ' C ' HG13 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.877 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.289 HG22 ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.734 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 1.185 ' OE1' HG21 ' A' ' 197' ' ' VAL . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.875 ' OH ' HD13 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.004 HD21 HD12 ' A' ' 257' ' ' LEU . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.933 ' HB ' HD11 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.88 ' CD2' HG21 ' A' ' 145' ' ' THR . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 145' ' ' THR . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.688 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.681 ' CD ' HD21 ' A' ' 112' ' ' LEU . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 158' ' ' TYR . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.94 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.191 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 1.113 HG21 ' CD ' ' A' ' 194' ' ' GLU . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 1.6 p-10 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.87 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 247' ' ' GLU . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.87 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.6 m-70 -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.191 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.004 HD12 HD21 ' A' ' 230' ' ' LEU . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 172' ' ' LEU . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.246 0.546 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.76 -47.59 3.14 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -161.91 122.95 2.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -1.181 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -135.11 34.88 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -38.89 63.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.79 152.03 23.93 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.84 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.81 -129.72 1.4 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -153.79 146.53 24.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -1.132 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.47 -106.82 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.06 90.85 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.89 3.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.717 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -107.43 84.48 0.38 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.832 HG13 ' HE3' ' A' ' 75' ' ' LYS . 46.1 t -161.96 -178.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.08 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 17' ' ' ASP . 11.5 t -102.39 169.12 8.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -1.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.407 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.777 ' H ' HG23 ' A' ' 15' ' ' THR . 1.1 m-20 -162.33 83.22 0.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.667 HG12 HG11 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -55.16 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 18' ' ' ILE . . . -36.88 -66.67 0.48 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.079 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.899 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 1.079 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD22 ' C ' ' A' ' 36' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 1.094 ' C ' HD12 ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.957 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 47.4 p-10 -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.957 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 39.2 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.62 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.699 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.059 ' O ' HD12 ' A' ' 42' ' ' LEU . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.781 ' HB3' HG23 ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.588 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.832 ' HE3' HG13 ' A' ' 14' ' ' VAL . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.686 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.708 HG11 ' CD ' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.618 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.136 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.136 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.987 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.704 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.943 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.814 ' CB ' HD12 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.75 ' NE2' HD21 ' A' ' 112' ' ' LEU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' HD22 ' A' ' 76' ' ' ASN . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.814 HD12 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.6 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.822 HE22 ' HB2' ' A' ' 168' ' ' ALA . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 134' ' ' ARG . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.706 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' A' ' 127' ' ' GLU . 2.5 m-20 -145.17 104.18 4.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 47.9 Cg_endo -74.49 51.17 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.123 1.591 . . . . 0.0 111.25 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 7.9 mm-40 -97.86 -24.91 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 108.918 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER 179.48 -77.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.586 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 0.5 OUTLIER -122.63 17.1 10.37 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.755 ' CG ' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -105.98 4.05 29.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 111.105 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.76 -1.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.95 . . . . 0.0 110.84 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 129' ' ' MET . 6.1 mmt -157.07 112.94 2.91 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.085 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.692 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.6 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.905 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.12 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 1.12 ' ND1' ' HB3' ' A' ' 141' ' ' ALA . 22.0 p-80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.791 ' O ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.761 ' CB ' ' HB2' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.713 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.002 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.729 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB2' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 1.002 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.925 HD22 ' HB3' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.742 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.749 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 1.008 ' CE1' HD21 ' A' ' 150' ' ' LEU . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.761 ' HB2' ' CB ' ' A' ' 153' ' ' ASP . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.493 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 34.7 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.749 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.64 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.691 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 192' ' ' SER . 0.4 OUTLIER -94.55 -156.96 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 17.1 mmmt -137.69 4.97 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.192 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . 1.207 ' O ' HD23 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -56.61 -167.03 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.899 . . . . 0.0 109.962 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.735 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 42.3 Cg_endo -70.47 -0.77 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.587 1.309 . . . . 0.0 109.81 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.627 ' OE2' ' CZ ' ' A' ' 220' ' ' TYR . 13.4 mt-10 -131.75 25.74 4.69 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.646 0.736 . . . . 0.0 109.135 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.207 HD23 ' O ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -35.42 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.749 ' H ' HD12 ' A' ' 195' ' ' LEU . 18.3 m-20 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.211 HG22 ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.64 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.085 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.183 HG22 ' N ' ' A' ' 216' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.957 ' HE2' HD13 ' A' ' 232' ' ' ILE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 1.189 ' OD1' HG13 ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.95 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.189 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.788 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . 1.011 ' C ' HG22 ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 1.183 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.806 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 218' ' ' VAL . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 1.211 ' CG ' HG22 ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.617 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.74 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.933 ' C ' HD12 ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.957 HD13 ' HE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 143' ' ' GLU . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.517 HG12 ' HD2' ' A' ' 158' ' ' TYR . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.989 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.639 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.408 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.784 ' H ' HG22 ' A' ' 248' ' ' THR . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.665 ' ND2' ' O ' ' A' ' 250' ' ' ASN . 0.6 OUTLIER 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.863 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.863 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 1.4 m-70 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.989 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.925 ' HB3' HD22 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.713 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.251 0.548 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.32 -143.46 5.9 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -100.36 115.69 30.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 t -154.92 -179.93 8.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.258 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.06 -162.21 11.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.21 104.46 2.48 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.96 113.14 0.55 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.06 102.18 2.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -102.05 124.1 47.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -1.109 . . . . 0.0 110.231 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.0 -134.1 1.59 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.65 54.34 2.48 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.88 91.81 0.44 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.2 -139.07 0.84 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 15' ' ' THR . 4.5 t -58.84 174.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.695 ' CB ' HG12 ' A' ' 18' ' ' ILE . 19.5 m -84.35 161.75 20.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.76 39.59 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -162.54 45.44 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.11 -0.994 . . . . 0.0 110.698 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.948 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -98.77 -79.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.948 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -128.22 7.02 6.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.773 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.831 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.116 HD13 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 1.196 HG23 ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' SER . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.755 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.745 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 23.9 p-10 -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.583 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.975 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t30 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.777 ' O ' HD13 ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.196 ' OG ' HG23 ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 1.064 ' O ' HG23 ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.678 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.18 HG22 ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.816 ' O ' HG23 ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' C ' ' HG2' ' A' ' 87' ' ' GLN . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.702 ' NE2' HD13 ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.681 HG11 ' CD ' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.573 ' N ' HG12 ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.091 ' O ' HD12 ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.091 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.802 ' O ' HD12 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.666 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.897 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.18 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG3' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.916 ' NE2' HD21 ' A' ' 112' ' ' LEU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.671 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.897 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 3.4 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 117' ' ' THR . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.49 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.693 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.28 177.72 1.23 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.684 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.6 Cg_endo -97.7 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.91 2.407 . . . . 0.0 110.834 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.5 mm-40 -11.56 -59.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.834 1.302 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.825 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.6 m80 -132.68 80.77 1.91 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.57 -35.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.175 0.512 . . . . 0.0 110.827 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.825 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -71.1 2.91 3.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.541 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 122' ' ' ASP . 4.5 mmtt -71.84 -172.79 0.88 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.584 -1.322 . . . . 0.0 109.533 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -155.61 124.15 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.751 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.567 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.877 ' HD3' HD12 ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.62 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 113' ' ' THR . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.671 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.663 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.731 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.731 ' N ' HD23 ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.483 ' CA ' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 155' ' ' MET . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.928 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.722 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.016 HG21 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.672 ' CB ' ' CE1' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.794 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.891 ' HE1' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.891 HD12 HD13 ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.928 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.722 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 24.0 p80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.702 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.848 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.81 -103.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 5.6 mtmt -162.68 -30.2 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.608 -0.683 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.595 ' HB3' HD13 ' A' ' 195' ' ' LEU . 27.9 t -45.07 139.79 3.87 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 110.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.604 ' HA ' ' ND2' ' A' ' 196' ' ' ASN . 46.3 Cg_endo -72.51 43.79 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.929 1.489 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.69 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 8.0 tt0 -142.14 -27.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 110.555 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.7 mp -104.94 20.65 18.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.337 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 1.1 m-20 -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.891 HG13 ' N ' ' A' ' 220' ' ' TYR . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.891 HD13 ' HE1' ' A' ' 174' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.05 HG22 ' N ' ' A' ' 216' ' ' GLY . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.902 ' CE2' ' HB1' ' A' ' 212' ' ' ALA . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.601 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 17.8 p80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.681 ' HE1' ' CE1' ' A' ' 210' ' ' HIS . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.889 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.794 ' N ' HG13 ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 1.05 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 228' ' ' TYR . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.891 ' N ' HG13 ' A' ' 197' ' ' VAL . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 1.01 ' HG2' HG21 ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.64 ' C ' HG23 ' A' ' 246' ' ' VAL . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.85 ' N ' HG23 ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.964 ' HB2' HG23 ' A' ' 218' ' ' VAL . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.545 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.165 HD12 ' CG2' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.716 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 1.165 ' CG2' HD12 ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.669 ' HB3' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.799 ' N ' HD12 ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.56 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 224' ' ' GLU . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.747 ' H ' HG22 ' A' ' 248' ' ' THR . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.932 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.729 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.1 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.672 ' CE1' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.855 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.721 HD13 ' HE2' ' A' ' 228' ' ' TYR . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.722 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.709 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.617 ' O ' ' HE2' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.212 0.53 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.28 68.71 0.33 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -151.66 100.91 2.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 110.263 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 t -158.23 33.41 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.92 -154.48 6.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.29 137.75 6.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.95 21.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.19 90.33 1.31 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.1 p -153.26 154.39 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -1.114 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.86 -144.62 3.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.77 60.25 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.11 49.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.59 -42.56 0.87 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.1 m -58.93 169.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.225 -1.162 . . . . 0.0 110.395 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 18' ' ' ILE . 8.5 m -69.99 153.58 43.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.336 -0.852 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.57 1.01 24.0 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.261 -0.9 . . . . 0.0 110.623 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.5 46.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.111 -0.993 . . . . 0.0 110.641 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.94 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.58 -79.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.151 -0.968 . . . . 0.0 109.942 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.94 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -120.25 -46.54 0.37 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.076 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.728 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.305 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.87 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.611 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.76 ' O ' HD12 ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.691 HD11 ' OD2' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.688 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.899 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.305 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.656 ' HB2' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 1.076 ' O ' HG22 ' A' ' 20' ' ' THR . 34.8 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.87 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' HD11 ' A' ' 54' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 11.7 t30 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 1.052 ' CB ' HD21 ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.832 ' HB ' HD12 ' A' ' 74' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.832 HD12 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.151 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.68 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.984 HG11 ' NE2' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 90' ' ' VAL . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 95' ' ' ILE . 25.4 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.105 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.649 ' O ' HD12 ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.105 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.596 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.962 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.808 HG22 HG23 ' A' ' 113' ' ' THR . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.151 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.584 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.508 ' H ' ' HG ' ' A' ' 108' ' ' SER . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.707 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.808 HG23 HG22 ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.425 HD12 ' HE ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 1.036 ' NE2' ' HB1' ' A' ' 168' ' ' ALA . 40.5 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.775 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 24.3 m-20 -122.34 104.37 37.63 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.689 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 42.8 Cg_endo -70.11 104.06 1.32 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.197 1.63 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.772 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 35.7 mt-10 -163.24 -34.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.071 0.938 . . . . 0.0 108.945 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.772 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -178.27 -77.46 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.858 0.837 . . . . 0.0 108.795 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.591 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 7.9 t -122.64 17.66 10.36 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -103.26 -6.99 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.402 -0.811 . . . . 0.0 111.068 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.775 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.49 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.333 -0.854 . . . . 0.0 111.71 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER -157.0 137.54 13.09 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 110.246 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' H ' ' HB ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.743 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HE ' HD12 ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.827 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.061 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.59 ' O ' ' HB2' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.804 HG23 ' CB ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.069 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 1.061 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.061 HD23 ' CD ' ' A' ' 149' ' ' LYS . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 1.005 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.581 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 1.057 ' CE2' HD13 ' A' ' 232' ' ' ILE . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.894 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.714 ' C ' HD21 ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.65 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.645 ' HB3' ' CB ' ' A' ' 191' ' ' LYS . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 1.036 ' HB1' ' NE2' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.679 ' N ' ' HD2' ' A' ' 191' ' ' LYS . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.827 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.616 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.06 HD13 ' HB3' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.12 HD13 ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.858 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.005 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.858 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 1.12 ' CA ' HD13 ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.695 HG21 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -95.23 150.41 20.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.735 ' N ' HD12 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -45.83 -72.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.697 ' HB2' HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -37.85 171.57 0.02 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.918 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.603 ' HG2' ' OE2' ' A' ' 194' ' ' GLU . 44.9 Cg_endo -71.79 -14.48 29.85 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.98 1.516 . . . . 0.0 110.199 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.658 ' O ' HD23 ' A' ' 190' ' ' LEU . 56.1 mp0 -87.88 30.69 0.82 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 109.244 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.94 HD12 ' N ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -46.89 -13.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 111.364 -179.177 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.514 ' H ' HD12 ' A' ' 195' ' ' LEU . 4.8 m120 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 220' ' ' TYR . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 220' ' ' TYR . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.087 ' CD2' HG22 ' A' ' 218' ' ' VAL . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.631 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.119 HG13 ' C ' ' A' ' 215' ' ' SER . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.91 ' HE1' ' HB1' ' A' ' 212' ' ' ALA . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 1.011 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 5.6 p-80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 1.011 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 5.9 m-70 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . 1.119 ' C ' HG13 ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.954 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.087 HG22 ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.666 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.989 ' HB2' HG13 ' A' ' 197' ' ' VAL . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.686 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.601 ' OE1' ' HB3' ' A' ' 194' ' ' GLU . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.597 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.708 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.066 ' CD2' HG21 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.042 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.057 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 1.061 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.551 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 1.042 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.059 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 253' ' ' HIS . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.691 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.86 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.059 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.67 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.06 ' HB3' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.894 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 2.3 pt20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.63 -115.15 0.51 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -99.52 94.29 6.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.172 . . . . 0.0 110.171 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -120.65 -170.18 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.32 -130.05 1.14 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.24 -172.73 49.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 67.07 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.16 78.63 1.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -94.52 151.72 19.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -1.14 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.42 94.4 1.55 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.77 145.23 20.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.17 178.71 20.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.48 -169.99 3.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.1 m -58.97 -179.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.7 ' CB ' HG12 ' A' ' 18' ' ' ILE . 11.1 m -72.2 156.28 39.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.12 0.14 29.3 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 110.621 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 16.4 t70 -162.47 46.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.063 -1.023 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.92 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.01 -79.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.147 -0.971 . . . . 0.0 109.982 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.92 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -107.46 -45.71 1.12 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.096 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.1 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.744 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' O ' ' CG ' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.704 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.69 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.847 ' O ' HD22 ' A' ' 40' ' ' LEU . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.549 ' HB2' ' N ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 1.001 ' HA ' HD21 ' A' ' 65' ' ' ASN . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 88' ' ' ILE . 25.2 p-10 -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.1 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.789 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 1.096 ' O ' HG22 ' A' ' 20' ' ' THR . 45.0 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.588 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 1.001 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.4 t30 -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.704 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.678 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.118 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.679 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.874 ' CG ' HD13 ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 1.018 HG22 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.657 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 1.018 ' CG ' HG22 ' A' ' 85' ' ' ILE . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG21 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.122 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.122 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 97' ' ' LEU . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 96' ' ' THR . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.607 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.581 ' OE1' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.955 ' O ' HG12 ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.678 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.851 ' OE1' ' HB1' ' A' ' 237' ' ' ALA . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.621 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.018 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.745 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.506 HE21 ' HE2' ' A' ' 135' ' ' PHE . 21.7 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.681 HG22 ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.681 ' N ' HG22 ' A' ' 117' ' ' THR . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 1.1 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -119.96 -171.84 0.22 Allowed Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.61 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 53.2 Cg_endo -92.94 23.11 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.593 1.529 . . . . 0.0 114.376 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.742 ' HB3' ' CD2' ' A' ' 125' ' ' HIS . 6.2 mt-10 -150.63 -102.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.652 -1.905 . . . . 0.0 112.16 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -131.28 -97.02 0.33 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.65 ' C ' ' O ' ' A' ' 125' ' ' HIS . 3.7 m -36.32 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' C ' ' CB ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -115.36 74.14 0.87 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.039 176.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.754 ' CE ' HG21 ' A' ' 130' ' ' VAL . 7.2 pttt -135.39 -149.17 0.33 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.448 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -121.77 110.74 16.29 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.043 -1.035 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG21 ' CE ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.018 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.121 ' HB3' ' ND1' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 1.121 ' ND1' ' HB3' ' A' ' 141' ' ' ALA . 22.2 p-80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.977 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.626 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.783 ' O ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 152' ' ' LYS . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.858 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.606 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 170' ' ' GLY . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.679 ' HB3' ' CD2' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 1.069 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.912 ' HA2' HD11 ' A' ' 187' ' ' ILE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 161' ' ' THR . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.711 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.938 HD13 ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.994 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 1.056 HG23 ' O ' ' A' ' 182' ' ' GLN . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.946 ' OD1' ' HB3' ' A' ' 180' ' ' ALA . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.858 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.946 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 179' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 1.056 ' O ' HG23 ' A' ' 176' ' ' ILE . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.692 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 2.5 t-80 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.144 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 1.144 ' N ' HD12 ' A' ' 187' ' ' ILE . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.761 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.069 HD23 ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -41.23 178.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -60.6 0.57 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.464 -0.773 . . . . 0.0 111.953 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 195' ' ' LEU . 3.2 m -151.16 125.74 4.59 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.801 -1.187 . . . . 0.0 110.967 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 48.9 Cg_endo -74.47 11.59 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.947 1.498 . . . . 0.0 110.16 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.98 -26.79 12.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.369 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.5 mp -86.12 10.62 13.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.849 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.698 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.997 HG13 ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.056 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.989 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.826 HG22 HG21 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.788 ' CA ' HG22 ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.584 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.005 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 204' ' ' ILE . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.942 HG23 HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.698 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 199' ' ' LEU . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.997 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.947 ' HB2' HG22 ' A' ' 197' ' ' VAL . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.056 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . 1.189 ' C ' HD12 ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.189 HD12 ' C ' ' A' ' 229' ' ' SER . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 1.013 HG13 HG23 ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.851 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 156' ' ' ALA . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 1.11 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.909 HG12 ' CE1' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.575 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.909 ' CE1' HG12 ' A' ' 246' ' ' VAL . 0.1 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 1.11 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.051 ' CD1' HD11 ' A' ' 230' ' ' LEU . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.2 mm100 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.3 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.296 0.569 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.22 121.15 5.34 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -153.79 174.03 15.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -153.97 105.05 2.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.34 -144.54 10.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.43 149.61 20.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.39 154.13 27.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.23 -107.86 0.33 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.8 p -149.59 -60.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -1.132 . . . . 0.0 110.21 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.41 70.24 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.16 56.21 0.31 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.53 176.71 0.63 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.94 165.03 38.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 18' ' ' ILE . 2.3 m -58.94 153.93 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.313 -1.11 . . . . 0.0 110.338 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.896 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.8 t -84.03 174.25 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.08 6.38 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 110.69 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.896 ' H ' HG23 ' A' ' 15' ' ' THR . 12.7 m-20 -133.47 42.94 2.95 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.116 -0.99 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.2 mt -115.62 -79.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 0.0 109.996 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -140.64 16.09 2.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.749 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.919 ' HB1' ' N ' ' A' ' 59' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.899 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.796 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 38' ' ' LYS . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.593 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HB3' HD12 ' A' ' 30' ' ' LEU . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.753 ' O ' HD22 ' A' ' 40' ' ' LEU . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.753 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.9 HG23 ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.787 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.666 ' CA ' HG13 ' A' ' 88' ' ' ILE . 11.9 p-10 -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 26' ' ' LEU . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.599 ' CA ' ' CB ' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.919 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.612 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.74 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.662 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 15.8 t30 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.9 ' HB2' HG23 ' A' ' 41' ' ' THR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.64 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.073 ' CB ' HD21 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.073 HD21 ' CB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 2.3 m120 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.7 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.737 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 1.061 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' A' ' 85' ' ' ILE . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.91 ' CD1' HD22 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.673 HG11 ' CD ' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.145 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.91 HD22 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.145 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.061 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.608 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.925 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.91 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.707 ' NE2' HD21 ' A' ' 112' ' ' LEU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.653 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' HG3' ' A' ' 119' ' ' GLN . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 2.8 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.741 ' N ' ' O ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -142.11 104.69 5.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 122' ' ' ASP . 48.1 Cg_endo -74.7 48.08 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.238 1.652 . . . . 0.0 111.414 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.757 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -88.0 -40.27 14.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.384 1.088 . . . . 0.0 108.353 178.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.757 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 13.0 m80 -164.35 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.24 17.07 9.11 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.741 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mt-10 -106.2 9.57 32.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 111.595 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -57.14 -0.57 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.121 -0.987 . . . . 0.0 111.17 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.601 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -156.77 125.44 5.82 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.233 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 1.045 HD12 ' O ' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.906 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.653 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.6 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.237 HG21 ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 1.02 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.61 ' CD ' ' C ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.098 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 1.098 ' CD ' HD23 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 1.21 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.746 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.981 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.924 ' C ' HD21 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.895 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.731 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.71 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' C ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 1.249 ' CE1' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.996 HG21 ' CE1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.753 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.981 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 1.21 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.753 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.652 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.542 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.142 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.645 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.126 HD11 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.16 -103.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -164.88 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 110.74 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.627 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -53.02 132.88 49.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 110.045 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.0 Cg_endo -71.37 46.12 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.958 1.504 . . . . 0.0 110.004 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.417 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -149.86 -32.3 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 110.334 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HB2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp -91.08 6.93 42.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.313 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.715 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.943 ' CG2' HG23 ' A' ' 187' ' ' ILE . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.249 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.013 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.934 ' CG1' HG23 ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.996 ' CE1' HG21 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.685 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.665 ' CB ' HG22 ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.593 ' HA ' ' OE1' ' A' ' 208' ' ' GLU . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 1.02 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.685 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 240' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 1.051 HG22 ' HB2' ' A' ' 199' ' ' LEU . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 218' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.777 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.432 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.142 ' OH ' HD13 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.926 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.059 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.79 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 1.237 ' N ' HG21 ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 1.059 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.992 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.599 HG22 ' N ' ' A' ' 249' ' ' ALA . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.599 ' N ' HG22 ' A' ' 248' ' ' THR . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 251' ' ' GLY . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.513 ' NE2' ' OG1' ' A' ' 248' ' ' THR . 1.2 m-70 -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.992 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.814 HD23 ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.791 ' HB2' HD12 ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 9.1 mm100 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.238 0.542 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.03 -128.93 2.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 t -153.31 115.2 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -1.104 . . . . 0.0 110.205 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -101.04 148.33 25.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.05 -94.66 0.1 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.81 5.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.96 -54.48 3.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.39 -69.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -102.26 -51.11 3.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 43.07 0.26 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.94 140.93 4.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.43 112.35 0.52 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.16 157.66 35.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG12 ' H ' ' A' ' 15' ' ' THR . 6.1 t -58.91 -172.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -1.167 . . . . 0.0 110.21 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.835 ' H ' HG12 ' A' ' 14' ' ' VAL . 9.1 m -105.15 154.34 20.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.8 0.74 25.78 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.308 -0.87 . . . . 0.0 110.577 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -162.4 46.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -0.999 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.3 -79.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.946 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -91.44 -60.82 1.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.122 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.998 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 1.122 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.617 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.619 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 1.008 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.603 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.774 ' HB3' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' THR . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 14.6 t30 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.843 ' HB2' HG23 ' A' ' 41' ' ' THR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.7 m-80 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.83 ' HB ' HD13 ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.669 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' HD23 ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.008 HD11 ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.902 HG11 ' CD ' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.522 ' N ' HG12 ' A' ' 90' ' ' VAL . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 1.067 ' O ' HD12 ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.095 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.631 ' O ' HD12 ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.095 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.688 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.58 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.68 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 1.004 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.843 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.03 ' CD1' ' HB1' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD12 ' NH1' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.713 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 37.1 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.9 pt20 -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' CB ' ' HG2' ' A' ' 127' ' ' GLU . 0.5 OUTLIER -117.27 -171.36 0.2 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.711 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 53.1 Cg_endo -89.93 35.98 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.67 1.58 . . . . 0.0 110.917 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.713 ' O ' ' N ' ' A' ' 127' ' ' GLU . 35.1 mt-10 -164.09 96.86 0.81 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.114 -0.991 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.756 ' N ' ' HB3' ' A' ' 128' ' ' LYS . 70.3 m-70 -12.78 -52.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.744 0.783 . . . . 0.0 111.158 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 124' ' ' GLU . 34.2 t -51.59 -41.51 61.26 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.394 -0.817 . . . . 0.0 109.51 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.725 ' HG2' ' CB ' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -117.09 -3.8 11.51 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.984 0.897 . . . . 0.0 109.272 179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.756 ' HB3' ' N ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -56.99 8.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.712 . . . . 0.0 112.244 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.721 ' CB ' ' HD3' ' A' ' 128' ' ' LYS . 3.7 ttp -155.89 152.54 28.43 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.578 -0.701 . . . . 0.0 109.584 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.498 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.713 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.557 ' NH1' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 163' ' ' PHE . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.837 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.944 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 1.004 ' HE1' ' HB2' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.044 HG23 ' CG ' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.115 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' HG2' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.711 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.989 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.663 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.41 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.728 ' CG ' ' CG ' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.989 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 1.118 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.832 ' HD1' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.765 ' HB ' ' CE1' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.858 HG23 ' CA ' ' A' ' 183' ' ' GLY . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 1.115 ' CE2' ' HB2' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.67 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.858 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.765 ' CE1' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.742 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.089 HG23 HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.728 ' CG ' ' CG ' ' A' ' 167' ' ' ASP . 44.3 m170 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.251 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.62 -106.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.546 ' CG ' ' HE2' ' A' ' 171' ' ' LYS . 1.6 mtpt -155.52 -30.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.761 ' HB3' HD13 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -45.93 134.41 6.74 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 121.52 -0.737 . . . . 0.0 110.043 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.54 46.2 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.171 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.5 mt-10 -153.79 -31.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.251 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp -84.84 2.79 40.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.225 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.692 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 1.089 HG23 HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.951 ' CD2' HG13 ' A' ' 218' ' ' VAL . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.002 HG11 ' CG2' ' A' ' 214' ' ' ILE . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ILE . . . . . 0.652 HD13 ' HB ' ' A' ' 213' ' ' VAL . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . 0.707 ' CG ' HG22 ' A' ' 213' ' ' VAL . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 1.044 ' CG ' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.707 HG22 ' CG ' ' A' ' 207' ' ' ASP . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.002 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.877 ' C ' HG13 ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.951 HG13 ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.917 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.747 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.743 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 1.199 ' CE2' HD13 ' A' ' 230' ' ' LEU . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.899 ' C ' HD12 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.199 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.819 HG22 HD12 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.944 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.869 ' HB3' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.733 ' HG2' ' CE1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.688 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.857 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.964 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.47 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.65 ' N ' HG23 ' A' ' 248' ' ' THR . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.752 ' H ' HG23 ' A' ' 248' ' ' THR . 0.8 OUTLIER 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.878 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.47 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.878 ' CE1' ' O ' ' A' ' 251' ' ' GLY . 2.6 m-70 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 165' ' ' SER . 0.3 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.964 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.566 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 1.069 HD12 HD21 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 1.03 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.711 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 2.3 pm0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' HD22 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.94 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.037 HD23 HD11 ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.997 ' O ' HD12 ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.69 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD23 ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.749 ' OG ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.139 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.928 ' ND2' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.656 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.074 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.037 HD11 HD23 ' A' ' 26' ' ' LEU . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.933 ' O ' HG22 ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.651 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 1.081 ' OH ' HD12 ' A' ' 69' ' ' LEU . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 1.139 ' C ' HD12 ' A' ' 46' ' ' ILE . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.677 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 3.1 t-20 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 43' ' ' GLU . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.081 HD12 ' OH ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.705 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 13.6 m120 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.787 ' HB ' HD13 ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.802 HD23 ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.802 ' HB2' HD23 ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.078 HG22 ' CE1' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 1.074 ' CD2' HD13 ' A' ' 52' ' ' LEU . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.709 HG22 ' CG ' ' A' ' 87' ' ' GLN . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.709 ' CG ' HG22 ' A' ' 85' ' ' ILE . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 94' ' ' LEU . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.677 HG11 ' CD ' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.092 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.092 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 87' ' ' GLN . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.911 HG22 HG23 ' A' ' 113' ' ' THR . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.078 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.703 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.686 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.946 ' N ' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 104' ' ' VAL . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.616 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.561 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.696 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 21.5 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.498 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.696 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 1.6 ptm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 121.196 0.522 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.725 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.976 HD12 ' C ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 141' ' ' ALA . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.274 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.686 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.6 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.614 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.997 HD22 ' HG2' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.846 HG11 ' CD ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.891 ' CE2' HG21 ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.887 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 170' ' ' GLY . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.737 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.736 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 1.054 ' OD2' HD11 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.801 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.124 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.124 ' CE2' HD13 ' A' ' 172' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.491 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.978 HG12 HG11 ' A' ' 201' ' ' VAL . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.773 ' CE1' ' HA ' ' A' ' 153' ' ' ASP . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.682 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.605 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.763 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.957 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.2 t60 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.054 HD11 ' OD2' ' A' ' 167' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.581 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 1.4 mp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 1.087 ' O ' HG23 ' A' ' 197' ' ' VAL . 7.2 m120 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.087 HG23 ' O ' ' A' ' 196' ' ' ASN . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.612 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.791 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.629 ' C ' HG23 ' A' ' 201' ' ' VAL . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.978 HG11 HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.991 ' CE1' ' HB1' ' A' ' 212' ' ' ALA . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.971 ' CA ' HG22 ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.991 ' HB1' ' CE1' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.971 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.604 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.756 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.614 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.238 HD11 ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.624 ' HA3' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.891 HG21 ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 1.274 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.811 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.997 ' HG2' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.846 ' CD ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.613 ' O ' ' OE1' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.811 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.796 ' O ' HG23 ' A' ' 232' ' ' ILE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.881 HG23 HG13 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.596 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 1.132 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.713 HG22 ' N ' ' A' ' 249' ' ' ALA . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 248' ' ' THR . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 2.7 m-80 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.466 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.636 ' N ' ' CD2' ' A' ' 253' ' ' HIS . 1.3 m170 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.736 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.737 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.238 ' CD1' HD11 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.887 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CG ' ' A' ' 158' ' ' TYR . 27.7 mm-40 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.959 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.793 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.137 HD22 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 1.007 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.662 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.66 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 45' ' ' SER . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 47' ' ' SER . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 46' ' ' ILE . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.137 ' CD1' HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.624 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.874 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.761 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.687 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.705 ' CG ' HD23 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 6.2 t-20 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.007 ' CB ' ' HB3' ' A' ' 28' ' ' ALA . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.896 HG22 HD13 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.896 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.689 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.63 ' NH2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.82 ' O ' HG23 ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.72 ' OE1' HD23 ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.088 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.71 ' CD ' HG11 ' A' ' 90' ' ' VAL . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.047 ' O ' HD12 ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.088 ' HB ' HD12 ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.047 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 1.136 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 113' ' ' THR . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.625 ' NE2' ' HB2' ' A' ' 108' ' ' SER . 0.3 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.625 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.81 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.907 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 104' ' ' VAL . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.136 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.982 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG2' ' C ' ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.698 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.744 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.665 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 163' ' ' PHE . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.519 ' CD ' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.749 ' CE1' ' HG3' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.085 ' CD1' HD11 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.085 HD11 ' CD1' ' A' ' 147' ' ' PHE . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 178' ' ' PHE . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CB ' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.807 ' CD1' HD12 ' A' ' 176' ' ' ILE . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 172' ' ' LEU . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.664 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.982 ' HB2' ' HG2' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.009 HD11 ' CB ' ' A' ' 259' ' ' ALA . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.018 ' CE1' HD13 ' A' ' 199' ' ' LEU . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.951 HG21 ' CZ ' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.747 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.73 ' CB ' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.052 ' HB1' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.747 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.66 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 187' ' ' ILE . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.724 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 3.9 t-160 -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.802 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.592 0.711 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.802 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.129 ' CG1' HG12 ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.1 ' CD2' HG22 ' A' ' 218' ' ' VAL . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.138 HG21 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.951 ' CZ ' HG21 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.777 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 1.052 ' HG3' ' HB1' ' A' ' 179' ' ' ALA . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.639 ' CG ' HG22 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.736 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.757 HG22 HG11 ' A' ' 201' ' ' VAL . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.98 ' C ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.875 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.129 HG12 ' CG1' ' A' ' 197' ' ' VAL . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.826 HD12 ' C ' ' A' ' 218' ' ' VAL . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.848 ' CD ' HG21 ' A' ' 197' ' ' VAL . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.684 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.541 ' O ' HD11 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.771 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.138 ' CD2' HG21 ' A' ' 201' ' ' VAL . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.498 ' C ' HD12 ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.001 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 1.044 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.978 ' HB3' HG23 ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 237' ' ' ALA . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HG3' ' CE1' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.907 ' OE2' HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 1.044 HG23 ' O ' ' A' ' 231' ' ' GLY . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.489 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 1.001 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.951 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.977 HG12 ' CD2' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 252' ' ' ILE . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.625 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.401 HG23 ' HG3' ' A' ' 247' ' ' GLU . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.977 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.73 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.798 HD12 HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 1.009 ' CB ' HD11 ' A' ' 172' ' ' LEU . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.677 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.736 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.116 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.808 ' O ' HD22 ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.808 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 69' ' ' LEU . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.114 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.603 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 ' HA2' ' A' ' 64' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 22' ' ' LEU . 46.3 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.627 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 1.114 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 42' ' ' LEU . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.793 ' HB2' HG23 ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 42' ' ' LEU . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.834 ' HB ' HD13 ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.834 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.656 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.084 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.758 ' C ' HD12 ' A' ' 88' ' ' ILE . 1.1 mt-30 -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' CG2' ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 94' ' ' LEU . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.053 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.966 ' CG2' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.969 HD12 ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.828 ' O ' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.992 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 1.9 tp60 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.885 HG22 HG23 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.084 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.436 ' H ' ' CD ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.509 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.037 HD12 ' HB1' ' A' ' 258' ' ' ALA . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.885 HG23 HG22 ' A' ' 104' ' ' VAL . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.992 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.704 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.583 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 129' ' ' MET . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 1.3 t0 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.589 ' HA ' ' HG2' ' A' ' 121' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.704 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.0 HD12 HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.622 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 140' ' ' ILE . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.752 ' HB3' ' CG ' ' A' ' 233' ' ' PHE . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.802 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.045 HG21 ' C ' ' A' ' 234' ' ' GLY . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.595 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.804 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 1.048 ' O ' HG12 ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.039 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 1.048 HG12 ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.634 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.774 ' HE1' ' HB1' ' A' ' 156' ' ' ALA . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.672 HG21 ' NE2' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.786 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 189' ' ' HIS . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.941 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.622 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.039 HD12 ' CE1' ' A' ' 174' ' ' TYR . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 158' ' ' TYR . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.039 ' CE1' HD12 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 184' ' ' HIS . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.761 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 1.039 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.792 ' HA3' HG22 ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.951 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.417 ' H ' ' HG ' ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.858 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 196' ' ' ASN . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.988 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.54 0.686 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.636 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.721 ' HA ' ' HB2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.615 ' C ' HG23 ' A' ' 218' ' ' VAL . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.249 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.063 HG21 HG23 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.684 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 1.029 ' CG ' HG13 ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 211' ' ' HIS . 28.8 p-80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.017 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.029 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.063 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.585 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.979 ' C ' HD12 ' A' ' 219' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.979 HD12 ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.721 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 2.2 t30 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD23 ' A' ' 219' ' ' LEU . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.841 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.739 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.249 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.569 ' C ' HD12 ' A' ' 230' ' ' LEU . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.017 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.758 ' CE2' ' HG3' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 1.045 ' C ' HG21 ' A' ' 145' ' ' THR . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.748 ' N ' HG21 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.758 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.786 ' HB ' HD12 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.015 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 1.028 HG12 ' CD2' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.57 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.606 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 1.028 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.838 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.726 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.033 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 1.037 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.656 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.6 mm-40 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.76 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.071 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.977 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.938 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 37' ' ' LEU . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.758 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 68' ' ' SER . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.624 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.621 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.409 ' C ' HD23 ' A' ' 52' ' ' LEU . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' CD2' ' A' ' 26' ' ' LEU . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.671 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 1.071 ' O ' HG22 ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.938 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD2' HD13 ' A' ' 42' ' ' LEU . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.864 ' HA ' HD12 ' A' ' 42' ' ' LEU . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.728 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.95 ' HB ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.094 HD21 ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.094 ' HG2' HD21 ' A' ' 74' ' ' LEU . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.082 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.687 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.657 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.721 HG11 ' CD ' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.134 ' O ' HD12 ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.134 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.783 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.58 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.728 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.926 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.082 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.689 ' HB2' ' NE2' ' A' ' 238' ' ' GLN . 1.9 mm100 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.02 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.159 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.906 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.77 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.603 ' HG3' ' C ' ' A' ' 117' ' ' THR . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.652 ' HE2' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.357 0.599 . . . . 0.0 110.556 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.525 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.757 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.416 ' C ' ' HD2' ' A' ' 144' ' ' HIS . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.661 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 5.0 m170 -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.372 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.902 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.082 ' O ' HD12 ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.717 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.774 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.687 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.678 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.924 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CG ' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.555 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.077 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.14 HG21 ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.945 ' CZ ' ' HB2' ' A' ' 180' ' ' ALA . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.752 ' HB1' ' HE2' ' A' ' 205' ' ' LYS . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.945 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.958 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.74 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.809 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.809 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.168 HG21 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.659 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.058 HD21 ' CB ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.058 ' CB ' HD21 ' A' ' 190' ' ' LEU . 4.0 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.329 0.585 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.68 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.4 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.017 ' HB ' HG23 ' A' ' 187' ' ' ILE . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.077 HD21 ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.066 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 214' ' ' ILE . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.14 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.865 ' CG ' HG22 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.712 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.848 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.372 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.919 ' CG2' HG11 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.783 ' N ' HG13 ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.857 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.168 ' CG1' HG21 ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.86 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.831 ' HB2' HG22 ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.596 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.789 ' CB ' HG22 ' A' ' 197' ' ' VAL . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.597 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.826 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.889 ' CD2' HD22 ' A' ' 199' ' ' LEU . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.94 HD23 HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.824 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.822 ' CB ' HG21 ' A' ' 145' ' ' THR . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.796 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 1.159 ' OE2' HD21 ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.94 HG22 HD23 ' A' ' 230' ' ' LEU . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.641 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 251' ' ' GLY . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.837 ' H ' HG23 ' A' ' 248' ' ' THR . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.979 ' O ' HG22 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.671 ' HB2' ' CG1' ' A' ' 246' ' ' VAL . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.642 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.687 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.686 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.753 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.951 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.041 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.084 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 1.041 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.597 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.692 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.823 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.823 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.697 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.084 HD11 HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.657 ' HB3' HG22 ' A' ' 20' ' ' THR . 49.2 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.678 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 1.056 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.813 ' HB3' HG23 ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD12 ' OH ' ' A' ' 63' ' ' TYR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.936 HG22 HD13 ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HD23 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.77 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.878 HE22 HD23 ' A' ' 97' ' ' LEU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.023 HD12 ' CB ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 90' ' ' VAL . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CD ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.039 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.023 ' CB ' HD12 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.643 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.827 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.81 ' HA ' HG13 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.695 ' CD ' HD22 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.709 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.827 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.643 ' N ' HG22 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.575 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 163' ' ' PHE . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.951 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.214 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.09 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.632 ' O ' ' HE2' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.731 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.765 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.623 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.655 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.206 ' CG ' HD11 ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.43 HG22 ' OE1' ' A' ' 103' ' ' GLN . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.022 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.614 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.56 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.954 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.865 HD12 ' HE1' ' A' ' 174' ' ' TYR . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.865 ' HE1' HD12 ' A' ' 172' ' ' LEU . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.206 HD11 ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.682 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.98 ' HD3' HD13 ' A' ' 204' ' ' ILE . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.796 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.4 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.796 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 1.141 ' NE2' HG21 ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 195' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.436 0.636 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.923 HG12 ' CB ' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.061 HD12 ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.061 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.98 HD13 ' HD3' ' A' ' 181' ' ' LYS . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 1.063 ' OD1' HG13 ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.907 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.907 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.09 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.063 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.822 HG12 ' C ' ' A' ' 226' ' ' GLY . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.923 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.746 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.822 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.732 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.507 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.652 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 1.214 ' N ' HG21 ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.827 ' OE2' HD11 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.699 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.778 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 1.141 HG21 ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.71 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.467 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.76 ' H ' HG23 ' A' ' 248' ' ' THR . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.71 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.956 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.622 ' H ' ' CD2' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.076 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.08 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.703 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.682 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.754 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.913 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.805 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.064 HD12 ' N ' ' A' ' 31' ' ' ASP . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 1.064 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.68 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.007 ' O ' HD11 ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' HG2' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.02 ' CB ' HD22 ' A' ' 30' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 1.049 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.007 HD11 ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.149 HD21 ' CB ' ' A' ' 67' ' ' ASP . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 1.085 ' O ' HD12 ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.684 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.696 HD13 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.823 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.913 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.149 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.676 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 39' ' ' SER . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.697 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.619 HG21 ' CE1' ' A' ' 105' ' ' TYR . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.61 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.964 HG23 ' OG ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.907 ' HG3' HG22 ' A' ' 85' ' ' ILE . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.99 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.688 HG11 ' CD ' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.577 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.105 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.105 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.99 ' HB ' HD12 ' A' ' 88' ' ' ILE . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 96' ' ' THR . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.964 ' OG ' HG23 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.664 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.62 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.982 ' HD2' ' HB2' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.448 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.982 ' HB2' ' HD2' ' A' ' 106' ' ' LYS . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.824 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.669 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 118' ' ' GLU . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.691 ' N ' HG22 ' A' ' 117' ' ' THR . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.651 ' NE2' ' SD ' ' A' ' 129' ' ' MET . 22.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.689 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.651 ' SD ' ' NE2' ' A' ' 119' ' ' GLN . 9.3 mmt . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.33 0.586 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.78 ' O ' HG23 ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.669 ' HA ' ' N ' ' A' ' 113' ' ' THR . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.888 HD12 ' C ' ' A' ' 140' ' ' ILE . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.448 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.264 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.117 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 1.117 ' CD ' HD23 ' A' ' 150' ' ' LEU . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.904 ' HA ' ' HB3' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 1.003 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.963 HG23 ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.653 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.681 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.764 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.85 ' HB2' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.711 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.963 ' O ' HG23 ' A' ' 161' ' ' THR . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.214 ' CD2' ' HB2' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.974 ' OH ' HD22 ' A' ' 257' ' ' LEU . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.071 HG21 ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.626 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.98 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.858 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.698 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.846 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.673 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.557 ' HB3' ' ND2' ' A' ' 196' ' ' ASN . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 168' ' ' ALA . 3.4 pp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.85 ' HB2' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.337 0.589 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.855 HG13 ' CA ' ' A' ' 220' ' ' TYR . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.698 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.272 HD22 ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.963 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.101 HG12 ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.071 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.663 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 1.139 ' CG ' HG13 ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.83 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.139 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.855 ' CG2' HD21 ' A' ' 230' ' ' LEU . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 1.101 ' C ' HG12 ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.855 ' CA ' HG13 ' A' ' 197' ' ' VAL . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.689 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.694 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.272 ' CE1' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.855 HD21 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.83 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.732 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 1.264 ' N ' HG21 ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.824 ' CD ' HD21 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.073 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.661 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.709 HG22 ' N ' ' A' ' 249' ' ' ALA . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.709 ' N ' HG22 ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.903 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.903 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.764 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.2 m170 -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.073 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.724 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.974 HD22 ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.49 ' C ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 1.214 ' HB2' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.677 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.865 HG22 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.668 ' HB ' ' HB1' ' A' ' 59' ' ' ALA . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HB3' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.805 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.597 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 6.2 t60 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD13 ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.01 HD13 ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.594 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.789 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.789 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.693 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.522 HE21 HD21 ' A' ' 22' ' ' LEU . 33.1 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' HG22 ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.666 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.834 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 3.5 t-20 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.01 ' HB3' HD13 ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.688 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.5 OUTLIER -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.751 ' HB ' ' CE2' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.923 ' CD1' HD13 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.612 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.756 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.135 ' O ' HD12 ' A' ' 95' ' ' ILE . 5.0 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.756 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.86 HD12 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.612 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.934 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 1.049 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 113' ' ' THR . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.794 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.68 ' NE2' ' OE1' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.685 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.142 HD21 ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.865 HG23 HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.934 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.72 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.644 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.699 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.47 ' H ' ' N ' ' A' ' 129' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.697 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 2.9 tpp . . . . . 0 C--O 1.215 -0.728 0 CA-C-O 121.194 0.521 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.749 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.451 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 133' ' ' ARG . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.659 HD13 ' CE2' ' A' ' 163' ' ' PHE . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.58 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.963 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.685 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 39.7 m-70 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.793 HG21 ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.208 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.841 ' CG ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.803 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.578 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.767 ' HB1' ' HE1' ' A' ' 158' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 258' ' ' ALA . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.425 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.557 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.618 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.725 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.862 HD13 ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.862 ' CE1' HD13 ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.963 ' CD1' HG11 ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.803 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.997 ' HD2' ' HB1' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.739 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.3 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 1.064 ' O ' HD22 ' A' ' 199' ' ' LEU . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.725 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.69 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.499 0.666 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.772 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.991 ' CG1' HG12 ' A' ' 218' ' ' VAL . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.687 ' C ' HD13 ' A' ' 199' ' ' LEU . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.018 ' CG1' HG23 ' A' ' 214' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.006 ' OH ' HD13 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.683 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.756 ' CA ' HG22 ' A' ' 213' ' ' VAL . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.629 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.208 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.756 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.018 HG23 ' CG1' ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.029 HG13 HD12 ' A' ' 199' ' ' LEU . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.787 ' CB ' HG22 ' A' ' 197' ' ' VAL . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.751 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.748 ' C ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.809 ' CE2' HD13 ' A' ' 257' ' ' LEU . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.006 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.793 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 145' ' ' THR . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.782 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 1.142 ' CD ' HD21 ' A' ' 112' ' ' LEU . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 230' ' ' LEU . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.153 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.516 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 1.011 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.765 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.765 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 30.1 t-20 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.675 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.3 m170 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.735 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.153 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.826 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.772 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 2.1 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 1.067 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.038 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.643 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.617 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.622 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.665 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HG ' ' C ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.746 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.739 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 20' ' ' THR . 33.2 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 1.038 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.739 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.624 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 5.9 t-20 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 41' ' ' THR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.686 HD23 ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.665 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.676 ' HB ' HD13 ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.676 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.704 ' HA ' ' CD ' ' A' ' 260' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.664 ' NH1' ' OE1' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.746 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.702 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG11 ' CD ' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.62 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.141 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.141 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.755 ' O ' HD12 ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.686 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.698 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.832 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HD2' HD22 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.006 HD23 HD12 ' A' ' 140' ' ' ILE . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.832 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.593 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.698 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t0 . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.947 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.041 0.448 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.594 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.701 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.006 HD12 HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.635 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 211' ' ' HIS . 6.7 m-70 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.613 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.103 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 1.103 ' CD ' HD23 ' A' ' 150' ' ' LEU . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.935 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.624 ' HA ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.747 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 176' ' ' ILE . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.695 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB3' ' HA3' ' A' ' 170' ' ' GLY . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.742 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.474 ' CA ' HG22 ' A' ' 255' ' ' ILE . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.727 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.858 HD22 ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.049 ' CE2' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.795 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.747 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.795 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 176' ' ' ILE . 3.5 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.721 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 17.1 p-80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.733 HG22 ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.708 ' HB2' HD23 ' A' ' 190' ' ' LEU . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.133 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.133 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.43 0.633 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.959 HG11 HG12 ' A' ' 218' ' ' VAL . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.221 ' CD2' HG22 ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.02 HG11 HG23 ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.072 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.7 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.743 ' OD1' HG13 ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.884 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.743 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.02 HG23 HG11 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.724 ' N ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.865 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.221 HG22 ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.785 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.829 ' N ' HG13 ' A' ' 197' ' ' VAL . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.731 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.646 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.029 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 1.009 ' C ' HD12 ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.107 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.884 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.702 ' CE1' HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.678 ' HA2' ' CG ' ' A' ' 239' ' ' GLU . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.635 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.716 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.864 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.841 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.744 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 1.091 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 1.091 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.107 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.695 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.102 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.658 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.137 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.402 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.945 HG23 ' HB2' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.736 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.483 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.771 HD13 ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 1.102 ' O ' HG22 ' A' ' 20' ' ' THR . 31.2 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 1.137 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.945 ' HB2' HG23 ' A' ' 41' ' ' THR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.696 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.677 HG21 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.991 ' HB2' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.137 HG22 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.917 ' NE2' HD23 ' A' ' 97' ' ' LEU . 60.4 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.736 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.737 HG11 ' CD ' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.113 ' O ' HD12 ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.113 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.009 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.696 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.658 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.494 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.765 HG22 HG23 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.137 ' CE2' HG22 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' CE ' HG21 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 238' ' ' GLN . 11.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.687 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.633 ' O ' HD23 ' A' ' 112' ' ' LEU . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 105' ' ' TYR . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.765 HG23 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.694 ' N ' HD12 ' A' ' 115' ' ' LEU . 5.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.569 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.56 ' N ' HG22 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 65.1 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.623 ' OD1' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.4 0.619 . . . . 0.0 110.594 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.676 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.646 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.69 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.571 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.92 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.956 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.78 ' C ' ' HE2' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.67 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 6.0 m170 -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.671 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CD1' ' HG3' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.846 ' HB3' ' OE2' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.968 ' CE1' HG12 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.73 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 254' ' ' HIS . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.77 HD22 HD22 ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.738 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.993 HG21 ' CE1' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.758 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.758 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.984 ' H ' HG22 ' A' ' 176' ' ' ILE . 6.0 t60 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.581 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.164 HG21 ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.754 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.859 ' HB3' HD23 ' A' ' 190' ' ' LEU . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.859 HD23 ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.529 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 1.2 mp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.754 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.5 m120 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.176 ' CG1' HG12 ' A' ' 218' ' ' VAL . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.015 HD11 ' CZ ' ' A' ' 228' ' ' TYR . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.054 HG13 ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.993 ' CE1' HG21 ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.982 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.878 ' CG ' HG13 ' A' ' 213' ' ' VAL . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.871 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.871 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 31.0 m80 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.098 ' HB3' HG23 ' A' ' 232' ' ' ILE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.878 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.959 HD11 HG23 ' A' ' 240' ' ' VAL . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 1.054 ' C ' HG13 ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.842 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.176 HG12 ' CG1' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.69 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.534 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.733 ' OE2' HG21 ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.643 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.015 ' CZ ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.981 HD21 ' CD1' ' A' ' 257' ' ' LEU . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.098 HG23 ' HB3' ' A' ' 212' ' ' ALA . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.956 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.713 ' CA ' ' HB3' ' A' ' 238' ' ' GLN . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.846 ' OE2' ' HB3' ' A' ' 156' ' ' ALA . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 261' ' ' GLN . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 107' ' ' GLN . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.968 HG12 ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.705 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.93 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.157 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.643 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.555 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.447 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.677 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 1.5 m170 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.687 ' N ' ' CD2' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.157 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.981 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.705 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.73 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 12.7 t60 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.877 ' O ' HD23 ' A' ' 40' ' ' LEU . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.651 HG22 ' H ' ' A' ' 47' ' ' SER . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.059 HD11 HD22 ' A' ' 26' ' ' LEU . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.632 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.895 ' O ' HG22 ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' THR . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.632 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.701 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.823 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 66' ' ' GLY . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.834 ' HB2' HG23 ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.924 HG22 HD21 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HB2' HD12 ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.697 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 1.182 ' OE1' HD23 ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.001 HG11 ' CD ' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.107 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.2 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.107 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.798 ' O ' HD12 ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.182 HD23 ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.771 ' OE1' HG22 ' A' ' 96' ' ' THR . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 81' ' ' ARG . 9.0 mm-40 -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HB ' ' A' ' 113' ' ' THR . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.886 ' CB ' HD11 ' A' ' 74' ' ' LEU . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.684 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.931 ' HB ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.799 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.665 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.496 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.661 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.414 0.626 . . . . 0.0 110.662 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 130' ' ' VAL . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' HB1' ' A' ' 114' ' ' ALA . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.678 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.877 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.908 ' HB3' ' CG ' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.908 ' CG ' ' HB3' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.901 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.666 ' CG ' ' CD ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.583 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.72 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 154' ' ' VAL . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 1.11 ' HB1' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.11 ' OH ' ' HB1' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.625 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.64 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.005 ' CD2' HD22 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.19 ' CZ ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.122 HG21 ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.941 ' CD2' ' HB3' ' A' ' 180' ' ' ALA . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.941 ' HB3' ' CD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.672 ' HG3' ' CE1' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.903 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.672 ' CE1' ' HG3' ' A' ' 182' ' ' GLN . 38.6 p-80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.929 HD13 ' OH ' ' A' ' 228' ' ' TYR . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 196' ' ' ASN . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.7 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 189' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 195' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.507 0.67 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.702 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 3.3 m120 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.105 HG13 ' C ' ' A' ' 219' ' ' LEU . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.19 HD21 ' CZ ' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.072 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.122 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 1.103 HD12 HG21 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.754 ' CA ' HG12 ' A' ' 213' ' ' VAL . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.565 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.956 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.103 HG21 HD12 ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.057 HG23 HG11 ' A' ' 201' ' ' VAL . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.597 ' CA ' HG22 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.957 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 1.105 ' C ' HG13 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 1.017 ' HB2' HG22 ' A' ' 197' ' ' VAL . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HG2' ' CE2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.579 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.676 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.801 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.127 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.731 ' C ' HD12 ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.936 ' OE2' HD11 ' A' ' 112' ' ' LEU . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.832 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.129 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.952 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.62 HG23 ' H ' ' A' ' 250' ' ' ASN . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.589 ' N ' HG23 ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.62 ' H ' HG23 ' A' ' 248' ' ' THR . 7.9 p30 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.952 HG23 ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.578 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.129 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.6 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.005 HD22 ' CD2' ' A' ' 172' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.061 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.948 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.645 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' HA ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.628 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.247 HD21 ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.984 ' O ' HD12 ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' H ' ' A' ' 47' ' ' SER . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.672 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.641 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.034 HD11 HD23 ' A' ' 26' ' ' LEU . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.629 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 20' ' ' THR . 5.2 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.671 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.948 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.924 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.645 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.247 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.6 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.924 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.05 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 m120 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.05 HG23 ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.191 HG13 ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.48 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.749 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.823 HG22 ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.823 ' CD ' HG22 ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.672 HG21 ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.885 HG12 ' H ' ' A' ' 92' ' ' GLY . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.885 ' H ' HG12 ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.921 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.913 HD12 ' OE1' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.921 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.728 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.627 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 80' ' ' SER . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.191 ' CE2' HG13 ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.716 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.584 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 106' ' ' LYS . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' A' ' 137' ' ' ILE . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.627 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' A' ' 132' ' ' LYS . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.685 ' NE2' ' HB2' ' A' ' 97' ' ' LEU . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 1.005 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.16 0.505 . . . . 0.0 110.073 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.545 ' CG2' ' C ' ' A' ' 129' ' ' MET . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.6 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.568 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.609 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.14 HD12 ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 11.5 m170 -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.88 HG21 ' CD2' ' A' ' 233' ' ' PHE . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.011 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HD2' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.772 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.775 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.709 ' HB1' ' CG ' ' A' ' 235' ' ' GLU . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 174' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.688 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.71 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.768 ' HZ ' ' HE2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.76 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.538 ' HB2' ' CA ' ' A' ' 164' ' ' GLY . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.678 ' C ' ' HB3' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.813 ' N ' ' HB3' ' A' ' 162' ' ' ALA . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.942 ' O ' HG23 ' A' ' 157' ' ' THR . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.718 ' C ' HD13 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.006 HD12 ' CA ' ' A' ' 183' ' ' GLY . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.738 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.972 ' CE2' ' HB3' ' A' ' 180' ' ' ALA . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 178' ' ' PHE . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.972 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.755 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 1.006 ' CA ' HD12 ' A' ' 176' ' ' ILE . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.89 HG21 HG11 ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.703 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.831 ' CE1' ' CG2' ' A' ' 255' ' ' ILE . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.692 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.185 HG21 ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.289 ' CD2' HG22 ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.877 HG22 ' HA3' ' A' ' 216' ' ' GLY . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 1.144 ' CE1' HG23 ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.576 HG13 ' HB ' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.903 ' CA ' HG22 ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.951 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.951 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.011 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.903 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.144 HG23 ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.784 ' C ' HG13 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.877 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.289 HG22 ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.734 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 1.185 ' OE1' HG21 ' A' ' 197' ' ' VAL . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.875 ' OH ' HD13 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.004 HD21 HD12 ' A' ' 257' ' ' LEU . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.933 ' HB ' HD11 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.88 ' CD2' HG21 ' A' ' 145' ' ' THR . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 145' ' ' THR . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.688 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.681 ' CD ' HD21 ' A' ' 112' ' ' LEU . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 158' ' ' TYR . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.94 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.191 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.552 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 11.0 p30 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.671 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 247' ' ' GLU . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.731 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.191 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.004 HD12 HD21 ' A' ' 230' ' ' LEU . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 172' ' ' LEU . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.079 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.899 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 1.079 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD22 ' C ' ' A' ' 36' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 1.094 ' C ' HD12 ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.957 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.957 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 64.5 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.62 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.699 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.059 ' O ' HD12 ' A' ' 42' ' ' LEU . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.781 ' HB3' HG23 ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.588 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.582 ' O ' HD12 ' A' ' 74' ' ' LEU . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.686 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.708 HG11 ' CD ' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.618 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.136 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.136 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.987 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.704 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.943 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.814 ' CB ' HD12 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.75 ' NE2' HD21 ' A' ' 112' ' ' LEU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' HD22 ' A' ' 76' ' ' ASN . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.814 HD12 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.6 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.822 HE22 ' HB2' ' A' ' 168' ' ' ALA . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 134' ' ' ARG . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.706 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.706 ' CE ' ' HB3' ' A' ' 121' ' ' GLN . 6.1 mmt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.19 0.519 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.692 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.6 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.905 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.32 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 1.32 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 7.1 p80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.791 ' O ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.761 ' CB ' ' HB2' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.713 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.002 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.729 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB2' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 1.002 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.925 HD22 ' HB3' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.742 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.749 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 1.008 ' CE1' HD21 ' A' ' 150' ' ' LEU . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.761 ' HB2' ' CB ' ' A' ' 153' ' ' ASP . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.493 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 11.0 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.749 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.64 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.691 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.501 ' N ' ' ND1' ' A' ' 189' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.749 HD12 ' H ' ' A' ' 196' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.749 ' H ' HD12 ' A' ' 195' ' ' LEU . 1.6 m120 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.211 HG22 ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.64 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.085 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.183 HG22 ' N ' ' A' ' 216' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.957 ' HE2' HD13 ' A' ' 232' ' ' ILE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 1.189 ' OD1' HG13 ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.95 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.189 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.788 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 1.011 ' C ' HG22 ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 1.183 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.806 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 218' ' ' VAL . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 1.211 ' CG ' HG22 ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.617 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.74 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.933 ' C ' HD12 ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.957 HD13 ' HE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 143' ' ' GLU . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.517 HG12 ' HD2' ' A' ' 158' ' ' TYR . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.989 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.639 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.408 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.784 ' H ' HG22 ' A' ' 248' ' ' THR . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 21.1 t-20 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.668 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.1 m170 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.989 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.925 ' HB3' HD22 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.713 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.616 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.773 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.831 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.897 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.116 HD13 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 1.196 HG23 ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' SER . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.755 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.745 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.583 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.975 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t-20 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.777 ' O ' HD13 ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.196 ' OG ' HG23 ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 1.064 ' O ' HG23 ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.678 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.18 HG22 ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.816 ' O ' HG23 ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' C ' ' HG2' ' A' ' 87' ' ' GLN . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.702 ' NE2' HD13 ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.681 HG11 ' CD ' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.573 ' N ' HG12 ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.091 ' O ' HD12 ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.091 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.802 ' O ' HD12 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.666 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.897 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.18 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG3' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.916 ' NE2' HD21 ' A' ' 112' ' ' LEU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.671 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.897 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 32.7 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 117' ' ' THR . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.49 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.693 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 130' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.327 0.584 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.567 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.877 ' HD3' HD12 ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.62 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 113' ' ' THR . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.671 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.663 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.731 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.731 ' N ' HD23 ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.483 ' CA ' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 155' ' ' MET . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.928 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.722 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.016 HG21 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.83 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.794 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.891 ' HE1' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.891 HD12 HD13 ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.928 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.722 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 25.6 p-80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.728 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.848 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.7 mp . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.407 0.622 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.891 HG13 ' N ' ' A' ' 220' ' ' TYR . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.891 HD13 ' HE1' ' A' ' 174' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.05 HG22 ' N ' ' A' ' 216' ' ' GLY . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.902 ' CE2' ' HB1' ' A' ' 212' ' ' ALA . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.601 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 6.1 p-80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.889 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.794 ' N ' HG13 ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 1.05 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 228' ' ' TYR . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.891 ' N ' HG13 ' A' ' 197' ' ' VAL . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 1.01 ' HG2' HG21 ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.64 ' C ' HG23 ' A' ' 246' ' ' VAL . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.85 ' N ' HG23 ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.964 ' HB2' HG23 ' A' ' 218' ' ' VAL . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.545 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.165 HD12 ' CG2' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.716 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 1.165 ' CG2' HD12 ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.669 ' HB3' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.799 ' N ' HD12 ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.56 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 224' ' ' GLU . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.747 ' H ' HG22 ' A' ' 248' ' ' THR . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.932 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.657 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.0 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.83 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.855 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.721 HD13 ' HE2' ' A' ' 228' ' ' TYR . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.722 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.709 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.617 ' O ' ' HE2' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.687 ' O ' ' CD2' ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.076 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.728 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.305 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.87 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.611 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.76 ' O ' HD12 ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.691 HD11 ' OD2' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.688 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.899 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.305 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.656 ' HB2' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 1.076 ' O ' HG22 ' A' ' 20' ' ' THR . 4.1 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.87 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' HD11 ' A' ' 54' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.3 t-20 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 1.052 ' CB ' HD21 ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.832 ' HB ' HD12 ' A' ' 74' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.832 HD12 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.151 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.68 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.89 HG11 ' CD ' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 90' ' ' VAL . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 95' ' ' ILE . 5.3 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.105 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.649 ' O ' HD12 ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.105 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.596 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.962 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.808 HG22 HG23 ' A' ' 113' ' ' THR . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.151 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.584 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.508 ' H ' ' HG ' ' A' ' 108' ' ' SER . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.707 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.808 HG23 HG22 ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.425 HD12 ' HE ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.891 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 15.8 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.632 ' OD2' ' CG2' ' A' ' 130' ' ' VAL . 24.3 m-20 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 121.356 0.598 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.466 ' H ' ' HB ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.743 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HE ' HD12 ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.827 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.061 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.662 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 8.2 m170 -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.804 HG23 ' CB ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.069 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 1.061 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.061 HD23 ' CD ' ' A' ' 149' ' ' LYS . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 1.005 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.581 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 1.057 ' CE2' HD13 ' A' ' 232' ' ' ILE . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.894 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.714 ' C ' HD21 ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.65 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.635 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.891 ' HB1' ' OE1' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 190' ' ' LEU . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.827 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.616 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.06 HD13 ' HB3' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.12 HD13 ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.858 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.005 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.858 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 1.12 ' CA ' HD13 ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.695 HG21 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.94 HD12 ' N ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.514 ' H ' HD12 ' A' ' 195' ' ' LEU . 2.9 m-80 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 220' ' ' TYR . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 220' ' ' TYR . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.087 ' CD2' HG22 ' A' ' 218' ' ' VAL . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.631 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.119 HG13 ' C ' ' A' ' 215' ' ' SER . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.91 ' HE1' ' HB1' ' A' ' 212' ' ' ALA . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.75 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.796 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 6.0 p80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.804 ' CB ' HG23 ' A' ' 145' ' ' THR . 60.0 m170 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 1.119 ' C ' HG13 ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.954 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.087 HG22 ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.666 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.989 ' HB2' HG13 ' A' ' 197' ' ' VAL . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.686 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.597 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.597 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.708 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.066 ' CD2' HG21 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.042 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.057 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 1.061 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.551 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 1.042 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.059 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 253' ' ' HIS . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.691 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.86 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.059 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.67 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.06 ' HB3' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.894 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.883 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.096 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.1 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.744 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.664 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 27' ' ' THR . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.69 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.847 ' O ' HD22 ' A' ' 40' ' ' LEU . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CB ' ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.1 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.789 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 1.096 ' O ' HG22 ' A' ' 20' ' ' THR . 54.3 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.588 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.772 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.677 ' HB2' ' N ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.678 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.118 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.679 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HD2' ' NE2' ' A' ' 103' ' ' GLN . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.874 ' CG ' HD13 ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 1.018 HG22 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.657 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 1.018 ' CG ' HG22 ' A' ' 85' ' ' ILE . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.639 HG21 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.122 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.122 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 97' ' ' LEU . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 96' ' ' THR . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.607 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.717 ' NE2' HG21 ' A' ' 161' ' ' THR . 1.6 mm-40 -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.955 ' O ' HG12 ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.678 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.851 ' OE1' ' HB1' ' A' ' 237' ' ' ALA . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.621 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.018 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.745 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 36.9 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.681 HG22 ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.681 ' N ' HG22 ' A' ' 117' ' ' THR . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' HD22 ' A' ' 97' ' ' LEU . 6.2 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.629 ' OD2' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.847 0.832 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.549 ' CG2' ' C ' ' A' ' 129' ' ' MET . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.018 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.321 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 1.321 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 7.1 p80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.977 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.626 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.783 ' O ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 152' ' ' LYS . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.858 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.606 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 170' ' ' GLY . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 1.069 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.912 ' HA2' HD11 ' A' ' 187' ' ' ILE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 161' ' ' THR . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.711 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.938 HD13 ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.994 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 1.056 HG23 ' O ' ' A' ' 182' ' ' GLN . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.946 ' OD1' ' HB3' ' A' ' 180' ' ' ALA . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.858 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.946 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 179' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 1.056 ' O ' HG23 ' A' ' 176' ' ' ILE . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.692 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 2.8 t-160 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.144 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 1.144 ' N ' HD12 ' A' ' 187' ' ' ILE . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.761 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.069 HD23 ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.698 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.997 HG13 ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.056 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.989 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.826 HG22 HG21 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.788 ' CA ' HG22 ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.584 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.005 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 204' ' ' ILE . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.942 HG23 HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.698 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 199' ' ' LEU . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.997 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.947 ' HB2' HG22 ' A' ' 197' ' ' VAL . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.056 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 1.189 ' C ' HD12 ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.189 HD12 ' C ' ' A' ' 229' ' ' SER . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 1.013 HG13 HG23 ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.851 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 156' ' ' ALA . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 1.11 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.951 HG12 ' CD2' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.575 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.951 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 1.11 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.051 ' CD1' HD11 ' A' ' 230' ' ' LEU . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 13.9 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.749 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.919 ' HB1' ' N ' ' A' ' 59' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.899 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.796 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 38' ' ' LYS . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.593 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HB3' HD12 ' A' ' 30' ' ' LEU . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.753 ' O ' HD22 ' A' ' 40' ' ' LEU . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.753 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.9 HG23 ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.787 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.666 ' CA ' HG13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 26' ' ' LEU . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.515 HE22 ' NH1' ' A' ' 81' ' ' ARG . 30.5 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.599 ' CA ' ' CB ' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.919 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.612 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.74 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.662 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.6 t-20 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.586 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.9 ' HB2' HG23 ' A' ' 41' ' ' THR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.64 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.073 ' CB ' HD21 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.073 HD21 ' CB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 7.9 m-80 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.7 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.737 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 1.061 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' A' ' 85' ' ' ILE . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.91 ' CD1' HD22 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.673 HG11 ' CD ' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.145 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.91 HD22 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.145 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.061 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.608 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.925 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.91 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.707 ' NE2' HD21 ' A' ' 112' ' ' LEU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.653 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' HG3' ' A' ' 119' ' ' GLN . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 129' ' ' MET . 1.5 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.601 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.219 0.533 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 1.045 HD12 ' O ' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.906 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.653 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.6 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.237 HG21 ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 1.02 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.61 ' CD ' ' C ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.098 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 1.098 ' CD ' HD23 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 1.21 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.746 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.981 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.924 ' C ' HD21 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.895 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.731 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.71 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' C ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 1.249 ' CE1' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.996 HG21 ' CE1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.753 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.981 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 1.21 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.753 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.652 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.542 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.142 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.645 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.126 HD11 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HB2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.378 0.609 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.715 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.943 ' CG2' HG23 ' A' ' 187' ' ' ILE . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.249 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.013 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.934 ' CG1' HG23 ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.996 ' CE1' HG21 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.685 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.665 ' CB ' HG22 ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.593 ' HA ' ' OE1' ' A' ' 208' ' ' GLU . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 1.02 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.685 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 240' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 1.051 HG22 ' HB2' ' A' ' 199' ' ' LEU . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 218' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.777 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.432 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.142 ' OH ' HD13 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.926 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.059 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . 0.79 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 1.237 ' N ' HG21 ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 1.059 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.992 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.718 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.599 ' N ' HG22 ' A' ' 248' ' ' THR . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 251' ' ' GLY . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.718 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.9 OUTLIER -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.992 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.814 HD23 ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.791 ' HB2' HD12 ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 39.2 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.871 ' O ' HD23 ' A' ' 22' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.122 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.998 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 1.122 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.617 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.619 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 1.008 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.603 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.774 ' HB3' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' THR . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 1.5 t-20 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.843 ' HB2' HG23 ' A' ' 41' ' ' THR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 5.0 m120 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.83 ' HB ' HD13 ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.669 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' HD23 ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.008 HD11 ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.902 HG11 ' CD ' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.522 ' N ' HG12 ' A' ' 90' ' ' VAL . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 1.067 ' O ' HD12 ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.095 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.631 ' O ' HD12 ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.095 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.688 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.58 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.68 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' NE2' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.843 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.03 ' CD1' ' HB1' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.557 HD12 ' NH1' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.713 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 5.0 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.599 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.606 ' HG2' ' N ' ' A' ' 130' ' ' VAL . 3.7 ttp . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.498 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.713 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.557 ' NH1' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 163' ' ' PHE . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.837 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.944 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.751 ' CE1' ' HB2' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.044 HG23 ' CG ' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 1.115 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' HG2' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.711 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.989 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.663 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.41 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.601 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.742 ' OD2' ' CD2' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.989 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 1.118 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.832 ' HD1' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.565 ' HB ' ' NE2' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.858 HG23 ' CA ' ' A' ' 183' ' ' GLY . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 1.115 ' CE2' ' HB2' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.67 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.858 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.741 ' O ' ' CD2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.742 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.089 HG23 HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.742 ' CD2' ' OD2' ' A' ' 167' ' ' ASP . 10.8 m-70 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.251 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.251 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.38 0.61 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.692 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 1.089 HG23 HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.951 ' CD2' HG13 ' A' ' 218' ' ' VAL . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.002 HG11 ' CG2' ' A' ' 214' ' ' ILE . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ILE . . . . . 0.652 HD13 ' HB ' ' A' ' 213' ' ' VAL . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.707 ' CG ' HG22 ' A' ' 213' ' ' VAL . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 1.044 ' CG ' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.707 HG22 ' CG ' ' A' ' 207' ' ' ASP . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.002 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.877 ' C ' HG13 ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.951 HG13 ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.917 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.747 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.743 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 1.199 ' CE2' HD13 ' A' ' 230' ' ' LEU . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.899 ' C ' HD12 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.199 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.819 HG22 HD12 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.944 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.751 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.548 ' HB1' ' NE2' ' A' ' 261' ' ' GLN . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.733 ' HG2' ' CE1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.688 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.857 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.964 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.47 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.65 ' N ' HG23 ' A' ' 248' ' ' THR . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.752 ' H ' HG23 ' A' ' 248' ' ' THR . 3.5 m-80 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.739 ' O ' HG22 ' A' ' 248' ' ' THR . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.47 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.676 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 1.9 m170 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.607 ' H ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.964 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . 0.566 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 1.069 HD12 HD21 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 1.03 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.711 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.258 0.552 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -47.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.2 m -94.35 -33.86 13.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -1.174 . . . . 0.0 110.204 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.3 m -101.34 119.38 38.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -153.55 130.81 3.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.38 70.24 0.24 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.2 103.06 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.44 -106.97 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.1 p -90.44 54.48 2.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -1.153 . . . . 0.0 110.177 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.02 24.87 11.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.31 -23.95 68.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.79 -114.58 0.39 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.32 -106.69 0.54 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.983 HG12 HG21 ' A' ' 18' ' ' ILE . 2.3 m -58.91 136.94 21.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.259 -1.142 . . . . 0.0 110.35 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.872 HG22 HG12 ' A' ' 18' ' ' ILE . 14.5 t -116.23 -160.98 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 110.31 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.4 6.74 0.95 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.728 ' H ' HG23 ' A' ' 15' ' ' THR . 1.5 t70 -162.29 47.43 0.17 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.091 -1.006 . . . . 0.0 110.866 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG12 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -106.29 -78.36 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.149 -0.969 . . . . 0.0 109.914 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.982 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -97.1 69.08 0.8 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.933 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.51 -1.02 1.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -1.155 . . . . 0.0 110.355 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -31.57 -41.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.018 HD13 ' N ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -63.86 -37.75 88.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -1.151 . . . . 0.0 110.221 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.653 ' N ' ' O ' ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.035 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.94 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.43 -8.78 37.63 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 110.249 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.11 -10.38 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.786 . . . . 0.0 110.165 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.037 HD23 HD11 ' A' ' 54' ' ' LEU . 3.6 mp -106.42 -31.8 8.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.262 -0.899 . . . . 0.0 110.215 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -117.61 -12.4 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 110.149 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.94 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -114.18 93.17 29.64 Favored Pre-proline 0 C--N 1.298 -1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.21 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.705 ' HA ' ' CB ' ' A' ' 70' ' ' ASN . 46.1 Cg_endo -72.77 -162.12 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.068 1.562 . . . . 0.0 110.441 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.65 -167.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 110.279 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -165.34 -157.95 0.35 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.198 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.678 ' C ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -115.11 42.91 2.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.142 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.678 ' CG ' ' C ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -168.12 21.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 110.307 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 33.2 m-20 -74.35 95.1 2.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.201 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.3 pttp -55.65 -10.06 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.245 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.582 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -147.78 -162.39 10.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -29.33 142.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -1.09 . . . . 0.0 110.232 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 42.2 mttt -113.69 -12.8 12.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.178 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.997 ' O ' HD12 ' A' ' 40' ' ' LEU . 31.3 p 175.52 177.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.117 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.997 HD12 ' O ' ' A' ' 39' ' ' SER . 1.7 mp -154.7 109.12 2.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.69 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 51.1 m -67.91 158.12 33.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.039 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD23 ' OG ' ' A' ' 45' ' ' SER . 3.7 mt -121.9 43.75 2.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.206 -0.934 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HG3' ' CG2' ' A' ' 41' ' ' THR . 37.4 mt-10 -46.66 -29.76 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 0.0 110.094 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -135.67 -1.96 2.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.749 ' OG ' HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -43.72 -32.96 1.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.139 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -125.81 -161.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 110.123 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.13 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.101 0.953 . . . . 0.0 110.901 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.677 ' HG3' ' ND2' ' A' ' 49' ' ' ASN . 12.4 pt20 -102.61 -1.48 30.2 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.055 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.928 ' ND2' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -118.52 49.84 1.25 Allowed 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.329 -0.857 . . . . 0.0 110.34 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.656 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -29.88 -34.07 0.01 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.9 p -154.77 134.69 12.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -1.181 . . . . 0.0 110.228 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.074 HD13 ' CD2' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 123.63 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.404 -0.81 . . . . 0.0 110.162 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.2 m -85.13 149.81 25.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 110.266 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.037 HD11 HD23 ' A' ' 26' ' ' LEU . 1.1 pp -143.52 129.01 19.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.168 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.634 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 32.9 t -109.12 136.45 48.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.198 -0.938 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.791 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -104.47 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.933 ' O ' HG22 ' A' ' 20' ' ' THR . 27.1 mt-30 -74.62 43.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.171 -0.956 . . . . 0.0 110.252 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.651 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . 179.91 -40.03 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.59 177.4 11.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.244 -1.151 . . . . 0.0 110.313 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 6.7 pt-20 -137.21 163.84 29.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.274 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.824 ' CD ' ' CE1' ' A' ' 63' ' ' TYR . 4.8 ttmt -151.86 154.02 35.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 110.124 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 62' ' ' THR . 4.5 t -87.07 125.77 34.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.915 . . . . 0.0 110.404 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.081 ' OH ' HD12 ' A' ' 69' ' ' LEU . 16.1 m-85 -125.91 173.61 8.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 1.139 ' C ' HD12 ' A' ' 46' ' ' ILE . . . 153.21 172.74 21.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.677 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 3.1 t-20 -48.9 123.67 7.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.064 -1.256 . . . . 0.0 109.969 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 43' ' ' GLU . . . 94.42 -5.4 70.74 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.674 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 1.9 m-20 -75.52 -178.98 4.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -1.12 . . . . 0.0 110.26 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' ' CE2' ' A' ' 63' ' ' TYR . 95.2 p -141.27 165.0 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.081 HD12 ' OH ' ' A' ' 63' ' ' TYR . 6.6 tp -138.9 157.89 45.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.141 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.705 ' CB ' ' HA ' ' A' ' 29' ' ' PRO . 13.6 m120 -135.89 105.75 6.22 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -0.915 . . . . 0.0 110.238 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.787 ' HB ' HD13 ' A' ' 74' ' ' LEU . 5.0 p -118.23 34.05 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.232 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -56.63 -10.21 4.24 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.623 ' O ' ' O ' ' A' ' 74' ' ' LEU . 13.5 tttt -96.29 -37.68 10.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 110.252 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.802 HD23 ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -35.56 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 110.699 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 78' ' ' LYS . 8.7 mmtt -125.98 -158.52 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.762 . . . . 0.0 110.237 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 27.2 m120 -67.32 -30.15 69.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 110.316 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 1.1 p-10 -135.79 69.92 1.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.042 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.802 ' HB2' HD23 ' A' ' 74' ' ' LEU . 11.8 mmtt -107.08 153.33 22.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.179 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.078 HG22 ' CE1' ' A' ' 105' ' ' TYR . 1.1 t -113.37 164.48 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 110.325 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -148.26 78.63 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.418 -0.801 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -107.6 125.22 51.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.333 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.779 ' CD2' HD13 ' A' ' 54' ' ' LEU . 2.7 p90 -152.73 161.52 42.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.069 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 16.0 t70 -93.31 140.2 29.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.232 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 1.074 ' CD2' HD13 ' A' ' 52' ' ' LEU . 47.4 p90 -158.96 153.78 24.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.709 HG22 ' CG ' ' A' ' 87' ' ' GLN . 38.6 mt -111.54 121.8 64.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 110.265 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.67 ' NH2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -84.61 101.2 11.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 110.078 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.709 ' CG ' HG22 ' A' ' 85' ' ' ILE . 5.0 mt-30 -122.17 134.41 54.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 94' ' ' LEU . 1.3 mp -130.41 112.17 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.322 -0.861 . . . . 0.0 110.177 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.664 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 9.5 tt0 -140.75 99.89 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.677 HG11 ' CD ' ' A' ' 93' ' ' GLN . 90.0 t -95.64 171.21 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.874 . . . . 0.0 110.02 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -70.39 6.91 1.18 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 110.566 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.86 38.32 0.07 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.092 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.8 mt-30 -152.41 -138.13 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.235 -1.156 . . . . 0.0 110.669 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 88' ' ' ILE . 2.4 mp -45.52 158.81 0.07 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.832 -0.543 . . . . 0.0 110.282 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.092 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.5 OUTLIER -169.82 96.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 110.137 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.608 ' CG2' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER 179.92 173.73 0.93 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.3 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 87' ' ' GLN . 3.4 mp -143.45 135.16 26.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.89 . . . . 0.0 110.236 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.627 ' CG ' ' HB2' ' A' ' 86' ' ' ARG . 6.2 pt-20 -141.38 128.35 20.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 0.0 110.205 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.5 t -97.73 154.76 17.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -0.874 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -176.11 -175.54 43.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.03 159.84 16.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -1.178 . . . . 0.0 110.255 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.839 ' CD2' ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -121.54 140.29 52.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.466 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.815 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 2.9 mm100 -135.45 100.61 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.352 -0.843 . . . . 0.0 109.579 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.911 HG22 HG23 ' A' ' 113' ' ' THR . 39.0 t -119.4 115.13 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.002 . . . . 0.0 110.559 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.078 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -105.23 152.25 23.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.121 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.703 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -124.84 133.74 52.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.135 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.693 ' OE1' ' CB ' ' A' ' 239' ' ' GLU . 1.6 mm-40 -101.75 -139.72 0.34 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.258 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.3 t -97.54 -43.39 7.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.18 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.86 -26.49 5.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 109.973 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.686 ' CB ' ' HA2' ' A' ' 142' ' ' GLY . 0.3 OUTLIER -114.64 -154.98 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 110.085 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' O ' ' O ' ' A' ' 140' ' ' ILE . . . -172.31 169.36 5.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.374 -0.829 . . . . 0.0 109.944 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.946 ' N ' HD23 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -142.26 129.65 21.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.018 . . . . 0.0 110.65 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.911 HG23 HG22 ' A' ' 104' ' ' VAL . 85.7 m -111.82 175.58 5.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.001 -1.062 . . . . 0.0 110.575 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.815 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . . . -167.1 121.06 1.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.612 -0.68 . . . . 0.0 109.634 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 69.9 mt -99.92 141.19 33.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.559 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.616 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 3.0 mt-30 -125.44 147.84 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.877 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.561 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 60.8 m -123.59 160.29 27.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.321 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -147.41 -33.55 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -145.24 145.39 31.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -144.2 -179.72 6.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.946 . . . . 0.0 110.298 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.696 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 21.5 mt-30 -152.73 148.04 26.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.389 -0.819 . . . . 0.0 109.846 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.761 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -126.16 103.6 26.36 Favored Pre-proline 0 N--CA 1.499 2.002 0 C-N-CA 118.811 -1.155 . . . . 0.0 110.559 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HG3' ' O ' ' A' ' 95' ' ' ILE . 48.4 Cg_endo -74.73 48.83 2.01 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.265 1.666 . . . . 0.0 111.707 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.752 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 8.3 mm-40 -90.99 -28.57 17.92 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.381 1.086 . . . . 0.0 108.435 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.752 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -75.7 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.82 17.43 10.21 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.706 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.5 OUTLIER -103.02 5.46 38.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 111.113 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.761 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.62 36.92 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.138 -0.976 . . . . 0.0 111.209 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.706 ' N ' ' O ' ' A' ' 127' ' ' GLU . 1.6 ptm -157.58 141.89 16.24 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.155 -0.966 . . . . 0.0 110.083 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.64 168.23 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 110.218 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -155.02 124.7 6.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.188 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 131' ' ' ALA . 0.6 OUTLIER 174.36 164.77 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 110.232 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -107.93 106.46 16.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.452 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.6 OUTLIER -118.66 110.96 17.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 110.211 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.725 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 10.0 p90 -107.68 112.43 25.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.869 . . . . 0.0 110.364 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 115' ' ' LEU . 2.8 ttp85 -106.31 107.79 18.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.036 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.976 HD12 ' C ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -49.87 158.64 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.264 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.753 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -132.76 -159.12 9.09 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.753 ' O ' ' O ' ' A' ' 138' ' ' GLY . 13.8 t0 -0.41 133.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 122.118 0.961 . . . . 0.0 113.004 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.812 HD12 ' O ' ' A' ' 141' ' ' ALA . 1.2 pp -58.69 -152.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.219 -0.926 . . . . 0.0 110.465 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.274 ' HB1' ' CD2' ' A' ' 233' ' ' PHE . . . -106.82 -172.66 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.332 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.686 ' HA2' ' CB ' ' A' ' 110' ' ' SER . . . -69.01 -55.98 9.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.664 ' O ' ' CB ' ' A' ' 233' ' ' PHE . 5.0 mt-10 -151.17 120.91 7.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.738 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -89.84 77.55 6.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.265 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.6 ' C ' ' HA ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -107.04 126.69 52.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 110.089 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.705 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -58.86 121.93 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.872 ' CZ ' ' CZ ' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -45.6 -18.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.041 -1.037 . . . . 0.0 109.915 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.614 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 19.3 t70 -57.91 -10.3 1.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.319 -0.863 . . . . 0.0 110.291 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.3 OUTLIER -72.33 1.42 7.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.348 -0.845 . . . . 0.0 109.694 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.997 HD22 ' HG2' ' A' ' 235' ' ' GLU . 0.5 OUTLIER 179.74 57.3 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.511 -0.743 . . . . 0.0 109.818 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.66 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.9 Cg_endo -87.35 94.2 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.179 1.621 . . . . 0.0 110.56 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 16.2 mttt -141.28 -76.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 109.988 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 8.9 t70 -151.1 42.65 0.77 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.438 -0.789 . . . . 0.0 109.976 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.846 HG11 ' CD ' ' A' ' 236' ' ' LYS . 76.4 t -97.83 110.75 26.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.161 -0.962 . . . . 0.0 110.776 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 2.8 mtm -67.64 114.04 5.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 109.598 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 203' ' ' TYR . . . -90.68 103.29 16.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 110.732 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.706 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 8.7 m -110.91 137.69 48.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.891 ' CE2' HG21 ' A' ' 232' ' ' ILE . 11.3 m-85 -138.47 148.48 44.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.105 -0.997 . . . . 0.0 110.605 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.887 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.68 144.28 26.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 109.508 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -174.49 -136.74 2.3 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.072 -1.537 . . . . 0.0 110.489 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 170' ' ' GLY . 52.7 m -125.41 155.72 39.96 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -1.029 . . . . 0.0 110.709 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -129.2 -178.63 4.73 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.68 -0.637 . . . . 0.0 109.521 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.737 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 0.7 OUTLIER -150.5 128.99 12.17 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.147 -0.971 . . . . 0.0 110.302 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -104.93 168.25 15.73 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.736 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 m -89.03 -6.82 56.9 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.164 -1.198 . . . . 0.0 110.744 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -143.42 6.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 1.054 ' OD2' HD11 ' A' ' 190' ' ' LEU . 1.0 OUTLIER -124.9 172.9 9.0 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.447 -0.783 . . . . 0.0 109.181 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.762 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -71.66 131.85 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.762 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.51 -114.04 0.01 OUTLIER Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.801 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 175.12 156.75 14.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.682 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 0.8 OUTLIER -141.24 120.97 13.43 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.03 -1.277 . . . . 0.0 108.54 178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.124 HD13 ' CE2' ' A' ' 174' ' ' TYR . 1.8 pp -148.74 155.42 40.96 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.16 -1.416 . . . . 0.0 112.629 -178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.671 HG23 ' CB ' ' A' ' 159' ' ' ARG . 50.0 m -142.04 120.61 12.51 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.124 ' CE2' HD13 ' A' ' 172' ' ' LEU . 8.3 m-85 -123.67 158.78 30.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.91 -1.119 . . . . 0.0 111.476 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.491 ' O ' ' HA2' ' A' ' 183' ' ' GLY . 2.7 m -117.9 105.42 11.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.978 HG12 HG11 ' A' ' 201' ' ' VAL . 0.9 OUTLIER -103.86 169.57 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 111.598 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.701 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 22.3 t0 -121.62 137.59 54.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.759 -0.588 . . . . 0.0 109.841 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.773 ' CE1' ' HA ' ' A' ' 153' ' ' ASP . 28.7 p90 -42.43 -147.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.529 1.157 . . . . 0.0 113.461 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.66 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.54 -43.82 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.48 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.761 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.4 52.24 0.05 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.692 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -17.87 76.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.26 0.552 . . . . 0.0 110.948 -178.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.761 ' N ' ' O ' ' A' ' 180' ' ' ALA . 42.0 tt0 -133.31 114.26 13.55 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.682 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -150.91 171.07 30.68 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.294 -1.431 . . . . 0.0 110.781 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.605 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 179.44 134.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.779 -0.836 . . . . 0.0 109.256 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -153.54 -149.82 5.29 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.061 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 185' ' ' GLY . 25.8 mttt -143.36 142.3 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -1.133 . . . . 0.0 110.481 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.7 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -108.29 135.66 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 109.9 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.763 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 3.0 pt-20 -162.27 150.34 14.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.957 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.2 t60 -162.73 -64.54 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.151 -0.968 . . . . 0.0 110.563 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.054 HD11 ' OD2' ' A' ' 167' ' ' ASP . 0.1 OUTLIER -95.82 -160.28 0.78 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.522 0.677 . . . . 0.0 111.061 -179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.942 ' HA ' HD23 ' A' ' 195' ' ' LEU . 8.5 mmmt -125.89 7.56 7.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.416 -0.802 . . . . 0.0 110.147 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.951 ' HB2' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -48.31 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.512 -0.743 . . . . 0.0 110.139 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.6 Cg_endo -67.65 -0.64 5.49 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.345 1.182 . . . . 0.0 109.705 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 195' ' ' LEU . 8.6 pt-20 -135.76 41.5 2.7 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.942 HD23 ' HA ' ' A' ' 191' ' ' LYS . 1.4 mp -37.11 -68.64 0.14 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.838 0.828 . . . . 0.0 110.331 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 1.087 ' O ' HG23 ' A' ' 197' ' ' VAL . 7.2 m120 -132.87 -177.55 4.55 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.204 0.526 . . . . 0.0 110.337 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.087 HG23 ' O ' ' A' ' 196' ' ' ASN . 2.1 t -176.89 172.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.297 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.612 ' N ' ' CG1' ' A' ' 197' ' ' VAL . 13.6 m-20 -102.32 136.3 42.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.791 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -133.35 158.22 43.53 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.084 -1.01 . . . . 0.0 110.171 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.629 ' C ' HG23 ' A' ' 201' ' ' VAL . . . -107.12 178.11 4.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.978 HG11 HG12 ' A' ' 176' ' ' ILE . 11.1 t -157.85 157.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.871 -1.143 . . . . 0.0 110.914 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -146.96 123.13 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.586 -0.696 . . . . 0.0 109.572 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.991 ' CE1' ' HB1' ' A' ' 212' ' ' ALA . 0.6 OUTLIER -89.17 114.8 26.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.121 -0.987 . . . . 0.0 110.808 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 2.7 mm -101.14 170.68 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 0.0 109.66 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 7.9 mtmt -82.08 -73.22 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -72.76 95.59 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.813 1.428 . . . . 0.0 110.877 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.971 ' CA ' HG22 ' A' ' 213' ' ' VAL . 47.7 t0 -70.97 -129.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.893 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.618 ' C ' ' CD ' ' A' ' 209' ' ' LYS . 19.5 mt-10 -60.52 -23.73 64.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.007 . . . . 0.0 109.774 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' CD ' ' C ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -152.88 -48.47 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.806 . . . . 0.0 109.752 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.792 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 35.5 p-80 -170.13 40.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.786 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.792 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 2.7 m170 -126.41 -166.58 1.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.245 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.991 ' HB1' ' CE1' ' A' ' 203' ' ' TYR . . . -72.12 133.47 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.459 -0.775 . . . . 0.0 110.051 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.971 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.3 OUTLIER -109.86 160.76 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.184 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.714 HD11 ' CD1' ' A' ' 232' ' ' ILE . 17.2 mm -144.62 128.98 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.199 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 202' ' ' ALA . 72.9 m -145.59 137.77 25.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 110.095 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.38 -177.48 40.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.8 p -130.79 127.45 38.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -1.147 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.797 HG22 HG11 ' A' ' 197' ' ' VAL . 13.7 p -92.37 145.61 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 121.186 -0.946 . . . . 0.0 110.34 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -158.6 142.78 15.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.724 ' CD2' ' HB2' ' A' ' 222' ' ' GLN . 4.5 t80 -97.84 155.4 17.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.838 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -73.52 1.42 9.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.112 -0.992 . . . . 0.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.724 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -93.72 -60.59 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.883 . . . . 0.0 109.971 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.604 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.2 OUTLIER 178.7 26.56 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.735 -0.603 . . . . 0.0 110.445 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 4.5 tt0 -86.81 154.68 20.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.604 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 0.0 OUTLIER -144.7 76.53 1.5 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.669 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.756 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -104.12 174.21 22.09 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.1 OUTLIER -127.08 -178.46 4.43 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.461 -1.023 . . . . 0.0 109.991 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.614 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -159.17 127.68 5.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.0 -1.062 . . . . 0.0 110.836 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.69 121.29 9.17 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.538 -0.726 . . . . 0.0 109.522 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.238 HD11 ' CD1' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -144.12 177.37 8.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.081 -1.012 . . . . 0.0 111.062 -179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.624 ' HA3' ' OD2' ' A' ' 207' ' ' ASP . . . -134.37 125.54 3.87 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.891 HG21 ' CE2' ' A' ' 158' ' ' TYR . 16.3 mt -93.92 154.77 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.051 -1.264 . . . . 0.0 110.995 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 1.274 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -126.91 85.16 2.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.108 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.811 ' HA3' ' HB2' ' A' ' 238' ' ' GLN . . . 178.24 136.38 2.52 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.997 ' HG2' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -36.01 -47.67 0.55 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.017 -1.284 . . . . 0.0 108.129 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.846 ' CD ' HG11 ' A' ' 154' ' ' VAL . 0.0 OUTLIER 177.83 37.48 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.613 ' O ' ' OE1' ' A' ' 261' ' ' GLN . . . -170.03 15.05 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.043 -177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.811 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 85.8 mm-40 -93.5 -97.51 0.14 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.568 -1.332 . . . . 0.0 110.886 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.796 ' O ' HG23 ' A' ' 232' ' ' ILE . 9.9 mp0 -148.6 174.9 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.971 -1.091 . . . . 0.0 111.23 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.881 HG23 HG13 ' A' ' 232' ' ' ILE . 12.2 p -144.42 134.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 110.17 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.596 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.25 140.99 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.408 -0.807 . . . . 0.0 109.956 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 1.132 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -178.15 -139.22 3.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.557 ' HA ' ' HA2' ' A' ' 256' ' ' GLY . 23.5 p -158.32 -176.83 6.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.341 -1.094 . . . . 0.0 109.938 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -155.91 170.99 20.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -121.51 140.96 51.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 0.0 109.705 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -132.2 109.61 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 110.632 -179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -97.5 131.86 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 110.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.713 HG22 ' N ' ' A' ' 249' ' ' ALA . 88.0 m -92.28 -109.59 0.1 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 248' ' ' THR . . . -133.18 -0.72 3.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 109.869 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 249' ' ' ALA . 2.7 m-80 -164.34 20.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 110.023 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -166.08 175.27 41.65 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.466 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 2.6 mp -137.23 128.15 40.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.334 -1.097 . . . . 0.0 110.206 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.636 ' N ' ' CD2' ' A' ' 253' ' ' HIS . 1.3 m170 -111.12 161.09 16.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.2 -0.938 . . . . 0.0 110.27 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.736 ' CD2' ' OG ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -127.69 123.79 36.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -118.36 123.2 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.111 -0.993 . . . . 0.0 110.767 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.737 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.87 155.24 28.81 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.238 ' CD1' HD11 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -129.07 152.4 48.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.916 -1.344 . . . . 0.0 111.214 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.8 109.61 3.46 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.887 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.89 168.97 18.49 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.804 -1.185 . . . . 0.0 111.298 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 261' ' ' GLN . 0.6 OUTLIER -116.93 165.67 13.06 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.319 0.58 . . . . 0.0 110.119 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CG ' ' A' ' 158' ' ' TYR . 27.7 mm-40 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.208 0.528 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.97 97.8 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -101.2 118.7 37.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -1.177 . . . . 0.0 110.113 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.9 p -154.87 166.59 33.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 0.0 110.172 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.04 111.46 3.29 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.26 -133.41 2.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.42 83.56 1.5 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.66 164.13 32.47 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -157.26 153.32 27.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.338 -1.096 . . . . 0.0 110.229 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.95 -72.36 1.21 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.29 90.26 0.44 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.35 -136.3 0.21 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.08 -56.36 1.07 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.064 HG11 HD13 ' A' ' 18' ' ' ILE . 2.8 t -58.84 -164.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -1.214 . . . . 0.0 110.257 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.873 ' H ' HG12 ' A' ' 14' ' ' VAL . 2.9 t -79.83 168.04 19.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 110.249 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' CG ' ' A' ' 17' ' ' ASP . . . -64.31 -1.1 1.49 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 8.5 m-20 -162.29 67.51 0.24 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.244 -0.91 . . . . 0.0 110.227 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.064 HD13 HG11 ' A' ' 14' ' ' VAL . 1.1 mt -39.5 -29.6 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.959 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -71.85 -80.59 0.36 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.874 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.35 -1.23 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -1.139 . . . . 0.0 110.38 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -68.31 -17.87 70.78 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 19' ' ' GLY . 1.2 pp -62.81 -39.63 94.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -1.183 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.793 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.26 -11.18 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.038 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -94.71 -8.83 36.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.149 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -77.37 -25.84 51.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.434 -0.791 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.137 HD22 ' CD1' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -93.49 -33.46 13.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 110.174 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.666 ' O ' ' N ' ' A' ' 29' ' ' PRO . 4.9 m -90.68 -6.65 54.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 1.007 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . . . -28.03 88.12 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.499 -0.751 . . . . 0.0 110.315 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.666 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.51 115.15 4.23 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.121 1.59 . . . . 0.0 110.379 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' C ' ' O ' ' A' ' 29' ' ' PRO . 1.2 tp -29.52 133.53 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.662 ' OD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -179.99 146.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -76.19 -2.34 30.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.06 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' NZ ' ' OD1' ' A' ' 31' ' ' ASP . 1.2 mppt? -67.91 -1.91 6.48 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.405 -0.809 . . . . 0.0 110.199 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' OD2' ' O ' ' A' ' 36' ' ' GLY . 13.6 p-10 -84.83 160.37 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.176 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -75.63 -18.37 59.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -174.92 -103.55 0.17 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 0.6 OUTLIER -46.68 143.1 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -1.157 . . . . 0.0 110.215 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 36' ' ' GLY . 8.1 mptt -106.37 -25.7 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.66 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.3 p 176.11 -175.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.207 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 39' ' ' SER . 96.0 mt -154.67 128.37 8.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 110.281 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 m -97.43 134.8 40.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.0 110.207 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.697 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 5.2 mp -86.54 131.61 34.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 45' ' ' SER . 23.7 tt0 -32.95 157.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.166 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.54 52.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 43' ' ' GLU . 22.8 t -47.85 -54.53 12.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.189 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 ' H ' ' A' ' 47' ' ' SER . 1.3 mt -96.28 -157.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.277 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.715 ' H ' HG22 ' A' ' 46' ' ' ILE . 14.6 m -165.26 -163.25 0.66 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.897 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -54.71 -11.59 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -100.2 54.51 0.9 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.518 -0.739 . . . . 0.0 110.488 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.615 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.91 91.33 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 40.6 p -113.4 135.3 54.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.196 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -162.63 151.92 15.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.275 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.696 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -120.15 154.65 34.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.915 . . . . 0.0 110.19 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.137 ' CD1' HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -135.99 130.73 34.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 0.0 110.275 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.624 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 46.6 t -122.39 149.22 44.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -122.52 -173.41 2.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.874 ' O ' HG22 ' A' ' 20' ' ' THR . 47.8 mt-30 -74.45 43.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 110.214 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -174.89 -46.79 0.05 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.761 ' H ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.52 177.24 11.41 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.256 -1.143 . . . . 0.0 110.279 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 14.4 pt-20 -140.53 162.27 35.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 110.254 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.687 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 7.1 tttp -140.04 152.33 46.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.195 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.708 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -83.83 112.87 20.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.334 -0.854 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.705 ' CG ' HD23 ' A' ' 54' ' ' LEU . 2.6 m-30 -101.76 173.14 6.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.301 -0.875 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 144.24 -129.24 3.54 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.642 ' ND2' ' HA ' ' A' ' 47' ' ' SER . 6.2 t-20 -65.15 133.98 52.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 110.069 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -18.11 45.28 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.697 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 6.3 m-20 26.59 98.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.539 -0.977 . . . . 0.0 110.391 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.7 m -102.43 132.35 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -132.36 97.75 4.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 110.145 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.007 ' CB ' ' HB3' ' A' ' 28' ' ' ALA . 4.9 m120 -90.28 104.65 17.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 110.21 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.896 HG22 HD13 ' A' ' 74' ' ' LEU . 12.0 p -119.46 41.07 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.178 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -59.57 -7.6 6.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 55.0 mttm -108.91 -46.3 3.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.896 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.19 163.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.668 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -120.68 -128.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -0.787 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.613 ' O ' ' O ' ' A' ' 107' ' ' GLN . 56.4 m-80 -125.57 7.01 7.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.689 ' CB ' ' HD2' ' A' ' 260' ' ' LYS . 52.7 m-20 -149.12 68.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.153 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 18' ' ' ILE . 24.7 mtpt -152.96 157.94 41.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.821 ' CG2' ' CE2' ' A' ' 105' ' ' TYR . 1.5 t -116.74 166.25 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 0.2 OUTLIER -145.48 90.62 2.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.63 ' NH2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -101.28 125.17 47.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 110.149 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.744 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 23.5 p90 -144.01 159.51 42.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 0.0 110.228 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 4.6 p-10 -97.65 142.8 29.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.902 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.3 p90 -145.09 -169.61 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.82 ' O ' HG23 ' A' ' 85' ' ' ILE . 10.5 tt -146.97 106.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.152 -0.967 . . . . 0.0 110.347 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -90.58 104.14 16.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.108 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.72 ' OE1' HD23 ' A' ' 97' ' ' LEU . 3.7 mt-30 -142.81 138.47 30.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.477 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.088 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.8 OUTLIER -124.21 112.34 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HG2' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -140.65 114.57 9.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 110.292 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 93' ' ' GLN . 79.3 t -104.27 171.03 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.972 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 3.4 m-20 -68.04 3.9 1.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.08 -1.013 . . . . 0.0 110.49 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 42.13 0.07 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.71 ' CD ' HG11 ' A' ' 90' ' ' VAL . 22.7 mt-30 -154.63 -138.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.231 -1.158 . . . . 0.0 110.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.18 159.94 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.262 0.553 . . . . 0.0 110.449 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.047 ' O ' HD12 ' A' ' 97' ' ' LEU . 11.3 mm -153.39 17.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.426 -0.796 . . . . 0.0 110.016 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.088 ' HB ' HD12 ' A' ' 88' ' ' ILE . 4.0 m -53.66 155.32 3.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.346 -0.847 . . . . 0.0 110.377 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.047 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -161.88 96.88 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.0 110.112 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.5 mt-10 -146.62 129.32 16.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' HG13 ' A' ' 85' ' ' ILE . 7.5 t -106.8 165.48 11.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.037 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -174.06 -165.11 30.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 3.7 mt-10 -116.85 159.83 21.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -1.116 . . . . 0.0 110.195 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.744 ' CB ' ' CE1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -120.53 143.45 48.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.344 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 1.136 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -137.62 102.22 4.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.974 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 113' ' ' THR . 15.4 t -111.82 120.24 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 0.0 110.326 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.821 ' CE2' ' CG2' ' A' ' 79' ' ' VAL . 1.4 t80 -115.64 123.32 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 110.108 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HD2' ' CB ' ' A' ' 111' ' ' ALA . 15.2 tptt -106.0 130.99 53.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.253 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.625 ' NE2' ' HB2' ' A' ' 108' ' ' SER . 0.3 OUTLIER -111.63 -139.61 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.159 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.625 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 20.5 m -65.99 -104.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.201 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -85.52 -19.1 31.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.103 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.612 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -107.01 -161.99 0.82 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.81 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.54 -173.92 1.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 110.191 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.907 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -154.5 127.09 8.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.214 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 104' ' ' VAL . 1.9 m -109.03 169.43 8.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.28 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.136 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -160.83 124.69 3.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.075 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -108.78 141.04 41.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 -179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.982 ' HG2' ' HB2' ' A' ' 168' ' ' ALA . 2.8 tp60 -132.44 149.26 52.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 110.153 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 3.5 m -114.92 165.99 12.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG2' ' C ' ' A' ' 117' ' ' THR . 1.8 mt-10 -142.26 -44.89 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.208 -0.932 . . . . 0.0 110.459 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -118.63 155.3 31.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.43 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.698 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.9 mt-10 -116.63 -178.2 3.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.371 -0.831 . . . . 0.0 110.745 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -118.16 153.87 33.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.4 OUTLIER -117.16 175.28 2.05 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.96 -1.087 . . . . 0.0 111.643 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.683 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.0 Cg_endo -96.42 -73.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.95 2.434 . . . . 0.0 110.73 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.683 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.0 OUTLIER -11.2 -59.55 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 122.869 1.319 . . . . 0.0 109.281 179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.839 ' O ' ' N ' ' A' ' 127' ' ' GLU . 63.8 m80 -130.14 80.19 1.94 Allowed 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 2.0 p -21.27 -31.8 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.247 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -80.77 7.14 11.01 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.089 -1.007 . . . . 0.0 110.485 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 20.2 mttt -71.9 -157.49 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.644 -1.285 . . . . 0.0 110.13 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -156.06 145.35 20.72 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.833 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.698 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -121.78 -176.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.384 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.85 114.8 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.596 ' CG ' ' OE2' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -152.97 141.45 20.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.556 ' HD2' ' CG ' ' A' ' 166' ' ' ASP . 0.3 OUTLIER -107.98 106.54 16.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.9 mtp180 -117.36 119.74 36.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.907 . . . . 0.0 110.078 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.744 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 4.7 p90 -122.12 112.77 18.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.665 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 1.8 tmm_? -104.06 167.73 9.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 110.08 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 163' ' ' PHE . 49.6 mm -129.83 98.58 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 110.258 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 33.68 2.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -52.18 148.9 5.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 110.212 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -129.58 44.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 110.13 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.46 134.54 56.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.052 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.81 16.46 0.38 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.519 ' CD ' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -88.82 -161.78 0.79 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.227 -1.16 . . . . 0.0 109.871 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.749 ' CE1' ' HG3' ' A' ' 235' ' ' GLU . 5.5 m170 -97.97 89.37 4.54 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.793 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.978 HG23 ' HB3' ' A' ' 233' ' ' PHE . 0.2 OUTLIER -50.5 -14.62 0.19 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -75.32 116.03 15.61 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.526 -0.734 . . . . 0.0 110.125 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.085 ' CD1' HD11 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -59.83 -7.25 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.094 -1.004 . . . . 0.0 109.539 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 149' ' ' LYS . 4.3 t70 -59.47 -29.23 67.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.973 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.742 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 7.5 mptt -82.53 28.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.733 0.778 . . . . 0.0 109.173 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.085 HD11 ' CD1' ' A' ' 147' ' ' PHE . 0.8 OUTLIER 178.53 59.62 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 178' ' ' PHE . 39.5 Cg_endo -81.62 115.67 2.83 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 O-C-N 124.599 1.841 . . . . 0.0 110.909 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.852 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -170.49 94.49 0.22 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.73 ' HA ' ' CB ' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -54.07 56.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 122.391 1.091 . . . . 0.0 108.755 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.852 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.257 85.6 t -111.27 161.65 9.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.725 -177.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 2.8 mtt -73.14 105.19 4.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.839 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.479 ' O ' ' CD1' ' A' ' 158' ' ' TYR . . . -90.68 103.42 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.455 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 53.9 m -77.4 156.19 31.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.66 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.807 ' CD1' HD12 ' A' ' 176' ' ' ILE . 55.9 m-85 -142.46 140.24 31.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.057 -1.027 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 10.2 ptp85 -149.72 136.07 19.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.698 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.27 -154.54 7.9 Favored Glycine 0 N--CA 1.486 2.033 0 C-N-CA 118.788 -1.673 . . . . 0.0 110.889 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.464 ' O ' HD23 ' A' ' 172' ' ' LEU . 58.7 m -120.63 155.51 33.64 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.637 -0.92 . . . . 0.0 110.327 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.664 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -135.62 179.8 6.12 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.554 0.693 . . . . 0.0 110.162 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.728 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.2 p90 -154.9 132.47 11.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.466 -0.771 . . . . 0.0 109.339 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.42 145.55 23.08 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.527 -1.321 . . . . 0.0 110.393 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.589 ' O ' ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -29.14 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.516 -0.991 . . . . 0.0 110.633 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -53.5 -9.54 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.498 -0.751 . . . . 0.0 110.501 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.679 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 12.8 m-20 -99.63 171.6 7.81 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.544 -0.722 . . . . 0.0 109.686 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.982 ' HB2' ' HG2' ' A' ' 116' ' ' GLN . . . -131.53 11.99 4.91 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 108.776 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -129.55 147.35 17.86 Favored Glycine 0 N--CA 1.48 1.608 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 162' ' ' ALA . . . -178.01 161.68 28.8 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 188' ' ' GLU . 28.5 mttt -136.05 144.65 45.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.134 -1.215 . . . . 0.0 109.153 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.009 HD11 ' CB ' ' A' ' 259' ' ' ALA . 1.5 pp -136.73 101.29 4.56 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.754 -1.178 . . . . 0.0 111.829 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 89.9 m -104.88 118.69 37.18 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.018 ' CE1' HD13 ' A' ' 199' ' ' LEU . 2.6 m-85 -127.93 150.11 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 112.605 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.838 HG22 ' O ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -116.5 98.04 6.34 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.951 HG21 ' CZ ' ' A' ' 203' ' ' TYR . 3.6 mt -111.18 119.97 60.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 112.255 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.747 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.6 m-20 -70.44 157.97 36.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.73 ' CB ' ' HA ' ' A' ' 153' ' ' ASP . 24.8 t80 -35.92 167.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.916 0.865 . . . . 0.0 112.429 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.052 ' HB1' ' HG3' ' A' ' 205' ' ' LYS . . . -40.02 -67.27 0.24 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.143 0.497 . . . . 0.0 110.966 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.22 43.89 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -0.883 . . . . 0.0 109.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.747 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 16.6 mtpt -137.99 -94.0 0.2 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 0.0 111.086 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 176' ' ' ILE . 0.6 OUTLIER -162.9 176.99 9.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.747 -1.221 . . . . 0.0 111.529 -179.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.747 ' HA3' ' CD1' ' A' ' 203' ' ' TYR . . . -161.8 94.02 0.12 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.729 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 8.4 p-80 -140.15 155.25 47.05 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.211 -1.17 . . . . 0.0 109.975 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.723 ' N ' ' CD2' ' A' ' 174' ' ' TYR . . . -156.23 -149.85 5.47 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.104 -1.522 . . . . 0.0 110.461 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.66 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 5.4 mtpm? -132.78 140.63 48.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.655 -0.909 . . . . 0.0 109.247 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -89.26 121.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 120.931 -1.106 . . . . 0.0 109.853 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.766 ' N ' HD12 ' A' ' 187' ' ' ILE . 17.0 mt-10 -100.94 71.37 1.42 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.465 -0.772 . . . . 0.0 109.875 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.814 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 3.9 t-160 -98.37 109.54 22.28 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.558 0.694 . . . . 0.0 109.915 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -49.67 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 110.815 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.756 ' O ' ' O ' ' A' ' 192' ' ' SER . 14.3 mttt -71.73 15.28 0.15 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.892 -0.505 . . . . 0.0 111.735 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.814 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 0.2 OUTLIER -45.02 -162.02 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.577 -0.702 . . . . 0.0 110.053 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.756 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 41.4 Cg_endo -69.16 12.39 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 122.516 0.745 . . . . 0.0 110.72 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' CG ' ' O ' ' A' ' 193' ' ' PRO . 0.2 OUTLIER 179.84 -52.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.967 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.802 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 0.3 OUTLIER 176.04 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.488 -0.758 . . . . 0.0 109.346 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.802 ' ND2' ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER 178.84 -168.76 0.09 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.129 ' CG1' HG12 ' A' ' 218' ' ' VAL . 0.9 OUTLIER -168.31 163.39 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.111 . . . . 0.0 110.767 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -84.94 120.77 26.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.809 . . . . 0.0 110.041 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.1 ' CD2' HG22 ' A' ' 218' ' ' VAL . 6.2 mt -98.07 124.73 42.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.345 -0.847 . . . . 0.0 111.566 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -130.5 119.47 22.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.333 -0.854 . . . . 0.0 109.159 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.138 HG21 ' CD2' ' A' ' 228' ' ' TYR . 91.6 t -145.0 157.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 0.0 111.28 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.93 149.87 30.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.442 -0.786 . . . . 0.0 109.519 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.951 ' CZ ' HG21 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -94.92 135.04 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.777 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -118.04 126.22 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 110.085 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 1.052 ' HG3' ' HB1' ' A' ' 179' ' ' ALA . 4.6 mttt -81.82 -33.0 0.63 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.794 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.755 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.6 Cg_endo -77.77 58.76 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.732 1.385 . . . . 0.0 110.744 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.639 ' CG ' HG22 ' A' ' 213' ' ' VAL . 31.7 t0 -75.58 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -47.28 -20.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.419 179.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 208' ' ' GLU . 20.7 mmtm -167.12 -55.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.1 OUTLIER -159.62 14.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.464 -0.773 . . . . 0.0 110.153 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.736 ' CG ' ' HB ' ' A' ' 145' ' ' THR . 12.8 m170 -79.34 163.74 24.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . . . -85.91 136.74 33.16 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.931 -1.105 . . . . 0.0 109.663 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 204' ' ' ILE . 0.2 OUTLIER -122.54 157.27 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 110.436 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.757 HG22 HG11 ' A' ' 201' ' ' VAL . 2.2 mt -128.18 105.24 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.352 -0.842 . . . . 0.0 109.796 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.98 ' C ' HG13 ' A' ' 201' ' ' VAL . 74.0 m -125.29 120.98 32.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 0.0 110.297 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.875 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -163.63 -159.43 10.71 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.5 OUTLIER -136.19 135.37 39.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.17 -1.194 . . . . 0.0 110.719 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.129 HG12 ' CG1' ' A' ' 197' ' ' VAL . 1.7 t -94.04 122.07 45.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.398 -0.814 . . . . 0.0 109.484 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.826 HD12 ' C ' ' A' ' 218' ' ' VAL . 4.4 mp -156.55 164.18 38.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 110.745 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.663 ' O ' ' N ' ' A' ' 222' ' ' GLN . 1.1 t80 -97.38 155.96 16.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.8 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 220' ' ' TYR . 11.5 t30 -35.99 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.112 -0.993 . . . . 0.0 110.471 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.663 ' N ' ' O ' ' A' ' 220' ' ' TYR . 4.2 pt20 -176.02 41.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.481 -0.762 . . . . 0.0 110.104 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.622 ' O ' ' O ' ' A' ' 224' ' ' GLU . 18.2 m-20 -138.75 -120.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 0.0 110.926 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.848 ' CD ' HG21 ' A' ' 197' ' ' VAL . 2.3 tt0 -32.31 161.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 111.391 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.684 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 18.4 mttt -142.8 77.18 1.56 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.541 ' O ' HD11 ' A' ' 219' ' ' LEU . . . -106.29 174.2 20.27 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.963 -1.113 . . . . 0.0 110.899 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.771 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 23.5 m -120.12 163.28 17.93 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.692 -0.887 . . . . 0.0 109.747 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.138 ' CD2' HG21 ' A' ' 201' ' ' VAL . 19.0 t80 -131.03 130.08 42.83 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 120.841 -1.162 . . . . 0.0 111.129 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.498 ' C ' HD12 ' A' ' 230' ' ' LEU . 20.3 m -148.1 116.6 6.6 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.496 -0.753 . . . . 0.0 109.723 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.001 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.2 mp -153.69 176.19 12.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.848 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 1.044 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -129.73 143.03 14.22 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.06 138.14 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.046 -1.267 . . . . 0.0 111.468 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.978 ' HB3' HG23 ' A' ' 145' ' ' THR . 2.0 p90 -139.23 150.46 45.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 237' ' ' ALA . . . 177.96 62.09 0.07 OUTLIER Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HG3' ' CE1' ' A' ' 144' ' ' HIS . 3.9 tm-20 -39.51 -27.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.521 -1.576 . . . . 0.0 107.976 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 234' ' ' GLY . 4.7 mttm -160.89 25.95 0.14 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.112 -1.811 . . . . 0.0 106.112 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.739 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -148.74 83.44 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.055 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.741 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -57.77 55.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.667 0.746 . . . . 0.0 110.097 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.907 ' OE2' HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -104.17 156.01 18.24 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.648 -0.657 . . . . 0.0 109.89 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 1.044 HG23 ' O ' ' A' ' 231' ' ' GLY . 7.9 p -148.34 150.31 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 110.451 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.489 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -145.18 149.02 34.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.439 -0.788 . . . . 0.0 109.845 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 1.001 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.95 -150.44 9.18 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.464 -1.351 . . . . 0.0 110.137 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 254' ' ' HIS . 2.0 t -158.25 130.67 7.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.48 -1.012 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.951 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.19 160.36 15.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 110.578 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.666 ' O ' ' N ' ' A' ' 227' ' ' SER . 24.5 mt-10 -99.3 145.59 27.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.977 HG12 ' CD2' ' A' ' 253' ' ' HIS . 2.1 t -135.34 122.03 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.029 -1.045 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.401 ' HG3' HG23 ' A' ' 252' ' ' ILE . 2.3 mt-10 -117.18 129.06 55.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.6 m -107.7 -173.53 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.069 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.625 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.92 -2.05 8.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.115 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 9.8 t30 179.72 41.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.257 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -166.49 97.03 0.13 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.401 HG23 ' HG3' ' A' ' 247' ' ' GLU . 2.8 mp -90.79 135.45 26.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.281 -1.129 . . . . 0.0 110.281 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.977 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -163.88 161.34 22.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.73 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -116.45 146.86 42.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 110.069 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.951 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -117.13 120.94 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 110.148 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.54 138.18 16.09 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.798 HD12 HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -122.45 155.74 35.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.099 -1.236 . . . . 0.0 111.511 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.53 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.84 111.16 3.68 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 1.009 ' CB ' HD11 ' A' ' 172' ' ' LEU . . . -143.28 162.31 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.665 -1.272 . . . . 0.0 111.839 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -118.82 161.17 20.6 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.199 0.524 . . . . 0.0 109.746 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.59 ' OXT' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.192 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.168 0.509 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -141.81 85.83 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.6 p -101.93 -169.42 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.215 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t -102.35 -33.07 9.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.215 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.7 178.96 38.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.71 171.09 55.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.84 -132.23 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.12 -130.55 6.66 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -151.87 167.08 29.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -1.15 . . . . 0.0 110.198 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.79 -175.93 31.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.25 -100.64 0.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.65 -148.17 5.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.96 59.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.863 HG11 HD13 ' A' ' 18' ' ' ILE . 2.8 t -58.86 -162.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -1.167 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.862 ' H ' HG12 ' A' ' 14' ' ' VAL . 8.8 t -70.66 168.6 16.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.192 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' O ' ' OD1' ' A' ' 17' ' ' ASP . . . -64.22 -1.16 1.47 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 15' ' ' THR . 4.9 m-20 -162.39 67.12 0.23 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.307 -0.87 . . . . 0.0 110.252 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.863 HD13 HG11 ' A' ' 14' ' ' VAL . 1.1 mt -39.27 -29.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' HD21 ' A' ' 22' ' ' LEU . . . -68.4 -78.59 0.3 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.677 HG22 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -64.01 -1.42 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -1.14 . . . . 0.0 110.361 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.57 -29.17 2.7 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -90.92 -34.93 15.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -1.144 . . . . 0.0 110.271 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.736 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.36 -11.25 0.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -93.94 -8.8 39.09 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.402 -0.811 . . . . 0.0 110.209 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 71' ' ' THR . . . -86.02 -16.17 39.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.256 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.116 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.5 mp -106.37 -12.41 15.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -109.95 -8.7 14.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.293 -0.88 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -122.28 95.91 46.7 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.76 . . . . 0.0 110.215 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' A' ' 30' ' ' LEU . 46.6 Cg_endo -73.0 -171.33 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.075 1.566 . . . . 0.0 110.443 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 29' ' ' PRO . 8.6 tp -34.15 142.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.24 123.67 1.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 110.206 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -64.71 -2.33 2.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' CE ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -66.72 -1.88 4.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.381 -0.825 . . . . 0.0 110.219 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -93.06 166.01 12.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 110.219 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -113.98 -3.12 13.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.8 -111.46 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.7 mm? -71.39 138.92 49.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -1.148 . . . . 0.0 110.197 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 39' ' ' SER . 71.1 mttt -97.49 -28.49 13.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.808 ' O ' HD22 ' A' ' 40' ' ' LEU . 16.7 p 175.45 -176.76 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -152.81 136.13 15.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 68' ' ' SER . 1.4 m -79.81 154.18 28.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.907 . . . . 0.0 110.19 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 69' ' ' LEU . 1.2 mp -82.02 -162.39 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -60.47 1.54 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' ' 45' ' ' SER . 4.8 t70 -170.62 23.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.261 -0.9 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.581 ' C ' ' O ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -29.91 -43.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.087 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.114 HD12 ' C ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -98.33 -158.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.292 -0.88 . . . . 0.0 110.034 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.516 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -176.82 -159.71 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.331 -0.855 . . . . 0.0 110.431 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.95 -3.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.439 -0.788 . . . . 0.0 110.328 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.603 ' C ' HG12 ' A' ' 88' ' ' ILE . 1.8 p30 -59.56 -86.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.339 -0.851 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' A' ' 88' ' ' ILE . . . -162.83 -97.62 0.12 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.574 HG22 ' HA2' ' A' ' 64' ' ' GLY . 7.4 p -154.83 177.19 11.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -1.125 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.7 pp -149.94 123.5 9.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.993 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.94 146.78 27.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 0.0 110.192 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -139.11 128.98 24.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 0.0 110.199 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 66.2 m -110.49 140.53 44.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -106.95 -174.2 2.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.566 HE21 HD11 ' A' ' 22' ' ' LEU . 46.3 mt-30 -74.43 43.41 0.18 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.291 -0.88 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.736 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -179.83 -40.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.62 177.26 11.42 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.225 -1.162 . . . . 0.0 110.289 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.627 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.8 pt-20 -137.7 164.94 27.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 10.6 tttt -151.97 144.07 23.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.184 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.428 ' O ' ' HD1' ' A' ' 63' ' ' TYR . 8.9 t -71.32 158.61 36.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.232 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.824 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -138.53 113.02 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.31 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 1.114 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -104.93 175.0 21.98 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -48.95 125.97 11.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.249 . . . . 0.0 110.036 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.82 -3.36 84.82 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 42' ' ' LEU . 5.7 p-10 -28.99 147.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -1.084 . . . . 0.0 110.247 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.793 ' HB2' HG23 ' A' ' 41' ' ' THR . 40.8 t -125.68 164.66 20.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 42' ' ' LEU . 23.5 mt -110.85 148.35 32.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 12.3 m-80 -123.2 106.39 10.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.834 ' HB ' HD13 ' A' ' 74' ' ' LEU . 70.9 p -140.7 43.6 1.84 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 110.165 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.35 -21.07 39.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.617 ' O ' ' O ' ' A' ' 74' ' ' LEU . 77.3 mttt -86.67 -44.67 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.21 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.834 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -35.27 163.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 110.685 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 36.4 mmtt -110.89 -167.79 1.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.442 -0.786 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.596 ' O ' ' O ' ' A' ' 107' ' ' GLN . 12.4 m-80 -86.6 31.01 0.69 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.656 ' HB3' ' CE ' ' A' ' 260' ' ' LYS . 11.7 m-20 -170.78 78.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 8.4 mmtp -149.47 176.25 10.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.3 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.084 HG22 ' CZ ' ' A' ' 105' ' ' TYR . 1.5 t -118.92 166.68 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.292 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.22 77.92 1.42 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.887 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.48 134.87 52.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.877 . . . . 0.0 110.298 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.866 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 24.6 p90 -152.98 161.35 42.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 110.147 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -98.51 125.31 43.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 110.135 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.8 p90 -133.97 155.84 49.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.828 HG22 ' O ' ' A' ' 98' ' ' GLU . 0.6 OUTLIER -119.33 120.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.204 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 98' ' ' GLU . 11.8 mtm180 -84.51 101.05 11.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.159 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.758 ' C ' HD12 ' A' ' 88' ' ' ILE . 1.1 mt-30 -147.42 165.95 28.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.274 -0.891 . . . . 0.0 110.007 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.966 HD13 ' CG2' ' A' ' 95' ' ' ILE . 2.7 mp -127.26 174.79 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.12 -0.987 . . . . 0.0 110.599 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -142.25 111.39 6.43 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.466 -0.771 . . . . 0.0 109.439 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 94' ' ' LEU . 24.5 t -68.64 130.97 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.123 -0.986 . . . . 0.0 110.272 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' C ' ' O ' ' A' ' 90' ' ' VAL . 12.3 t70 -36.23 -23.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 110.365 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.702 ' O ' ' CG ' ' A' ' 93' ' ' GLN . . . -125.75 7.51 7.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.702 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 66.2 mt-30 -163.81 -155.85 0.33 Allowed 'General case' 0 C--N 1.311 -1.104 0 O-C-N 120.927 -1.337 . . . . 0.0 110.047 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.053 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -118.01 -148.7 0.43 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.548 -0.72 . . . . 0.0 109.747 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.966 ' CG2' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -171.79 175.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.699 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 1.1 m -46.88 160.64 0.08 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.975 -1.078 . . . . 0.0 109.437 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.969 HD12 ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -148.2 128.36 13.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 110.125 -179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.828 ' O ' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.79 154.65 33.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.219 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -139.09 123.76 18.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 110.176 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' A' ' 116' ' ' GLN . . . -150.67 174.94 29.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 6.5 tm-20 -105.83 150.01 25.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.345 -1.091 . . . . 0.0 110.246 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.866 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.87 139.94 41.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.92 . . . . 0.0 110.188 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.992 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 1.9 tp60 -134.49 98.29 4.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.885 HG22 HG23 ' A' ' 113' ' ' THR . 34.5 t -120.17 150.74 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 110.302 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.084 ' CZ ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -145.24 116.7 8.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.265 -0.897 . . . . 0.0 110.192 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 3.4 ptmt -94.86 142.84 27.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.897 . . . . 0.0 110.204 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.677 ' HG2' ' CD1' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -116.78 -111.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.206 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.436 ' H ' ' CD ' ' A' ' 107' ' ' GLN . 2.7 m -97.99 -94.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.967 . . . . 0.0 110.291 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.44 32.19 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.509 ' HB3' HD11 ' A' ' 140' ' ' ILE . 6.5 t -164.85 -166.3 1.03 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.147 -0.971 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 140' ' ' ILE . . . -172.38 149.14 2.16 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 110.349 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.037 HD12 ' HB1' ' A' ' 258' ' ' ALA . 0.1 OUTLIER -110.61 155.02 22.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.004 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.885 HG23 HG22 ' A' ' 104' ' ' VAL . 21.7 m -131.39 173.99 10.52 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.122 -0.986 . . . . 0.0 110.807 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.992 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -168.97 120.64 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.618 -0.676 . . . . 0.0 109.565 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.704 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 13.1 mt -101.28 141.9 33.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 110.615 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.615 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 16.4 mt-30 -132.11 142.57 49.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.932 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 134' ' ' ARG . 7.4 m -120.85 164.62 16.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.287 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.583 ' HG3' ' HA2' ' A' ' 100' ' ' GLY . 5.2 mt-10 -145.15 -32.11 0.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.235 -0.915 . . . . 0.0 110.418 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.91 155.09 51.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.694 ' O ' ' N ' ' A' ' 130' ' ' VAL . 6.9 mt-10 -145.67 121.58 10.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.881 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 129' ' ' MET . 3.4 mt-30 -137.65 152.18 49.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 110.219 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.3 t0 -117.22 -179.28 0.62 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.232 -0.917 . . . . 0.0 111.072 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.68 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.7 Cg_endo -95.56 -1.31 2.29 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.985 1.79 . . . . 0.0 111.692 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.37 -104.03 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.756 -1.215 . . . . 0.0 110.925 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.669 ' HA ' ' HG2' ' A' ' 128' ' ' LYS . 8.0 p-80 -158.77 -33.2 0.07 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.558 0.694 . . . . 0.0 110.27 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.504 ' N ' ' CG ' ' A' ' 125' ' ' HIS . 9.7 t -77.32 -36.9 53.52 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 109.357 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mm-40 -115.32 4.67 14.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.477 -0.764 . . . . 0.0 109.734 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.69 -7.15 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.037 0.922 . . . . 0.0 110.63 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.694 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -157.26 133.19 9.46 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.544 178.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.694 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.9 t -151.81 168.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.037 -1.04 . . . . 0.0 110.35 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.25 114.82 3.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -163.93 -162.24 0.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.235 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.0 mtm-85 -122.55 129.7 52.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 110.274 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.59 ' O ' ' OG1' ' A' ' 117' ' ' THR . 2.1 ttt-85 -150.4 110.97 4.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.905 . . . . 0.0 109.963 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.838 ' CZ ' ' CE1' ' A' ' 254' ' ' HIS . 38.4 p90 -123.95 125.84 45.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 110.624 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.704 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -93.61 168.0 11.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.871 . . . . 0.0 109.422 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.755 ' CD1' ' CE2' ' A' ' 163' ' ' PHE . 16.1 mm -133.05 138.31 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.916 -1.115 . . . . 0.0 110.824 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . -125.48 29.9 4.63 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.624 ' O ' ' O ' ' A' ' 138' ' ' GLY . 11.0 t70 -24.12 146.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.542 -0.975 . . . . 0.0 110.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.0 HD12 HD23 ' A' ' 112' ' ' LEU . 2.9 tt -52.96 -167.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -0.793 . . . . 0.0 110.388 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.622 ' N ' HG23 ' A' ' 140' ' ' ILE . . . -152.81 27.79 0.54 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.968 0.889 . . . . 0.0 109.967 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 140' ' ' ILE . . . -117.01 15.44 13.54 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.752 ' HB3' ' CG ' ' A' ' 233' ' ' PHE . 0.4 OUTLIER -79.27 40.28 0.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -1.195 . . . . 0.0 110.117 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.802 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 20.6 m170 -98.61 8.75 44.54 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.714 -0.616 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.045 HG21 ' C ' ' A' ' 234' ' ' GLY . 8.6 t -106.98 102.55 11.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.92 -1.112 . . . . 0.0 111.136 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.73 ' CB ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.79 128.65 38.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 110.441 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.5 m-30 -42.69 -21.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.397 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.595 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 16.7 t0 -42.6 -22.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -78.89 12.8 1.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.768 0.794 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.804 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.6 OUTLIER -178.15 56.26 0.1 OUTLIER Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.654 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 41.8 Cg_endo -82.7 81.31 2.47 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.332 1.701 . . . . 0.0 110.49 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 1.048 ' O ' HG12 ' A' ' 154' ' ' VAL . 10.7 mmtp -117.91 69.78 0.79 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.039 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -26.37 65.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.396 1.093 . . . . 0.0 110.943 -178.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.048 HG12 ' O ' ' A' ' 152' ' ' LYS . 13.9 p -135.14 109.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.839 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.634 ' HA ' ' C ' ' A' ' 176' ' ' ILE . 12.3 ptt? -31.04 140.53 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.283 -0.885 . . . . 0.0 110.349 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.831 ' CB ' ' CZ ' ' A' ' 178' ' ' PHE . . . -127.58 129.41 47.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 110.339 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -78.0 130.54 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.948 . . . . 0.0 110.447 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.774 ' HE1' ' HB1' ' A' ' 156' ' ' ALA . 10.1 m-85 -133.68 151.62 51.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.93 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 6.7 ptp180 -141.44 146.03 36.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.356 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -163.38 -173.85 32.57 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.915 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.672 HG21 ' NE2' ' A' ' 103' ' ' GLN . 97.3 m -122.74 155.68 36.0 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.49 177.08 9.76 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.786 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 1.0 OUTLIER -134.93 133.9 40.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 110.0 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' HA3' ' HE1' ' A' ' 189' ' ' HIS . . . -108.92 143.35 16.28 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.016 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 254' ' ' HIS . 1.0 OUTLIER -71.59 -4.81 29.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -1.146 . . . . 0.0 110.235 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -137.22 2.1 2.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.525 ' CB ' ' ND1' ' A' ' 189' ' ' HIS . 3.5 m-20 -124.85 171.24 10.31 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.36 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.17 68.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.963 -1.086 . . . . 0.0 109.947 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.49 -115.52 0.5 Allowed Glycine 0 C--N 1.281 -2.526 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.941 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.17 95.61 0.1 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.622 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 57.6 mtmt -91.59 127.24 36.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.273 -1.722 . . . . 0.0 108.341 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.039 HD12 ' CE1' ' A' ' 174' ' ' TYR . 2.1 pt? -136.08 153.5 51.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.592 -1.317 . . . . 0.0 112.881 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 158' ' ' TYR . 1.3 m -132.79 112.44 11.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.039 ' CE1' HD12 ' A' ' 172' ' ' LEU . 8.9 m-85 -96.59 129.24 44.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.895 -1.128 . . . . 0.0 112.096 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 156' ' ' ALA . 1.7 m -128.24 98.05 4.96 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 184' ' ' HIS . 37.0 pt -139.16 154.82 25.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.029 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.708 ' OD1' ' CA ' ' A' ' 154' ' ' VAL . 9.7 t0 -72.33 114.55 10.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.831 ' CZ ' ' CB ' ' A' ' 156' ' ' ALA . 11.1 m-85 -46.66 -120.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.542 -0.724 . . . . 0.0 111.541 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.761 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . . . -33.36 -39.52 0.05 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.266 -0.896 . . . . 0.0 110.253 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 1.039 ' HB2' ' HB3' ' A' ' 153' ' ' ASP . . . -71.05 51.36 0.15 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 19.9 mttt -17.5 74.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.231 0.538 . . . . 0.0 111.319 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.762 ' N ' ' O ' ' A' ' 180' ' ' ALA . 17.6 tt0 -161.83 116.63 1.96 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.373 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.792 ' HA3' HG22 ' A' ' 176' ' ' ILE . . . -176.79 -155.36 13.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.951 ' N ' HG22 ' A' ' 176' ' ' ILE . 56.4 p-80 -158.41 175.37 13.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -1.192 . . . . 0.0 110.109 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.417 ' H ' ' HG ' ' A' ' 199' ' ' LEU . . . -136.78 120.6 2.18 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.617 -1.278 . . . . 0.0 109.927 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.573 ' O ' ' CG ' ' A' ' 186' ' ' LYS . 0.1 OUTLIER -111.87 112.1 23.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.434 -1.039 . . . . 0.0 109.42 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.858 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -131.0 163.6 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.122 -0.986 . . . . 0.0 110.948 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 196' ' ' ASN . 2.0 mt-10 -109.72 88.52 2.77 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 190' ' ' LEU . 2.0 t-80 -29.9 -60.35 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.5 -110.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.467 -0.771 . . . . 0.0 110.223 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.461 ' HG2' ' NZ ' ' A' ' 171' ' ' LYS . 8.5 mttt -145.41 -31.87 0.39 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.363 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.729 ' H ' HD12 ' A' ' 190' ' ' LEU . 1.5 t -64.38 134.54 96.02 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.664 -0.648 . . . . 0.0 110.08 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.39 46.16 0.72 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 124.071 1.564 . . . . 0.0 110.102 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.574 ' C ' HD12 ' A' ' 195' ' ' LEU . 5.4 mt-10 -145.29 -34.2 0.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 110.355 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.988 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.9 mp -104.4 25.51 10.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.056 -1.027 . . . . 0.0 110.287 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 192' ' ' SER . 0.5 OUTLIER -63.72 -155.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.472 -0.767 . . . . 0.0 109.909 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.721 ' HA ' ' HB2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -139.01 116.51 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 110.736 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.615 ' C ' HG23 ' A' ' 218' ' ' VAL . 37.0 t70 -92.87 93.51 8.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 108.806 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.249 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -103.75 157.2 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.25 -0.906 . . . . 0.0 111.58 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -137.98 119.47 14.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.063 HG21 HG23 ' A' ' 214' ' ' ILE . 0.2 OUTLIER -146.23 164.36 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 111.675 -177.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.807 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -110.52 149.84 29.77 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.502 -0.749 . . . . 0.0 109.245 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.759 ' CD2' ' O ' ' A' ' 178' ' ' PHE . 2.4 t80 -78.56 163.81 25.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.657 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.684 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 5.1 mt -135.98 145.59 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.418 -0.801 . . . . 0.0 109.713 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.761 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 9.0 mttt -81.34 -73.71 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.028 -1.045 . . . . 0.0 110.488 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.761 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.9 Cg_endo -73.89 88.14 1.1 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.737 1.388 . . . . 0.0 110.734 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 1.029 ' CG ' HG13 ' A' ' 213' ' ' VAL . 51.0 t0 -57.25 -121.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.041 . . . . 0.0 109.944 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 11.3 mt-10 -86.18 1.17 51.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -165.66 -57.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.543 -0.723 . . . . 0.0 109.741 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 211' ' ' HIS . 28.8 p-80 -168.56 41.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.958 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.821 ' CD2' ' CD2' ' A' ' 210' ' ' HIS . 2.7 m170 -127.32 173.07 10.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 109.916 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.017 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -73.97 156.27 37.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.009 . . . . 0.0 109.91 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.029 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -147.11 168.79 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.043 -1.035 . . . . 0.0 110.467 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.063 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -157.79 130.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.773 ' O ' HG23 ' A' ' 201' ' ' VAL . 9.8 t -143.76 135.88 26.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.059 -1.025 . . . . 0.0 110.923 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.585 ' HA3' ' HB ' ' A' ' 201' ' ' VAL . . . -171.9 -176.96 41.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 175.37 5.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.31 -1.112 . . . . 0.0 110.054 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.979 ' C ' HD12 ' A' ' 219' ' ' LEU . 9.1 p -152.22 159.28 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.018 -1.051 . . . . 0.0 111.484 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.979 HD12 ' C ' ' A' ' 218' ' ' VAL . 5.3 mp -158.41 130.28 6.75 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.721 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 5.5 t80 -161.45 93.97 0.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.595 -1.315 . . . . 0.0 111.513 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 222' ' ' GLN . 2.2 t30 176.91 -54.93 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.566 1.174 . . . . 0.0 109.279 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 223' ' ' ASP . 5.6 pt20 178.56 -25.57 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.333 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.615 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 21.8 t70 179.19 27.09 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.371 0.605 . . . . 0.0 109.57 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD23 ' A' ' 219' ' ' LEU . 4.3 tt0 -70.69 -171.47 0.52 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.872 . . . . 0.0 110.567 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 223' ' ' ASP . 1.5 mptp? -159.13 85.06 0.8 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.651 0.739 . . . . 0.0 109.374 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.841 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -97.39 161.0 21.34 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.739 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 66.8 m -109.75 160.84 15.98 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.523 -0.986 . . . . 0.0 109.85 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.249 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -141.19 122.39 14.77 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.074 -1.016 . . . . 0.0 110.831 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.569 ' C ' HD12 ' A' ' 230' ' ' LEU . 68.3 m -147.49 118.26 7.58 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.5 -0.75 . . . . 0.0 109.412 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.033 HD21 ' CD1' ' A' ' 257' ' ' LEU . 4.4 mp -145.21 168.41 20.47 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.058 -1.027 . . . . 0.0 110.468 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.56 123.9 6.0 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.017 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -107.87 146.88 13.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.224 -1.162 . . . . 0.0 110.183 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.758 ' CE2' ' HG3' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -145.01 -163.89 1.81 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.477 -0.765 . . . . 0.0 109.865 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 1.045 ' C ' HG21 ' A' ' 145' ' ' THR . . . 178.92 77.51 0.06 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.748 ' N ' HG21 ' A' ' 145' ' ' THR . 20.2 tt0 -33.56 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.072 -1.252 . . . . 0.0 109.132 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 234' ' ' GLY . 6.7 ttmt 178.01 35.47 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -158.53 -139.72 0.07 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.593 0.711 . . . . 0.0 110.67 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 5.1 mp0 -129.83 67.06 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.65 -0.656 . . . . 0.0 110.562 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.758 ' HG3' ' CE2' ' A' ' 233' ' ' PHE . 10.3 tp10 -105.11 148.58 26.69 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.861 -1.15 . . . . 0.0 110.691 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.786 ' HB ' HD12 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -163.26 136.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.195 -0.941 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.19 143.93 30.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.284 -0.885 . . . . 0.0 110.067 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.715 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -165.47 -154.02 7.88 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.016 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 61.1 p -158.31 130.29 6.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.383 -1.069 . . . . 0.0 109.325 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.015 ' O ' HD12 ' A' ' 255' ' ' ILE . . . -106.12 165.99 10.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.601 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 227' ' ' SER . 19.9 mt-10 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.442 -0.786 . . . . 0.0 109.397 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 1.028 HG12 ' CD2' ' A' ' 253' ' ' HIS . 6.3 t -102.19 138.4 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.04 -1.038 . . . . 0.0 110.832 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.2 135.52 45.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.191 -0.943 . . . . 0.0 110.026 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -109.44 -176.73 3.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.57 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.32 2.49 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.186 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.606 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 52.9 t-20 -173.65 31.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -154.2 -179.4 29.49 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.5 OUTLIER -168.37 128.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.322 -1.105 . . . . 0.0 110.27 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 1.028 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -146.36 161.52 40.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.043 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.838 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -121.89 157.85 30.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.888 . . . . 0.0 110.034 -179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.015 HD12 ' O ' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -138.18 119.59 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.522 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.726 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.51 129.86 9.54 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.033 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -120.36 157.03 30.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.905 -1.35 . . . . 0.0 112.147 -178.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 1.037 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.86 126.54 8.85 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.95 160.98 39.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.334 . . . . 0.0 112.108 -178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.656 ' CE ' ' HB3' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -130.17 165.97 21.23 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.25 0.547 . . . . 0.0 109.666 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.69 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 7.6 mm-40 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.229 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.207 0.527 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.14 -145.1 4.13 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -100.58 170.64 8.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -1.115 . . . . 0.0 110.192 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.5 p -100.54 109.6 21.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.242 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.57 126.23 1.8 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.5 -131.66 1.91 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.09 113.27 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.06 -52.52 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.2 t -102.86 -37.25 7.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -1.139 . . . . 0.0 110.284 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.99 85.69 0.13 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.8 -88.8 1.37 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.39 -129.75 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.65 -70.88 1.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.0 m -58.97 168.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.165 -1.197 . . . . 0.0 110.303 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.822 HG21 HD12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -87.5 -51.09 6.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 110.205 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.631 ' N ' HG22 ' A' ' 15' ' ' THR . . . 179.76 -115.07 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.246 -0.909 . . . . 0.0 110.177 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -92.8 39.45 1.04 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.255 -0.903 . . . . 0.0 109.845 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.978 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -106.35 -79.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.862 0.839 . . . . 0.0 110.116 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.978 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -64.88 -72.85 0.65 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.071 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.23 -1.19 1.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -1.174 . . . . 0.0 110.412 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -50.96 -30.46 22.76 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.813 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.4 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -1.162 . . . . 0.0 110.198 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -54.97 -11.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.14 -8.83 38.38 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 71' ' ' THR . . . -67.39 -31.61 71.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.418 -0.801 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.977 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.34 -39.05 6.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 110.251 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.938 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 2.0 m -60.06 -6.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.932 . . . . 0.0 110.181 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.22 97.61 22.45 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.431 -0.793 . . . . 0.0 110.124 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.61 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.2 Cg_endo -73.04 172.39 15.6 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.013 1.533 . . . . 0.0 110.467 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' PRO . 10.3 tp -37.87 167.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.881 . . . . 0.0 110.197 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 33' ' ' LYS . 5.9 t70 -176.54 148.88 0.75 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.175 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.654 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 47.2 m80 -48.77 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 31' ' ' ASP . 2.7 mtpt 179.99 -72.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.85 125.35 37.42 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.618 -0.676 . . . . 0.0 110.251 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -138.81 2.34 2.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.14 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.91 75.74 0.06 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 38' ' ' LYS . 3.0 tm? -163.17 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -1.104 . . . . 0.0 110.229 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 37' ' ' LEU . 1.1 mmpp? -124.28 -10.93 7.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 0.0 109.991 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.758 ' O ' HD22 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.41 125.29 44.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.208 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -155.3 157.69 37.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 110.205 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.799 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.3 m -104.21 145.27 30.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 110.249 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.864 HD12 ' HA ' ' A' ' 68' ' ' SER . 3.6 mp -82.57 106.61 14.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.611 ' C ' ' O ' ' A' ' 42' ' ' LEU . 24.4 tt0 -28.28 -40.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 110.368 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 42' ' ' LEU . 4.5 p30 179.97 36.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 110.208 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' C ' ' O ' ' A' ' 44' ' ' ASP . 1.9 t -29.74 -39.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.957 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.673 ' O ' ' ND2' ' A' ' 65' ' ' ASN . 9.0 mt -122.85 144.04 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 110.04 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.624 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -71.94 154.35 41.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.779 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.674 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 14.7 pt20 -41.97 -20.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.07 -1.018 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.677 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -83.36 48.28 1.38 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.621 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.27 85.53 0.1 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.409 ' C ' HD23 ' A' ' 52' ' ' LEU . 41.7 p -108.24 134.53 50.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -1.146 . . . . 0.0 110.047 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.783 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 1.5 pt? -162.9 162.05 26.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -122.56 154.78 37.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.977 HD11 ' CD2' ' A' ' 26' ' ' LEU . 3.1 pp -138.46 131.57 29.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.115 -0.99 . . . . 0.0 110.426 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.2 p -106.77 121.07 43.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 0.0 110.146 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.671 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -83.22 -176.8 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 1.071 ' O ' HG22 ' A' ' 20' ' ' THR . 49.6 mt-30 -74.53 43.59 0.19 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.247 -0.908 . . . . 0.0 110.251 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -178.3 -38.79 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.938 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 172.0 18.48 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.222 -1.164 . . . . 0.0 110.164 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -134.75 161.14 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 9.5 tttp -151.89 130.16 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.552 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -66.47 125.12 24.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.092 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.783 ' CZ ' ' CD1' ' A' ' 52' ' ' LEU . 8.4 p90 -138.66 144.47 39.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.318 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.662 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . -161.6 -122.01 0.6 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -65.19 121.08 13.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -1.198 . . . . 0.0 109.795 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.35 -5.57 84.58 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.757 ' OD2' HD13 ' A' ' 42' ' ' LEU . 6.0 p-10 -33.42 159.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.573 -0.957 . . . . 0.0 110.32 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.864 ' HA ' HD12 ' A' ' 42' ' ' LEU . 6.2 t -141.21 162.27 35.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.33 104.82 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.879 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.728 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -105.55 118.29 36.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.467 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.95 ' HB ' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -136.27 25.3 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -0.911 . . . . 0.0 110.459 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -45.68 82.32 0.0 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.5 mttp 179.58 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.156 . . . . 0.0 110.186 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.094 HD21 ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.83 -171.44 2.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.197 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -113.77 -141.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.282 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 11.2 m-80 -69.24 -4.18 16.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 110.24 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -94.75 50.51 1.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 109.96 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.094 ' HG2' HD21 ' A' ' 74' ' ' LEU . 31.5 mtpt -62.39 90.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.095 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.082 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -94.26 161.1 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 110.213 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -162.68 86.37 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.849 . . . . 0.0 110.317 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -123.73 124.99 43.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.135 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.934 ' CZ ' HD22 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -160.95 169.91 21.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 110.244 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 9.5 t70 -94.51 129.29 41.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.931 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.79 170.95 15.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 110.294 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.6 tt -121.49 109.55 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 0.0 110.155 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.687 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 13.0 ptp180 -84.36 114.64 22.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.092 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.603 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 17.9 mt-30 -149.51 139.8 22.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 110.644 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.677 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 1.0 OUTLIER -132.25 112.22 19.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.392 -0.818 . . . . 0.0 109.944 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.657 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 7.2 tt0 -140.72 124.15 16.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.721 HG11 ' CD ' ' A' ' 93' ' ' GLN . 69.4 t -111.44 170.83 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.869 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -66.07 0.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.443 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.55 43.75 0.08 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.134 ' O ' HD12 ' A' ' 95' ' ' ILE . 19.7 mt-30 -154.81 -138.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.258 -1.142 . . . . 0.0 110.698 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 3.4 mm? -45.51 162.71 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 121.306 0.574 . . . . 0.0 110.524 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.134 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -165.76 17.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 110.027 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.783 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -57.81 171.94 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.33 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.959 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -168.53 131.03 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.285 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 mt-10 -169.63 136.22 1.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.262 -0.899 . . . . 0.0 110.228 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.58 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.1 t -120.99 158.99 26.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.276 -0.89 . . . . 0.0 110.207 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.97 -154.85 14.11 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 36.5 mt-10 -114.36 159.79 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -1.143 . . . . 0.0 110.188 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.728 ' HB2' ' CD2' ' A' ' 84' ' ' PHE . 2.1 t80 -130.42 146.73 52.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.184 -0.948 . . . . 0.0 110.364 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.926 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 5.7 tm0? -142.58 102.84 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.871 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 77.5 t -116.59 157.57 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.268 -0.895 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.082 ' CD2' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -150.96 155.09 38.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.756 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.709 ' CB ' ' HB2' ' A' ' 78' ' ' LYS . 4.6 mttt -141.91 146.52 35.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 110.422 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.689 ' HB2' ' NE2' ' A' ' 238' ' ' GLN . 1.9 mm100 -118.71 -137.39 0.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 t -80.66 -61.16 2.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -120.07 -13.69 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -0.916 . . . . 0.0 110.177 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t -107.7 -177.51 3.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.907 . . . . 0.0 110.198 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.02 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.73 -178.52 1.91 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 110.197 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.159 HD21 ' OE2' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -161.03 171.63 18.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 110.274 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 138' ' ' GLY . 1.2 p -146.45 172.88 12.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -173.03 141.75 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.906 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -143.02 141.21 31.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.209 -0.932 . . . . 0.0 110.448 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.77 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.2 tt0 -121.93 93.79 4.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.223 -0.923 . . . . 0.0 110.132 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.641 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 74.6 m -56.17 171.5 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.603 ' HG3' ' C ' ' A' ' 117' ' ' THR . 41.6 mt-10 -153.92 -47.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.003 . . . . 0.0 110.454 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -111.62 155.01 24.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 110.369 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 5.9 mt-10 -125.66 -179.67 4.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.62 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.55 153.74 34.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.427 -0.796 . . . . 0.0 109.83 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.26 170.44 6.36 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 120.97 -1.081 . . . . 0.0 111.232 -178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.656 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.5 Cg_endo -96.08 -73.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.869 2.379 . . . . 0.0 110.23 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 123' ' ' PRO . 10.2 mt-10 -13.42 -58.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.92 1.343 . . . . 0.0 109.501 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.846 ' O ' ' N ' ' A' ' 127' ' ' GLU . 59.6 m80 -130.3 79.72 1.92 Allowed 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.6 t -21.13 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.493 . . . . 0.0 110.963 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.846 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.3 mt-10 -73.96 1.02 11.74 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.715 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -81.99 146.18 29.86 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.461 179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.652 ' HE2' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -129.3 133.18 47.34 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 110.556 -179.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -91.08 171.01 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.386 -0.822 . . . . 0.0 109.639 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.84 114.93 19.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.274 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 131' ' ' ALA . 26.9 mmtt -147.33 -162.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 110.083 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -141.92 106.42 4.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 0.0 110.208 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.525 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -114.89 110.73 20.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.91 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.757 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.5 p90 -100.15 111.79 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.439 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.685 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -102.35 159.92 14.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.677 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 1.5 tp -141.51 157.76 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.146 -0.971 . . . . 0.0 110.343 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 113' ' ' THR . . . -150.69 51.28 0.53 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 9.1 t70 -81.49 127.3 32.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.362 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.927 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -112.81 45.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.088 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -66.95 125.67 26.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.374 -0.829 . . . . 0.0 110.272 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.84 40.55 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.416 ' C ' ' HD2' ' A' ' 144' ' ' HIS . 0.4 OUTLIER -87.32 -156.86 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.033 . . . . 0.0 110.611 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.661 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 5.0 m170 -97.65 64.95 1.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.486 0.66 . . . . 0.0 109.875 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.848 HG23 ' CG ' ' A' ' 211' ' ' HIS . 2.5 t -107.38 26.29 10.4 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.469 -0.769 . . . . 0.0 111.679 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 2.4 m -57.44 73.86 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.093 -1.004 . . . . 0.0 109.071 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.372 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -34.18 -33.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.544 -0.722 . . . . 0.0 110.24 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.596 ' HA ' ' CD ' ' A' ' 205' ' ' LYS . 27.4 t0 -62.45 -8.05 5.53 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.213 -0.929 . . . . 0.0 109.87 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.902 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.1 OUTLIER -87.1 7.73 26.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 110.059 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.082 ' O ' HD12 ' A' ' 150' ' ' LEU . 2.5 pp -176.13 55.56 0.13 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 110.041 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.717 ' HB3' ' CB ' ' A' ' 179' ' ' ALA . 45.9 Cg_endo -87.83 101.33 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.12 1.589 . . . . 0.0 110.574 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.75 ' O ' ' CZ ' ' A' ' 178' ' ' PHE . 19.2 mtpt -141.53 -79.08 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 110.022 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.774 ' HA ' ' CE1' ' A' ' 178' ' ' PHE . 25.8 m-20 -151.16 44.18 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 99.5 t -93.57 109.31 21.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -0.916 . . . . 0.0 111.331 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.13 110.23 5.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.248 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 176' ' ' ILE . . . -90.35 103.33 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.729 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 7.8 m -113.18 134.53 54.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.387 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.775 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 16.9 m-85 -141.22 160.1 40.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.079 . . . . 0.0 110.895 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.687 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.76 150.04 31.46 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.678 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -172.79 -151.9 8.3 Favored Glycine 0 N--CA 1.486 1.97 0 C-N-CA 118.378 -1.868 . . . . 0.0 111.309 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.9 t -118.92 156.3 29.78 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.903 -0.763 . . . . 0.0 110.291 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.924 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -128.86 -178.67 4.71 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.657 -0.652 . . . . 0.0 109.863 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.733 ' CG ' ' HA2' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -157.89 124.26 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 110.512 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.555 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -110.04 166.98 12.56 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 11.8 t -89.45 -6.03 56.84 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.239 -1.153 . . . . 0.0 110.71 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.13 -1.12 3.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.206 -0.934 . . . . 0.0 109.957 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 189' ' ' HIS . 1.5 m-20 -124.95 172.96 8.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.753 ' O ' ' C ' ' A' ' 169' ' ' GLY . . . -76.17 139.0 41.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.753 ' C ' ' O ' ' A' ' 168' ' ' ALA . . . 2.62 -116.32 0.01 OUTLIER Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.62 161.35 25.34 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 188' ' ' GLU . 7.0 tmtm? -153.69 119.43 5.29 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -1.106 . . . . 0.0 108.561 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -151.5 151.95 32.32 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.23 -1.388 . . . . 0.0 112.33 -178.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 73.2 m -110.86 153.7 25.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.077 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -134.61 159.73 40.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.682 -1.261 . . . . 0.0 111.705 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 175' ' ' THR . 1.3 m -144.12 98.83 3.28 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.14 HG21 ' CD1' ' A' ' 203' ' ' TYR . 11.4 mt -109.47 149.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 112.494 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.774 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 26.3 t0 -103.3 128.92 50.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.945 ' CZ ' ' HB2' ' A' ' 180' ' ' ALA . 26.1 p90 -39.1 -163.93 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.616 1.198 . . . . 0.0 113.435 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.752 ' HB1' ' HE2' ' A' ' 205' ' ' LYS . . . -41.99 -5.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.365 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.945 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -65.07 -93.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.413 -1.429 . . . . 0.0 108.079 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -164.66 47.7 0.1 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.513 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.958 ' O ' HG23 ' A' ' 176' ' ' ILE . 1.7 tp60 -144.1 142.54 30.67 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 116.515 -2.074 . . . . 0.0 112.367 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.74 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -173.19 73.48 0.1 OUTLIER Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.976 -1.649 . . . . 0.0 108.976 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.809 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -127.16 178.67 5.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.221 -1.164 . . . . 0.0 110.156 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.809 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -179.99 -179.15 48.8 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.567 -1.302 . . . . 0.0 109.883 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 1.0 OUTLIER -104.8 142.72 34.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -1.055 . . . . 0.0 109.915 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.168 HG21 ' CG1' ' A' ' 218' ' ' VAL . 0.8 OUTLIER -110.18 137.03 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 110.371 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 171' ' ' LYS . 8.5 mt-10 -145.16 88.38 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.659 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 0.6 OUTLIER -46.19 -54.45 8.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.179 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.058 HD21 ' CB ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -94.25 -110.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 110.198 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 8.1 mttt -163.68 -30.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.765 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.678 ' O ' ' ND2' ' A' ' 196' ' ' ASN . 36.1 t -51.82 139.97 30.31 Favored Pre-proline 0 C--N 1.296 -1.76 0 O-C-N 121.507 -0.745 . . . . 0.0 110.092 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.48 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.7 Cg_endo -71.7 50.58 1.39 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.022 1.538 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.472 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.9 mt-10 -152.64 -33.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.862 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.058 ' CB ' HD21 ' A' ' 190' ' ' LEU . 4.0 mp -98.01 13.92 29.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 110.311 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.68 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.4 OUTLIER -84.4 175.78 9.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.847 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.017 ' HB ' HG23 ' A' ' 187' ' ' ILE . 62.4 t -149.42 158.87 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 110.217 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.69 117.75 35.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.077 HD21 ' CE2' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -104.3 157.18 17.32 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.082 -1.011 . . . . 0.0 110.542 -179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.066 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.01 122.74 13.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.648 -0.657 . . . . 0.0 109.315 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 214' ' ' ILE . 5.7 t -140.42 163.67 22.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.118 -0.988 . . . . 0.0 110.81 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.65 158.48 18.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.336 -0.853 . . . . 0.0 109.48 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.14 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.0 OUTLIER -92.97 140.32 29.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 110.646 -179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.953 ' O ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -126.29 130.17 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.778 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 11.4 mtmt -81.89 -29.28 0.49 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.847 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.778 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -76.76 45.23 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.529 1.278 . . . . 0.0 111.05 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.865 ' CG ' HG22 ' A' ' 213' ' ' VAL . 16.2 t0 -60.97 -143.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.469 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 7.2 mm-40 -46.7 -20.23 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.037 -1.039 . . . . 0.0 108.812 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.712 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 3.0 mptt -163.62 -58.36 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -157.36 10.05 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.563 -0.711 . . . . 0.0 110.45 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.848 ' CG ' HG23 ' A' ' 145' ' ' THR . 0.3 OUTLIER -71.34 -174.22 1.01 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.0 110.199 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.372 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -88.66 140.14 29.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.92 -1.113 . . . . 0.0 109.701 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 204' ' ' ILE . 2.4 t -125.46 169.24 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.091 -1.006 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.919 ' CG2' HG11 ' A' ' 201' ' ' VAL . 53.6 mt -150.08 112.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.751 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.783 ' N ' HG13 ' A' ' 201' ' ' VAL . 35.2 t -138.49 138.19 37.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 110.657 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.857 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -179.47 -143.41 5.42 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 3.8 p -136.0 175.43 9.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -1.188 . . . . 0.0 110.581 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.168 ' CG1' HG21 ' A' ' 187' ' ' ILE . 18.7 t -141.14 142.79 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.86 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -158.18 163.03 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.924 . . . . 0.0 110.212 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.831 ' HB2' HG22 ' A' ' 197' ' ' VAL . 46.8 t80 -151.08 155.62 39.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.919 . . . . 0.0 110.249 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.596 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 4.4 m120 -73.28 -1.62 18.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 5.0 mt-30 -160.18 40.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.232 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.789 ' CB ' HG22 ' A' ' 197' ' ' VAL . 0.5 OUTLIER -137.71 -76.2 0.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 110.612 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.597 ' HG2' ' C ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -179.49 -158.0 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.874 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 2.5 mptt -136.53 78.85 1.73 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.521 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -97.55 174.31 29.32 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.769 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.826 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -107.75 -178.28 3.58 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.673 -0.898 . . . . 0.0 109.677 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.889 ' CD2' HD22 ' A' ' 199' ' ' LEU . 4.3 t80 -155.52 123.59 5.79 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.978 -1.076 . . . . 0.0 111.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 215' ' ' SER . 58.8 m -147.65 112.2 5.31 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.488 -0.757 . . . . 0.0 109.214 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.94 HD23 HG22 ' A' ' 240' ' ' VAL . 0.5 OUTLIER -136.11 164.01 29.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 0.0 110.942 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.56 130.36 8.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.824 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -110.99 133.68 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.055 -1.262 . . . . 0.0 111.024 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.822 ' CB ' HG21 ' A' ' 145' ' ' THR . 0.2 OUTLIER -131.79 109.46 10.15 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.649 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.796 ' HA3' ' HB3' ' A' ' 238' ' ' GLN . . . 178.85 115.91 0.48 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.622 ' C ' ' O ' ' A' ' 234' ' ' GLY . 7.7 mt-10 -31.27 -47.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.086 -1.244 . . . . 0.0 108.519 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 29.4 pttt 177.67 37.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.664 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.258 . . -176.12 18.44 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.677 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.796 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 12.8 tp60 -94.02 -100.29 0.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.658 -1.277 . . . . 0.0 110.516 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 1.159 ' OE2' HD21 ' A' ' 112' ' ' LEU . 1.4 pt-20 -166.54 -171.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.172 -0.955 . . . . 0.0 111.119 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.94 HG22 HD23 ' A' ' 230' ' ' LEU . 6.1 p -152.06 119.45 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.58 -0.7 . . . . 0.0 109.414 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.528 ' CB ' ' OD2' ' A' ' 139' ' ' ASP . . . -129.94 143.18 50.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 0.0 110.666 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.78 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -174.53 -146.65 5.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.641 ' N ' HD12 ' A' ' 230' ' ' LEU . 65.9 m -158.46 135.09 9.55 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -1.045 . . . . 0.0 109.386 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.042 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.83 171.83 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.097 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 227' ' ' SER . 1.4 tt0 -103.19 164.94 11.32 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.679 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.6 t -147.05 105.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 4.8 mt-10 -101.91 118.78 37.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 110.105 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 251' ' ' GLY . 4.7 t -93.0 -132.9 0.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.125 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 250' ' ' ASN . . . -105.79 -0.37 25.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.195 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.837 ' H ' HG23 ' A' ' 248' ' ' THR . 0.5 OUTLIER 179.85 38.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -0.877 . . . . 0.0 110.23 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.979 ' O ' HG22 ' A' ' 248' ' ' THR . . . -174.78 120.82 0.8 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.489 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 93.4 mt -87.3 122.47 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.269 -1.136 . . . . 0.0 110.29 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.671 ' HB2' ' CG1' ' A' ' 246' ' ' VAL . 1.2 m170 -114.68 161.19 18.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.308 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.642 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -127.58 138.11 52.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 0.0 110.009 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.042 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -120.11 124.27 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 0.0 110.626 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.74 123.9 6.59 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.709 ' HB2' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -102.76 153.03 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.028 -1.278 . . . . 0.0 111.237 -178.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.45 109.22 3.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.687 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -138.98 164.3 30.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.873 -1.142 . . . . 0.0 111.506 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.686 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -115.95 165.57 12.95 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.292 0.568 . . . . 0.0 109.981 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.753 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 10.7 pt20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.229 0.538 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.77 155.18 17.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.9 p -161.21 33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 110.254 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -129.81 145.61 51.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.81 -88.48 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.96 -126.53 0.86 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.87 108.73 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.74 -109.37 0.74 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -149.31 177.9 9.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -1.171 . . . . 0.0 110.247 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.57 -155.39 31.69 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.15 -153.88 15.13 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.88 144.78 15.67 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.43 -100.57 0.14 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG12 HD13 ' A' ' 18' ' ' ILE . 2.0 m -58.91 155.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.271 -1.134 . . . . 0.0 110.34 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.933 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.9 t -96.71 174.05 7.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 0.0 110.155 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.07 6.22 0.99 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.94 . . . . 0.0 110.631 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.933 ' H ' HG23 ' A' ' 15' ' ' THR . 0.8 OUTLIER -133.21 44.17 2.85 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.14 -0.975 . . . . 0.0 110.601 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.67 -79.04 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.229 -0.919 . . . . 0.0 110.001 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -109.21 -56.95 0.54 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.657 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -63.32 -2.41 1.46 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.28 -22.93 61.57 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -53.33 -37.16 62.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -1.151 . . . . 0.0 110.205 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.728 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.04 -11.12 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.988 . . . . 0.0 110.072 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.041 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -94.43 -8.82 37.48 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.436 -0.79 . . . . 0.0 110.2 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 70' ' ' ASN . . . -79.75 -17.3 53.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.79 . . . . 0.0 110.252 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.084 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -106.29 -31.95 8.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.253 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -96.41 -6.32 37.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 1.041 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -113.19 92.55 22.46 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.344 -0.847 . . . . 0.0 110.21 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' O ' ' O ' ' A' ' 30' ' ' LEU . 45.7 Cg_endo -72.94 -179.52 4.36 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.933 1.491 . . . . 0.0 110.491 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 6.3 tp -31.5 155.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.314 -0.866 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -147.94 -170.64 3.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.239 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.657 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 26.3 t60 -120.1 51.61 1.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.199 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.86 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -75.71 170.23 16.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -112.84 -64.74 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.938 . . . . 0.0 110.268 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.12 -134.92 8.14 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.597 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -59.92 125.67 24.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' SER . 77.0 mttt -66.35 -39.13 88.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' HD23 ' A' ' 40' ' ' LEU . 13.7 p 175.55 169.55 0.35 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 110.147 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 39' ' ' SER . 29.3 mt -138.39 118.25 13.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.813 HG23 ' HB3' ' A' ' 68' ' ' SER . 4.5 m -106.85 138.51 42.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD12 ' O ' ' A' ' 67' ' ' ASP . 3.4 mp -84.2 102.46 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 110.05 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' C ' ' O ' ' A' ' 42' ' ' LEU . 20.8 tt0 -28.55 -73.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.0 110.368 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.582 ' O ' ' C ' ' A' ' 45' ' ' SER . 3.6 p30 -133.93 23.53 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.271 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.692 ' CB ' ' HB3' ' A' ' 42' ' ' LEU . 1.1 t -30.09 -50.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.823 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -111.27 -157.0 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.823 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -173.84 -177.67 1.42 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.525 -0.735 . . . . 0.0 109.618 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.28 -10.81 0.64 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 0.0 109.858 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.697 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.58 10.34 30.81 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.589 -0.694 . . . . 0.0 110.369 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.87 81.15 0.17 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 29.1 p -104.95 135.64 45.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -1.152 . . . . 0.0 110.112 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 2.0 pp -161.49 158.01 25.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.628 ' O ' ' CB ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -114.43 152.46 31.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 110.183 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.084 HD11 HD22 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -131.27 131.22 43.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.141 -0.974 . . . . 0.0 110.297 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 44.2 t -122.18 142.77 50.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 110.17 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -111.9 -174.66 2.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.146 -0.972 . . . . 0.0 110.225 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.657 ' HB3' HG22 ' A' ' 20' ' ' THR . 49.2 mt-30 -74.54 43.57 0.19 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 110.175 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -175.61 -43.61 0.05 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.696 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.36 11.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.268 -1.136 . . . . 0.0 110.191 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -142.65 157.8 44.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.187 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -138.37 126.66 23.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.678 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -56.45 114.15 1.89 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 110.189 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 1.056 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -98.73 112.95 24.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.19 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.88 -158.87 8.52 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.78 126.86 12.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.58 -3.48 85.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HD12 ' A' ' 42' ' ' LEU . 21.8 p-10 -27.74 142.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.411 -1.053 . . . . 0.0 110.334 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.813 ' HB3' HG23 ' A' ' 41' ' ' THR . 3.9 p -141.2 150.43 42.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD12 ' OH ' ' A' ' 63' ' ' TYR . 1.4 tp -117.12 139.35 50.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.174 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' ' O ' ' A' ' 25' ' ' ALA . 28.1 t-20 -116.04 118.02 31.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.204 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.936 HG22 HD13 ' A' ' 74' ' ' LEU . 6.2 p -130.3 34.71 4.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -52.94 -13.47 2.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.605 ' O ' ' O ' ' A' ' 74' ' ' LEU . 12.0 mptt -99.31 -49.75 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -1.172 . . . . 0.0 110.252 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -35.96 165.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.742 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -125.92 -159.94 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 39.5 m-80 -83.83 11.39 7.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.253 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' HB2' ' HE3' ' A' ' 260' ' ' LYS . 6.0 p-10 -149.55 66.54 1.0 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' CB ' HD23 ' A' ' 74' ' ' LEU . 33.9 mmtt -149.16 167.29 26.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 110.166 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 105' ' ' TYR . 2.2 t -130.05 169.3 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 110.391 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 104' ' ' VAL . 15.4 m -137.96 92.04 2.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.384 -0.822 . . . . 0.0 109.942 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -110.82 125.23 53.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 55' ' ' SER . 18.9 p90 -146.47 155.55 42.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -0.877 . . . . 0.0 110.135 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.38 140.68 29.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -0.922 . . . . 0.0 110.118 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.761 ' CE1' ' NH2' ' A' ' 86' ' ' ARG . 3.1 p90 -148.43 162.82 38.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.77 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.4 tt -117.2 110.12 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 110.34 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.761 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 1.8 mtm180 -84.49 101.59 12.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.878 HE22 HD23 ' A' ' 97' ' ' LEU . 1.2 mt-30 -138.12 145.64 41.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.545 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.023 HD12 ' CB ' ' A' ' 96' ' ' THR . 0.7 OUTLIER -130.26 112.32 23.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.366 -0.834 . . . . 0.0 109.643 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.726 ' CG ' ' CD1' ' A' ' 95' ' ' ILE . 0.9 OUTLIER -140.66 124.33 17.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.052 -1.03 . . . . 0.0 110.458 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 80.8 t -107.64 171.62 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.93 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 90' ' ' VAL . 7.7 t70 -66.94 2.03 1.64 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -0.947 . . . . 0.0 110.482 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.603 ' O ' ' CD ' ' A' ' 93' ' ' GLN . . . 179.57 38.18 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.603 ' CD ' ' O ' ' A' ' 92' ' ' GLY . 26.6 mm-40 -148.62 -137.68 0.09 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.274 -1.133 . . . . 0.0 110.691 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 22.6 mt -45.19 163.22 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.245 0.545 . . . . 0.0 110.531 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.039 ' O ' HD12 ' A' ' 97' ' ' LEU . 9.4 mm -157.26 24.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.533 -0.73 . . . . 0.0 109.976 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.023 ' CB ' HD12 ' A' ' 88' ' ' ILE . 77.1 m -52.51 158.12 1.34 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 110.459 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -165.11 99.46 0.74 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.222 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.675 ' N ' ' OE1' ' A' ' 87' ' ' GLN . 75.8 mt-10 -146.32 156.02 43.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.948 . . . . 0.0 110.274 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 22.7 t -119.27 162.17 19.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.124 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.643 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.65 176.72 44.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 116' ' ' GLN . 39.1 mt-10 -106.96 159.84 15.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.307 -1.113 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.735 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -123.88 139.4 54.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.827 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -137.23 103.67 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 0.0 109.933 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.608 ' CG2' ' CE1' ' A' ' 102' ' ' PHE . 34.6 t -120.07 106.46 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 110.593 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.81 ' HA ' HG13 ' A' ' 79' ' ' VAL . 1.2 t80 -85.83 158.16 20.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.695 ' CD ' HD22 ' A' ' 74' ' ' LEU . 13.5 mttm -134.33 135.61 42.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.349 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.63 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 2.6 pt20 -122.07 -126.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.634 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 23.9 m -76.03 -89.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -97.75 -29.13 13.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.903 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.709 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 1.4 m -100.23 -162.06 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.406 -0.809 . . . . 0.0 109.931 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.71 1.05 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.247 -0.908 . . . . 0.0 110.224 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.827 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -126.86 141.67 51.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.999 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -118.3 161.82 19.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.994 -1.066 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.827 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -165.15 120.57 1.35 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.747 . . . . 0.0 109.997 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 11.1 mt -114.04 103.47 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.273 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 101' ' ' GLU . 3.7 mt-30 -89.92 151.04 21.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.173 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.2 m -107.63 177.53 4.8 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.902 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.643 ' N ' HG22 ' A' ' 117' ' ' THR . 7.3 tp10 -141.2 -87.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.183 -0.948 . . . . 0.0 110.493 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.575 ' C ' ' HG2' ' A' ' 120' ' ' GLU . 3.7 pt20 -125.04 155.17 40.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.514 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' O ' ' N ' ' A' ' 130' ' ' VAL . 1.1 mt-10 -141.0 -179.15 5.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.353 -0.842 . . . . 0.0 110.186 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.76 151.99 24.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.218 -0.926 . . . . 0.0 109.963 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.789 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -124.65 103.96 31.14 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.899 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.3 49.99 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.268 1.667 . . . . 0.0 111.556 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.747 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 5.7 mm-40 -94.62 -27.86 15.68 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.346 1.07 . . . . 0.0 108.626 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.747 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.62 -76.77 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 t -122.68 17.34 10.33 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.705 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.2 OUTLIER -104.34 5.45 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.373 -0.829 . . . . 0.0 111.174 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.789 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.77 34.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.069 -1.019 . . . . 0.0 111.448 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.705 ' N ' ' O ' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -157.89 139.23 13.55 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.093 -1.004 . . . . 0.0 110.385 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.689 ' N ' ' O ' ' A' ' 120' ' ' GLU . 1.7 t -150.39 167.04 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.94 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -154.93 114.82 3.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.688 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 30.8 mtmt -165.6 129.75 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.915 . . . . 0.0 110.113 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -79.53 106.37 11.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.189 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 1.2 ttt180 -111.97 152.53 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CD1' ' CE1' ' A' ' 163' ' ' PHE . 13.1 p90 -147.7 109.02 4.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 110.484 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -95.45 107.51 19.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.807 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.619 HD13 ' HE2' ' A' ' 163' ' ' PHE . 9.7 tp -82.42 129.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.203 -0.935 . . . . 0.0 110.607 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -122.6 49.34 0.9 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 69.4 m-20 -60.69 122.8 15.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 0.0 110.601 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.951 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -127.0 78.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.495 179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.816 ' CB ' ' CE1' ' A' ' 233' ' ' PHE . . . -110.97 139.78 46.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 110.205 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.618 ' O ' ' OE1' ' A' ' 235' ' ' GLU . . . -60.32 64.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.765 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.4 OUTLIER -76.25 43.82 0.31 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.234 -1.156 . . . . 0.0 110.311 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 210' ' ' HIS . 58.9 m-70 -98.63 -1.87 39.79 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.214 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.5 t -107.13 106.47 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 111.281 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.59 120.97 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 108.918 178.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.09 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.5 OUTLIER -34.14 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 110.69 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' SER . 4.1 t0 -61.65 -5.53 1.95 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.945 . . . . 0.0 110.027 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.632 ' O ' ' HE2' ' A' ' 152' ' ' LYS . 1.4 tttm -87.22 -62.89 1.4 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.739 0.78 . . . . 0.0 110.726 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.731 ' HB3' ' CD ' ' A' ' 151' ' ' PRO . 3.6 tt -99.57 -64.07 0.08 OUTLIER Pre-proline 0 C--N 1.293 -1.869 0 O-C-N 121.655 -0.653 . . . . 0.0 110.284 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.765 ' HG3' ' CD1' ' A' ' 147' ' ' PHE . 41.8 Cg_endo -66.13 99.9 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.533 1.281 . . . . 0.0 110.214 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.692 ' O ' ' CB ' ' A' ' 179' ' ' ALA . 12.8 mmtp -89.1 -84.63 0.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.282 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -132.35 40.86 3.27 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.328 -0.857 . . . . 0.0 110.05 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.623 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 6.1 t -111.43 126.42 68.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 110.329 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.655 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 2.1 mtm -69.85 103.96 2.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.968 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.832 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -93.57 140.05 30.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 110.808 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.639 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 6.9 m -72.94 150.18 42.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.506 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.206 ' CG ' HD11 ' A' ' 176' ' ' ILE . 4.1 m-85 -145.81 132.73 20.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.92 -1.113 . . . . 0.0 110.565 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -149.78 145.17 26.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.351 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.703 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.19 -160.65 12.14 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.81 -1.662 . . . . 0.0 111.211 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.43 HG22 ' OE1' ' A' ' 103' ' ' GLN . 82.8 m -125.46 155.86 39.83 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.81 -0.818 . . . . 0.0 109.583 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.022 ' CB ' HD23 ' A' ' 257' ' ' LEU . . . -149.0 179.97 7.46 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.795 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CE1' ' CD1' ' A' ' 135' ' ' PHE . 5.1 p90 -133.59 137.55 45.54 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.967 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.614 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -114.48 144.1 18.23 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.014 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.56 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 9.8 t -73.08 -5.13 36.93 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.27 -1.135 . . . . 0.0 110.189 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 253' ' ' HIS . 0.9 OUTLIER -136.57 1.48 2.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.429 -0.795 . . . . 0.0 110.104 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 189' ' ' HIS . 7.7 m-20 -124.82 171.0 10.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.534 -0.729 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.71 -26.81 65.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.017 -1.052 . . . . 0.0 109.966 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.47 -113.14 0.4 Allowed Glycine 0 C--N 1.281 -2.504 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.954 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.9 92.64 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.444 ' O ' HD12 ' A' ' 187' ' ' ILE . 3.6 tppt? -91.31 123.27 34.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.477 -1.602 . . . . 0.0 109.342 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.865 HD12 ' HE1' ' A' ' 174' ' ' TYR . 1.0 OUTLIER -118.11 143.76 46.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 111.06 -178.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.7 m -153.63 104.28 2.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.865 ' HE1' HD12 ' A' ' 172' ' ' LEU . 13.2 p90 -155.9 160.53 40.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.0 110.665 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 9.9 m -96.43 159.24 15.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.374 -0.829 . . . . 0.0 109.532 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.206 HD11 ' CG ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -141.35 159.55 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.129 -0.982 . . . . 0.0 110.765 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.682 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 30.1 t0 -113.0 122.91 49.05 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.641 -0.662 . . . . 0.0 109.623 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.832 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 14.1 m-30 -50.44 -128.3 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.867 0.841 . . . . 0.0 111.466 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 152' ' ' LYS . . . -34.27 -46.79 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.718 -0.614 . . . . 0.0 110.438 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.751 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.65 51.59 0.06 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.98 ' HD3' HD13 ' A' ' 204' ' ' ILE . 25.5 mttt -18.02 76.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.244 0.545 . . . . 0.0 111.006 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' N ' ' O ' ' A' ' 180' ' ' ALA . 26.2 mt-30 -150.57 115.72 5.36 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.185 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 201' ' ' VAL . . . -153.23 165.65 31.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.796 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.4 OUTLIER 179.43 158.5 0.64 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -1.162 . . . . 0.0 110.126 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.796 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . -177.24 -127.07 1.02 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.02 166.31 24.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -1.169 . . . . 0.0 110.498 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.809 HG23 HG23 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.8 130.32 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -110.86 91.06 3.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.177 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 1.141 ' NE2' HG21 ' A' ' 246' ' ' VAL . 60.9 m80 -45.02 -41.96 7.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.194 -0.942 . . . . 0.0 110.11 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -93.97 -112.17 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.492 ' H ' HD12 ' A' ' 190' ' ' LEU . 18.2 mtpt -151.72 -33.52 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.81 . . . . 0.0 110.498 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.744 ' H ' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -61.68 132.71 93.26 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.667 -0.646 . . . . 0.0 110.073 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.82 45.11 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.002 1.527 . . . . 0.0 110.099 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -145.91 -30.85 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -0.843 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.889 HD12 ' N ' ' A' ' 195' ' ' LEU . 4.7 mp -92.83 13.75 19.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.112 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.738 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -75.39 -163.07 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.405 -0.809 . . . . 0.0 109.868 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.923 HG12 ' CB ' ' A' ' 220' ' ' TYR . 15.6 m -159.13 149.76 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.099 -1.0 . . . . 0.0 110.458 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 219' ' ' LEU . 37.7 m-20 -74.14 119.17 17.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.061 HD12 ' N ' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -111.5 157.3 20.48 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.094 -1.004 . . . . 0.0 110.898 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.061 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -143.56 119.88 10.9 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 214' ' ' ILE . 2.5 p -141.34 138.62 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 111.1 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 181' ' ' LYS . . . -110.8 129.14 55.93 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.44 -0.788 . . . . 0.0 109.504 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.851 ' CE2' ' CD2' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -71.43 153.65 42.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 110.343 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.98 HD13 ' HD3' ' A' ' 181' ' ' LYS . 9.4 mm -116.74 157.73 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.751 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 23.9 mtpt -81.62 -71.02 0.14 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.435 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.751 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.4 85.44 1.08 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.886 1.466 . . . . 0.0 110.57 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 1.063 ' OD1' HG13 ' A' ' 213' ' ' VAL . 37.8 t0 -66.13 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 109.879 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.597 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 21.5 mt-10 -66.33 -6.96 15.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.182 -0.949 . . . . 0.0 109.717 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.597 ' HD2' ' O ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -170.46 -67.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.758 . . . . 0.0 109.877 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.907 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 24.2 p80 -150.11 41.65 0.83 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.393 -0.817 . . . . 0.0 109.861 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.907 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 2.9 m80 -126.11 -172.35 2.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 110.1 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.09 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -90.64 154.54 19.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 0.0 110.044 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.063 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -134.48 170.76 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 201' ' ' VAL . 0.4 OUTLIER -146.55 119.47 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 79.7 p -141.84 133.22 26.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.308 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -172.99 -155.39 11.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.3 p -135.82 175.16 9.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 110.368 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.822 HG12 ' C ' ' A' ' 226' ' ' GLY . 11.7 p -152.16 155.86 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.354 -0.841 . . . . 0.0 110.078 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.613 ' O ' ' HB ' ' A' ' 197' ' ' VAL . 1.4 mp -156.01 153.6 29.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.002 . . . . 0.0 110.448 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.923 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.7 t80 -97.52 153.28 18.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.323 -0.861 . . . . 0.0 109.816 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.44 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 22.6 t-20 -70.68 -8.63 53.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.313 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.746 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -83.69 -63.64 1.31 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.814 0.816 . . . . 0.0 109.748 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.617 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 1.1 p30 178.02 25.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.85 -0.531 . . . . 0.0 110.496 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.8 tt0 -86.92 171.55 10.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 111.09 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 3.8 ptmt -154.2 81.42 1.13 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.576 0.703 . . . . 0.0 109.173 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.822 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -102.96 174.16 23.08 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.458 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.732 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 13.6 m -128.33 169.5 14.16 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.484 -1.009 . . . . 0.0 110.089 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.507 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.4 OUTLIER -135.55 126.31 27.33 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.117 -0.99 . . . . 0.0 110.859 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 230' ' ' LEU . 15.6 m -147.95 117.36 6.96 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.315 -0.866 . . . . 0.0 109.92 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.08 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.0 mp -151.7 176.17 11.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 110.568 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -116.9 125.71 6.67 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.606 -1.797 . . . . 0.0 108.606 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -104.83 143.5 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -1.235 . . . . 0.0 110.928 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.816 ' CE1' ' CB ' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -138.49 159.86 41.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.591 -0.693 . . . . 0.0 109.844 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.652 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.26 62.54 0.07 OUTLIER Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.917 -1.611 . . . . 0.0 111.006 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 1.214 ' N ' HG21 ' A' ' 145' ' ' THR . 4.5 pt-20 -62.82 -9.62 10.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.766 -1.432 . . . . 0.0 107.776 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 234' ' ' GLY . 34.8 tptt 179.69 34.49 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.714 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.92 92.16 0.16 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.278 -177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.733 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -59.65 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.718 0.77 . . . . 0.0 109.981 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.827 ' OE2' HD11 ' A' ' 112' ' ' LEU . 0.8 OUTLIER -104.96 153.39 21.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.608 -0.682 . . . . 0.0 110.097 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.699 ' HB ' ' CB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -152.11 148.16 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 110.477 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.22 150.68 37.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.778 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -176.87 -140.75 3.7 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 255' ' ' ILE . 57.2 p -158.17 133.68 8.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.474 -1.015 . . . . 0.0 109.552 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.7 171.16 7.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 110.199 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 227' ' ' SER . 27.9 mt-10 -119.81 124.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 1.141 HG21 ' NE2' ' A' ' 189' ' ' HIS . 2.3 t -112.72 126.38 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.162 -0.961 . . . . 0.0 110.603 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.71 ' OE1' HD11 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -118.94 131.78 56.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.045 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.7 t -98.12 -136.09 0.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.467 ' N ' ' OG1' ' A' ' 248' ' ' THR . . . -117.07 2.34 12.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.301 -0.874 . . . . 0.0 110.143 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.76 ' H ' HG23 ' A' ' 248' ' ' THR . 8.7 p30 -152.21 16.95 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 0.0 110.261 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -178.48 -166.38 34.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.71 HD11 ' OE1' ' A' ' 247' ' ' GLU . 0.8 OUTLIER -166.51 155.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.956 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.93 161.28 42.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.218 -0.926 . . . . 0.0 110.325 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.622 ' H ' ' CD2' ' A' ' 254' ' ' HIS . 0.2 OUTLIER -113.0 152.98 28.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.076 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -128.82 123.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.741 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.733 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -85.58 124.82 6.99 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.08 ' CD1' HD21 ' A' ' 230' ' ' LEU . 0.3 OUTLIER -116.73 157.85 24.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.306 . . . . 0.0 112.554 -177.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.622 ' HB1' HD13 ' A' ' 112' ' ' LEU . . . -153.08 109.11 3.33 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.703 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -134.46 157.45 46.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.76 -1.213 . . . . 0.0 111.648 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 239' ' ' GLU . 2.5 pttm -111.44 165.27 12.12 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.267 0.556 . . . . 0.0 109.855 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.682 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.3 mtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.513 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.4 -97.41 0.28 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -155.67 101.66 2.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.0 p -101.41 34.12 2.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -100.04 -167.4 29.25 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.0 -107.39 1.1 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.15 -158.36 14.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.99 -77.76 0.88 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.0 m -100.78 111.04 23.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.214 -1.168 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.29 75.04 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.95 175.0 28.39 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.23 -12.86 20.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.53 136.81 21.99 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 18' ' ' ILE . 2.5 m -58.83 138.54 19.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.278 -1.131 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.795 HG22 HD11 ' A' ' 18' ' ' ILE . 1.4 t -48.46 -35.59 13.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . 179.77 -24.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.61 ' HA ' ' OE1' ' A' ' 57' ' ' GLN . 4.3 p-10 -162.51 39.37 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 110.177 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.795 HD11 HG22 ' A' ' 15' ' ' THR . 15.7 mm -69.7 -23.99 26.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -79.26 36.18 1.97 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -4.86 1.52 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -1.151 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.8 -8.88 86.22 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.754 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -70.31 -41.12 73.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -1.13 . . . . 0.0 110.191 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.913 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -54.76 -11.27 0.57 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HA ' ' CB ' ' A' ' 28' ' ' ALA . 1.8 m-20 -94.51 -8.87 37.12 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.464 -0.773 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -96.28 -23.05 16.86 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.397 -0.815 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.931 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.57 -8.59 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 110.35 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.805 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -132.37 -82.3 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.603 ' C ' ' O ' ' A' ' 27' ' ' THR . . . -25.06 87.16 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.772 -0.58 . . . . 0.0 110.452 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.658 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.7 Cg_endo -72.86 -162.03 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.065 1.56 . . . . 0.0 110.517 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.064 HD12 ' N ' ' A' ' 31' ' ' ASP . 3.0 pp 179.93 -156.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.22 -0.925 . . . . 0.0 110.188 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 1.064 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -35.11 -81.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.465 -0.772 . . . . 0.0 110.208 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.689 ' O ' ' CE ' ' A' ' 33' ' ' LYS . 2.3 m-70 179.75 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.696 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' CE ' ' O ' ' A' ' 32' ' ' HIS . 1.8 mtmt 179.92 38.46 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.472 -0.768 . . . . 0.0 110.278 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.68 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . 31.2 m-20 -48.65 104.88 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 0.0 110.263 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.007 ' O ' HD11 ' A' ' 40' ' ' LEU . 3.4 pttp -44.57 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.923 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -168.59 79.85 0.1 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.988 HD13 ' HG2' ' A' ' 38' ' ' LYS . 2.8 tm? -155.44 -73.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -1.141 . . . . 0.0 110.224 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.02 ' CB ' HD22 ' A' ' 30' ' ' LEU . 20.0 mmtt -124.15 -12.83 7.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.176 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 1.049 ' HB3' HD21 ' A' ' 30' ' ' LEU . 1.6 t -150.27 171.67 16.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.007 HD11 ' O ' ' A' ' 35' ' ' LYS . 2.0 tp -154.65 131.08 10.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.213 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 53.0 m -98.68 134.35 41.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.19 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.149 HD21 ' CB ' ' A' ' 67' ' ' ASP . 4.3 pp -95.77 161.95 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.232 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 1.085 ' O ' HD12 ' A' ' 42' ' ' LEU . 12.8 pt-20 -40.85 169.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.32 -0.862 . . . . 0.0 110.282 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -78.73 56.52 1.89 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 t -49.25 -35.75 18.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.283 -0.885 . . . . 0.0 110.194 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -109.7 -157.34 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.488 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.5 m -175.96 -177.44 0.92 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.534 -0.729 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -55.12 -10.88 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.113 -0.992 . . . . 0.0 110.009 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.684 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.91 24.4 6.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.605 -0.684 . . . . 0.0 110.242 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -165.17 86.62 0.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 p -106.54 138.33 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -1.12 . . . . 0.0 110.198 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.696 HD13 ' CD1' ' A' ' 84' ' ' PHE . 1.6 pp -162.66 161.82 26.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 0.0 110.463 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -122.47 154.86 37.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.32 -0.862 . . . . 0.0 110.044 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 1.8 pp -131.84 130.53 41.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.637 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 79.5 p -104.14 153.17 21.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 110.037 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.823 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . . . -130.58 -168.74 2.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' OE1' ' HA ' ' A' ' 17' ' ' ASP . 2.6 tt0 -74.79 43.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 110.371 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.913 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . 179.85 -48.39 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.805 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.76 177.41 11.29 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.2 -1.177 . . . . 0.0 110.434 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 5.7 pt-20 -127.82 141.54 51.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 13.7 tptt -115.78 119.54 36.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 110.239 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.696 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -54.99 111.67 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.167 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.676 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -92.41 112.86 24.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 110.071 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.61 -160.03 10.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' ND2' ' O ' ' A' ' 46' ' ' ILE . 4.4 t-20 -48.89 132.03 18.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.0 110.2 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.581 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -13.26 63.1 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.149 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER 29.04 95.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.453 -1.028 . . . . 0.0 110.211 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 73.7 m -94.82 131.97 40.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.306 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -121.6 131.85 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.271 -0.893 . . . . 0.0 110.168 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.634 ' HB3' ' HA ' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -71.52 56.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 0.0 110.199 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.588 ' N ' ' HA ' ' A' ' 39' ' ' SER . 9.7 p -111.77 51.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA3' ' C ' ' A' ' 37' ' ' LEU . . . -33.11 -62.98 0.34 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HG3' ' C ' ' A' ' 72' ' ' GLY . 2.0 mttm -143.25 78.22 1.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -57.07 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.218 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -114.75 175.48 5.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.235 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.666 ' OD1' ' N ' ' A' ' 76' ' ' ASN . 4.2 p-10 -68.0 -5.19 15.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.288 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.697 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -147.99 64.44 1.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 110.067 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -129.64 117.21 20.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.619 HG21 ' CE1' ' A' ' 105' ' ' TYR . 1.2 p -94.46 172.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.145 0.974 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.61 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -132.92 95.68 3.62 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 3.5 ptm180 -113.7 124.93 53.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.494 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.739 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 3.4 p90 -161.13 147.68 14.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.98 136.15 33.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 110.202 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.742 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -144.23 151.01 38.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.964 HG23 ' OG ' ' A' ' 99' ' ' SER . 95.1 mt -106.5 108.35 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.199 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.43 107.9 16.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.123 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.907 ' HG3' HG22 ' A' ' 85' ' ' ILE . 11.9 mt-30 -142.34 148.39 37.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.99 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -129.25 112.46 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.332 -0.855 . . . . 0.0 109.992 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 4.5 tt0 -140.64 120.7 13.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 110.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.688 HG11 ' CD ' ' A' ' 93' ' ' GLN . 57.2 t -113.12 170.97 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.33 -0.857 . . . . 0.0 109.927 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.577 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.9 m-20 -67.11 2.76 1.38 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.945 . . . . 0.0 110.56 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.5 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.105 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.3 mt-30 -154.73 -139.11 0.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.176 -1.191 . . . . 0.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -45.37 162.79 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.252 0.548 . . . . 0.0 110.517 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.105 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -163.93 16.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 110.174 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.99 ' HB ' HD12 ' A' ' 88' ' ' ILE . 12.1 m -58.3 166.67 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.136 -0.978 . . . . 0.0 110.346 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.936 HD12 ' O ' ' A' ' 96' ' ' THR . 1.8 mp -157.64 99.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 4.6 mt-10 -133.29 152.91 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.964 ' OG ' HG23 ' A' ' 85' ' ' ILE . 16.5 m -144.05 162.58 35.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.932 . . . . 0.0 110.176 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.664 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . 177.34 -154.9 16.61 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -111.35 159.89 17.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -1.104 . . . . 0.0 110.169 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.742 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -131.79 124.82 30.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.379 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.62 ' NE2' ' HB3' ' A' ' 81' ' ' ARG . 11.0 mm-40 -115.69 127.9 55.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.73 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 97.1 t -140.51 106.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.019 -1.051 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . 2.4 m-85 -97.79 141.99 30.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 110.146 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.982 ' HD2' ' HB2' ' A' ' 111' ' ' ALA . 1.6 mmmt -127.96 132.72 49.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.244 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 3.0 pt20 -100.55 -129.85 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.874 . . . . 0.0 110.374 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.587 ' N ' ' HG3' ' A' ' 107' ' ' GLN . 36.3 t -98.15 -33.8 10.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -138.01 26.24 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.126 -0.984 . . . . 0.0 110.332 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.448 ' CB ' ' H ' ' A' ' 142' ' ' GLY . 0.4 OUTLIER -164.84 -164.18 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.086 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.982 ' HB2' ' HD2' ' A' ' 106' ' ' LYS . . . -172.5 133.58 0.63 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.246 -0.909 . . . . 0.0 110.139 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.824 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -110.89 117.22 32.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.669 ' N ' ' HA ' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -112.46 174.39 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 111.302 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' OG1' ' A' ' 113' ' ' THR . . . -156.71 120.2 4.22 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.207 0.527 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 51.9 mt -90.79 141.33 28.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 110.287 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 13.1 tt0 -145.73 111.62 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 110.161 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 118' ' ' GLU . 95.6 m -85.3 179.66 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.691 ' N ' HG22 ' A' ' 117' ' ' THR . 2.3 pp20? -160.42 -32.66 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.282 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.651 ' NE2' ' SD ' ' A' ' 129' ' ' MET . 22.1 tt0 -114.93 155.21 27.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -0.958 . . . . 0.0 110.372 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.689 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 5.6 mt-10 -121.43 -178.61 3.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.643 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.693 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -118.49 153.07 34.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.444 -0.785 . . . . 0.0 109.617 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB2' ' HB3' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -117.57 175.6 1.95 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.952 -1.093 . . . . 0.0 111.508 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.691 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.2 Cg_endo -96.69 -73.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.958 2.439 . . . . 0.0 110.925 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.724 ' CD ' ' CE1' ' A' ' 125' ' ' HIS . 22.2 tt0 -11.01 -59.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 122.791 1.281 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.829 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.8 m80 -132.0 81.04 1.94 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.39 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.829 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -72.99 4.11 4.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 110.591 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 1.065 ' O ' ' HE2' ' A' ' 129' ' ' MET . 5.2 mmtt -73.57 179.92 3.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.518 -1.364 . . . . 0.0 109.528 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 1.065 ' HE2' ' O ' ' A' ' 128' ' ' LYS . 9.3 mmt -141.16 125.36 17.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.693 ' CG2' ' O ' ' A' ' 121' ' ' GLN . 0.2 OUTLIER -95.04 -176.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.567 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.72 114.81 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 110.182 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 120' ' ' GLU . 2.0 tptt -147.22 179.57 7.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 110.315 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -139.97 107.37 5.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.23 111.0 7.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' CD1' ' O ' ' A' ' 135' ' ' PHE . 1.8 p90 -119.58 137.22 53.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 110.465 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 5.6 ttp180 -104.97 107.62 18.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.312 -0.867 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.78 ' O ' HG23 ' A' ' 137' ' ' ILE . 2.9 tp -78.91 111.14 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.594 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.56 39.72 1.79 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.669 ' HA ' ' N ' ' A' ' 113' ' ' THR . 2.0 p-10 -74.12 83.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -1.101 . . . . 0.0 110.542 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.888 HD12 ' C ' ' A' ' 140' ' ' ILE . 1.9 pp -86.92 176.74 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.414 -0.804 . . . . 0.0 110.203 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.809 ' CB ' ' CE2' ' A' ' 233' ' ' PHE . . . 179.65 147.36 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.982 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.448 ' H ' ' CB ' ' A' ' 110' ' ' SER . . . -62.62 54.68 0.04 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.757 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -69.58 49.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -1.166 . . . . 0.0 110.513 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.419 ' N ' ' O ' ' A' ' 142' ' ' GLY . 61.4 m-70 -98.37 -0.73 43.15 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.61 -0.681 . . . . 0.0 109.989 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.264 HG21 ' N ' ' A' ' 235' ' ' GLU . 5.9 t -107.07 102.54 11.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 111.107 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.74 127.17 30.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 0.0 109.461 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.811 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.57 -2.95 0.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.099 -1.0 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' OD1' ' CD ' ' A' ' 205' ' ' LYS . 28.6 t0 -94.16 7.85 43.78 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -122.49 0.13 9.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.185 -0.947 . . . . 0.0 110.822 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.117 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -117.97 -49.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.064 -1.022 . . . . 0.0 110.425 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 1.117 ' CD ' HD23 ' A' ' 150' ' ' LEU . 51.9 Cg_endo -92.67 -165.68 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.926 1.488 . . . . 0.0 110.498 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.61 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -149.67 -68.48 0.21 Allowed 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.698 0.761 . . . . 0.0 109.157 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.904 ' HA ' ' HB3' ' A' ' 180' ' ' ALA . 4.5 t70 -150.36 38.63 0.71 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 2.1 t -95.1 169.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.577 -0.702 . . . . 0.0 110.663 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.723 ' O ' ' CG ' ' A' ' 155' ' ' MET . 1.5 ptt? -98.49 107.76 20.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 110.64 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -111.01 103.37 11.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.14 -0.975 . . . . 0.0 110.064 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.654 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t -83.7 156.44 22.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 0.0 110.334 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.731 ' CE2' ' HB ' ' A' ' 176' ' ' ILE . 9.5 m-85 -133.78 145.57 49.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 1.003 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.19 158.92 44.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.865 . . . . 0.0 109.92 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . 172.22 -121.88 0.91 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.963 HG23 ' O ' ' A' ' 170' ' ' GLY . 8.9 m -139.96 129.03 23.63 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -1.199 . . . . 0.0 110.673 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.707 ' O ' ' N ' ' A' ' 170' ' ' GLY . . . -114.75 159.99 19.93 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.744 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 4.1 p90 -144.95 136.71 25.56 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.657 -1.217 . . . . 0.0 111.275 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.653 ' N ' ' HA3' ' A' ' 169' ' ' GLY . . . -113.55 124.81 6.68 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.681 ' HB3' ' CD2' ' A' ' 254' ' ' HIS . 10.2 p -60.82 -15.73 33.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -1.126 . . . . 0.0 109.623 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.764 ' HB3' ' CG ' ' A' ' 253' ' ' HIS . 0.1 OUTLIER -144.08 10.65 1.53 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.696 0.76 . . . . 0.0 109.136 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.592 ' OD2' ' OE2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -124.24 173.32 8.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.85 ' HB2' ' HB2' ' A' ' 195' ' ' LEU . . . -74.7 8.83 2.13 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.934 -1.103 . . . . 0.0 109.209 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.711 ' C ' ' HA ' ' A' ' 163' ' ' PHE . . . -33.12 119.44 0.2 Allowed Glycine 0 N--CA 1.48 1.584 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.963 ' O ' HG23 ' A' ' 161' ' ' THR . . . -157.51 -65.29 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 10.1 mttt -105.9 143.51 33.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -1.143 . . . . 0.0 109.496 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.214 ' CD2' ' HB2' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -125.03 133.11 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.177 -0.952 . . . . 0.0 110.936 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.59 ' C ' ' CD1' ' A' ' 174' ' ' TYR . 15.2 m -145.44 105.49 4.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 108.888 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.974 ' OH ' HD22 ' A' ' 257' ' ' LEU . 3.1 m-30 -118.27 160.29 21.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.015 . . . . 0.0 111.313 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 176' ' ' ILE . 55.8 m -124.25 97.75 5.46 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.071 HG21 ' CD1' ' A' ' 203' ' ' TYR . 2.1 mp -110.03 109.29 27.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 111.857 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.819 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 2.8 m-20 -68.13 134.44 50.54 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.78 ' CD1' ' CB ' ' A' ' 151' ' ' PRO . 6.6 m-85 -38.19 174.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.338 1.066 . . . . 0.0 112.872 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.88 -50.89 0.88 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.191 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.904 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . . . -68.14 34.98 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.972 -1.08 . . . . 0.0 111.235 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.819 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 18.4 tptt -161.02 -105.14 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.67 -1.269 . . . . 0.0 111.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.626 ' C ' ' HB2' ' A' ' 203' ' ' TYR . 2.9 pt20 -164.85 177.88 7.59 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.724 -1.235 . . . . 0.0 111.369 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.98 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -134.39 108.55 0.73 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.858 ' HA ' HG23 ' A' ' 201' ' ' VAL . 0.2 OUTLIER -128.9 166.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.726 -1.456 . . . . 0.0 110.439 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . 179.64 175.75 46.67 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.698 ' CB ' ' HA ' ' A' ' 198' ' ' ASP . 6.2 ptpt -142.7 159.78 41.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -1.131 . . . . 0.0 110.042 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.846 HG23 ' H ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER -87.09 136.22 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.673 ' HB3' ' CB ' ' A' ' 171' ' ' LYS . 21.3 tt0 -101.22 158.99 15.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.322 -0.861 . . . . 0.0 110.383 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.624 ' HB2' ' O ' ' A' ' 192' ' ' SER . 17.8 p-80 -54.51 140.62 33.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.499 -0.751 . . . . 0.0 110.845 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 168' ' ' ALA . 3.4 pp -94.02 -32.14 13.94 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.937 0.875 . . . . 0.0 109.631 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 190' ' ' LEU . 20.7 mttt -133.8 -7.98 2.77 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.392 0.615 . . . . 0.0 110.178 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 189' ' ' HIS . 0.6 OUTLIER 179.94 144.71 0.38 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.366 -0.834 . . . . 0.0 110.301 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 189' ' ' HIS . 45.2 Cg_endo -72.17 80.27 1.61 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.042 1.549 . . . . 0.0 110.436 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -138.5 -42.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.477 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.85 ' HB2' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -110.42 22.6 15.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.969 . . . . 0.0 110.683 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CE1' ' A' ' 220' ' ' TYR . 0.3 OUTLIER -64.65 145.84 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.266 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.855 HG13 ' CA ' ' A' ' 220' ' ' TYR . 25.7 t -135.31 170.03 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.969 -1.082 . . . . 0.0 111.299 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.698 ' HA ' ' CB ' ' A' ' 186' ' ' LYS . 16.9 t70 -108.46 138.9 44.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.423 -0.798 . . . . 0.0 109.676 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.272 HD22 ' CE1' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -120.14 159.0 25.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.179 -0.951 . . . . 0.0 110.83 -179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.963 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -139.05 128.43 24.24 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.101 HG12 ' C ' ' A' ' 215' ' ' SER . 0.0 OUTLIER -138.8 165.05 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.95 -1.094 . . . . 0.0 111.351 -178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.53 122.94 48.97 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.381 -0.824 . . . . 0.0 109.081 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.071 ' CD1' HG21 ' A' ' 176' ' ' ILE . 0.3 OUTLIER -73.61 129.21 37.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.663 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -115.57 155.0 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.542 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.762 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 13.5 mtmm -81.85 -74.91 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.586 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.762 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.43 107.36 2.37 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.658 1.346 . . . . 0.0 110.636 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 1.139 ' CG ' HG13 ' A' ' 213' ' ' VAL . 41.5 t0 -73.45 -125.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 0.0 109.795 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 22.6 mt-10 -70.98 -23.94 62.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.763 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 60.4 mttt -147.27 -60.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 109.901 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.803 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 0.6 OUTLIER -155.81 42.03 0.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.399 -0.813 . . . . 0.0 109.943 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.803 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.5 m170 -126.05 177.52 6.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.352 -0.843 . . . . 0.0 110.065 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.83 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -81.61 154.23 26.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.139 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -139.72 160.59 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.008 . . . . 0.0 110.743 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.855 ' CG2' HD21 ' A' ' 230' ' ' LEU . 10.1 mt -148.47 114.87 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 109.889 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 1.101 ' C ' HG12 ' A' ' 201' ' ' VAL . 35.8 t -123.32 145.69 48.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 228' ' ' TYR . . . 170.77 -161.69 34.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 25.2 p -136.07 175.17 9.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -1.139 . . . . 0.0 110.423 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.739 ' HB ' ' CD2' ' A' ' 228' ' ' TYR . 1.6 p -134.93 156.57 39.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.27 -0.894 . . . . 0.0 110.386 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.67 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -156.17 135.53 12.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.299 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.855 ' CA ' HG13 ' A' ' 197' ' ' VAL . 4.3 t80 -97.56 155.37 16.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.933 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.406 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 5.9 t30 -70.21 -8.82 53.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.186 -0.946 . . . . 0.0 110.532 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.689 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -78.28 -65.93 0.92 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.682 179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.07 33.55 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.831 -0.543 . . . . 0.0 110.047 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.592 ' OE2' ' OD2' ' A' ' 167' ' ' ASP . 4.2 tt0 -96.05 152.54 18.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.13 -0.981 . . . . 0.0 111.313 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.606 ' HA ' ' HG ' ' A' ' 219' ' ' LEU . 8.0 mtpp -145.71 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -103.91 174.01 22.12 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.947 -1.12 . . . . 0.0 111.075 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.694 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -111.13 -178.49 3.48 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.679 -0.895 . . . . 0.0 109.743 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.272 ' CE1' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -149.95 121.73 8.11 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.928 -1.107 . . . . 0.0 110.981 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 243' ' ' SER . 67.6 m -147.98 120.07 8.27 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.415 -0.803 . . . . 0.0 109.575 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.855 HD21 ' CG2' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -154.37 177.42 11.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.564 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -126.2 139.77 11.63 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.83 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -113.2 144.56 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 110.358 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.809 ' CE2' ' CB ' ' A' ' 141' ' ' ALA . 0.7 OUTLIER -139.71 156.26 46.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.355 -0.84 . . . . 0.0 110.051 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.732 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.59 57.91 0.08 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.806 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 1.264 ' N ' HG21 ' A' ' 145' ' ' THR . 3.8 pt-20 -64.77 -7.8 12.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.877 -1.367 . . . . 0.0 107.989 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.8 34.56 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.728 -1.952 . . . . 0.0 105.728 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.728 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -172.08 93.0 0.13 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.267 -177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.677 ' CB ' ' HB3' ' A' ' 261' ' ' GLN . 0.5 OUTLIER -59.33 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.693 0.758 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.824 ' CD ' HD21 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -104.0 153.84 20.37 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.75 -0.594 . . . . 0.0 110.068 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -154.95 136.79 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.145 -0.972 . . . . 0.0 110.142 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -144.21 157.47 44.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.988 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 230' ' ' LEU . . . -179.35 -145.79 6.44 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 229' ' ' SER . 74.2 m -158.6 132.41 7.68 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.349 -1.089 . . . . 0.0 109.248 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.073 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.37 171.51 7.29 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 7.8 mt-10 -103.02 162.53 12.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.158 -0.963 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.661 ' CG1' ' HB2' ' A' ' 253' ' ' HIS . 2.2 t -142.95 127.78 15.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.197 -0.939 . . . . 0.0 110.587 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 1.6 mt-10 -122.08 128.56 51.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.19 -0.944 . . . . 0.0 110.169 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.709 HG22 ' N ' ' A' ' 249' ' ' ALA . 84.4 m -101.57 -109.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.08 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.709 ' N ' HG22 ' A' ' 248' ' ' THR . . . -135.46 -0.63 2.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -159.34 15.2 0.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.903 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.89 -175.2 38.72 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.903 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.7 mp -141.09 131.11 26.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.257 -1.143 . . . . 0.0 110.298 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.764 ' CG ' ' HB3' ' A' ' 166' ' ' ASP . 1.2 m170 -110.11 161.39 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.444 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 165' ' ' SER . 1.2 p-80 -122.63 127.25 49.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 109.879 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.073 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -107.15 121.09 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.088 -1.007 . . . . 0.0 110.652 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.724 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.65 128.49 8.92 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.974 HD22 ' OH ' ' A' ' 174' ' ' TYR . 2.4 mt -109.74 141.35 42.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.028 -1.278 . . . . 0.0 111.058 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.49 ' C ' ' CD2' ' A' ' 172' ' ' LEU . . . -152.97 109.32 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 1.214 ' HB2' ' CD2' ' A' ' 172' ' ' LEU . . . -143.93 169.26 18.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.858 -1.151 . . . . 0.0 111.296 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.697 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -124.13 165.59 17.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.683 -0.636 . . . . 0.0 110.093 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.677 ' HB3' ' CB ' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.253 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.238 0.542 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.25 -82.69 0.33 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.4 p -147.25 88.08 1.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.203 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.4 m -162.07 116.33 1.87 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.251 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -152.98 121.14 1.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.59 -160.16 24.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.58 101.45 2.36 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.7 -102.09 0.18 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.1 p -151.43 101.17 2.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -1.138 . . . . 0.0 110.198 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.51 -126.98 0.86 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.5 134.87 12.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.45 64.03 3.26 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.18 128.13 2.97 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 14' ' ' VAL . 3.4 t -58.93 173.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -1.106 . . . . 0.0 110.242 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.899 ' OG1' HD12 ' A' ' 18' ' ' ILE . 53.6 m -84.7 161.49 20.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.893 . . . . 0.0 110.171 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' O ' ' OD2' ' A' ' 17' ' ' ASP . . . -71.29 2.1 5.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 110.557 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.585 ' H ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -162.43 44.71 0.14 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.007 -1.058 . . . . 0.0 110.704 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -107.81 -77.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.233 -0.917 . . . . 0.0 109.926 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.983 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -63.19 62.93 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.865 HG22 ' HA3' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -64.87 -0.54 1.55 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.591 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -30.84 -37.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -90.88 -35.71 14.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -1.184 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.831 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -54.52 -11.17 0.5 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 110.164 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.99 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -93.08 -10.13 37.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.41 -0.806 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 70' ' ' ASN . . . -91.25 -9.76 44.01 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.997 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.4 mp -106.56 -38.96 6.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 110.596 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.668 ' HB ' ' HB1' ' A' ' 59' ' ' ALA . 24.9 m -140.02 -5.95 1.28 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.018 -1.051 . . . . 0.0 111.211 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.99 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -133.27 83.28 50.88 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HB3' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -71.9 97.36 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.028 1.541 . . . . 0.0 110.416 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.805 HD23 ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -51.67 -161.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.345 -0.847 . . . . 0.0 110.313 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.597 ' HA ' ' OD1' ' A' ' 34' ' ' ASP . 1.8 p30 -162.55 20.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.373 -0.829 . . . . 0.0 110.059 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 6.2 t60 -67.63 2.01 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.128 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.4 mtpt -178.27 26.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.3 -0.875 . . . . 0.0 110.254 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -84.12 92.64 7.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -82.41 -78.57 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.336 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.39 -46.37 0.93 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.8 mm? -77.89 99.44 5.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -1.195 . . . . 0.0 110.288 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -79.8 -11.64 59.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 110.075 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.688 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 2.0 p -171.59 -174.33 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD13 ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -142.94 153.19 42.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.299 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -110.59 144.58 39.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.01 HD13 ' HB3' ' A' ' 67' ' ' ASP . 5.4 mp -83.95 150.2 25.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.594 ' O ' ' HA2' ' A' ' 66' ' ' GLY . 3.5 pt-20 -44.97 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.227 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.64 40.41 0.23 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.0 t -49.73 -53.99 21.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.789 HG22 ' H ' ' A' ' 47' ' ' SER . 1.9 mt -90.67 -159.39 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.304 -0.872 . . . . 0.0 110.251 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.789 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.98 175.93 1.22 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.504 -0.748 . . . . 0.0 109.827 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' SER . 9.1 pt20 -43.78 -20.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 109.959 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.693 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -101.85 54.85 0.81 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.556 0.693 . . . . 0.0 110.571 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.599 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . 179.87 91.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.608 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 24.7 p -109.09 135.74 49.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.258 -1.142 . . . . 0.0 110.089 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.2 pp -162.22 161.87 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.202 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -115.9 154.64 29.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.237 -0.915 . . . . 0.0 110.341 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -107.14 142.28 37.09 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 110.065 178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 83' ' ' ASP . 27.3 t -129.47 120.89 26.2 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.844 -0.535 . . . . 0.0 110.086 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -107.24 -178.75 3.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.522 HE21 HD21 ' A' ' 22' ' ' LEU . 33.1 mt-30 -74.77 43.04 0.18 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.304 -0.872 . . . . 0.0 110.263 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' HG22 ' A' ' 20' ' ' THR . . . 179.89 -36.69 0.07 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 27' ' ' THR . . . -154.77 177.51 11.17 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.093 -1.239 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.615 ' O ' ' OG1' ' A' ' 27' ' ' THR . 8.6 pt-20 -131.22 163.28 28.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.666 ' CB ' ' HB3' ' A' ' 26' ' ' LEU . 6.3 tptm -143.7 129.61 19.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.226 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 13.3 t -57.35 142.42 43.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.834 ' CE2' HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.63 112.97 16.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.75 -166.72 14.38 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 3.5 t-20 -48.92 131.64 18.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -1.125 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.78 -13.2 63.37 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.01 ' HB3' HD13 ' A' ' 42' ' ' LEU . 1.2 m-20 48.42 167.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.404 -1.056 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.712 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 4.2 p -141.29 144.52 34.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.952 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -142.53 97.71 3.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.144 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.688 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 0.5 OUTLIER -67.35 79.76 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 72' ' ' GLY . 20.6 p -115.68 50.18 1.03 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.129 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 73' ' ' LYS . . . -30.2 -43.0 0.06 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 2.9 mttm 179.93 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -1.132 . . . . 0.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.23 171.54 9.43 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 110.085 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -49.55 174.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.671 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 67.6 m-20 -95.76 -2.8 47.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.193 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.774 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 0.1 OUTLIER -150.48 77.53 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.951 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.537 ' C ' ' CE1' ' A' ' 105' ' ' TYR . 1.3 mmmm -145.02 124.59 13.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.751 ' HB ' ' CE2' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -53.87 172.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 110.661 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.69 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -162.86 81.05 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.692 -0.63 . . . . 0.0 109.862 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.712 ' HD3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -108.02 131.33 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.432 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.923 ' CD1' HD13 ' A' ' 54' ' ' LEU . 11.2 p90 -137.7 135.37 36.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 9.0 t70 -71.14 151.73 44.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.673 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -162.44 149.84 13.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.32 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.612 HG12 ' OG ' ' A' ' 99' ' ' SER . 94.3 mt -112.74 109.97 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.089 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.602 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.6 122.12 28.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.608 ' O ' ' OG1' ' A' ' 51' ' ' THR . 84.5 mt-30 -154.18 128.2 8.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 110.342 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.756 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -117.92 112.33 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.912 . . . . 0.0 110.195 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 17.5 tt0 -140.78 122.29 15.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.237 -0.914 . . . . 0.0 110.317 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.703 HG11 ' CD ' ' A' ' 93' ' ' GLN . 76.6 t -112.8 170.83 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.896 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 m-20 -66.6 1.83 1.58 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 0.0 110.528 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.634 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.61 43.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.135 ' O ' HD12 ' A' ' 95' ' ' ILE . 5.0 mt-30 -154.76 -139.15 0.08 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.144 -1.209 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 4.3 mm? -45.42 162.4 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.231 0.539 . . . . 0.0 110.506 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.135 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -164.79 16.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 110.132 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.756 ' HB ' HD12 ' A' ' 88' ' ' ILE . 39.6 m -60.21 164.58 4.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.86 HD12 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -157.06 117.58 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.848 . . . . 0.0 110.142 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.602 ' CG ' ' HG2' ' A' ' 120' ' ' GLU . 57.9 mt-10 -149.81 157.65 43.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.612 ' OG ' HG12 ' A' ' 85' ' ' ILE . 39.3 t -143.77 164.79 29.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.882 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 178.14 -163.35 31.43 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 116' ' ' GLN . 5.7 mt-10 -112.39 159.84 18.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -1.099 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.934 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -126.41 143.41 51.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.207 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 1.049 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 8.9 tp60 -140.0 110.99 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.293 -0.88 . . . . 0.0 109.96 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 113' ' ' THR . 0.2 OUTLIER -127.4 118.72 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 -179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.794 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 0.2 OUTLIER -99.08 149.13 23.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 4.0 tmtt? -118.41 129.44 55.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 0.0 110.239 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.68 ' NE2' ' OE1' ' A' ' 238' ' ' GLN . 0.8 OUTLIER -110.45 -124.76 0.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.377 -0.827 . . . . 0.0 110.198 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.1 t -83.41 -87.29 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.177 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -94.52 -31.61 13.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.685 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.5 OUTLIER -101.96 -156.62 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 109.877 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.63 -173.85 1.07 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.333 -0.855 . . . . 0.0 110.139 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.142 HD21 ' CD ' ' A' ' 239' ' ' GLU . 2.9 mt -124.43 143.65 50.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.796 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.865 HG23 HG13 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 110.659 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -164.2 120.61 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.812 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.934 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 7.3 mt -112.69 110.06 19.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.274 -0.891 . . . . 0.0 110.461 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.72 ' HG3' ' CE2' ' A' ' 135' ' ' PHE . 24.2 tt0 -98.12 144.0 28.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.644 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.4 m -109.3 163.93 12.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.964 . . . . 0.0 110.217 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 117' ' ' THR . 10.1 tp10 -132.8 -56.09 0.94 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -134.83 153.46 52.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 110.285 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' VAL . 2.1 mt-10 -141.59 179.58 6.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.699 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt20 -160.53 151.92 19.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.786 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 0.7 OUTLIER -125.32 103.96 28.99 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 120.944 -1.098 . . . . 0.0 110.886 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.41 50.13 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.25 1.658 . . . . 0.0 111.485 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.751 ' C ' ' CG ' ' A' ' 125' ' ' HIS . 6.7 mt-10 -95.14 -27.66 15.45 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.356 1.074 . . . . 0.0 108.656 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.751 ' CG ' ' C ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -179.57 -76.89 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.402 ' HA ' ' NZ ' ' A' ' 128' ' ' LYS . 0.5 OUTLIER -122.73 17.36 10.29 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.698 ' O ' ' N ' ' A' ' 129' ' ' MET . 0.8 OUTLIER -104.38 5.4 34.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.1 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.786 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.76 35.34 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.109 -0.994 . . . . 0.0 111.468 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.698 ' N ' ' O ' ' A' ' 127' ' ' GLU . 2.9 tpp -157.02 138.92 14.33 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.975 . . . . 0.0 110.161 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 120' ' ' GLU . 3.5 t -148.94 172.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.175 -0.953 . . . . 0.0 110.07 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -155.09 114.89 3.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.144 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 1.3 mttt -175.11 155.57 1.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 110.241 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.749 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 46.7 mtt-85 -101.26 106.39 17.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 110.234 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.451 ' H ' ' HB ' ' A' ' 117' ' ' THR . 5.3 mtt180 -113.72 111.37 21.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.157 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.749 ' CE1' ' HB3' ' A' ' 133' ' ' ARG . 31.4 m-85 -107.78 109.05 20.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 110.352 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -97.85 107.6 20.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.0 110.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.659 HD13 ' CE2' ' A' ' 163' ' ' PHE . 6.3 tp -79.45 125.82 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.451 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.58 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -114.89 47.93 0.99 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 63.9 m-20 -64.68 122.34 16.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.114 . . . . 0.0 110.499 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.963 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -120.54 74.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.963 . . . . 0.0 109.738 179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.821 ' CB ' ' CD2' ' A' ' 233' ' ' PHE . . . -47.13 154.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.075 -1.016 . . . . 0.0 110.217 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.685 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -81.37 -43.69 8.43 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 mt-10 -151.18 103.97 3.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 110.096 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 210' ' ' HIS . 39.7 m-70 -58.93 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.068 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.793 HG21 ' C ' ' A' ' 234' ' ' GLY . 0.5 OUTLIER -70.18 113.08 7.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.473 -0.767 . . . . 0.0 110.242 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.683 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -72.31 117.92 14.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.925 . . . . 0.0 110.103 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.208 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.8 m-30 -45.39 -18.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.128 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 151' ' ' PRO . 52.9 t0 -62.34 -5.37 2.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 110.588 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.841 ' CG ' HD23 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -83.29 -2.15 54.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.003 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.0 OUTLIER 179.68 57.12 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.557 -0.714 . . . . 0.0 109.381 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.803 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 44.5 Cg_endo -86.59 103.0 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.176 1.619 . . . . 0.0 111.028 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.578 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 3.1 mttt -141.61 -83.22 0.2 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.757 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.21 48.16 0.76 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.35 -0.844 . . . . 0.0 109.841 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 3.0 t -92.58 109.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.158 -0.964 . . . . 0.0 110.963 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 103.1 1.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.634 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.767 ' HB1' ' HE1' ' A' ' 158' ' ' TYR . . . -93.26 117.2 29.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.807 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.723 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -107.98 154.3 21.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.619 179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.797 ' CZ ' ' CD1' ' A' ' 232' ' ' ILE . 70.5 m-85 -150.58 158.67 44.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 111.072 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 5.4 ptp180 -149.8 140.29 22.45 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -168.31 -156.56 10.39 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 118.817 -1.659 . . . . 0.0 110.961 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 258' ' ' ALA . 51.1 m -124.79 155.84 38.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.792 -0.828 . . . . 0.0 110.015 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 256' ' ' GLY . . . -133.49 -179.75 5.71 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.732 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.0 OUTLIER -132.68 135.7 45.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.413 -0.804 . . . . 0.0 109.599 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.425 ' H ' ' HA2' ' A' ' 169' ' ' GLY . . . -109.45 129.7 9.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.063 -1.542 . . . . 0.0 110.056 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.557 ' O ' ' HD2' ' A' ' 133' ' ' ARG . 0.1 OUTLIER -62.99 -9.4 9.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -1.178 . . . . 0.0 109.806 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -133.09 2.9 3.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.672 0.749 . . . . 0.0 109.616 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.618 ' OD2' HD22 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -124.67 171.23 10.24 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.593 -0.692 . . . . 0.0 109.343 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.63 71.0 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.035 -1.04 . . . . 0.0 110.367 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.74 -109.26 0.26 Allowed Glycine 0 C--N 1.282 -2.464 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.698 ' N ' ' CD2' ' A' ' 189' ' ' HIS . . . 176.64 152.08 9.46 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.725 ' N ' ' HB2' ' A' ' 189' ' ' HIS . 0.0 OUTLIER -149.07 116.59 6.18 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.862 HD13 ' CE1' ' A' ' 174' ' ' TYR . 0.7 OUTLIER -149.38 155.55 40.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 117.897 -1.521 . . . . 0.0 113.2 -177.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 22.4 m -124.38 130.31 52.26 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.862 ' CE1' HD13 ' A' ' 172' ' ' LEU . 4.8 m-85 -115.18 151.28 34.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.859 -1.151 . . . . 0.0 111.48 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 1.4 m -146.59 111.4 5.29 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.963 ' CD1' HG11 ' A' ' 201' ' ' VAL . 2.9 mp -137.15 168.69 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.975 -1.078 . . . . 0.0 111.852 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 1.9 t70 -87.06 130.56 34.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.749 -0.595 . . . . 0.0 109.6 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.862 ' CZ ' ' CG ' ' A' ' 147' ' ' PHE . 3.0 t80 -48.07 -127.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.714 0.769 . . . . 0.0 111.848 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.803 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -33.48 -50.08 0.31 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.895 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.776 ' O ' ' N ' ' A' ' 182' ' ' GLN . . . -67.38 50.05 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.045 -1.034 . . . . 0.0 108.32 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.997 ' HD2' ' HB1' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -18.58 75.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.325 0.583 . . . . 0.0 110.879 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.776 ' N ' ' O ' ' A' ' 180' ' ' ALA . 7.9 tt0 -142.55 115.03 8.49 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 118.701 -1.2 . . . . 0.0 111.27 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 176' ' ' ILE . . . -179.52 -159.86 24.21 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.485 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.739 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.3 OUTLIER -170.75 160.14 6.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.588 -0.948 . . . . 0.0 109.348 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 1.064 ' O ' HD22 ' A' ' 199' ' ' LEU . . . -130.55 168.52 21.66 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.253 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -124.0 137.55 54.58 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.413 -1.051 . . . . 0.0 109.697 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -112.87 132.56 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.89 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 17.9 pt-20 -162.77 132.06 4.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.619 -0.675 . . . . 0.0 109.654 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.725 ' HB2' ' N ' ' A' ' 171' ' ' LYS . 74.9 t60 -162.52 -51.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.011 -1.056 . . . . 0.0 110.954 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.69 ' CD1' ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -39.8 175.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.72 0.771 . . . . 0.0 111.448 -178.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.01 -4.84 0.14 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.568 -0.708 . . . . 0.0 111.976 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.799 ' HB3' HD13 ' A' ' 195' ' ' LEU . 7.0 t -145.74 124.54 6.6 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 120.911 -1.118 . . . . 0.0 110.87 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.68 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 48.2 Cg_endo -75.38 13.27 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.21 1.637 . . . . 0.0 110.013 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -105.01 -27.83 11.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.291 -0.88 . . . . 0.0 110.155 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.7 mp -84.81 8.26 17.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.991 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.772 ' O ' HG23 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -83.88 -153.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.0 109.62 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.991 ' CG1' HG12 ' A' ' 218' ' ' VAL . 3.3 t -160.92 165.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.687 ' C ' HD13 ' A' ' 199' ' ' LEU . 1.8 m-20 -116.34 125.19 51.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -115.61 157.78 23.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.125 -0.985 . . . . 0.0 111.322 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.697 ' O ' ' CG2' ' A' ' 201' ' ' VAL . . . -84.51 178.91 7.53 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.461 -0.774 . . . . 0.0 109.143 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.018 ' CG1' HG23 ' A' ' 214' ' ' ILE . 95.9 t -161.37 128.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.981 -1.074 . . . . 0.0 110.722 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 181' ' ' LYS . . . -110.84 123.1 49.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -0.846 . . . . 0.0 109.72 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.006 ' OH ' HD13 ' A' ' 232' ' ' ILE . 0.1 OUTLIER -86.68 103.18 14.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.417 -0.802 . . . . 0.0 110.442 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.683 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 37.2 mt -100.64 171.18 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.719 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -82.02 -68.56 0.19 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.879 . . . . 0.0 110.038 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.719 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.2 Cg_endo -72.94 109.28 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.081 1.569 . . . . 0.0 110.298 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.756 ' CA ' HG22 ' A' ' 213' ' ' VAL . 49.0 t0 -94.19 -117.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.629 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 1.1 mt-10 -82.1 -32.47 30.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 7.0 mmtp -136.52 -53.27 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 110.077 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -170.16 33.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.311 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.674 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 24.4 p-80 -123.76 -175.68 3.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.208 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -68.3 146.1 53.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.756 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.1 OUTLIER -111.71 156.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.121 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.018 HG23 ' CG1' ' A' ' 201' ' ' VAL . 5.4 mm -140.02 101.85 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 0.0 110.039 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 202' ' ' ALA . 45.0 p -123.37 135.25 54.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -164.93 157.75 30.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 30.8 p -93.96 135.96 34.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 110.127 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.029 HG13 HD12 ' A' ' 199' ' ' LEU . 2.8 t -91.85 145.8 7.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.286 -0.884 . . . . 0.0 110.36 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -146.96 132.15 18.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.964 . . . . 0.0 110.243 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.787 ' CB ' HG22 ' A' ' 197' ' ' VAL . 4.9 t80 -97.41 155.57 16.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 109.968 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -76.89 -18.0 58.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 0.0 110.384 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.751 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -75.21 -65.49 0.88 Allowed 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.361 -0.837 . . . . 0.0 109.72 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.56 27.48 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.847 -0.533 . . . . 0.0 110.296 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.692 ' O ' ' CD ' ' A' ' 225' ' ' LYS . 5.4 tt0 -83.92 167.29 17.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 111.265 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.692 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 2.5 mmmt -150.92 81.23 1.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -113.16 174.11 15.59 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.078 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.748 ' C ' HG23 ' A' ' 218' ' ' VAL . 47.4 m -123.87 167.52 13.99 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.74 -0.859 . . . . 0.0 109.429 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.809 ' CE2' HD13 ' A' ' 257' ' ' LEU . 56.3 t80 -141.87 136.05 30.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.782 -1.199 . . . . 0.0 111.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 26.2 m -148.02 124.62 11.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.495 -0.753 . . . . 0.0 109.622 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 240' ' ' VAL . 0.8 OUTLIER -144.24 168.96 18.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -125.6 134.86 8.95 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.006 HD13 ' OH ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -114.77 134.63 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.261 -1.141 . . . . 0.0 110.919 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.821 ' CD2' ' CB ' ' A' ' 141' ' ' ALA . 0.1 OUTLIER -128.68 99.44 5.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.617 -0.677 . . . . 0.0 110.025 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.793 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.13 115.29 0.46 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 145' ' ' THR . 0.3 OUTLIER -31.95 -48.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 108.602 179.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.669 ' CE ' ' OE1' ' A' ' 235' ' ' GLU . 19.6 pttt 177.92 36.58 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' NE2' ' A' ' 261' ' ' GLN 0.251 . . -171.22 14.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.626 -0.829 . . . . 0.0 111.631 -176.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.782 ' HB3' ' HA3' ' A' ' 234' ' ' GLY . 5.9 tp-100 -95.39 -100.48 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.667 -1.27 . . . . 0.0 110.472 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 1.142 ' CD ' HD21 ' A' ' 112' ' ' LEU . 11.0 pt-20 -165.92 179.88 5.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.109 -0.994 . . . . 0.0 110.727 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 230' ' ' LEU . 8.4 p -148.75 119.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.68 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -129.25 147.58 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.257 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.76 ' CA ' ' CD1' ' A' ' 230' ' ' LEU . . . -176.8 -145.73 5.8 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.716 ' N ' HD12 ' A' ' 230' ' ' LEU . 72.2 m -158.3 -176.87 6.15 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.37 -1.077 . . . . 0.0 109.714 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.153 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.76 169.86 23.67 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -129.62 137.32 50.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.696 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.516 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.0 OUTLIER -127.96 131.32 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.05 -1.031 . . . . 0.0 110.862 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 1.011 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.7 OUTLIER -111.03 129.93 55.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.323 -0.86 . . . . 0.0 110.089 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.765 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.8 m -100.39 -166.07 1.28 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 110.005 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.765 ' H ' HG22 ' A' ' 248' ' ' THR . . . -71.72 -4.79 29.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 110.097 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 30.1 t-20 179.55 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 110.433 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.675 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.95 106.44 0.21 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 247' ' ' GLU . 20.8 mt -85.11 135.21 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.317 -1.108 . . . . 0.0 110.233 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.3 m170 -117.73 161.14 20.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.225 -0.922 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.735 ' CD2' ' O ' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.65 124.61 43.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 109.736 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.153 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -117.02 127.06 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.087 -1.008 . . . . 0.0 110.775 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.826 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -91.03 154.96 23.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 228' ' ' TYR . 1.9 mt -134.35 148.93 50.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 111.428 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 161' ' ' THR . . . -152.77 113.04 4.02 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.38 164.86 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.661 -1.274 . . . . 0.0 111.758 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.774 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 13.8 pttm -109.08 165.32 11.68 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.236 0.541 . . . . 0.0 109.99 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.772 ' HA ' ' CD2' ' A' ' 158' ' ' TYR . 2.1 pt20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.319 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.259 0.552 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.99 -130.86 1.5 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -154.04 131.39 11.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.4 m -153.7 121.58 6.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 110.212 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.62 -96.77 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.35 -103.65 0.17 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.71 160.85 30.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.3 -145.57 4.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.6 m -153.22 -171.32 3.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.19 61.26 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.52 67.43 0.31 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.5 -165.9 3.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.93 143.25 17.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 18' ' ' ILE . 2.1 m -58.97 155.04 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.261 -1.14 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.936 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.8 t -95.01 173.83 7.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.164 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.96 6.26 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.934 . . . . 0.0 110.674 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.936 ' H ' HG23 ' A' ' 15' ' ' THR . 1.0 OUTLIER -133.51 43.92 2.84 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.089 -1.007 . . . . 0.0 110.637 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.956 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.1 mt -112.66 -78.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 110.037 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 1.067 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -118.4 -44.35 0.52 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -63.61 -2.11 1.54 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.261 -1.141 . . . . 0.0 110.356 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -64.35 -17.92 62.44 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -48.28 -35.59 12.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -1.117 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.2 -11.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -94.24 -8.81 38.11 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.407 -0.808 . . . . 0.0 110.279 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -76.67 -25.66 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.395 -0.816 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -104.72 -31.01 9.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 110.196 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.038 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 4.8 m -79.73 -6.0 56.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 110.155 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.68 100.6 16.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 0.0 110.155 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.643 ' HA ' ' CG ' ' A' ' 70' ' ' ASN . 45.5 Cg_endo -73.16 -171.9 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.957 1.504 . . . . 0.0 110.429 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.585 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.3 tp -29.92 140.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.88 . . . . 0.0 110.22 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -137.92 109.95 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.617 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 61.9 t-80 -60.87 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.198 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 31' ' ' ASP . 5.8 mtmt -175.26 24.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 11.2 m-20 -87.71 166.45 14.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.875 . . . . 0.0 110.165 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -70.75 -79.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.928 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.31 -75.92 0.92 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.622 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.0 mm? -85.69 136.11 33.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.159 -1.201 . . . . 0.0 110.22 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 34' ' ' ASP . 56.5 mttt -97.38 -25.09 15.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.222 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.665 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 4.8 t 175.53 171.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HG ' ' C ' ' A' ' 39' ' ' SER . 29.6 mt -145.47 109.54 4.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 110.21 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 68' ' ' SER . 42.5 m -86.27 154.29 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.368 -0.832 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' O ' ' A' ' 43' ' ' GLU . 5.4 mp -96.97 129.79 44.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.209 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.659 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.7 pt-20 -49.08 -167.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.67 53.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.659 ' N ' ' O ' ' A' ' 43' ' ' GLU . 24.2 t -64.17 -47.76 78.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.0 mt -108.82 -156.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.375 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -176.34 -174.48 0.61 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.53 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -57.3 -8.86 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.968 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.746 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -96.45 13.47 27.79 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 110.276 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -155.32 81.47 0.17 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -105.59 139.38 40.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -1.124 . . . . 0.0 110.157 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 pp -162.04 161.83 28.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -114.48 154.64 27.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 0.0 110.378 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.739 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -105.27 141.23 37.16 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.275 -0.891 . . . . 0.0 110.199 179.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.606 ' O ' ' N ' ' A' ' 83' ' ' ASP . 19.4 t -136.13 121.06 18.69 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 121.261 0.553 . . . . 0.0 110.072 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -114.49 -177.02 3.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 20' ' ' THR . 33.2 mt-30 -74.52 43.64 0.19 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.305 -0.872 . . . . 0.0 110.268 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -170.36 -49.68 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 1.038 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.66 177.32 11.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.228 -1.16 . . . . 0.0 110.274 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 54' ' ' LEU . 8.7 pt-20 -127.39 164.22 22.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 8.9 tppt? -142.43 129.22 20.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 0.0 110.151 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 62' ' ' THR . 6.1 t -58.54 124.42 19.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.739 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -120.83 112.85 19.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.275 -0.891 . . . . 0.0 110.186 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.6 -157.49 8.13 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.624 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 5.9 t-20 -48.81 125.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -1.186 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.64 -0.65 83.04 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 11.4 p-10 -27.63 131.37 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -1.049 . . . . 0.0 110.357 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 41' ' ' THR . 94.0 p -129.44 158.24 39.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.226 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.686 HD23 ' OH ' ' A' ' 63' ' ' TYR . 4.3 mt -119.58 143.32 47.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.665 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 21.7 m-80 -119.55 74.38 1.0 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.676 ' HB ' HD13 ' A' ' 74' ' ' LEU . 39.6 p -95.44 45.44 1.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 110.203 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -58.74 -9.0 6.19 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' O ' ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -100.04 -45.7 5.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -1.183 . . . . 0.0 110.23 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.676 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.6 162.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.305 -0.872 . . . . 0.0 110.706 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' CD ' ' HB2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -134.49 -164.87 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -0.799 . . . . 0.0 110.238 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 76.6 m-20 -79.55 27.15 0.28 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -0.918 . . . . 0.0 110.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.704 ' HA ' ' CD ' ' A' ' 260' ' ' LYS . 58.5 m-20 -164.56 80.61 0.38 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.179 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.685 ' CG ' ' O ' ' A' ' 77' ' ' ASP . 9.6 mttp -172.24 153.96 3.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.105 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.735 HG13 ' HA ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -109.46 163.23 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 110.344 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.26 81.86 1.68 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.428 -0.795 . . . . 0.0 109.686 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.664 ' NH1' ' OE1' ' A' ' 57' ' ' GLN . 2.6 ptm180 -101.24 124.9 47.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.328 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 35.9 p90 -154.51 155.26 34.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.837 . . . . 0.0 110.019 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -92.19 136.43 33.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.218 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.1 p90 -152.52 143.84 23.27 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 110.141 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.843 HG23 ' O ' ' A' ' 98' ' ' GLU . 26.6 mt -115.36 121.34 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.686 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.53 101.19 11.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.32 -0.863 . . . . 0.0 109.936 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' HG2' ' HA ' ' A' ' 97' ' ' LEU . 2.9 mt-30 -124.18 137.69 54.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.454 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.746 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -130.05 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.355 -0.84 . . . . 0.0 109.839 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.702 ' HG3' ' CG1' ' A' ' 95' ' ' ILE . 2.5 tt0 -140.56 115.73 9.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 0.0 110.308 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG11 ' CD ' ' A' ' 93' ' ' GLN . 71.3 t -98.54 170.91 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.949 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.69 3.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.256 -0.903 . . . . 0.0 110.487 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.62 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.56 42.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.141 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.9 mt-30 -154.78 -138.77 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.222 -1.163 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 15.6 mt -45.43 162.84 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.827 -0.546 . . . . 0.0 110.59 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.141 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.11 17.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.516 -0.74 . . . . 0.0 110.083 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.755 ' O ' HD12 ' A' ' 97' ' ' LEU . 99.6 m -58.04 171.34 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 110.419 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.952 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -169.14 113.92 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.843 ' O ' HG23 ' A' ' 85' ' ' ILE . 13.2 pt-20 -140.6 151.4 44.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.97 . . . . 0.0 110.347 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.686 ' CB ' HG12 ' A' ' 85' ' ' ILE . 8.3 m -118.34 157.29 27.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.698 ' CA ' ' HA ' ' A' ' 117' ' ' THR . . . -176.48 160.67 28.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 116' ' ' GLN . 39.6 mt-10 -95.98 154.52 17.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -1.11 . . . . 0.0 110.184 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.746 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -114.56 135.67 53.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.832 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -128.14 98.16 5.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.928 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.581 HG23 ' CD1' ' A' ' 102' ' ' PHE . 53.1 t -118.42 104.85 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.212 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.735 ' HA ' HG13 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -78.5 154.56 30.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.328 -0.858 . . . . 0.0 110.328 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HD2' HD22 ' A' ' 74' ' ' LEU . 11.1 tttp -134.63 130.68 36.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.045 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.688 ' OE1' ' CB ' ' A' ' 260' ' ' LYS . 3.1 mm-40 -107.27 -135.05 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 110.257 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 65.9 m -85.44 -53.48 5.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.858 . . . . 0.0 110.186 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -122.6 -2.98 8.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.202 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.505 ' OG ' ' CD ' ' A' ' 239' ' ' GLU . 61.9 p -127.97 -165.73 1.53 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.223 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.6 151.83 2.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 110.2 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.006 HD23 HD12 ' A' ' 140' ' ' ILE . 4.5 mt -100.95 160.35 14.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 0.2 OUTLIER -129.35 161.13 31.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.909 . . . . 0.0 110.64 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.832 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -170.37 120.56 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 0.0 109.989 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 136' ' ' ARG . 9.6 mt -107.52 141.52 38.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 110.349 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.593 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 19.1 tt0 -140.17 147.21 39.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.698 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 7.2 m -122.04 169.5 10.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.152 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.57 -31.98 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.9 . . . . 0.0 110.345 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.73 155.1 44.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 110.354 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.692 ' O ' ' N ' ' A' ' 130' ' ' VAL . 7.6 mt-10 -143.22 154.13 43.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.905 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' CD ' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -160.61 151.95 19.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.154 -0.966 . . . . 0.0 110.294 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.751 ' O ' ' HA ' ' A' ' 128' ' ' LYS . 1.4 t0 -117.55 179.14 0.86 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.126 -0.984 . . . . 0.0 110.955 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' CD ' ' CG ' ' A' ' 122' ' ' ASP . 52.1 Cg_endo -95.08 12.04 1.5 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.823 1.682 . . . . 0.0 111.49 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -111.39 -105.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.784 -1.198 . . . . 0.0 110.911 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.717 ' ND1' ' N ' ' A' ' 126' ' ' SER . 4.7 p80 -156.62 -31.8 0.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.562 -0.711 . . . . 0.0 110.416 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.717 ' N ' ' ND1' ' A' ' 125' ' ' HIS . 22.3 t -81.62 -34.14 31.04 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.442 -0.786 . . . . 0.0 109.247 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.688 ' O ' ' N ' ' A' ' 122' ' ' ASP . 6.6 mt-10 -116.02 0.45 13.02 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.516 0.674 . . . . 0.0 109.311 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.751 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.04 -4.34 0.17 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.947 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.42 127.49 6.26 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.952 178.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.37 160.68 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.019 -1.051 . . . . 0.0 110.369 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.99 114.91 3.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 110.075 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.72 -162.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.923 . . . . 0.0 110.306 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -113.48 110.58 20.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.594 ' O ' ' OG1' ' A' ' 117' ' ' THR . 5.7 ttt180 -133.25 110.96 10.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.298 -0.876 . . . . 0.0 109.932 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 1.3 p90 -130.31 139.51 50.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 0.0 110.443 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.701 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -98.15 167.75 10.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.829 179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.77 102.02 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.094 -1.004 . . . . 0.0 110.464 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 113' ' ' THR . . . -100.93 95.33 1.39 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 140' ' ' ILE . 15.7 t70 -62.64 167.9 4.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.268 -1.136 . . . . 0.0 110.393 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.006 HD12 HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -54.68 -168.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 110.218 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ILE . . . -178.07 29.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.178 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -89.17 -72.83 1.27 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.635 ' CB ' ' HG3' ' A' ' 235' ' ' GLU . 3.2 mt-10 -151.07 106.29 3.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -1.146 . . . . 0.0 110.261 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 211' ' ' HIS . 6.7 m-70 -79.9 87.14 5.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 110.205 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -106.92 143.97 34.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 94.1 p -62.92 127.87 33.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.755 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -49.11 -63.04 1.22 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 110.369 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.613 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 2.4 t70 -22.81 -40.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.583 0.706 . . . . 0.0 110.824 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -56.69 -8.56 0.59 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.695 -0.628 . . . . 0.0 110.45 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.103 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.04 -49.71 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 111.142 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 1.103 ' CD ' HD23 ' A' ' 150' ' ' LEU . 47.5 Cg_endo -91.3 179.79 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.772 1.406 . . . . 0.0 110.866 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.935 ' O ' ' HB3' ' A' ' 180' ' ' ALA . 0.0 OUTLIER -153.11 -66.14 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.642 -0.661 . . . . 0.0 109.311 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.624 ' HA ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 t0 -150.76 28.9 0.69 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.527 -0.733 . . . . 0.0 109.946 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.747 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 2.1 t -107.93 169.99 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 110.682 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.688 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 26.6 ptm -90.15 148.96 22.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.301 -0.875 . . . . 0.0 110.618 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 176' ' ' ILE . . . -145.1 134.74 23.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.858 . . . . 0.0 110.202 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.715 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 1.3 m -108.18 156.29 19.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.716 ' CE2' ' HB3' ' A' ' 238' ' ' GLN . 13.6 m-85 -144.99 163.88 32.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.524 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . 11.1 ptp180 -149.61 143.9 25.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.4 -0.812 . . . . 0.0 108.997 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.695 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.22 -172.63 26.6 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 118.816 -1.659 . . . . 0.0 110.941 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.473 ' N ' ' O ' ' A' ' 258' ' ' ALA . 49.0 m -120.63 155.68 33.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB3' ' HA3' ' A' ' 170' ' ' GLY . . . -137.47 179.82 6.18 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.126 -0.984 . . . . 0.0 110.668 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.742 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -136.99 134.9 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.416 -0.802 . . . . 0.0 109.898 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.474 ' CA ' HG22 ' A' ' 255' ' ' ILE . . . -115.07 144.82 18.56 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.197 -1.478 . . . . 0.0 110.456 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 11.6 t -74.25 -9.67 58.84 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.355 -1.085 . . . . 0.0 109.781 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.46 0.87 6.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.527 -0.733 . . . . 0.0 109.67 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.78 171.08 10.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.19 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.11 -31.9 71.59 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.094 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.742 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.64 -107.88 0.24 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.727 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 176.94 153.94 11.39 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.713 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -153.51 119.15 5.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.996 . . . . 0.0 108.393 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.858 HD22 ' OH ' ' A' ' 228' ' ' TYR . 1.6 pp -149.72 155.16 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.459 -1.401 . . . . 0.0 112.272 -178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 46.1 m -117.72 126.96 53.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.049 ' CE2' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -109.85 137.54 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 53.7 m -111.78 97.33 6.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 203' ' ' TYR . 5.2 mt -111.76 109.17 27.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 110.704 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.795 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 3.0 m-20 -62.41 150.66 39.21 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.451 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.747 ' CE2' ' HB ' ' A' ' 154' ' ' VAL . 7.4 m-30 -36.22 166.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.143 0.973 . . . . 0.0 112.485 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 181' ' ' LYS . . . -36.71 -60.96 0.57 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.465 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -70.81 42.66 0.07 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.086 -1.009 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.795 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -145.75 -103.58 0.1 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.225 -0.922 . . . . 0.0 111.326 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.718 ' O ' HG23 ' A' ' 176' ' ' ILE . 3.5 pt20 -164.04 177.77 8.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.558 -1.339 . . . . 0.0 111.899 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.721 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -143.6 105.78 0.39 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.64 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 17.1 p-80 -157.88 159.68 36.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.959 -1.318 . . . . 0.0 110.269 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.686 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -173.39 -148.12 6.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 92.4 mttt -126.52 160.77 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 110.115 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.733 HG22 ' HG ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.8 141.0 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 0.0 110.388 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.713 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 15.9 pt-20 -146.36 97.55 2.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.248 -0.907 . . . . 0.0 110.114 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.708 ' HB2' HD23 ' A' ' 190' ' ' LEU . 7.6 m-70 -36.19 -50.1 0.71 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.139 -0.976 . . . . 0.0 109.444 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.133 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -95.2 -99.82 0.16 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 0.0 109.966 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.578 ' HA ' ' CD ' ' A' ' 188' ' ' GLU . 5.8 mtmt -168.3 -28.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.767 ' CB ' HD13 ' A' ' 195' ' ' LEU . 1.3 m -42.04 136.25 2.21 Favored Pre-proline 0 C--N 1.295 -1.796 0 O-C-N 121.457 -0.777 . . . . 0.0 110.084 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.516 ' HG2' ' OE2' ' A' ' 194' ' ' GLU . 45.1 Cg_endo -72.38 44.75 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.036 1.545 . . . . 0.0 110.285 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.516 ' OE2' ' HG2' ' A' ' 193' ' ' PRO . 8.7 mp0 -154.4 -30.93 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.282 -0.886 . . . . 0.0 110.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.133 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.7 mp -86.48 2.05 49.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 110.225 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.745 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 0.2 OUTLIER -85.31 -179.89 7.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.359 -0.838 . . . . 0.0 109.567 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.959 HG11 HG12 ' A' ' 218' ' ' VAL . 44.4 t -141.22 149.76 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.989 -1.069 . . . . 0.0 110.896 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.0 OUTLIER -70.54 89.92 0.72 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.503 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.221 ' CD2' HG22 ' A' ' 218' ' ' VAL . 1.5 mt -70.81 133.64 46.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.461 -0.774 . . . . 0.0 111.349 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -134.91 123.02 22.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.529 -0.732 . . . . 0.0 109.122 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.02 HG11 HG23 ' A' ' 214' ' ' ILE . 9.4 t -146.34 164.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.978 -1.076 . . . . 0.0 111.441 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.91 145.8 36.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 109.233 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.072 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.8 t80 -98.59 138.65 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 110.86 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.7 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 0.2 OUTLIER -123.91 164.58 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.468 -0.77 . . . . 0.0 109.516 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 8.0 mtpt -81.72 -73.77 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.0 110.592 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.2 Cg_endo -73.41 98.88 1.07 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.793 1.418 . . . . 0.0 110.867 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.743 ' OD1' HG13 ' A' ' 213' ' ' VAL . 55.0 t0 -67.86 -120.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.02 -1.05 . . . . 0.0 109.921 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.612 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -67.7 -26.14 66.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 109.891 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 0.1 OUTLIER -145.93 -59.53 0.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.398 -0.814 . . . . 0.0 109.816 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.806 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 25.9 p-80 -154.62 32.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.806 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 1.2 m170 -118.51 176.21 5.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -0.861 . . . . 0.0 110.181 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.884 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -69.05 155.79 39.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.844 . . . . 0.0 110.105 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.743 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -131.44 154.1 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 0.0 110.498 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.02 HG23 HG11 ' A' ' 201' ' ' VAL . 6.4 mt -147.46 108.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.782 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.724 ' N ' HG13 ' A' ' 201' ' ' VAL . 3.5 t -135.82 136.69 40.85 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.093 -1.004 . . . . 0.0 110.697 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.865 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -172.33 -140.89 3.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.7 p -136.06 175.02 9.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.0 110.577 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.221 HG22 ' CD2' ' A' ' 199' ' ' LEU . 95.7 t -131.43 120.04 44.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 121.525 -0.734 . . . . 0.0 109.696 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.785 ' C ' HG13 ' A' ' 197' ' ' VAL . 0.1 OUTLIER -146.77 132.49 18.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 0.0 110.942 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.829 ' N ' HG13 ' A' ' 197' ' ' VAL . 0.6 OUTLIER -117.18 155.88 28.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.252 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.575 ' O ' ' HG2' ' A' ' 222' ' ' GLN . 1.7 m120 -70.67 -5.58 30.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.895 . . . . 0.0 110.079 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 221' ' ' ASN . 1.7 mm-40 -154.79 38.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.098 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.731 ' CB ' ' HB3' ' A' ' 220' ' ' TYR . 38.3 t70 -128.93 -109.6 0.28 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 110.507 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CG ' ' OD2' ' A' ' 223' ' ' ASP . 0.4 OUTLIER -142.43 -154.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.349 -0.845 . . . . 0.0 110.636 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.85 76.68 1.66 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -97.75 174.66 29.41 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.87 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.646 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 32.4 m -124.0 176.45 6.34 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.692 -0.887 . . . . 0.0 109.764 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.029 ' OH ' HD22 ' A' ' 257' ' ' LEU . 0.8 OUTLIER -149.82 126.53 11.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.935 -1.103 . . . . 0.0 111.1 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 1.009 ' C ' HD12 ' A' ' 230' ' ' LEU . 41.4 m -147.84 125.07 11.49 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.51 -0.744 . . . . 0.0 109.315 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.107 HD21 ' CD1' ' A' ' 257' ' ' LEU . 5.5 mp -154.87 173.3 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.962 -1.086 . . . . 0.0 110.889 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.51 ' CA ' ' OD2' ' A' ' 207' ' ' ASP . . . -117.0 124.16 6.05 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.884 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.2 OUTLIER -105.94 147.95 10.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.118 -1.225 . . . . 0.0 110.742 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.702 ' CE1' HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.72 -174.41 4.06 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.643 -0.661 . . . . 0.0 109.359 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.678 ' HA2' ' CG ' ' A' ' 239' ' ' GLU . . . 179.82 81.4 0.06 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.635 ' HG3' ' CB ' ' A' ' 143' ' ' GLU . 12.6 tt0 -35.01 -28.8 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.158 -1.201 . . . . 0.0 109.048 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.678 ' N ' ' O ' ' A' ' 234' ' ' GLY . 13.9 tttm 178.52 35.14 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.593 ' C ' ' OE1' ' A' ' 238' ' ' GLN . . . -156.67 -142.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.534 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.716 ' HB3' ' CE2' ' A' ' 158' ' ' TYR . 2.0 mp0 -130.95 66.89 1.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.582 -0.699 . . . . 0.0 111.133 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.694 ' OE1' ' CD1' ' A' ' 233' ' ' PHE . 1.0 OUTLIER -104.93 134.01 48.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.688 -1.258 . . . . 0.0 110.287 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 0.9 OUTLIER -150.61 144.29 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 110.71 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.864 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -145.48 144.2 30.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.387 -0.821 . . . . 0.0 110.081 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.841 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -170.58 -158.55 14.67 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.542 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 72.2 m -144.61 149.56 35.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -1.131 . . . . 0.0 109.717 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.076 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -120.82 171.17 8.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.641 ' O ' ' N ' ' A' ' 227' ' ' SER . 21.1 mt-10 -125.08 134.69 52.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.35 -0.844 . . . . 0.0 109.445 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.564 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 0.9 OUTLIER -119.52 120.71 64.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.147 -0.97 . . . . 0.0 110.968 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -103.16 134.45 46.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.19 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.744 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 19.7 m -102.13 -124.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 0.0 110.184 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 248' ' ' THR . . . -127.47 0.99 6.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.996 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 85.2 m-20 -152.89 13.14 0.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.196 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 1.091 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -177.92 -158.39 20.71 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 1.091 HD12 ' C ' ' A' ' 251' ' ' GLY . 3.0 mp -156.19 143.9 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 121.19 -1.183 . . . . 0.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.744 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -114.88 161.36 18.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.493 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -128.27 126.57 41.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 109.376 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.076 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.7 OUTLIER -122.11 129.93 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.983 . . . . 0.0 111.095 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.739 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.93 152.47 25.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.069 -2.012 . . . . 0.0 108.069 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.107 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.2 mt -135.1 150.95 50.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.756 -1.437 . . . . 0.0 111.814 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -153.05 123.43 7.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.695 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -141.75 164.32 30.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.554 -1.341 . . . . 0.0 112.065 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 10.3 pttp -134.16 165.96 23.87 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.218 0.532 . . . . 0.0 109.758 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.234 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.242 0.544 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.48 137.18 4.64 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.2 m -148.75 103.25 3.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -1.143 . . . . 0.0 110.227 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.2 p -156.02 -59.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.225 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -90.36 -178.64 44.15 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.76 143.19 19.74 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.77 138.64 21.14 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.43 -168.84 20.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 p -103.59 116.74 32.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.82 111.27 3.85 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.37 52.41 0.53 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.75 93.11 0.09 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.84 -169.18 20.82 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 15' ' ' THR . 5.5 t -58.81 -176.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.374 -1.074 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.709 ' H ' HG12 ' A' ' 14' ' ' VAL . 8.0 t -59.06 162.87 3.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.0 110.193 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.28 -1.1 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.232 -0.917 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' H ' HG23 ' A' ' 15' ' ' THR . 5.1 p-10 -162.34 72.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.213 -0.93 . . . . 0.0 110.253 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.702 HG12 ' CG1' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -59.88 -40.87 84.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.289 -0.882 . . . . 0.0 110.149 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -50.08 -73.28 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.102 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.09 -1.38 1.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.255 -1.144 . . . . 0.0 110.417 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -54.65 -27.81 43.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -64.99 -38.34 90.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -1.172 . . . . 0.0 110.303 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.658 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . . . -55.15 -11.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.35 -8.77 37.91 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 70' ' ' ASN . . . -68.65 -43.2 76.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 110.165 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -93.75 -39.5 10.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.154 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.137 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 3.9 m -64.03 -6.19 5.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.31 -0.869 . . . . 0.0 110.195 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -131.49 100.35 16.6 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.573 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.5 Cg_endo -73.01 -175.52 1.97 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.047 1.551 . . . . 0.0 110.401 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' C ' ' O ' ' A' ' 29' ' ' PRO . 4.4 tp -31.97 142.31 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -174.89 134.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.402 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 2.0 t-80 -69.9 -2.24 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 110.103 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 1.6 ptpt -67.03 -1.97 4.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -103.17 -174.8 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 0.0 110.227 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -126.81 -58.62 1.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.09 -113.17 0.08 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 37' ' ' LEU . 4.6 mm? -96.18 122.65 39.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 39' ' ' SER . 34.5 mttp -64.25 -40.51 96.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.333 -0.854 . . . . 0.0 110.217 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' CB ' ' A' ' 70' ' ' ASN . 15.0 p 175.68 172.11 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.129 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -145.84 115.62 7.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.902 . . . . 0.0 110.192 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.945 HG23 ' HB2' ' A' ' 68' ' ' SER . 27.9 m -77.48 152.25 34.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 42' ' ' LEU . 5.3 mp -93.65 133.21 37.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.161 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 45' ' ' SER . 7.9 pt-20 -49.51 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -61.64 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 43' ' ' GLU . 14.0 p -61.58 -49.68 75.67 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 110.1 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG22 ' H ' ' A' ' 47' ' ' SER . 2.4 mt -107.5 -156.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.323 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 46' ' ' ILE . 1.4 m -173.6 -175.45 1.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.621 -0.675 . . . . 0.0 109.591 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.46 -8.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.08 -1.013 . . . . 0.0 109.924 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.736 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.79 9.09 38.59 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.452 -0.78 . . . . 0.0 110.345 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.635 ' HA2' HG12 ' A' ' 88' ' ' ILE . . . -154.38 80.9 0.18 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -107.04 137.65 44.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -1.109 . . . . 0.0 110.144 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 2.0 pp -159.28 161.8 35.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.908 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.483 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -112.41 154.49 25.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.199 -0.938 . . . . 0.0 110.392 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.771 HD13 ' CD2' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -106.05 141.03 38.11 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.175 179.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 t -135.64 120.99 19.13 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.09 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -112.92 -177.47 3.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.21 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 1.102 ' O ' HG22 ' A' ' 20' ' ' THR . 31.2 mt-30 -74.41 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.224 -0.922 . . . . 0.0 110.248 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -171.47 -48.44 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 1.137 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.61 177.42 11.23 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.165 -1.197 . . . . 0.0 110.263 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 6.1 pt-20 -130.7 170.26 14.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 110.208 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -148.92 132.03 16.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.214 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 62' ' ' THR . 3.1 t -62.4 119.06 8.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.937 . . . . 0.0 110.242 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.743 ' CE2' ' O ' ' A' ' 68' ' ' SER . 3.1 m-85 -118.06 112.75 20.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.134 -0.979 . . . . 0.0 110.222 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.89 -154.7 7.4 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.65 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -48.93 125.7 10.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -1.191 . . . . 0.0 110.059 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -1.37 83.62 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.612 ' O ' ' O ' ' A' ' 66' ' ' GLY . 7.4 p-10 -28.25 150.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.414 -1.051 . . . . 0.0 110.316 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.945 ' HB2' HG23 ' A' ' 41' ' ' THR . 48.0 t -129.12 165.03 22.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.289 -0.882 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 mt -133.33 117.71 17.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.696 ' CB ' ' HB3' ' A' ' 39' ' ' SER . 1.6 m-20 -104.49 119.6 39.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.677 HG21 ' CE ' ' A' ' 106' ' ' LYS . 2.3 p -111.35 27.55 9.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.308 -0.87 . . . . 0.0 110.261 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.3 -10.6 4.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 24' ' ' ASP . 6.7 mmtm -85.31 -32.7 22.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 110.248 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.7 pt? -131.01 152.15 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.192 -0.943 . . . . 0.0 110.215 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 6.0 tmtt? -149.23 5.31 0.64 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.241 -0.912 . . . . 0.0 110.677 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 35.6 m-80 -117.93 -104.06 0.41 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.38 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.675 ' OD1' ' NE2' ' A' ' 261' ' ' GLN . 5.3 m-20 -119.76 60.42 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.953 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.991 ' HB2' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -101.23 170.9 7.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 110.344 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.137 HG22 ' CE2' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -109.39 163.42 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.625 ' CB ' ' O ' ' A' ' 104' ' ' VAL . 6.8 m -136.22 89.25 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.77 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.93 125.15 52.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 110.37 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.861 ' CZ ' ' CG ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -149.15 148.8 30.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.939 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.74 143.43 26.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 110.299 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.785 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.2 p90 -160.8 143.99 13.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.877 . . . . 0.0 109.961 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 1.009 HG23 ' O ' ' A' ' 98' ' ' GLU . 5.8 mt -114.14 127.75 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 110.445 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.721 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -84.58 105.12 15.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.8 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.917 ' NE2' HD23 ' A' ' 97' ' ' LEU . 60.4 mt-30 -123.29 133.94 54.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 110.621 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.736 ' CG2' ' HA ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER -130.53 112.49 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.386 -0.821 . . . . 0.0 109.742 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 7.2 tt0 -140.58 117.54 11.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.134 -0.979 . . . . 0.0 110.381 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.737 HG11 ' CD ' ' A' ' 93' ' ' GLN . 72.9 t -99.9 170.76 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.363 -0.836 . . . . 0.0 110.106 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -67.01 2.53 1.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.104 -0.998 . . . . 0.0 110.567 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.65 43.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.113 ' O ' HD12 ' A' ' 95' ' ' ILE . 23.0 mt-30 -155.05 -138.9 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.21 -1.171 . . . . 0.0 110.681 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 11.4 mt -45.56 162.87 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 121.274 0.559 . . . . 0.0 110.546 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.113 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.26 17.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 110.199 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.757 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.1 m -58.22 168.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.134 -0.979 . . . . 0.0 110.329 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -170.88 96.82 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.875 . . . . 0.0 110.075 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.009 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt0 -127.17 155.66 43.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.387 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.696 ' CB ' HG12 ' A' ' 85' ' ' ILE . 95.0 p -104.43 163.59 12.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.658 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -171.06 156.97 27.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 116' ' ' GLN . 2.1 mt-10 -95.6 159.7 14.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -1.119 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.861 ' CG ' ' CZ ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -127.29 133.73 50.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.271 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.494 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -133.5 108.12 8.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.848 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.765 HG22 HG23 ' A' ' 113' ' ' THR . 94.2 t -130.15 115.74 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.137 ' CE2' HG22 ' A' ' 79' ' ' VAL . 3.9 t80 -93.86 158.15 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' CE ' HG21 ' A' ' 71' ' ' THR . 26.9 mttt -134.82 123.18 23.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.112 -0.993 . . . . 0.0 110.107 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 238' ' ' GLN . 11.3 pt20 -105.74 -140.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.325 -0.859 . . . . 0.0 110.218 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' HE22 ' A' ' 238' ' ' GLN . 67.5 m -74.49 -78.91 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.232 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 28.0 m80 -102.09 -27.64 12.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.915 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.687 ' HB2' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -98.55 -166.02 1.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.353 -0.842 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.633 ' O ' HD23 ' A' ' 112' ' ' LEU . . . -172.51 -173.7 1.07 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 105' ' ' TYR . 5.2 mt -142.34 142.31 32.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.887 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.765 HG23 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -127.94 162.07 27.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -168.0 120.5 0.87 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -106.45 141.14 38.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.987 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.694 ' N ' HD12 ' A' ' 115' ' ' LEU . 5.3 tt0 -131.89 152.63 50.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 110.367 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.569 ' HA ' ' CA ' ' A' ' 100' ' ' GLY . 21.3 m -118.84 170.1 9.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.56 ' N ' HG22 ' A' ' 117' ' ' THR . 6.2 mt-10 -141.06 -76.73 0.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.108 -0.995 . . . . 0.0 110.669 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 98' ' ' GLU . 65.1 mt-30 -111.63 155.24 23.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.97 . . . . 0.0 110.534 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.676 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -110.69 -179.16 3.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.477 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.673 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.31 153.42 35.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.407 -0.808 . . . . 0.0 109.874 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.7 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.36 170.51 6.29 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.993 -1.067 . . . . 0.0 111.249 -179.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.667 ' O ' ' C ' ' A' ' 124' ' ' GLU . 54.3 Cg_endo -96.19 -72.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.826 2.351 . . . . 0.0 110.276 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.667 ' C ' ' O ' ' A' ' 123' ' ' PRO . 2.5 mt-10 -13.93 -60.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.818 1.294 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.842 ' O ' ' N ' ' A' ' 127' ' ' GLU . 7.0 m80 -128.72 79.6 1.92 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.6 t -20.74 -33.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.117 0.484 . . . . 0.0 110.871 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.842 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -72.34 2.28 6.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.408 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.728 ' HE2' ' CG ' ' A' ' 125' ' ' HIS . 1.0 OUTLIER -84.25 146.2 27.91 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.583 -1.323 . . . . 0.0 109.494 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -127.92 137.05 52.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 110.594 -179.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.676 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.14 176.94 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.753 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -124.91 114.81 19.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.308 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.646 ' NZ ' ' OE2' ' A' ' 120' ' ' GLU . 2.4 mttp -152.18 129.47 11.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -92.11 106.42 18.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.216 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' H ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -118.77 113.09 20.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.061 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.74 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 13.7 p90 -124.27 109.02 12.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 110.404 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.69 ' CB ' ' HG ' ' A' ' 115' ' ' LEU . 6.0 ttp85 -98.56 167.92 10.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -0.869 . . . . 0.0 109.933 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.4 tp -132.81 125.55 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.571 ' O ' ' OG1' ' A' ' 113' ' ' THR . . . -115.44 46.52 1.15 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -61.61 122.65 15.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.209 -1.171 . . . . 0.0 110.438 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.92 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -121.41 78.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.243 -0.911 . . . . 0.0 109.641 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.956 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -127.19 139.36 52.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.78 ' C ' ' HE2' ' A' ' 211' ' ' HIS . . . -171.48 25.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' O ' ' NE2' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -66.42 -161.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.13 . . . . 0.0 110.191 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.67 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 6.0 m170 -91.59 42.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 110.049 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.671 ' HB ' ' HA ' ' A' ' 233' ' ' PHE . 27.4 p -74.62 26.71 0.08 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.352 -0.843 . . . . 0.0 111.081 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -58.82 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.934 -1.104 . . . . 0.0 109.846 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.77 ' CD1' ' HG3' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -27.79 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.222 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.8 t0 -74.25 15.48 0.32 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.134 -0.979 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -115.16 1.62 13.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.412 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 151' ' ' PRO . 0.8 OUTLIER -168.84 -59.48 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.969 . . . . 0.0 110.177 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 43.2 Cg_endo -69.02 80.39 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.761 1.401 . . . . 0.0 110.269 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.805 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 6.8 mttp -76.29 -86.1 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.328 -0.858 . . . . 0.0 110.533 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.693 ' OD1' ' CE ' ' A' ' 181' ' ' LYS . 9.6 t70 -136.58 44.79 2.35 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.294 -0.879 . . . . 0.0 110.027 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.691 ' HB ' ' CE2' ' A' ' 178' ' ' PHE . 19.7 t -118.0 169.62 8.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.323 -0.861 . . . . 0.0 110.451 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.637 ' CG ' ' OD1' ' A' ' 177' ' ' ASP . 0.6 OUTLIER -93.71 128.59 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.403 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.846 ' HB3' ' OE2' ' A' ' 235' ' ' GLU . . . -123.84 129.52 51.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.184 -0.948 . . . . 0.0 110.278 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.39 156.06 25.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.133 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.968 ' CE1' HG12 ' A' ' 240' ' ' VAL . 0.1 OUTLIER -145.53 148.14 32.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.963 . . . . 0.0 110.257 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 4.2 ptp180 -146.37 138.7 25.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.247 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.73 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -159.95 -175.22 30.68 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.757 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 258' ' ' ALA . 0.9 OUTLIER -114.9 155.78 26.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.909 -0.759 . . . . 0.0 109.108 179.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -137.11 179.86 6.14 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.263 -0.898 . . . . 0.0 110.644 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.722 ' CE2' ' HA3' ' A' ' 256' ' ' GLY . 1.6 p90 -156.32 130.27 8.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.745 -0.597 . . . . 0.0 109.409 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 167' ' ' ASP . . . -83.33 151.45 28.3 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.01 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.552 ' HB2' ' CD2' ' A' ' 254' ' ' HIS . 9.4 t -39.03 -93.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.302 -1.117 . . . . 0.0 110.463 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.79 -7.66 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.589 -0.695 . . . . 0.0 110.27 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 164' ' ' GLY . 2.1 m-20 -102.85 171.76 7.22 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.511 -0.743 . . . . 0.0 109.644 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 101' ' ' GLU . . . -131.24 12.8 5.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 108.684 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.716 ' C ' ' CD2' ' A' ' 189' ' ' HIS . . . -128.13 146.75 16.96 Favored Glycine 0 N--CA 1.481 1.669 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.699 ' CA ' ' CG ' ' A' ' 189' ' ' HIS . . . -169.74 150.71 15.5 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -152.52 136.11 16.07 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.008 -1.29 . . . . 0.0 109.023 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.77 HD22 HD22 ' A' ' 257' ' ' LEU . 1.2 pp -151.78 127.52 10.2 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.303 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' A' ' 186' ' ' LYS . 16.5 m -97.22 124.81 41.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.738 ' CD2' ' OH ' ' A' ' 203' ' ' TYR . 0.2 OUTLIER -103.45 150.8 23.52 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.845 -1.159 . . . . 0.0 111.81 -178.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -146.49 106.91 4.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.993 HG21 ' CE1' ' A' ' 203' ' ' TYR . 19.9 pt -137.4 155.79 32.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 111.644 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.758 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 0.9 OUTLIER -98.48 139.25 34.5 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.805 ' CD2' ' N ' ' A' ' 152' ' ' LYS . 14.3 m-30 -36.41 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.381 1.086 . . . . 0.0 113.094 -176.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.982 ' HB1' ' HD2' ' A' ' 205' ' ' LYS . . . -40.6 -54.63 2.51 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.413 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.622 ' O ' ' CD ' ' A' ' 181' ' ' LYS . . . -68.9 40.99 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.077 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.758 ' HB3' ' CB ' ' A' ' 177' ' ' ASP . 6.3 mmmt -156.92 -109.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.037 -1.04 . . . . 0.0 111.411 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' ASP . 3.4 tt0 -165.89 178.95 6.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.077 -1.014 . . . . 0.0 110.918 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.695 ' HA2' ' CB ' ' A' ' 176' ' ' ILE . . . -136.54 155.93 22.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.984 ' H ' HG22 ' A' ' 176' ' ' ILE . 6.0 t60 -179.39 126.54 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.335 . . . . 0.0 109.756 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -136.89 -161.88 9.17 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.581 ' CA ' ' HB2' ' A' ' 199' ' ' LEU . 2.9 ptmt -137.66 132.47 32.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 110.086 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.164 HG21 ' CG1' ' A' ' 218' ' ' VAL . 1.6 tp -100.12 123.68 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.754 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 2.6 pt-20 -162.1 146.73 12.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.161 -0.962 . . . . 0.0 111.012 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.859 ' HB3' HD23 ' A' ' 190' ' ' LEU . 63.0 t60 -162.57 -66.09 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.35 -0.844 . . . . 0.0 110.495 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.94 HD12 ' HB2' ' A' ' 192' ' ' SER . 0.1 OUTLIER -95.97 -161.11 0.84 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.54 0.686 . . . . 0.0 111.108 -179.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.96 ' HA ' HD23 ' A' ' 195' ' ' LEU . 24.0 mmtt -122.6 8.09 9.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.569 -0.707 . . . . 0.0 110.011 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.94 ' HB2' HD12 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -47.21 -167.93 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.452 -0.78 . . . . 0.0 110.191 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.736 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 40.0 Cg_endo -67.03 -1.07 5.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.321 1.169 . . . . 0.0 109.711 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.741 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.7 OUTLIER -137.1 41.31 2.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.96 HD23 ' HA ' ' A' ' 191' ' ' LYS . 1.2 mp -34.97 -69.65 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.815 0.817 . . . . 0.0 110.316 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.754 ' ND2' ' CB ' ' A' ' 188' ' ' GLU . 7.5 m120 -130.93 167.74 18.49 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 121.813 -0.554 . . . . 0.0 110.147 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.176 ' CG1' HG12 ' A' ' 218' ' ' VAL . 2.6 t -152.87 163.64 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.113 -0.992 . . . . 0.0 110.466 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.61 ' OD2' ' O ' ' A' ' 219' ' ' LEU . 2.9 m-20 -85.56 101.09 12.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 110.144 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.015 HD11 ' CZ ' ' A' ' 228' ' ' TYR . 2.1 mt -77.44 133.97 38.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.349 -0.844 . . . . 0.0 111.408 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.618 ' O ' ' HA3' ' A' ' 216' ' ' GLY . . . -137.27 123.08 20.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.485 -0.76 . . . . 0.0 109.021 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.054 HG13 ' C ' ' A' ' 215' ' ' SER . 5.4 t -149.37 157.42 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.9 -1.125 . . . . 0.0 111.715 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.85 127.44 55.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.372 -0.83 . . . . 0.0 109.374 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.993 ' CE1' HG21 ' A' ' 176' ' ' ILE . 14.1 m-85 -92.41 136.76 32.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.967 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -115.75 167.68 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.809 . . . . 0.0 109.932 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.982 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 1.4 mttp -82.02 -67.39 0.21 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 0.0 110.363 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.7 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.8 Cg_endo -72.54 98.51 0.96 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.976 1.514 . . . . 0.0 110.552 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.878 ' CG ' HG13 ' A' ' 213' ' ' VAL . 27.0 t0 -84.04 -117.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 110.104 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 10.4 pt-20 -88.03 -8.27 55.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HB3' ' ND1' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -164.64 -59.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.89 . . . . 0.0 110.237 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.871 ' CD2' ' CE1' ' A' ' 211' ' ' HIS . 3.6 p-80 -159.97 28.88 0.18 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.132 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.871 ' CE1' ' CD2' ' A' ' 210' ' ' HIS . 31.0 m80 -120.08 -178.23 3.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.315 -0.866 . . . . 0.0 109.904 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.098 ' HB3' HG23 ' A' ' 232' ' ' ILE . . . -87.59 151.0 23.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 0.0 109.975 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.878 HG13 ' CG ' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -115.98 152.0 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -0.97 . . . . 0.0 110.274 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.959 HD11 HG23 ' A' ' 240' ' ' VAL . 4.9 mt -129.67 104.94 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 1.054 ' C ' HG13 ' A' ' 201' ' ' VAL . 32.6 m -122.89 123.67 41.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.842 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -169.73 -165.94 27.91 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 1.4 m -136.68 152.47 50.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -1.21 . . . . 0.0 110.668 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.176 HG12 ' CG1' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -91.74 124.1 44.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.443 -0.786 . . . . 0.0 109.45 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.61 ' O ' ' OD2' ' A' ' 198' ' ' ASP . 0.2 OUTLIER -133.72 134.27 42.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.044 -1.035 . . . . 0.0 110.708 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.69 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 2.7 t80 -97.75 155.4 17.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.651 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.71 4.06 5.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.534 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -97.99 -60.64 1.52 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.16 -0.963 . . . . 0.0 109.9 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 225' ' ' LYS . 0.4 OUTLIER 178.17 26.77 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.428 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.733 ' OE2' HG21 ' A' ' 197' ' ' VAL . 3.3 tt0 -80.7 156.79 26.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.023 -1.048 . . . . 0.0 110.742 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -145.35 78.2 1.54 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.385 -0.822 . . . . 0.0 109.308 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -106.61 170.9 16.66 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.574 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.643 ' N ' ' O ' ' A' ' 245' ' ' GLU . 5.9 p -117.07 168.26 10.43 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.55 -0.971 . . . . 0.0 109.78 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.015 ' CZ ' HD11 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -148.84 129.93 14.47 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 120.874 -1.142 . . . . 0.0 110.863 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.62 ' O ' ' HG ' ' A' ' 230' ' ' LEU . 18.5 m -147.73 112.3 5.32 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.981 HD21 ' CD1' ' A' ' 257' ' ' LEU . 2.2 mp -144.98 173.01 12.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.061 -1.025 . . . . 0.0 111.084 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.85 124.95 6.35 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.098 HG23 ' HB3' ' A' ' 212' ' ' ALA . 1.1 tt -97.61 144.79 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.117 -1.225 . . . . 0.0 111.398 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.956 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 12.2 m-85 -123.23 161.37 24.68 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.713 ' CA ' ' HB3' ' A' ' 238' ' ' GLN . . . 3.37 88.66 0.0 OUTLIER Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.846 ' OE2' ' HB3' ' A' ' 156' ' ' ALA . 28.9 tt0 -47.02 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.498 -1.001 . . . . 0.0 110.759 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 261' ' ' GLN . 2.6 tptt -94.8 16.51 15.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.234 -0.916 . . . . 0.0 109.895 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -132.83 -23.66 2.0 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.34 -0.85 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.715 ' NE2' ' NE2' ' A' ' 107' ' ' GLN . 4.1 tp-100 -127.48 -103.31 0.33 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.624 ' CB ' ' HA ' ' A' ' 260' ' ' LYS . 2.4 pp20? -168.23 -170.1 1.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.083 -1.011 . . . . 0.0 110.635 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.968 HG12 ' CE1' ' A' ' 158' ' ' TYR . 7.7 p -157.73 118.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 109.522 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.705 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -146.28 158.78 43.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.153 -0.967 . . . . 0.0 110.642 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.93 ' CA ' HD23 ' A' ' 230' ' ' LEU . . . -177.48 -134.24 1.99 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' A' ' 230' ' ' LEU . 27.8 m -155.09 172.98 17.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -1.1 . . . . 0.0 109.508 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.157 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -156.52 170.95 21.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.955 . . . . 0.0 110.379 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.643 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.5 mt-10 -131.87 119.78 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.376 -0.827 . . . . 0.0 109.579 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.555 ' HA ' ' CA ' ' A' ' 226' ' ' GLY . 1.9 t -96.94 146.0 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.246 -0.909 . . . . 0.0 110.628 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -131.29 128.06 39.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 110.168 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.5 m -108.41 -169.43 1.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.441 -0.787 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -61.89 -9.56 7.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 110.027 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 35.3 t30 179.37 57.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 110.416 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.677 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 103.64 0.18 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.447 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 71.1 mt -84.36 124.59 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.166 -1.196 . . . . 0.0 110.155 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.741 ' CE1' ' OE2' ' A' ' 194' ' ' GLU . 1.5 m170 -112.5 161.58 16.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.139 -0.975 . . . . 0.0 110.579 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.687 ' N ' ' CD2' ' A' ' 254' ' ' HIS . 0.0 OUTLIER -131.69 121.6 24.54 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.344 -0.847 . . . . 0.0 109.376 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.157 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.8 OUTLIER -119.99 125.14 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.123 -0.986 . . . . 0.0 111.2 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.722 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.85 144.35 20.27 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.981 ' CD1' HD21 ' A' ' 230' ' ' LEU . 1.4 mt -129.5 156.3 44.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.806 -1.408 . . . . 0.0 111.573 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.705 ' HA ' ' CB ' ' A' ' 241' ' ' ALA . . . -152.78 117.5 5.05 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.73 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -138.94 166.67 23.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.6 -1.312 . . . . 0.0 111.936 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 5.0 ptmt -129.73 165.37 22.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.19 0.519 . . . . 0.0 109.666 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.675 ' NE2' ' OD1' ' A' ' 77' ' ' ASP . 8.9 pt20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.2 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.261 0.553 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.89 142.72 17.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 m -102.83 -173.35 2.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -1.127 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.9 p -155.23 138.88 16.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 110.225 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.56 81.83 1.67 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.34 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.89 -110.97 0.32 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.69 -167.41 17.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 p -104.51 -173.15 2.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -1.166 . . . . 0.0 110.257 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.06 -165.7 15.4 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.86 101.74 1.96 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.48 -113.54 1.85 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.86 27.08 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 15' ' ' THR . 3.9 t -58.91 -176.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -1.119 . . . . 0.0 110.19 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.758 HG21 HG12 ' A' ' 18' ' ' ILE . 6.9 m -101.39 150.79 22.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.01 1.93 19.32 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.247 -0.908 . . . . 0.0 110.665 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.39 46.59 0.16 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.951 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.85 -79.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.16 -0.963 . . . . 0.0 109.965 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.951 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -102.53 -45.8 1.62 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.8 -0.65 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -1.129 . . . . 0.0 110.421 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -46.33 -33.71 5.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -48.16 -42.87 30.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -1.124 . . . . 0.0 110.242 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.27 -11.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 110.048 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.759 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -94.73 -8.71 36.89 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.456 -0.777 . . . . 0.0 110.205 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.07 -32.51 44.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.421 -0.8 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.059 HD22 HD11 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -90.17 -15.94 30.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 0.0 110.231 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -114.19 -82.97 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.103 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -27.23 87.32 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.804 -0.56 . . . . 0.0 110.385 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.59 179.04 5.97 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.074 1.565 . . . . 0.0 110.387 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' O ' ' O ' ' A' ' 29' ' ' PRO . 4.9 mp -30.97 154.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.249 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -163.76 131.21 3.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.87 . . . . 0.0 110.219 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.631 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 12.7 t60 -63.13 56.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER 179.71 27.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.6 167.92 20.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 ttpp -88.19 -67.96 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 110.151 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 37' ' ' LEU . . . -119.48 -143.96 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.2 mm? -34.46 127.19 0.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -1.128 . . . . 0.0 110.223 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 39' ' ' SER . 33.7 mttm -64.41 -42.56 96.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.877 ' O ' HD23 ' A' ' 40' ' ' LEU . 12.4 t 176.84 177.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.877 HD23 ' O ' ' A' ' 39' ' ' SER . 17.9 mt -147.1 97.84 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.126 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.834 HG23 ' HB2' ' A' ' 68' ' ' SER . 3.7 m -78.24 155.49 30.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.236 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.3 mp -99.4 126.19 45.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 45' ' ' SER . 8.5 pt-20 -51.76 -157.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 110.25 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -61.63 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 110.166 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 43' ' ' GLU . 26.4 t -65.96 -50.72 63.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.877 . . . . 0.0 110.223 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.651 HG22 ' H ' ' A' ' 47' ' ' SER . 1.2 mt -105.68 -157.31 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER 179.98 -168.48 0.11 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.622 -0.674 . . . . 0.0 109.754 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -55.5 -10.5 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.992 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.65 3.42 53.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.485 -0.76 . . . . 0.0 110.41 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -144.56 74.88 0.31 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.6 p -111.2 134.01 53.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -1.149 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.93 161.97 25.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -117.47 140.41 49.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.899 179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.059 HD11 HD22 ' A' ' 26' ' ' LEU . 1.5 pp -122.66 129.19 51.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.989 . . . . 0.0 110.285 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.632 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 31.2 t -117.61 131.68 56.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.094 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . . . -102.06 -175.07 2.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.895 ' O ' HG22 ' A' ' 20' ' ' THR . 48.2 mt-30 -74.55 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 110.236 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.55 -44.44 0.06 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 27' ' ' THR . . . -154.54 166.99 31.58 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.33 -1.1 . . . . 0.0 110.276 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.632 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 16.6 pt-20 -128.42 162.41 27.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.281 -0.887 . . . . 0.0 110.219 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.701 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -144.85 119.86 10.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.68 112.17 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.204 -0.935 . . . . 0.0 110.185 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.823 ' CG ' HD23 ' A' ' 54' ' ' LEU . 1.4 m-30 -95.96 112.89 24.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.245 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.0 -157.06 7.19 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.98 126.88 13.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -1.11 . . . . 0.0 110.076 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.75 -3.69 84.93 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.58 ' C ' ' O ' ' A' ' 66' ' ' GLY . 12.5 p-10 -28.24 139.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.32 -1.106 . . . . 0.0 110.193 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.834 ' HB2' HG23 ' A' ' 41' ' ' THR . 2.2 t -134.49 164.68 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.214 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -142.11 133.45 26.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.358 -0.839 . . . . 0.0 110.071 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 39' ' ' SER . 1.2 m-20 -112.24 140.4 46.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.924 HG22 HD21 ' A' ' 74' ' ' LEU . 4.2 p -122.38 18.01 10.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -51.35 -14.72 1.51 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' N ' ' C ' ' A' ' 71' ' ' THR . 61.0 mmtt -90.08 -20.84 22.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.252 -1.146 . . . . 0.0 110.317 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 ' HB2' ' A' ' 78' ' ' LYS . 1.8 pt? -136.76 153.61 50.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.967 . . . . 0.0 110.293 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -145.16 4.21 1.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.935 . . . . 0.0 110.555 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 18.4 t-20 -119.12 -110.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 110.319 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.759 ' CB ' ' CD ' ' A' ' 260' ' ' LYS . 1.2 m-20 -117.35 62.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 109.607 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.938 ' HB2' HD12 ' A' ' 74' ' ' LEU . 7.8 mptt -94.65 108.59 20.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.435 -0.79 . . . . 0.0 110.672 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.775 ' CG2' ' CD ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -52.56 173.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.549 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.655 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -169.26 81.48 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.577 -0.702 . . . . 0.0 109.983 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.775 ' CD ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -113.37 151.85 30.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 110.373 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.697 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 17.4 p90 -160.28 172.8 16.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' HB2' ' OE2' ' A' ' 101' ' ' GLU . 24.5 t70 -107.34 132.81 52.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -0.934 . . . . 0.0 110.163 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.746 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.9 p90 -137.98 -179.29 5.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 110.177 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 52' ' ' LEU . 70.5 mt -127.21 113.24 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 110.399 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.694 ' CZ ' ' HB2' ' A' ' 98' ' ' GLU . 2.2 ttp85 -84.5 116.36 23.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.73 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 1.182 ' OE1' HD23 ' A' ' 97' ' ' LEU . 21.4 mt-30 -135.06 130.62 35.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.704 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -114.82 112.14 38.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.311 -0.868 . . . . 0.0 109.911 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.8 tt0 -141.38 133.3 27.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.123 -0.986 . . . . 0.0 110.409 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.001 HG11 ' CD ' ' A' ' 93' ' ' GLN . 61.1 t -116.71 169.09 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.858 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.6 t70 -62.93 -2.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.096 -1.002 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' C ' ' CG ' ' A' ' 93' ' ' GLN . . . 179.5 48.57 0.08 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.107 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.2 mt-30 -157.59 -138.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.287 -1.126 . . . . 0.0 110.688 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 68.4 mt -45.3 164.11 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.316 0.579 . . . . 0.0 110.686 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.107 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -168.65 20.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.537 -0.727 . . . . 0.0 109.699 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.798 ' O ' HD12 ' A' ' 97' ' ' LEU . 28.7 m -57.99 171.96 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.334 -0.854 . . . . 0.0 110.489 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.182 HD23 ' OE1' ' A' ' 87' ' ' GLN . 0.7 OUTLIER -167.48 104.46 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.306 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.771 ' OE1' HG22 ' A' ' 96' ' ' THR . 0.3 OUTLIER -128.48 144.61 51.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.135 -0.978 . . . . 0.0 110.173 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 49.1 p -118.22 152.56 35.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.848 . . . . 0.0 110.204 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.648 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -169.25 -158.66 13.44 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 83' ' ' ASP . 13.7 tp10 -111.17 159.88 17.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -1.096 . . . . 0.0 110.186 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -135.26 124.13 24.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.332 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.575 ' NE2' ' CB ' ' A' ' 81' ' ' ARG . 9.0 mm-40 -107.24 133.67 51.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.931 HG22 ' HB ' ' A' ' 113' ' ' THR . 79.0 t -146.28 111.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.029 -1.044 . . . . 0.0 110.322 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.741 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 3.1 m-85 -102.03 152.28 21.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.966 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.886 ' CB ' HD11 ' A' ' 74' ' ' LEU . 17.7 tptt -122.59 127.0 48.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.0 109.998 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.661 ' OE1' ' N ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -96.88 -151.64 0.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.474 -0.766 . . . . 0.0 110.348 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.5 m -65.99 -64.7 0.8 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.344 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.661 ' N ' ' OE1' ' A' ' 107' ' ' GLN . 26.4 m80 -123.04 42.81 3.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.211 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.684 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 0.6 OUTLIER -164.89 -160.31 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 110.252 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.38 134.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.355 -0.841 . . . . 0.0 110.153 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD11 ' OE2' ' A' ' 239' ' ' GLU . 0.2 OUTLIER -117.67 122.44 43.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.29 -0.881 . . . . 0.0 109.781 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.931 ' HB ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -125.68 173.65 8.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 0.0 111.005 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.799 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -153.81 127.21 8.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.737 -0.602 . . . . 0.0 109.712 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.0 mt -89.62 141.35 28.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.159 -0.963 . . . . 0.0 110.474 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.729 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 20.0 tm0? -141.71 108.27 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.346 -0.846 . . . . 0.0 110.08 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 118' ' ' GLU . 3.3 m -77.99 177.62 8.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.665 ' N ' HG22 ' A' ' 117' ' ' THR . 0.3 OUTLIER -160.96 -30.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.125 -0.985 . . . . 0.0 110.712 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.496 ' HG3' ' HG3' ' A' ' 118' ' ' GLU . 36.4 mt-30 -126.37 155.19 42.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.0 110.562 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.659 ' HA ' ' HG3' ' A' ' 98' ' ' GLU . 1.8 mt-10 -119.98 -179.26 3.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 110.562 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.661 ' HG3' ' CB ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -119.27 153.22 35.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.383 -0.823 . . . . 0.0 109.766 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -118.58 169.66 7.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.066 -1.021 . . . . 0.0 111.284 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.673 ' O ' ' C ' ' A' ' 124' ' ' GLU . 53.4 Cg_endo -96.03 -72.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.783 2.322 . . . . 0.0 110.25 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.73 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 1.3 mm-40 -14.63 -60.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.785 1.279 . . . . 0.0 109.557 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.848 ' O ' ' N ' ' A' ' 127' ' ' GLU . 4.2 m80 -128.05 79.65 1.91 Allowed 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.664 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.7 p -20.85 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.221 0.534 . . . . 0.0 110.941 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.848 ' N ' ' O ' ' A' ' 125' ' ' HIS . 1.1 pt-20 -73.08 2.83 6.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.098 -1.001 . . . . 0.0 110.492 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -84.37 144.8 28.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.654 -1.279 . . . . 0.0 109.451 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.61 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -125.03 132.71 53.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 110.662 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.622 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 1.7 t -91.11 -176.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 0.0 109.613 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 130' ' ' VAL . . . -124.9 114.84 19.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.126 -0.984 . . . . 0.0 110.221 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.586 ' CG ' ' OE1' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -130.31 106.39 8.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 110.263 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -130.54 110.69 11.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 110.027 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' HB1' ' A' ' 114' ' ' ALA . 9.1 t80 -115.34 121.16 42.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 110.397 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.8 ttp85 -97.35 167.77 10.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.959 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.57 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.8 tp -137.89 126.32 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 110.458 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 113' ' ' THR . . . -153.54 90.13 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.678 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 6.8 m-20 -120.55 147.13 45.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -1.166 . . . . 0.0 110.434 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.877 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.42 82.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.268 -0.895 . . . . 0.0 109.664 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.908 ' HB3' ' CG ' ' A' ' 144' ' ' HIS . . . -50.72 159.12 0.57 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.943 . . . . 0.0 110.34 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 110' ' ' SER . . . -55.9 -49.82 64.58 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.3 OUTLIER -151.22 38.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.302 -1.116 . . . . 0.0 110.032 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.908 ' CG ' ' HB3' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -39.35 86.64 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.622 -0.674 . . . . 0.0 110.286 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.703 ' OG1' ' CG ' ' A' ' 235' ' ' GLU . 0.8 OUTLIER -101.42 177.33 4.96 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.926 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.694 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.58 117.78 14.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 110.221 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.901 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -49.54 -15.73 0.17 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.19 -0.944 . . . . 0.0 109.493 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.666 ' CG ' ' CD ' ' A' ' 205' ' ' LYS . 65.8 t0 -55.07 -11.52 0.7 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.294 -0.879 . . . . 0.0 109.869 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.694 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -72.06 -0.6 12.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -0.794 . . . . 0.0 109.983 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.5 OUTLIER -175.4 54.89 0.13 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.817 . . . . 0.0 110.326 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 48.6 Cg_endo -89.49 95.24 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.923 1.486 . . . . 0.0 110.516 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.583 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 5.4 mtpt -141.38 -78.47 0.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 110.026 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.72 ' HA ' ' CE2' ' A' ' 178' ' ' PHE . 1.4 p30 -151.31 40.04 0.68 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 154' ' ' VAL . 1.7 t -92.75 109.05 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.161 -0.962 . . . . 0.0 110.717 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.22 132.37 41.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.807 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.11 ' HB1' ' OH ' ' A' ' 158' ' ' TYR . . . -131.6 103.42 6.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.97 . . . . 0.0 110.99 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.416 ' C ' ' CG ' ' A' ' 158' ' ' TYR . 1.2 t -92.92 156.19 17.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.11 ' OH ' ' HB1' ' A' ' 156' ' ' ALA . 76.7 m-85 -147.49 161.11 41.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.859 -1.151 . . . . 0.0 111.07 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.625 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -150.2 140.98 22.73 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.707 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -164.09 -159.63 11.11 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 118.257 -1.925 . . . . 0.0 111.365 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.611 ' CB ' ' OH ' ' A' ' 105' ' ' TYR . 1.3 m -113.24 156.45 23.27 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.702 0.763 . . . . 0.0 110.016 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.64 ' HB1' HD23 ' A' ' 257' ' ' LEU . . . -133.65 179.78 6.01 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.625 -0.672 . . . . 0.0 110.04 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.745 ' CZ ' ' O ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -147.8 122.01 9.56 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.482 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.566 ' O ' ' C ' ' A' ' 165' ' ' SER . . . -83.36 131.84 10.66 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.219 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -30.12 -90.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.496 -1.002 . . . . 0.0 110.318 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.96 -6.39 0.57 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.561 -0.712 . . . . 0.0 110.071 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 164' ' ' GLY . 3.8 t70 -101.71 172.04 7.19 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.602 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.745 ' O ' ' CZ ' ' A' ' 163' ' ' PHE . . . -129.2 17.09 6.09 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 108.574 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.03 148.14 19.64 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 189' ' ' HIS . . . -159.48 149.02 18.55 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 189' ' ' HIS . 13.9 tptp -153.85 128.21 9.17 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.953 -1.321 . . . . 0.0 109.394 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.005 ' CD2' HD22 ' A' ' 257' ' ' LEU . 3.6 pp -152.29 155.18 37.17 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.033 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.6 m -116.86 126.45 53.03 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.19 ' CZ ' HD21 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -106.61 151.65 24.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.03 -1.044 . . . . 0.0 111.574 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 175' ' ' THR . 1.0 OUTLIER -139.45 98.12 3.43 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.122 HG21 ' CD1' ' A' ' 203' ' ' TYR . 59.3 mt -114.56 121.35 66.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.948 . . . . 0.0 111.924 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.805 ' CB ' ' CG ' ' A' ' 181' ' ' LYS . 1.5 m-20 -77.82 148.25 34.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.941 ' CD2' ' HB3' ' A' ' 180' ' ' ALA . 12.1 p90 -36.3 153.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.85 0.833 . . . . 0.0 112.045 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 203' ' ' TYR . . . -39.26 -37.83 0.46 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.282 0.563 . . . . 0.0 110.477 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.941 ' HB3' ' CD2' ' A' ' 178' ' ' PHE . . . -67.62 2.39 1.87 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.805 ' CG ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -126.72 -96.95 0.42 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.205 -0.934 . . . . 0.0 111.219 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.672 ' HG3' ' CE1' ' A' ' 184' ' ' HIS . 27.1 pt20 -164.45 178.01 7.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.836 -1.165 . . . . 0.0 111.305 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.903 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -141.21 117.03 1.17 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.672 ' CE1' ' HG3' ' A' ' 182' ' ' GLN . 38.6 p-80 -166.49 172.87 10.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.824 -1.398 . . . . 0.0 110.542 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -179.44 -158.24 21.3 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 51.8 mttt -118.6 148.0 43.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -1.203 . . . . 0.0 110.004 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.929 HD13 ' OH ' ' A' ' 228' ' ' TYR . 1.1 tp -120.31 133.09 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.621 ' HG3' ' HB3' ' A' ' 196' ' ' ASN . 1.7 mt-10 -137.5 93.85 2.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.906 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.7 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 20.6 m170 -27.51 -97.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.755 . . . . 0.0 110.151 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.572 ' HG ' ' OG ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -94.83 -159.82 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 110.06 179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.686 ' O ' ' N ' ' A' ' 193' ' ' PRO . 30.0 mtpt -54.19 -15.11 1.35 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.029 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.701 ' CB ' ' HB2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -28.15 88.2 0.04 OUTLIER Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.726 -0.609 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.686 ' N ' ' O ' ' A' ' 191' ' ' LYS . 43.9 Cg_endo -71.29 -2.73 11.65 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 109.806 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.747 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 9.5 mt-10 -142.64 0.65 1.28 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.539 -0.726 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 195' ' ' LEU . 1.3 mp -111.44 29.69 7.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.108 -0.995 . . . . 0.0 110.233 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.702 ' O ' ' CG ' ' A' ' 220' ' ' TYR . 3.3 m120 -101.74 -169.93 1.75 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 0.0 110.087 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.105 HG13 ' C ' ' A' ' 219' ' ' LEU . 77.0 t -146.87 138.66 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 110.681 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 219' ' ' LEU . 2.5 t70 -70.12 123.05 20.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.178 -0.951 . . . . 0.0 108.938 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.19 HD21 ' CZ ' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -103.93 157.51 17.05 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.996 -1.065 . . . . 0.0 111.101 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.072 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -142.07 162.49 35.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -170.52 164.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 0.0 111.014 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' SER . . . -110.49 132.94 53.75 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.407 -0.808 . . . . 0.0 109.203 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.122 ' CD1' HG21 ' A' ' 176' ' ' ILE . 2.1 t80 -94.16 111.25 22.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.567 -0.708 . . . . 0.0 110.203 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 1.103 HD12 HG21 ' A' ' 213' ' ' VAL . 4.9 mt -117.33 -175.69 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.287 -0.883 . . . . 0.0 110.183 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 6.7 mtmt -88.87 -70.07 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.1 Cg_endo -71.53 102.49 1.29 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.942 1.496 . . . . 0.0 110.496 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.754 ' CA ' HG12 ' A' ' 213' ' ' VAL . 51.2 t0 -83.61 -114.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.859 . . . . 0.0 110.358 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.448 ' HB3' ' HE3' ' A' ' 209' ' ' LYS . 4.0 mt-10 -82.42 -30.68 29.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.877 . . . . 0.0 110.294 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.565 ' H ' ' CE1' ' A' ' 211' ' ' HIS . 3.6 mttt -134.95 -52.52 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 110.131 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.694 ' O ' ' CA ' ' A' ' 146' ' ' SER . 34.4 p-80 -170.02 23.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 207' ' ' ASP . 19.3 p-80 -114.62 -175.77 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.156 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.956 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -64.48 146.15 54.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.092 -1.005 . . . . 0.0 109.913 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.103 HG21 HD12 ' A' ' 204' ' ' ILE . 2.0 m -113.72 148.57 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.417 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.057 HG23 HG11 ' A' ' 201' ' ' VAL . 0.7 OUTLIER -139.3 101.67 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.457 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.597 ' CA ' HG22 ' A' ' 201' ' ' VAL . 41.2 t -136.68 136.87 39.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.107 -0.996 . . . . 0.0 110.993 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 201' ' ' VAL . . . -172.09 -137.19 2.28 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -134.86 175.04 9.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -1.121 . . . . 0.0 110.156 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.957 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.5 p -152.17 138.87 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.146 -0.971 . . . . 0.0 110.327 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 1.105 ' C ' HG13 ' A' ' 197' ' ' VAL . 4.8 mp -158.47 147.67 19.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 110.49 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 1.017 ' HB2' HG22 ' A' ' 197' ' ' VAL . 8.2 t80 -97.69 155.57 16.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 1.6 t-20 -65.59 -16.14 63.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HG2' ' CE2' ' A' ' 220' ' ' TYR . 15.8 mm100 -65.94 -69.55 0.29 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.333 -0.855 . . . . 0.0 109.765 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.579 ' OD1' ' O ' ' A' ' 223' ' ' ASP . 0.4 OUTLIER 178.49 27.74 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.78 -0.575 . . . . 0.0 110.146 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.579 ' C ' ' HG3' ' A' ' 225' ' ' LYS . 6.3 tt0 -86.92 163.9 16.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 111.092 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.676 ' HA ' ' CD2' ' A' ' 219' ' ' LEU . 6.3 mtpp -148.4 79.78 1.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.801 ' C ' HG12 ' A' ' 218' ' ' VAL . . . -112.36 174.2 16.02 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.851 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 218' ' ' VAL . 57.9 m -118.71 -179.28 3.76 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.746 -0.855 . . . . 0.0 109.35 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.127 ' CG ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.28 128.77 9.19 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.832 -1.168 . . . . 0.0 111.544 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.731 ' C ' HD12 ' A' ' 230' ' ' LEU . 32.8 p -147.87 127.86 13.63 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.627 -0.671 . . . . 0.0 109.261 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 257' ' ' LEU . 3.7 mp -152.16 176.83 11.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.871 -1.143 . . . . 0.0 110.958 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.616 ' HA2' ' OD2' ' A' ' 207' ' ' ASP . . . -116.9 137.54 13.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -120.07 145.22 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -1.185 . . . . 0.0 110.904 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.807 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -138.13 138.65 38.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.595 -0.691 . . . . 0.0 109.78 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -141.03 4.19 2.33 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.237 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.703 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -34.61 -29.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.965 -1.315 . . . . 0.0 109.113 179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.5 ttmm 179.92 35.21 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -166.91 84.01 0.25 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.739 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.64 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -61.85 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.417 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.936 ' OE2' HD11 ' A' ' 112' ' ' LEU . 17.9 tt0 -104.94 163.1 12.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 259' ' ' ALA . 11.6 p -146.4 137.06 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.881 . . . . 0.0 110.037 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.01 132.4 20.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 110.09 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.832 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -175.68 -153.25 10.16 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.972 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 25.1 p -148.86 -176.76 5.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.354 -1.086 . . . . 0.0 109.711 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.129 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -157.38 171.47 20.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 227' ' ' SER . 14.3 mt-10 -116.58 142.43 46.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.1 t -140.02 114.9 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.073 -1.017 . . . . 0.0 110.907 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.952 ' HG3' HG23 ' A' ' 252' ' ' ILE . 0.1 OUTLIER -106.97 137.32 45.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.412 -0.805 . . . . 0.0 110.077 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.62 HG23 ' H ' ' A' ' 250' ' ' ASN . 2.4 t -92.88 -111.6 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 110.205 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.589 ' N ' HG23 ' A' ' 248' ' ' THR . . . -118.14 2.37 12.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.62 ' H ' HG23 ' A' ' 248' ' ' THR . 7.9 p30 179.97 36.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.248 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.683 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.98 116.93 0.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.952 HG23 ' HG3' ' A' ' 247' ' ' GLU . 0.5 OUTLIER -83.71 145.98 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.178 -1.19 . . . . 0.0 110.439 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.683 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 2.2 m170 -127.34 161.19 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.208 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.578 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -121.02 125.05 46.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.874 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.129 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -113.74 123.09 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.636 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.6 ' C ' ' HG ' ' A' ' 257' ' ' LEU . . . -85.5 154.75 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.005 HD22 ' CD2' ' A' ' 172' ' ' LEU . 2.4 mt -138.74 150.17 45.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.863 -1.375 . . . . 0.0 111.482 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.77 115.73 4.59 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.707 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -144.8 156.3 43.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.653 -1.279 . . . . 0.0 111.731 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.759 ' CD ' ' CB ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -117.36 165.87 12.97 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.267 0.556 . . . . 0.0 109.831 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.232 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.195 0.521 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.36 64.86 0.31 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 t -155.99 -45.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -1.103 . . . . 0.0 110.187 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.2 t -134.92 136.01 41.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 110.235 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.65 120.84 1.02 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.63 -143.74 4.19 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.79 -145.71 4.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.09 24.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -155.85 -50.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -1.142 . . . . 0.0 110.167 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.64 67.18 3.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.07 -146.01 19.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.44 -103.56 0.77 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.64 146.45 49.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.8 t -58.86 172.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.253 -1.145 . . . . 0.0 110.287 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 14.2 t -112.78 -21.76 11.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 110.202 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 15' ' ' THR . . . 179.79 -115.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.296 -0.877 . . . . 0.0 110.144 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.565 ' HB2' HD21 ' A' ' 74' ' ' LEU . 16.1 t70 -103.39 41.75 1.24 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.272 -0.893 . . . . 0.0 109.931 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.967 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -100.68 -80.21 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.87 0.843 . . . . 0.0 110.151 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.967 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -57.8 -160.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.061 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.87 -0.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -1.141 . . . . 0.0 110.384 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -49.65 -31.51 15.47 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.658 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -66.73 -37.1 83.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.271 -1.135 . . . . 0.0 110.197 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -53.05 -12.51 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.128 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -92.19 -8.83 44.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.368 -0.832 . . . . 0.0 110.137 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.697 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -84.11 -20.17 33.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.759 . . . . 0.0 110.22 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -106.38 -30.75 8.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 110.194 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.948 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -82.47 -8.34 59.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.645 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -106.43 89.61 4.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.441 -0.787 . . . . 0.0 110.134 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' HA ' ' OD1' ' A' ' 70' ' ' ASN . 45.4 Cg_endo -72.97 175.94 9.75 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.062 1.559 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.9 tp -29.94 126.59 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.86 . . . . 0.0 110.237 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.592 ' OD1' ' CE ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -159.38 122.66 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 110.2 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -64.48 -2.36 2.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.592 ' CE ' ' OD1' ' A' ' 31' ' ' ASP . 2.6 mtmt -66.63 -1.79 4.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.308 -0.87 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 9.5 p-10 -87.46 155.43 20.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.212 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -68.79 -58.27 4.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.28 -0.888 . . . . 0.0 110.234 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.1 -58.61 0.13 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.628 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 4.0 mm? -95.91 134.71 38.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.197 -1.178 . . . . 0.0 110.213 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' SER . 1.7 pttt -103.38 -16.86 15.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 31.7 p 175.9 -174.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.208 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -149.11 140.01 22.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.216 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m -114.44 120.11 39.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.125 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.247 HD21 ' CB ' ' A' ' 67' ' ' ASP . 3.9 pp -71.11 160.18 33.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.202 -0.937 . . . . 0.0 110.204 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.984 ' O ' HD12 ' A' ' 42' ' ' LEU . 9.2 pt-20 -42.53 176.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.586 ' O ' ' C ' ' A' ' 45' ' ' SER . 6.9 p-10 -81.17 35.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 44' ' ' ASP . 54.3 p -29.8 -40.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.274 -0.891 . . . . 0.0 110.221 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG22 ' H ' ' A' ' 47' ' ' SER . 1.8 mt -105.7 -158.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 110.289 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -172.69 -177.88 1.79 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -47.81 -17.46 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.07 -1.019 . . . . 0.0 110.01 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.672 ' C ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.87 54.04 0.92 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.555 -0.716 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.641 ' HA2' ' CG1' ' A' ' 88' ' ' ILE . . . 179.82 91.62 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.9 p -112.68 135.41 53.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -1.157 . . . . 0.0 110.127 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.659 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -162.63 161.82 26.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 110.456 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -121.31 154.62 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 110.06 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.034 HD11 HD23 ' A' ' 26' ' ' LEU . 1.8 pp -130.72 132.09 45.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.629 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.0 t -111.45 145.65 38.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.298 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' CB ' HD13 ' A' ' 26' ' ' LEU . . . -115.03 -171.17 1.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 1.061 ' O ' HG22 ' A' ' 20' ' ' THR . 5.2 tt0 -74.72 43.08 0.18 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.671 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.8 -43.81 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.948 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.53 177.39 11.25 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.629 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 7.6 pt-20 -131.44 157.93 42.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.278 -0.888 . . . . 0.0 110.335 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE2' ' O ' ' A' ' 68' ' ' SER . 1.3 tttp -133.93 126.86 31.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 62' ' ' THR . 12.9 t -54.24 135.41 44.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.924 ' OH ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -123.13 112.93 18.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 67' ' ' ASP . . . -123.94 -160.27 10.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.645 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.8 t-20 -49.08 133.83 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.103 -1.234 . . . . 0.0 110.103 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.76 -15.25 57.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.247 ' CB ' HD21 ' A' ' 42' ' ' LEU . 1.1 m-20 27.9 94.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -1.031 . . . . 0.0 110.285 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.6 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 7.8 t -90.16 132.8 35.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 0.0 110.246 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.924 HD12 ' OH ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -111.41 136.52 50.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.115 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.05 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 m120 -103.31 132.03 49.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.05 HG23 ' O ' ' A' ' 70' ' ' ASN . 1.2 p -171.67 42.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 110.222 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.628 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -62.29 64.65 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.616 ' O ' ' O ' ' A' ' 74' ' ' LEU . 4.9 ptmm? 179.98 -53.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.197 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.616 ' O ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -34.95 163.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.667 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.684 ' O ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -135.09 -130.95 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 110.184 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.749 ' O ' ' N ' ' A' ' 78' ' ' LYS . 1.4 t-20 -52.69 -155.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.141 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' CB ' ' HG2' ' A' ' 260' ' ' LYS . 0.6 OUTLIER 3.52 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.814 0.816 . . . . 0.0 110.955 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.749 ' N ' ' O ' ' A' ' 76' ' ' ASN . 4.2 mtpp -77.49 99.8 5.81 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.215 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.191 HG13 ' CE2' ' A' ' 105' ' ' TYR . 0.5 OUTLIER -92.68 162.65 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.222 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 1.9 m -155.88 101.3 2.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.388 -0.82 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.48 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -121.56 125.21 46.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 110.251 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.749 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 20.5 p90 -159.88 146.14 15.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 11.0 t70 -90.67 143.61 26.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 110.215 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 2.4 p90 -150.56 158.12 43.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.161 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.823 HG22 ' CD ' ' A' ' 87' ' ' GLN . 61.3 mt -106.91 107.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -84.36 116.77 23.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 110.165 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.823 ' CD ' HG22 ' A' ' 85' ' ' ILE . 2.5 mt-30 -154.03 140.0 18.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.672 HG21 ' C ' ' A' ' 49' ' ' ASN . 1.1 mp -127.18 112.46 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.292 -0.88 . . . . 0.0 110.013 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -140.75 122.21 15.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.136 -0.977 . . . . 0.0 110.481 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.885 HG12 ' H ' ' A' ' 92' ' ' GLY . 4.1 t -117.01 158.55 17.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.514 -0.741 . . . . 0.0 109.807 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.5 2.36 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.032 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.885 ' H ' HG12 ' A' ' 90' ' ' VAL . . . -167.0 21.43 0.1 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.921 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -135.23 -161.3 1.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.014 -1.286 . . . . 0.0 109.684 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.913 HD12 ' OE1' ' A' ' 93' ' ' GLN . 17.9 mt -44.6 177.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.182 -0.949 . . . . 0.0 111.16 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.921 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.9 OUTLIER -167.07 18.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.716 -0.615 . . . . 0.0 110.016 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.728 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -59.49 154.51 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.79 HD12 ' O ' ' A' ' 95' ' ' ILE . 3.1 mp -143.48 130.43 20.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.629 ' CG ' ' O ' ' A' ' 97' ' ' LEU . 23.0 mt-10 -164.94 149.35 9.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 110.334 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 28.3 t -132.07 161.09 34.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 110.178 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.627 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -175.42 -154.98 11.89 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 116' ' ' GLN . 4.6 tt0 -115.86 159.87 20.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -1.089 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.743 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -130.91 123.58 29.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.858 . . . . 0.0 110.29 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' N ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -117.96 124.58 48.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 109.926 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 80' ' ' SER . 67.3 t -134.21 127.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.063 -1.023 . . . . 0.0 110.382 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.191 ' CE2' HG13 ' A' ' 79' ' ' VAL . 14.6 m-85 -115.18 158.17 22.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.118 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.716 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 15.4 mttm -131.82 134.45 45.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.91 . . . . 0.0 110.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.664 ' OE1' ' CB ' ' A' ' 110' ' ' SER . 4.0 pt20 -99.71 -126.41 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.263 -0.898 . . . . 0.0 110.221 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.643 ' CB ' ' OE1' ' A' ' 143' ' ' GLU . 0.4 OUTLIER -98.08 -49.25 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.315 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.584 ' HB2' ' HG3' ' A' ' 143' ' ' GLU . 40.7 m-70 -123.9 25.03 8.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.18 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.664 ' CB ' ' OE1' ' A' ' 107' ' ' GLN . 0.5 OUTLIER -164.92 -162.36 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.164 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 106' ' ' LYS . . . -172.66 138.54 0.86 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.681 HD21 ' CD ' ' A' ' 239' ' ' GLU . 0.1 OUTLIER -104.68 171.88 7.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.312 -0.868 . . . . 0.0 109.734 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -155.99 170.51 21.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' A' ' 137' ' ' ILE . . . -153.72 124.03 7.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.622 -0.674 . . . . 0.0 109.664 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . 93.0 mt -93.86 141.22 28.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.925 . . . . 0.0 110.54 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 100' ' ' GLY . 20.6 tt0 -132.69 140.77 48.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.038 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.627 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 30.3 m -112.65 167.48 10.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.256 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 117' ' ' THR . 16.6 pt-20 -154.3 -33.02 0.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -121.68 155.09 35.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.381 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' OE2' ' HB2' ' A' ' 132' ' ' LYS . 6.1 mt-10 -159.28 167.93 27.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 110.297 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.7 pt20 -149.3 151.32 33.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 127' ' ' GLU . 3.4 m-20 -140.97 104.65 6.19 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.003 -1.06 . . . . 0.0 111.102 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 46.7 Cg_endo -73.59 51.03 2.14 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.201 1.632 . . . . 0.0 111.327 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.753 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 6.3 mm-40 -95.35 -25.66 16.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.264 1.03 . . . . 0.0 108.801 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.756 ' CD2' ' HG3' ' A' ' 127' ' ' GLU . 0.6 OUTLIER 179.4 -76.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 1.3 t -122.87 17.09 10.17 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.756 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -106.63 6.34 29.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 111.132 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.53 8.38 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.171 -0.956 . . . . 0.0 111.807 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 1.005 ' HE3' ' HA ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -157.17 114.16 3.04 Favored 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.488 -0.758 . . . . 0.0 110.073 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.545 ' CG2' ' C ' ' A' ' 129' ' ' MET . 1.6 t -151.38 174.52 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.141 -0.974 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.0 114.96 19.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.6 ' HB2' ' OE2' ' A' ' 120' ' ' GLU . 2.1 mmtt -121.86 164.65 17.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.69 106.56 14.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.097 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 5.5 mtt180 -124.86 114.18 18.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.05 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.871 ' CE1' ' CE1' ' A' ' 254' ' ' HIS . 4.2 p90 -119.52 112.98 20.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.33 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -109.89 107.53 17.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.876 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.568 HG13 ' OD1' ' A' ' 139' ' ' ASP . 1.5 tp -84.36 126.48 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.37 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.926 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -112.93 47.43 1.04 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.609 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 10.3 m-20 -56.42 70.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.14 HD12 ' N ' ' A' ' 141' ' ' ALA . 1.7 pp -65.5 -158.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 110.499 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.14 ' N ' HD12 ' A' ' 140' ' ' ILE . . . -161.79 176.8 10.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 110.213 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 110' ' ' SER . . . -176.04 -35.8 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.643 ' OE1' ' CB ' ' A' ' 108' ' ' SER . 0.8 OUTLIER -97.7 142.61 29.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -1.2 . . . . 0.0 110.503 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.602 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 11.5 m170 -51.0 85.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.326 -0.859 . . . . 0.0 110.019 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.88 HG21 ' CD2' ' A' ' 233' ' ' PHE . 4.9 p -86.03 4.51 37.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.35 -0.844 . . . . 0.0 110.479 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.0 OUTLIER -58.64 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 109.877 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.011 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.9 OUTLIER -32.15 -30.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.177 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 146' ' ' SER . 17.1 t0 -67.25 2.67 1.5 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.151 -0.968 . . . . 0.0 110.254 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.619 ' HD2' ' O ' ' A' ' 146' ' ' SER . 0.0 OUTLIER -110.45 2.23 18.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.6 tt -159.21 -62.54 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.032 . . . . 0.0 110.342 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.772 ' HG3' ' CG ' ' A' ' 147' ' ' PHE . 43.4 Cg_endo -68.08 85.44 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.584 1.307 . . . . 0.0 110.29 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.615 ' O ' ' HB2' ' A' ' 178' ' ' PHE . 4.3 mtpm? -98.24 -81.6 0.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.08 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.775 ' HA ' ' CD2' ' A' ' 178' ' ' PHE . 5.8 m-20 -115.6 35.88 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.42 -0.8 . . . . 0.0 109.512 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 178' ' ' PHE . 14.9 p -126.3 125.31 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.316 -0.865 . . . . 0.0 110.571 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.677 ' CG ' ' CG ' ' A' ' 177' ' ' ASP . 2.4 ttp -60.33 148.65 36.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.353 -0.842 . . . . 0.0 110.194 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.709 ' HB1' ' CG ' ' A' ' 235' ' ' GLU . . . -149.7 103.44 3.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 110.352 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.942 HG23 ' O ' ' A' ' 174' ' ' TYR . 12.3 m -85.6 149.3 25.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.817 ' CE2' ' CG1' ' A' ' 176' ' ' ILE . 2.5 m-85 -126.14 154.77 42.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.155 -0.966 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.688 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -149.94 148.01 28.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.922 . . . . 0.0 109.566 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.71 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -169.57 -155.05 9.64 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.813 -1.66 . . . . 0.0 110.897 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.697 ' O ' ' CD2' ' A' ' 172' ' ' LEU . 98.3 m -117.03 152.78 33.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.814 -0.815 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB3' ' N ' ' A' ' 171' ' ' LYS . . . -131.34 179.5 5.99 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.377 -0.827 . . . . 0.0 110.463 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.768 ' HZ ' ' HE2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -150.56 131.87 14.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.643 -0.661 . . . . 0.0 109.578 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.76 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -83.72 144.11 21.93 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.013 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 164' ' ' GLY . 4.0 m -26.86 -100.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -1.092 . . . . 0.0 110.672 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.22 -1.73 0.8 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.35 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' CG ' ' HD3' ' A' ' 193' ' ' PRO . 13.8 m-20 -92.46 171.89 8.74 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.482 -0.762 . . . . 0.0 109.829 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.82 10.0 5.94 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 108.796 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 189' ' ' HIS . . . -133.28 145.32 17.36 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.678 ' C ' ' HB3' ' A' ' 162' ' ' ALA . . . -169.97 163.29 36.69 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.813 ' N ' ' HB3' ' A' ' 162' ' ' ALA . 24.6 mttt -145.35 147.63 32.51 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.228 -1.16 . . . . 0.0 109.288 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.003 HD11 ' HB2' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -141.37 94.65 2.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.71 -1.196 . . . . 0.0 111.929 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.9 m -100.21 115.5 30.01 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.942 ' O ' HG23 ' A' ' 157' ' ' THR . 1.7 m-85 -122.89 153.73 39.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.897 -1.127 . . . . 0.0 112.283 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.718 ' C ' HD13 ' A' ' 176' ' ' ILE . 54.0 m -120.52 100.25 7.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.006 HD12 ' CA ' ' A' ' 183' ' ' GLY . 5.1 mm -108.82 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 112.257 -177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.738 ' CB ' ' HB3' ' A' ' 181' ' ' LYS . 1.3 m-20 -73.52 143.27 46.6 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.972 ' CE2' ' HB3' ' A' ' 180' ' ' ALA . 35.2 p90 -35.98 161.31 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.11 0.957 . . . . 0.0 112.438 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 178' ' ' PHE . . . -34.21 -49.09 0.35 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.393 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.972 ' HB3' ' CE2' ' A' ' 178' ' ' PHE . . . -71.11 38.81 0.06 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 110.379 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.755 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 7.2 mmtt -155.06 -102.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 111.323 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -164.23 178.03 7.89 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.958 -178.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 1.006 ' CA ' HD12 ' A' ' 176' ' ' ILE . . . -148.67 93.01 0.15 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.727 ' C ' ' CD2' ' A' ' 174' ' ' TYR . 24.0 p-80 -135.31 160.13 39.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.058 -1.26 . . . . 0.0 110.256 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.741 ' HA3' ' CG ' ' A' ' 174' ' ' TYR . . . -154.39 -159.5 9.26 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.1 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 4.1 mtmp? -128.33 135.78 50.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.49 -1.006 . . . . 0.0 109.627 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.89 HG21 HG11 ' A' ' 218' ' ' VAL . 0.8 OUTLIER -87.73 113.88 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.066 -1.021 . . . . 0.0 109.918 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.703 ' HB2' ' CB ' ' A' ' 171' ' ' LYS . 3.7 mm-40 -101.57 94.17 5.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.342 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.832 ' CG ' ' CB ' ' A' ' 192' ' ' SER . 0.2 OUTLIER -105.95 86.89 2.46 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.233 -0.917 . . . . 0.0 110.051 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.844 HD23 ' H ' ' A' ' 190' ' ' LEU . 0.2 OUTLIER -32.79 -107.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.571 -0.706 . . . . 0.0 111.446 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -79.69 -0.97 36.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.214 -0.929 . . . . 0.0 110.768 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.832 ' CB ' ' CG ' ' A' ' 189' ' ' HIS . 1.0 OUTLIER -60.7 173.66 0.62 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.623 ' O ' ' HG3' ' A' ' 194' ' ' GLU . 46.9 Cg_endo -74.05 36.65 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.972 1.512 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 1.113 ' CD ' HG21 ' A' ' 246' ' ' VAL . 4.3 mt-10 -168.93 43.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 110.179 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -5.32 -69.51 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.72 0.771 . . . . 0.0 111.141 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 188' ' ' GLU . 0.7 OUTLIER -165.68 131.45 2.56 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.852 -0.53 . . . . 0.0 110.139 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.185 HG21 ' OE1' ' A' ' 224' ' ' GLU . 91.6 t -133.11 169.44 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.97 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.539 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.9 OUTLIER -83.81 105.22 14.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.382 -0.824 . . . . 0.0 110.497 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.289 ' CD2' HG22 ' A' ' 218' ' ' VAL . 4.1 mt -85.96 125.53 33.44 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.411 -0.805 . . . . 0.0 111.354 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -126.19 120.96 31.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 108.989 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.877 HG22 ' HA3' ' A' ' 216' ' ' GLY . 86.3 t -143.99 163.73 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.054 -1.029 . . . . 0.0 111.685 -178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.476 ' N ' HG12 ' A' ' 201' ' ' VAL . . . -117.76 124.11 47.65 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 1.144 ' CE1' HG23 ' A' ' 214' ' ' ILE . 3.2 m-30 -95.68 122.35 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 110.553 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.576 HG13 ' HB ' ' A' ' 213' ' ' VAL . 0.3 OUTLIER -95.01 -178.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 0.0 109.916 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.765 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.4 OUTLIER -86.18 -73.41 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.753 -179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.765 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.4 Cg_endo -72.47 116.09 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.813 1.428 . . . . 0.0 110.896 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.903 ' CA ' HG22 ' A' ' 213' ' ' VAL . 39.6 t0 -103.49 -130.15 0.26 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.279 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.416 ' N ' ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -49.02 -50.69 34.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.102 -0.999 . . . . 0.0 110.318 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 210' ' ' HIS . 10.7 mttp -132.55 -55.37 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.196 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.951 ' CE1' ' HE2' ' A' ' 211' ' ' HIS . 13.4 p80 -153.16 33.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.951 ' HE2' ' CE1' ' A' ' 210' ' ' HIS . 0.6 OUTLIER -118.16 176.15 5.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 109.811 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.011 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -80.87 141.48 34.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -0.917 . . . . 0.0 109.896 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.903 HG22 ' CA ' ' A' ' 207' ' ' ASP . 0.2 OUTLIER -100.02 164.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.118 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.144 HG23 ' CE1' ' A' ' 203' ' ' TYR . 71.2 mt -147.53 101.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.784 ' C ' HG13 ' A' ' 201' ' ' VAL . 79.1 p -126.25 115.76 20.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.877 ' HA3' HG22 ' A' ' 201' ' ' VAL . . . -153.35 -166.04 14.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 59.6 p -137.0 146.96 45.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -1.187 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.289 HG22 ' CD2' ' A' ' 199' ' ' LEU . 18.5 t -91.36 135.19 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.678 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -136.32 132.57 35.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.036 -1.04 . . . . 0.0 110.915 -179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.734 ' CB ' ' HB2' ' A' ' 224' ' ' GLU . 58.2 t80 -97.9 156.6 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.371 -0.831 . . . . 0.0 109.561 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.651 ' C ' ' O ' ' A' ' 220' ' ' TYR . 8.4 m120 -14.27 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.843 0.83 . . . . 0.0 111.015 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 220' ' ' TYR . 11.5 pt20 179.42 26.84 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.813 -0.554 . . . . 0.0 109.987 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -128.3 -3.39 5.58 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.26 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 1.185 ' OE1' HG21 ' A' ' 197' ' ' VAL . 4.8 tt0 -124.45 152.92 42.72 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.903 -1.123 . . . . 0.0 111.305 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.43 ' CG ' ' C ' ' A' ' 224' ' ' GLU . 14.4 mtpt -145.65 77.39 1.5 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.537 -0.727 . . . . 0.0 109.079 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -107.02 172.27 17.83 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.879 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 0.5 OUTLIER -119.04 163.7 16.59 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.655 -0.909 . . . . 0.0 109.664 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.875 ' OH ' HD13 ' A' ' 257' ' ' LEU . 1.1 t80 -137.89 132.72 32.9 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.909 -1.119 . . . . 0.0 111.277 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.625 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.2 OUTLIER -147.93 119.95 8.24 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.511 -0.743 . . . . 0.0 109.376 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.004 HD21 HD12 ' A' ' 257' ' ' LEU . 3.1 mp -152.52 171.38 18.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.828 -1.17 . . . . 0.0 111.359 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.62 141.46 16.78 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.933 ' HB ' HD11 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -115.23 136.6 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.259 . . . . 0.0 111.461 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.88 ' CD2' HG21 ' A' ' 145' ' ' THR . 3.9 m-85 -114.24 160.13 19.37 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.763 ' H ' HG22 ' A' ' 145' ' ' THR . . . 2.41 78.63 0.0 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.749 ' HB3' ' CZ ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER -58.06 -36.92 73.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.25 -1.147 . . . . 0.0 110.278 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 235' ' ' GLU . 11.8 tttm -111.17 34.87 3.81 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.3 -0.875 . . . . 0.0 108.888 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -171.32 -29.81 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.384 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.688 ' HB2' ' CA ' ' A' ' 234' ' ' GLY . 71.3 mt-30 -117.68 -102.62 0.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 110.774 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.681 ' CD ' HD21 ' A' ' 112' ' ' LEU . 13.5 pt-20 -168.27 -170.64 1.32 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.049 -1.032 . . . . 0.0 111.229 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 158' ' ' TYR . 4.8 p -154.46 119.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 109.428 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.645 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.66 158.89 43.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 110.732 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.94 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.88 -152.08 10.58 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 229' ' ' SER . 57.3 p -142.12 -176.85 4.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.253 -1.145 . . . . 0.0 109.502 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.191 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -165.86 171.19 13.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.924 -1.11 . . . . 0.0 110.344 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 227' ' ' SER . 26.0 mt-10 -125.01 136.3 53.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.776 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 1.113 HG21 ' CD ' ' A' ' 194' ' ' GLU . 1.4 t -120.8 134.65 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 110.723 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.627 ' HG3' HG23 ' A' ' 252' ' ' ILE . 1.0 OUTLIER -114.75 121.9 44.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.781 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.2 m -94.85 -168.61 1.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' H ' HG22 ' A' ' 248' ' ' THR . . . -65.26 -7.22 12.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -0.932 . . . . 0.0 110.101 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 249' ' ' ALA . 11.0 p30 179.51 49.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -0.811 . . . . 0.0 110.456 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.671 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . 179.89 109.47 0.26 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.627 HG23 ' HG3' ' A' ' 247' ' ' GLU . 3.0 mp -86.67 127.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.241 -1.153 . . . . 0.0 110.274 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.731 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.0 OUTLIER -119.96 161.22 21.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.486 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.871 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -118.91 131.77 56.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 109.828 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.191 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.6 OUTLIER -118.56 124.18 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 110.76 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -88.05 151.64 23.07 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.004 HD12 HD21 ' A' ' 230' ' ' LEU . 3.0 mt -137.25 149.98 47.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.972 -1.311 . . . . 0.0 111.149 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.757 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -152.52 118.24 5.38 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 1.003 ' HB2' HD11 ' A' ' 172' ' ' LEU . . . -146.01 168.22 21.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.658 -1.276 . . . . 0.0 111.811 -178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.668 ' HA ' ' CB ' ' A' ' 239' ' ' GLU . 0.0 OUTLIER -118.43 165.5 13.82 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.221 0.534 . . . . 0.0 109.793 179.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.689 ' CB ' ' O ' ' A' ' 235' ' ' GLU . 3.9 pt20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.2 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.246 0.546 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -92.76 -47.59 3.14 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -161.91 122.95 2.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -1.181 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.9 m -135.11 34.88 3.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.174 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -38.89 63.09 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.79 152.03 23.93 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.84 -86.84 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.81 -129.72 1.4 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -153.79 146.53 24.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -1.132 . . . . 0.0 110.166 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.47 -106.82 0.35 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.06 90.85 0.11 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.89 3.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.717 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -107.43 84.48 0.38 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.832 HG13 ' HE3' ' A' ' 75' ' ' LYS . 46.1 t -161.96 -178.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.08 . . . . 0.0 110.144 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 17' ' ' ASP . 11.5 t -102.39 169.12 8.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 110.247 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -1.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 110.407 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.777 ' H ' HG23 ' A' ' 15' ' ' THR . 1.1 m-20 -162.33 83.22 0.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.667 HG12 HG11 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -55.16 -72.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.229 -0.919 . . . . 0.0 110.394 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 18' ' ' ILE . . . -36.88 -66.67 0.48 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -64.46 -1.16 1.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.159 -1.201 . . . . 0.0 110.389 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -34.56 -41.89 0.27 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD12 ' HB1' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -73.0 -35.86 66.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -1.075 . . . . 0.0 110.244 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.642 ' CB ' HG22 ' A' ' 20' ' ' THR . . . -55.39 -11.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 0.0 110.069 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.079 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -94.42 -8.72 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.476 -0.765 . . . . 0.0 110.165 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 26' ' ' LEU . . . -87.38 -12.09 47.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.398 -0.814 . . . . 0.0 110.061 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.899 HD12 ' N ' ' A' ' 26' ' ' LEU . 3.0 mp -106.45 -18.27 14.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.141 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.695 ' OG1' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER -118.45 -12.63 9.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 0.0 110.285 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 1.079 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -104.07 87.84 1.75 Allowed Pre-proline 0 C--N 1.299 -1.61 0 O-C-N 121.474 -0.766 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.63 ' HA ' ' ND2' ' A' ' 70' ' ' ASN . 45.8 Cg_endo -73.08 -162.54 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.036 1.545 . . . . 0.0 110.445 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 29' ' ' PRO . 7.2 tp -42.32 129.82 3.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.25 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.96 133.45 33.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -70.55 -2.32 13.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -66.58 -2.05 4.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' HA3' ' A' ' 72' ' ' GLY . 32.7 m-20 -97.06 170.85 8.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.29 -0.882 . . . . 0.0 110.172 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -127.75 -5.28 5.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.881 . . . . 0.0 110.222 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -142.45 -58.68 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD22 ' C ' ' A' ' 36' ' ' GLY . 3.5 mm? -124.64 123.75 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -1.13 . . . . 0.0 110.232 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 39' ' ' SER . 16.6 mttt -91.27 -19.53 22.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 110.103 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 1.094 ' C ' HD12 ' A' ' 40' ' ' LEU . 30.3 p 175.53 -177.52 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 110.155 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.094 HD12 ' C ' ' A' ' 39' ' ' SER . 6.2 mp -149.83 121.66 8.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.182 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 68' ' ' SER . 22.1 m -93.67 130.6 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 110.296 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 67' ' ' ASP . 1.1 mt -52.34 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.93 -72.31 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.212 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 45' ' ' SER . 2.1 t70 -151.1 11.98 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.57 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.0 m -29.97 -50.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.957 HG22 ' HA3' ' A' ' 50' ' ' GLY . 1.1 mt -110.27 85.55 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.294 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 49' ' ' ASN . 0.3 OUTLIER -37.59 160.29 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.651 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 16.0 pt20 -41.73 -21.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 109.97 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.662 ' C ' ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -85.84 48.18 1.56 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.591 -0.693 . . . . 0.0 110.351 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.957 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -163.04 84.05 0.11 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 64.5 p -101.43 136.09 41.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 0.0 109.841 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 52' ' ' LEU . 1.1 pt? -161.88 161.89 29.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.549 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.565 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -125.36 154.23 42.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -0.841 . . . . 0.0 110.071 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.825 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.5 pp -138.12 130.85 29.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 110.312 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 65.6 m -109.32 137.94 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.295 -0.878 . . . . 0.0 110.216 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -103.45 -174.57 2.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 110.164 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 20' ' ' THR . 64.5 mt-30 -74.57 43.33 0.18 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 110.249 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.62 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.9 -39.71 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.695 ' CB ' ' OG1' ' A' ' 27' ' ' THR . . . -154.56 177.54 11.09 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.19 -1.182 . . . . 0.0 110.223 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.625 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.7 pt-20 -135.64 156.53 48.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HG2' ' CE1' ' A' ' 63' ' ' TYR . 5.8 tttt -133.88 125.09 27.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.0 110.115 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.699 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -60.93 113.03 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 110.244 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.745 ' CE2' ' OD2' ' A' ' 67' ' ' ASP . 0.9 OUTLIER -97.54 112.91 24.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.33 -0.856 . . . . 0.0 110.162 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . -123.66 178.31 16.44 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.7 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 2.6 t-20 -48.77 125.15 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -1.186 . . . . 0.0 109.979 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.39 -4.56 85.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.059 ' O ' HD12 ' A' ' 42' ' ' LEU . 36.9 t70 -33.81 159.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.515 -0.991 . . . . 0.0 110.352 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.781 ' HB3' HG23 ' A' ' 41' ' ' THR . 14.9 p -137.05 165.11 26.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 110.161 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -118.52 151.94 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.147 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 22.7 m-80 -111.22 77.93 1.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 0.0 110.215 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.58 ' O ' ' C ' ' A' ' 72' ' ' GLY . 4.4 p -115.78 53.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.196 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -31.6 -57.85 0.33 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -162.58 75.31 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.131 . . . . 0.0 110.219 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.588 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -63.98 -163.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.233 -0.917 . . . . 0.0 110.233 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.832 ' HE3' HG13 ' A' ' 14' ' ' VAL . 8.3 mttm -95.51 165.1 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 4.6 m120 -85.5 25.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 110.186 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 7.3 p-10 -163.31 76.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' ASP . 13.7 mmtt -162.52 158.33 23.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.09 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.797 HG13 ' HA ' ' A' ' 105' ' ' TYR . 1.5 t -116.95 165.21 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.411 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 1.0 OUTLIER -119.2 84.99 2.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 5.7 ptm180 -102.56 125.02 49.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 0.0 110.36 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.815 ' CE1' ' CB ' ' A' ' 102' ' ' PHE . 13.5 p90 -151.82 136.59 17.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.994 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.2 t70 -76.29 135.8 39.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.366 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.722 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.0 p90 -151.79 171.45 17.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 0.0 109.861 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.987 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.5 mp -140.92 129.33 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.41 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.674 ' NH2' ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -87.07 118.43 26.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.942 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.686 ' HG2' ' CB ' ' A' ' 97' ' ' LEU . 8.0 mt-30 -142.24 127.45 18.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.488 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' ' C ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -121.32 112.61 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.32 -0.863 . . . . 0.0 109.874 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.3 tt0 -139.67 119.37 13.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 110.379 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.708 HG11 ' CD ' ' A' ' 93' ' ' GLN . 75.8 t -102.88 171.0 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.376 -0.827 . . . . 0.0 110.008 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.56 ' N ' HG12 ' A' ' 90' ' ' VAL . 1.8 t70 -67.08 2.56 1.46 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.19 -0.944 . . . . 0.0 110.539 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.618 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.53 42.72 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.136 ' O ' HD12 ' A' ' 95' ' ' ILE . 20.8 mt-30 -154.76 -139.21 0.08 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.204 -1.174 . . . . 0.0 110.686 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.661 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -45.51 162.98 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.281 0.562 . . . . 0.0 110.557 -179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.136 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.54 17.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.469 -0.769 . . . . 0.0 110.191 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.672 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.8 m -59.44 169.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.7 OUTLIER -166.94 127.83 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.13 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.987 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.1 mt-10 -151.56 144.66 24.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.704 ' CB ' HG12 ' A' ' 85' ' ' ILE . 21.0 t -106.88 159.27 16.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.931 . . . . 0.0 110.189 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -179.4 158.5 22.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' GLN . 7.5 tt0 -95.76 159.85 14.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -1.14 . . . . 0.0 110.157 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.82 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -120.72 136.93 54.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.305 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.943 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 7.2 mm-40 -127.35 98.42 5.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.94 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 84.1 t -114.68 104.42 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.048 -1.032 . . . . 0.0 110.554 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.814 ' CB ' HD12 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -74.06 156.39 37.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 110.158 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.588 ' HD3' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.0 110.317 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.75 ' NE2' HD21 ' A' ' 112' ' ' LEU . 9.3 mt-30 -105.49 -133.82 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -0.846 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' HD22 ' A' ' 76' ' ' ASN . 22.9 t -97.19 -58.05 2.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.256 -0.902 . . . . 0.0 110.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -110.92 9.39 22.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.188 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.753 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.0 OUTLIER -154.29 -161.12 1.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 110.17 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.748 ' HB1' ' O ' ' A' ' 105' ' ' TYR . . . -172.46 163.63 5.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.0 110.271 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.814 HD12 ' CB ' ' A' ' 105' ' ' TYR . 0.7 OUTLIER -110.61 171.7 7.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 109.903 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.6 ' HB ' ' C ' ' A' ' 138' ' ' GLY . 25.3 m -135.55 171.05 15.0 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.123 -0.985 . . . . 0.0 110.887 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.943 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -174.9 120.6 0.22 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.858 -0.526 . . . . 0.0 109.607 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 91.7 mt -109.96 141.23 43.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.159 -0.963 . . . . 0.0 110.615 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.822 HE22 ' HB2' ' A' ' 168' ' ' ALA . 2.2 tt0 -138.1 138.41 38.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.885 . . . . 0.0 110.003 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 ' HB ' ' CB ' ' A' ' 134' ' ' ARG . 60.1 m -120.06 165.49 14.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.173 -0.954 . . . . 0.0 110.291 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 117' ' ' THR . 12.9 pt-20 -146.92 -32.02 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 110.426 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -111.75 155.09 24.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.258 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.686 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.3 OUTLIER -151.64 131.49 13.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.351 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.706 ' HB3' ' CE ' ' A' ' 129' ' ' MET . 1.2 pt20 -119.98 140.61 50.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 109.967 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.74 ' N ' ' O ' ' A' ' 127' ' ' GLU . 2.5 m-20 -145.17 104.18 4.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.811 -1.181 . . . . 0.0 111.377 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' A' ' 128' ' ' LYS . 47.9 Cg_endo -74.49 51.17 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.123 1.591 . . . . 0.0 111.25 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.762 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 7.9 mm-40 -97.86 -24.91 15.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.091 -1.006 . . . . 0.0 108.918 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.762 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.6 OUTLIER 179.48 -77.34 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.586 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 0.5 OUTLIER -122.63 17.1 10.37 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.755 ' CG ' ' CD2' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -105.98 4.05 29.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.497 -0.752 . . . . 0.0 111.105 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -56.76 -1.52 0.06 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.95 . . . . 0.0 110.84 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 129' ' ' MET . 6.1 mmt -157.07 112.94 2.91 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.085 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.686 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.36 165.99 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 110.264 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.96 114.84 19.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 110.15 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -129.1 -164.72 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.31 -0.869 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.498 ' HE ' ' HA ' ' A' ' 166' ' ' ASP . 6.0 mmt-85 -130.54 106.49 8.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.48 ' CB ' ' HB ' ' A' ' 117' ' ' THR . 2.3 ttt180 -121.63 110.99 16.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.002 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CE2' ' HB2' ' A' ' 116' ' ' GLN . 31.5 m-85 -115.05 120.81 41.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 0.0 110.399 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.692 ' CB ' ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -105.31 146.1 29.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 109.697 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -114.4 148.18 17.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.161 -0.962 . . . . 0.0 110.515 -179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.6 ' C ' ' HB ' ' A' ' 113' ' ' THR . . . -166.48 155.46 26.69 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 2.9 p30 179.69 148.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.075 -1.25 . . . . 0.0 110.515 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.905 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -132.44 81.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.307 -0.87 . . . . 0.0 109.758 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.32 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -54.53 140.68 33.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.753 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -47.54 -53.44 12.64 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -151.09 40.54 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 110.04 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 1.32 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 7.1 p80 -48.74 79.89 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.605 -0.684 . . . . 0.0 110.515 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.669 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -107.37 -162.07 0.82 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.487 -0.758 . . . . 0.0 110.166 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.696 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 3.6 t -69.85 134.77 48.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 0.3 OUTLIER -50.94 -14.53 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.151 -0.968 . . . . 0.0 109.555 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 149' ' ' LYS . 7.8 m-20 -48.26 -30.08 4.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.092 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.743 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.4 OUTLIER -86.81 27.7 0.97 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.008 HD21 ' CE1' ' A' ' 178' ' ' PHE . 0.2 OUTLIER 179.39 58.18 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.695 ' O ' ' CD ' ' A' ' 152' ' ' LYS . 41.1 Cg_endo -83.08 101.17 0.98 Allowed 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 124.398 1.736 . . . . 0.0 110.909 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.791 ' O ' HG12 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -149.42 83.51 1.42 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.761 ' CB ' ' HB2' ' A' ' 180' ' ' ALA . 19.8 m-20 -58.62 48.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.558 0.694 . . . . 0.0 110.519 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 152' ' ' LYS . 2.3 p -107.84 108.64 25.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.125 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -30.19 111.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 110.324 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -113.27 109.66 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.175 -0.953 . . . . 0.0 110.356 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -65.53 156.24 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.265 -0.897 . . . . 0.0 109.959 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.742 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 4.9 m-85 -140.68 149.12 41.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.155 -0.965 . . . . 0.0 110.482 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.4 ptp180 -137.57 136.62 37.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.083 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.713 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -153.25 -174.82 23.98 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.72 -1.705 . . . . 0.0 111.079 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 258' ' ' ALA . 99.6 m -120.61 150.73 40.44 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.002 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -149.15 -179.97 7.44 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.096 -1.002 . . . . 0.0 111.37 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.729 ' CZ ' ' HA3' ' A' ' 256' ' ' GLY . 8.9 p90 -144.44 131.51 20.5 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -83.31 145.96 23.44 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.37 -1.395 . . . . 0.0 110.375 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.624 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.3 p -26.18 -101.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.47 -1.018 . . . . 0.0 110.965 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.498 ' HA ' ' HE ' ' A' ' 133' ' ' ARG . 0.9 OUTLIER -54.37 -8.69 0.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.473 -0.767 . . . . 0.0 110.579 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' O ' ' O ' ' A' ' 164' ' ' GLY . 1.6 m-20 -99.6 171.53 7.86 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.421 -0.799 . . . . 0.0 109.811 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.822 ' HB2' HE22 ' A' ' 116' ' ' GLN . . . -128.33 7.72 5.93 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 108.782 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 189' ' ' HIS . . . -133.16 148.1 19.21 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 1.002 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.97 100.46 0.14 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.7 ' CB ' ' O ' ' A' ' 188' ' ' GLU . 31.2 tttt -90.99 148.23 22.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.615 -1.521 . . . . 0.0 109.012 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.925 HD22 ' HB3' ' A' ' 257' ' ' LEU . 0.8 OUTLIER -140.25 110.42 6.57 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.696 -1.201 . . . . 0.0 111.977 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 37.9 m -93.31 112.38 24.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.742 ' OH ' ' CE2' ' A' ' 228' ' ' TYR . 2.4 m-85 -96.74 153.32 17.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.931 -1.106 . . . . 0.0 112.285 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 175' ' ' THR . 1.5 m -135.97 98.73 3.96 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.749 ' CG2' ' HA2' ' A' ' 183' ' ' GLY . 14.3 pt -128.07 169.59 19.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.069 -1.02 . . . . 0.0 112.503 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.751 ' CB ' ' HB2' ' A' ' 182' ' ' GLN . 47.4 t0 -113.67 125.68 54.41 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 1.008 ' CE1' HD21 ' A' ' 150' ' ' LEU . 10.1 m-85 -40.31 -157.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.422 1.106 . . . . 0.0 112.674 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -42.59 -4.99 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 112.232 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.761 ' HB2' ' CB ' ' A' ' 153' ' ' ASP . . . -65.62 -93.93 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.467 -1.395 . . . . 0.0 108.657 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.493 ' C ' ' HG3' ' A' ' 182' ' ' GLN . 18.5 tttp -164.41 44.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.829 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.751 ' HB2' ' CB ' ' A' ' 177' ' ' ASP . 11.0 mt-30 -144.81 140.42 28.43 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 116.758 -1.977 . . . . 0.0 112.614 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.749 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -161.79 86.22 0.11 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.76 ' CD2' ' N ' ' A' ' 185' ' ' GLY . 0.0 OUTLIER -136.45 171.49 14.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.958 -1.319 . . . . 0.0 110.076 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.76 ' N ' ' CD2' ' A' ' 184' ' ' HIS . . . 179.42 -179.79 48.83 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.384 -1.388 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.64 ' HE3' ' CB ' ' A' ' 198' ' ' ASP . 49.6 mtpt -135.43 166.01 24.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.404 -1.056 . . . . 0.0 109.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.691 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.6 OUTLIER -120.53 146.53 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.072 -1.017 . . . . 0.0 110.374 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.7 ' O ' ' CB ' ' A' ' 171' ' ' LYS . 11.8 pt-20 -162.57 129.86 3.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.587 ' CE1' ' HA3' ' A' ' 169' ' ' GLY . 1.3 t-80 -161.13 -55.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.103 -0.998 . . . . 0.0 110.685 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 192' ' ' SER . 0.4 OUTLIER -94.55 -156.96 0.53 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 110.62 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 17.1 mmmt -137.69 4.97 2.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.192 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 1.207 ' O ' HD23 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -56.61 -167.03 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.899 . . . . 0.0 109.962 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.735 ' HD2' ' CB ' ' A' ' 192' ' ' SER . 42.3 Cg_endo -70.47 -0.77 8.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.587 1.309 . . . . 0.0 109.81 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.627 ' OE2' ' CZ ' ' A' ' 220' ' ' TYR . 13.4 mt-10 -131.75 25.74 4.69 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.646 0.736 . . . . 0.0 109.135 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.207 HD23 ' O ' ' A' ' 192' ' ' SER . 0.1 OUTLIER -35.42 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.781 0.8 . . . . 0.0 110.588 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.749 ' H ' HD12 ' A' ' 195' ' ' LEU . 1.6 m120 -90.45 176.25 6.78 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.771 -0.581 . . . . 0.0 110.543 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.211 HG22 ' CG ' ' A' ' 220' ' ' TYR . 73.5 t -152.4 154.46 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 110.492 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.64 ' CB ' ' HE3' ' A' ' 186' ' ' LYS . 19.3 t0 -112.38 105.4 13.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.216 -0.927 . . . . 0.0 109.448 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -110.91 157.47 19.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.083 -1.011 . . . . 0.0 111.16 -179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.085 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -141.69 122.78 14.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.183 HG22 ' N ' ' A' ' 216' ' ' GLY . 2.0 t -132.97 164.65 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.139 -0.976 . . . . 0.0 111.129 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.499 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -109.49 145.55 36.06 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.496 -0.753 . . . . 0.0 109.461 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.957 ' HE2' HD13 ' A' ' 232' ' ' ILE . 21.0 t80 -90.83 162.82 14.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.647 ' N ' ' CD1' ' A' ' 203' ' ' TYR . 28.2 mt -149.87 164.3 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 109.789 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.77 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 55.6 mttt -81.68 -73.16 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 110.329 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.77 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 47.5 Cg_endo -73.08 122.44 8.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.723 1.38 . . . . 0.0 110.575 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 1.189 ' OD1' HG13 ' A' ' 213' ' ' VAL . 38.0 t0 -97.21 -134.18 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 110.115 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 5.8 mm-40 -53.6 -56.39 17.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.161 -0.962 . . . . 0.0 109.909 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 208' ' ' GLU . 2.2 mppt? -113.88 -55.93 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.351 -0.843 . . . . 0.0 109.814 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.804 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 16.5 p80 -162.37 44.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.983 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.804 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 3.6 m170 -125.19 -170.56 2.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.95 ' CB ' HG23 ' A' ' 232' ' ' ILE . . . -82.71 150.73 26.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.02 . . . . 0.0 110.059 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.189 HG13 ' OD1' ' A' ' 207' ' ' ASP . 0.0 OUTLIER -123.44 155.34 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.117 -0.99 . . . . 0.0 110.521 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.788 ' CG2' HG11 ' A' ' 201' ' ' VAL . 2.9 mt -155.51 107.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 109.716 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 1.011 ' C ' HG22 ' A' ' 201' ' ' VAL . 29.7 t -147.34 155.1 41.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 1.183 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -176.87 -135.92 2.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.98 168.65 18.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 110.199 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.806 ' C ' HD12 ' A' ' 219' ' ' LEU . 14.8 p -152.78 168.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.152 -0.967 . . . . 0.0 110.983 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.806 HD12 ' C ' ' A' ' 218' ' ' VAL . 3.1 mp -156.02 132.52 10.23 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 1.211 ' CG ' HG22 ' A' ' 197' ' ' VAL . 20.3 p90 -159.95 92.81 1.03 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.71 -1.244 . . . . 0.0 111.002 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.617 ' HB2' ' OE1' ' A' ' 224' ' ' GLU . 35.8 t-20 176.15 -57.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.46 1.124 . . . . 0.0 109.031 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 221' ' ' ASN . 0.2 OUTLIER 178.69 -26.5 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.283 179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 23.6 t70 178.35 23.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.684 -0.635 . . . . 0.0 110.493 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.748 ' OE2' ' CD1' ' A' ' 220' ' ' TYR . 1.5 pt-20 -73.39 -163.06 0.14 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.994 -1.066 . . . . 0.0 110.38 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER -155.2 85.15 1.07 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.844 0.83 . . . . 0.0 109.071 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 218' ' ' VAL . . . -95.84 151.59 20.02 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.74 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 36.2 m -101.1 170.71 8.08 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.404 -1.057 . . . . 0.0 110.479 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -154.12 123.14 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.289 -0.882 . . . . 0.0 110.482 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.933 ' C ' HD12 ' A' ' 230' ' ' LEU . 61.0 p -147.61 138.17 23.23 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.355 -0.841 . . . . 0.0 109.795 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.1 177.02 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.056 -1.028 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.83 141.56 16.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.957 HD13 ' HE2' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -118.2 146.49 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.242 . . . . 0.0 110.79 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.798 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -137.15 147.37 45.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.579 -0.701 . . . . 0.0 109.814 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -151.74 5.93 0.53 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.674 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 143' ' ' GLU . 5.7 tt0 -47.25 -20.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.66 -1.494 . . . . 0.0 109.046 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 234' ' ' GLY . 1.0 OUTLIER 179.96 35.4 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -171.38 80.44 0.07 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.661 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.737 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 3.1 mt-30 -62.06 52.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 109.738 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.683 ' N ' ' O ' ' A' ' 237' ' ' ALA . 15.0 mt-10 -109.07 179.29 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.608 -0.683 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.517 HG12 ' HD2' ' A' ' 158' ' ' TYR . 11.7 p -160.06 127.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.2 44.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.185 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.969 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -177.4 -150.46 8.46 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 51.5 m -158.63 138.13 11.75 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -1.066 . . . . 0.0 109.203 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.989 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -105.75 171.16 7.48 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.116 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 227' ' ' SER . 29.8 mt-10 -127.56 119.94 27.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 109.174 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.639 ' HA ' ' HA2' ' A' ' 226' ' ' GLY . 2.6 t -97.16 137.94 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 111.222 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.408 ' H ' ' HA2' ' A' ' 226' ' ' GLY . 0.6 OUTLIER -125.03 122.64 37.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.6 m -104.25 -164.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.043 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.784 ' H ' HG22 ' A' ' 248' ' ' THR . . . -75.05 -3.76 34.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 21.1 t-20 179.61 47.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.668 ' O ' ' NE2' ' A' ' 253' ' ' HIS . . . -179.99 107.41 0.22 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' C ' ' CD2' ' A' ' 253' ' ' HIS . 27.2 mt -86.68 130.99 35.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.226 -1.161 . . . . 0.0 110.223 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.73 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 1.1 m170 -116.16 161.16 19.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -128.85 136.06 49.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.989 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -123.37 119.54 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 110.929 -179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.729 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -86.52 137.23 14.75 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.151 -1.98 . . . . 0.0 108.151 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.925 ' HB3' HD22 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -132.08 156.71 45.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.846 -1.385 . . . . 0.0 111.965 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 161' ' ' THR . . . -152.79 115.17 4.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.713 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -136.14 161.27 36.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.742 -1.224 . . . . 0.0 111.845 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.695 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -131.13 165.64 22.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.858 -0.526 . . . . 0.0 109.665 179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.742 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 21.8 mm-40 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.251 0.548 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.32 -143.46 5.9 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -100.36 115.69 30.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 t -154.92 -179.93 8.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.258 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.06 -162.21 11.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.21 104.46 2.48 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.96 113.14 0.55 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.06 102.18 2.14 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.2 m -102.05 124.1 47.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.314 -1.109 . . . . 0.0 110.231 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.0 -134.1 1.59 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.65 54.34 2.48 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.88 91.81 0.44 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.2 -139.07 0.84 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 15' ' ' THR . 4.5 t -58.84 174.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -1.177 . . . . 0.0 110.262 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.695 ' CB ' HG12 ' A' ' 18' ' ' ILE . 19.5 m -84.35 161.75 20.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 110.255 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.63 -1.76 39.59 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -162.54 45.44 0.14 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.11 -0.994 . . . . 0.0 110.698 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.948 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -98.77 -79.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.14 -0.975 . . . . 0.0 109.988 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.948 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -128.22 7.02 6.75 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -5.03 1.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -1.143 . . . . 0.0 110.322 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.59 -8.78 85.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.773 ' HB3' ' HB1' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -68.94 -44.1 73.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -1.103 . . . . 0.0 110.24 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 58' ' ' GLY . . . -55.56 -11.03 0.77 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.831 ' HA ' ' HB3' ' A' ' 28' ' ' ALA . 1.3 m-20 -95.28 -8.81 34.9 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.187 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.897 ' C ' HD23 ' A' ' 26' ' ' LEU . . . -83.09 -20.05 35.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.435 -0.791 . . . . 0.0 110.156 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.116 HD13 ' CD1' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -106.27 -45.73 4.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 0.0 110.111 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' PRO . 16.1 p -127.84 -84.11 0.59 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.025 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 24' ' ' ASP . . . -27.4 87.56 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.717 0 O-C-N 121.773 -0.579 . . . . 0.0 110.332 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' THR . 46.3 Cg_endo -73.66 118.13 5.34 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.131 1.595 . . . . 0.0 110.47 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HA ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -81.77 29.58 0.39 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 29' ' ' PRO . 3.8 p30 -102.89 4.49 37.69 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.823 -0.548 . . . . 0.0 110.115 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.79 -3.75 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -0.915 . . . . 0.0 109.973 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -151.83 9.66 0.53 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.422 -0.799 . . . . 0.0 110.373 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -112.7 120.75 42.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.137 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 101.32 13.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.78 -149.0 8.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.629 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.5 mm? -60.34 142.04 55.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -1.113 . . . . 0.0 110.061 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 39' ' ' SER . 1.2 mtpt -73.92 -22.37 59.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.939 . . . . 0.0 110.224 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.676 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 3.9 t 175.49 -177.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 39' ' ' SER . 3.9 mm? -117.84 98.15 6.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.243 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 1.196 HG23 ' OG ' ' A' ' 68' ' ' SER . 33.0 m -87.16 147.29 25.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.209 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 67' ' ' ASP . 4.9 mp -91.35 128.26 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.171 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 45' ' ' SER . 4.5 pt-20 -42.75 176.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 0.0 110.208 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 11.3 t70 -61.5 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 43' ' ' GLU . 30.9 t -60.11 -50.42 73.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 0.0 110.202 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.755 HG22 ' H ' ' A' ' 47' ' ' SER . 1.5 mt -105.37 -156.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.341 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.755 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -172.45 -167.64 0.47 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.512 -0.743 . . . . 0.0 109.772 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -52.01 -13.88 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.745 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -99.77 53.89 0.93 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.575 -0.703 . . . . 0.0 110.529 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.583 ' N ' HG23 ' A' ' 88' ' ' ILE . . . 179.96 91.59 0.08 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.5 p -117.13 135.2 53.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.147 . . . . 0.0 110.178 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.688 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.4 OUTLIER -162.65 161.91 26.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.234 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -119.44 154.68 33.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.155 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.116 ' CD1' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -138.37 131.44 29.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.207 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.635 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 23.2 t -121.49 152.97 38.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.925 . . . . 0.0 110.201 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.866 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -124.96 -172.03 2.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 43.6 0.19 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.325 -0.86 . . . . 0.0 110.206 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 23' ' ' ALA . . . -174.15 -49.13 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' O ' HD12 ' A' ' 26' ' ' LEU . . . -154.6 177.3 11.36 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.259 -1.142 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 13.4 pt-20 -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 4.8 tptt -144.31 129.57 18.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 62' ' ' THR . 1.3 t -56.16 113.91 1.74 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 110.224 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.975 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -97.04 112.89 24.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.232 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.66 -160.55 9.39 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.652 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 3.0 t-20 -48.91 128.28 15.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -1.174 . . . . 0.0 110.067 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.599 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.72 -5.49 84.56 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.777 ' O ' HD13 ' A' ' 42' ' ' LEU . 9.1 p-10 -28.75 121.95 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.405 -1.056 . . . . 0.0 110.247 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.196 ' OG ' HG23 ' A' ' 41' ' ' THR . 11.7 m -119.09 165.09 14.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' OH ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -121.9 114.11 20.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.87 . . . . 0.0 110.126 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 1.064 ' O ' HG23 ' A' ' 71' ' ' THR . 3.1 m-20 -78.28 128.46 33.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.064 HG23 ' O ' ' A' ' 70' ' ' ASN . 0.6 OUTLIER 179.94 43.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.669 ' C ' ' O ' ' A' ' 71' ' ' THR . . . 0.06 -68.84 0.0 OUTLIER Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 71' ' ' THR . 29.7 mtpt -155.2 90.21 1.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -1.153 . . . . 0.0 110.209 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -73.59 -162.94 0.14 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.678 ' CE ' ' HD2' ' A' ' 78' ' ' LYS . 12.9 mtmt -87.04 150.2 24.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.66 ' ND2' ' O ' ' A' ' 108' ' ' SER . 2.4 m-20 -79.42 25.29 0.32 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.691 ' OD1' ' CD ' ' A' ' 260' ' ' LYS . 65.6 m-20 -164.39 79.39 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -0.888 . . . . 0.0 110.169 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.724 ' O ' ' CD1' ' A' ' 105' ' ' TYR . 16.9 mtpt -158.31 178.18 10.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.18 HG22 ' CE2' ' A' ' 105' ' ' TYR . 1.8 t -122.9 167.78 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 22' ' ' LEU . 17.8 t -159.2 85.11 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -111.72 131.26 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.262 -0.899 . . . . 0.0 110.193 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 19.8 p90 -136.75 150.79 48.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 110.202 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 9.6 t70 -81.75 146.65 29.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.146 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.704 ' C ' ' CD1' ' A' ' 84' ' ' PHE . 2.1 p90 -160.9 161.99 31.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -0.936 . . . . 0.0 110.191 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.816 ' O ' HG23 ' A' ' 85' ' ' ILE . 5.3 tt -123.73 107.39 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 110.262 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' C ' ' HG2' ' A' ' 87' ' ' GLN . 4.1 ptp180 -84.45 111.83 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 110.069 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.702 ' NE2' HD13 ' A' ' 85' ' ' ILE . 2.7 mt-30 -149.1 136.97 20.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 110.429 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.754 HD12 ' HB ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -121.66 112.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.334 -0.854 . . . . 0.0 109.993 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 1.6 tt0 -140.28 114.65 9.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.681 HG11 ' CD ' ' A' ' 93' ' ' GLN . 53.4 t -103.99 171.07 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.837 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.573 ' N ' HG12 ' A' ' 90' ' ' VAL . 6.1 m-20 -68.07 4.2 1.32 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.56 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.635 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.67 41.65 0.07 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.091 ' O ' HD12 ' A' ' 95' ' ' ILE . 22.4 mt-30 -154.7 -139.02 0.08 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.164 -1.197 . . . . 0.0 110.681 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.8 mm? -45.35 163.22 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.311 0.577 . . . . 0.0 110.573 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.091 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.8 OUTLIER -164.18 16.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 110.144 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.802 ' O ' HD12 ' A' ' 97' ' ' LEU . 6.9 m -57.65 157.23 7.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.338 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' O ' ' A' ' 96' ' ' THR . 2.2 mp -150.11 124.79 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 0.0 110.233 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' LEU . 14.5 mt-10 -156.39 141.56 17.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.935 . . . . 0.0 110.264 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.666 ' CB ' HG13 ' A' ' 85' ' ' ILE . 1.4 t -131.79 157.34 44.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.604 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 177.37 -154.99 16.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 4.0 tt0 -127.58 159.73 33.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -1.13 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.897 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -122.34 137.75 54.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.965 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.622 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -127.1 111.08 13.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.862 . . . . 0.0 110.199 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 2.3 t -123.39 130.52 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 110.305 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.18 ' CE2' HG22 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -121.54 122.86 40.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 110.188 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG3' ' CB ' ' A' ' 111' ' ' ALA . 9.9 mptt -90.31 141.03 29.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 110.284 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.916 ' NE2' HD21 ' A' ' 112' ' ' LEU . 1.8 mm-40 -103.72 -135.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.236 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.66 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 58.2 m -98.02 -36.04 10.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.466 ' HB2' ' CA ' ' A' ' 142' ' ' GLY . 8.2 m80 -115.79 -25.84 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.671 ' N ' ' HA2' ' A' ' 142' ' ' GLY . 0.1 OUTLIER -137.16 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -161.61 143.51 11.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.534 -0.729 . . . . 0.0 109.842 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD21 ' NE2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.62 171.55 7.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 109.682 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 104' ' ' VAL . 0.3 OUTLIER -151.13 160.86 43.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 0.0 110.763 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -151.84 120.53 6.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.674 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.897 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 26.1 mt -95.84 141.82 28.84 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 110.437 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 32.7 tt0 -142.62 115.09 8.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -0.937 . . . . 0.0 109.983 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.642 HG22 ' N ' ' A' ' 118' ' ' GLU . 92.7 m -84.21 176.82 8.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.935 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.642 ' N ' HG22 ' A' ' 117' ' ' THR . 12.0 pt-20 -149.78 -34.09 0.18 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 0.0 110.195 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.49 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 1.5 tp-100 -124.85 155.23 39.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 0.0 110.267 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.693 ' CB ' ' HB ' ' A' ' 130' ' ' VAL . 3.3 mm-40 -112.9 -178.94 3.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.599 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.665 ' OE1' ' N ' ' A' ' 97' ' ' LEU . 2.2 tt0 -118.96 152.92 35.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HB2' ' CB ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -118.28 177.72 1.23 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 120.996 -1.065 . . . . 0.0 111.395 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.684 ' O ' ' C ' ' A' ' 124' ' ' GLU . 55.6 Cg_endo -97.7 -73.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.91 2.407 . . . . 0.0 110.834 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.5 mm-40 -11.56 -59.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.834 1.302 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.825 ' O ' ' N ' ' A' ' 127' ' ' GLU . 1.6 m80 -132.68 80.77 1.91 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 122' ' ' ASP . 1.5 p -20.57 -35.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.175 0.512 . . . . 0.0 110.827 -177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.825 ' N ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -71.1 2.91 3.9 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.541 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 122' ' ' ASP . 4.5 mmtt -71.84 -172.79 0.88 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.584 -1.322 . . . . 0.0 109.533 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -155.61 124.15 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.751 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.693 ' HB ' ' CB ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -91.31 -176.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 179.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.71 114.83 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.073 -1.017 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.636 ' CD ' ' CG ' ' A' ' 120' ' ' GLU . 14.1 ptmt -157.69 163.96 37.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.23 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -119.27 111.83 18.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.567 ' HD2' ' NZ ' ' A' ' 132' ' ' LYS . 0.1 OUTLIER -139.43 110.8 7.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CG ' ' CZ ' ' A' ' 163' ' ' PHE . 43.4 p90 -115.93 139.22 50.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 110.546 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.877 ' HD3' HD12 ' A' ' 115' ' ' LEU . 2.1 ttp85 -93.73 167.91 11.34 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.851 . . . . 0.0 109.704 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.62 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 2.7 tp -137.12 122.29 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 110.616 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 113' ' ' THR . . . -122.72 76.14 0.36 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 140' ' ' ILE . 6.8 p-10 -68.03 131.35 45.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -1.114 . . . . 0.0 110.771 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER 179.76 111.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.372 -0.83 . . . . 0.0 109.593 179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.854 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -124.1 -174.87 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 110.768 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.671 ' HA2' ' N ' ' A' ' 110' ' ' SER . . . -29.96 -65.27 0.14 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -151.75 102.49 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.289 -1.124 . . . . 0.0 110.461 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 233' ' ' PHE . 6.5 p80 -83.85 65.14 8.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.644 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.663 ' CB ' ' HG2' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -107.03 -172.07 2.01 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.618 -0.676 . . . . 0.0 110.742 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.697 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.3 OUTLIER -65.88 123.99 21.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 0.0 111.085 -179.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 49.0 p90 -49.2 -16.81 0.18 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.561 0.696 . . . . 0.0 109.96 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 146' ' ' SER . 1.6 t70 -63.19 -6.63 4.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.06 -1.025 . . . . 0.0 110.672 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.77 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 2.1 mptt -83.01 -5.66 59.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.122 -0.986 . . . . 0.0 110.904 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.731 HD23 ' N ' ' A' ' 151' ' ' PRO . 2.1 tt -162.43 -62.32 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.087 -1.008 . . . . 0.0 110.458 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.731 ' N ' HD23 ' A' ' 150' ' ' LEU . 44.0 Cg_endo -67.95 159.77 51.46 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.706 1.372 . . . . 0.0 110.342 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 2.2 mppt? -144.16 -65.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.243 -0.91 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.483 ' CA ' ' HB2' ' A' ' 180' ' ' ALA . 2.2 p30 -150.26 24.33 0.82 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.272 -0.892 . . . . 0.0 110.105 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 155' ' ' MET . 54.2 t -93.18 169.42 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 121.284 -0.885 . . . . 0.0 110.191 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.623 ' CE ' ' OE1' ' A' ' 182' ' ' GLN . 0.0 OUTLIER -99.85 100.52 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.287 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.928 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.64 122.35 33.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 110.316 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.606 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 5.8 t -74.77 156.15 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CE2' ' O ' ' A' ' 238' ' ' GLN . 28.6 m-85 -141.27 149.26 41.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.104 -0.998 . . . . 0.0 110.649 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 12.7 ptp180 -149.9 131.73 15.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.093 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.722 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -162.42 -158.33 9.54 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 118.766 -1.683 . . . . 0.0 111.111 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.016 HG21 ' CG1' ' A' ' 79' ' ' VAL . 2.9 t -124.51 156.04 37.96 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.872 -0.781 . . . . 0.0 110.115 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.932 ' HB2' HD21 ' A' ' 172' ' ' LEU . . . -130.62 -179.03 5.05 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.427 -0.795 . . . . 0.0 110.113 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CZ ' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -133.41 136.08 45.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 109.855 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 169' ' ' GLY . . . -114.32 132.22 10.35 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.014 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.83 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -64.71 -12.34 45.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -1.146 . . . . 0.0 109.774 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.6 2.21 6.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.588 0.709 . . . . 0.0 109.715 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -124.6 171.28 10.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.595 -0.691 . . . . 0.0 109.248 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.6 -33.56 71.62 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.69 -107.35 0.22 Allowed Glycine 0 C--N 1.283 -2.383 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.794 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.23 158.28 20.07 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.702 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 1.7 mttm -153.89 119.39 5.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.491 -1.005 . . . . 0.0 108.465 178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.932 HD21 ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -151.88 155.12 37.47 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.168 -1.413 . . . . 0.0 112.577 -178.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 52.2 m -114.87 124.67 52.31 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.891 ' HE1' HD13 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.49 157.13 16.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 111.646 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.75 HG22 ' O ' ' A' ' 175' ' ' THR . 0.9 OUTLIER -138.0 98.91 3.75 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.891 HD12 HD13 ' A' ' 232' ' ' ILE . 1.1 pt -121.19 169.43 12.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.312 1.053 . . . . 0.0 112.411 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.766 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 44.4 t0 -120.39 124.41 45.43 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.928 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 22.1 m-30 -42.15 -156.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.468 1.127 . . . . 0.0 112.726 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . . . -41.61 -6.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.516 -0.74 . . . . 0.0 112.402 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 178' ' ' PHE . . . -65.79 -95.53 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.447 . . . . 0.0 108.578 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -164.66 47.65 0.1 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.145 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.766 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -145.63 140.19 27.16 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 117.157 -1.817 . . . . 0.0 112.485 -179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.722 ' HA2' ' CG2' ' A' ' 176' ' ' ILE . . . -168.26 79.24 0.1 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 200' ' ' ALA . 25.6 p-80 -146.59 170.71 16.36 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.987 -1.302 . . . . 0.0 110.733 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.694 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -176.49 -161.08 24.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 7.9 mtpt -108.63 170.44 8.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -1.107 . . . . 0.0 109.824 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER -148.04 103.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.728 ' CB ' ' ND2' ' A' ' 196' ' ' ASN . 13.3 pt-20 -120.52 97.58 5.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.178 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.848 ' CE1' HG21 ' A' ' 255' ' ' ILE . 2.2 m-70 -33.21 -54.63 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.7 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.81 -103.45 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.348 -0.845 . . . . 0.0 110.007 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 5.6 mtmt -162.68 -30.2 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.608 -0.683 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.595 ' HB3' HD13 ' A' ' 195' ' ' LEU . 27.9 t -45.07 139.79 3.87 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 110.094 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.452 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 46.3 Cg_endo -72.51 43.79 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.929 1.489 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.69 ' O ' ' CE2' ' A' ' 220' ' ' TYR . 8.0 tt0 -142.14 -27.58 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 110.555 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 195' ' ' LEU . 2.7 mp -104.94 20.65 18.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.071 . . . . 0.0 110.337 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.748 ' O ' ' CD1' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -97.53 115.24 27.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.858 . . . . 0.0 110.046 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.891 HG13 ' N ' ' A' ' 220' ' ' TYR . 23.4 t -81.57 160.76 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 110.531 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 219' ' ' LEU . 2.2 t70 -88.27 95.47 10.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.903 . . . . 0.0 109.941 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.891 HD13 ' HE1' ' A' ' 174' ' ' TYR . 1.7 mt -72.69 126.69 30.5 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.339 -0.851 . . . . 0.0 111.211 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 120.13 25.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.435 -0.791 . . . . 0.0 109.021 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.05 HG22 ' N ' ' A' ' 216' ' ' GLY . 4.0 t -149.67 162.14 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 111.319 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 201' ' ' VAL . . . -110.67 136.42 49.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.441 -0.787 . . . . 0.0 109.276 179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.902 ' CE2' ' HB1' ' A' ' 212' ' ' ALA . 16.8 t80 -82.07 103.28 11.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.343 -0.848 . . . . 0.0 110.227 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 1.0 OUTLIER -79.83 166.95 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.743 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtmm -81.89 -70.68 0.14 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.829 . . . . 0.0 110.275 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.743 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 45.3 Cg_endo -72.14 122.43 8.4 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.887 1.467 . . . . 0.0 110.45 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.648 ' OD1' HG13 ' A' ' 213' ' ' VAL . 58.5 t0 -100.7 -121.99 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.601 ' O ' ' HD3' ' A' ' 209' ' ' LYS . 10.1 mt-10 -70.96 -38.7 72.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 110.048 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.601 ' HD3' ' O ' ' A' ' 208' ' ' GLU . 16.3 mmtt -136.93 -49.99 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.999 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.697 ' O ' ' CA ' ' A' ' 146' ' ' SER . 6.1 p-80 -170.03 44.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 0.4 OUTLIER -125.95 -160.4 0.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 110.11 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -85.25 151.58 23.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.128 -0.983 . . . . 0.0 110.118 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.737 HG21 ' O ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -129.26 155.2 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.889 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.3 mm -148.22 107.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.762 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.794 ' N ' HG13 ' A' ' 201' ' ' VAL . 15.2 m -138.2 143.75 40.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 110.724 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 1.05 ' N ' HG22 ' A' ' 201' ' ' VAL . . . -171.36 -135.87 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 66.1 p -136.51 139.35 42.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.221 -1.164 . . . . 0.0 110.778 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.964 HG23 ' HB2' ' A' ' 228' ' ' TYR . 2.8 t -92.35 126.75 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.407 -0.808 . . . . 0.0 109.786 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -148.37 121.43 8.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 -179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.891 ' N ' HG13 ' A' ' 197' ' ' VAL . 8.6 t80 -102.25 155.58 18.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.919 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.423 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 3.4 t-20 -74.31 -9.41 58.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.119 -0.988 . . . . 0.0 110.88 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 220' ' ' TYR . 0.7 OUTLIER -75.27 -66.12 0.8 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.173 -0.955 . . . . 0.0 109.851 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 7.0 t70 178.92 25.95 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.882 -0.511 . . . . 0.0 110.403 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 1.01 ' HG2' HG21 ' A' ' 246' ' ' VAL . 1.7 tt0 -84.51 155.23 22.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.64 ' C ' HG23 ' A' ' 246' ' ' VAL . 5.0 mtpt -149.77 79.36 1.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.481 -0.762 . . . . 0.0 109.418 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.85 ' N ' HG23 ' A' ' 246' ' ' VAL . . . -131.73 174.05 20.3 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.925 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 71.6 m -111.32 -179.59 3.76 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.708 -0.878 . . . . 0.0 109.354 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.964 ' HB2' HG23 ' A' ' 218' ' ' VAL . 0.5 OUTLIER -150.91 138.64 19.78 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.911 -1.118 . . . . 0.0 111.094 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.424 ' N ' ' CD1' ' A' ' 228' ' ' TYR . 2.1 t -147.8 131.76 17.17 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 242' ' ' GLY . 0.4 OUTLIER -159.27 165.84 32.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.793 -1.192 . . . . 0.0 110.94 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.545 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -115.61 127.71 7.71 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.165 HD12 ' CG2' ' A' ' 240' ' ' VAL . 0.1 OUTLIER -112.51 145.35 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.094 -1.239 . . . . 0.0 111.585 -178.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.782 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.0 OUTLIER -94.26 147.64 22.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -162.05 -28.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.126 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.716 ' N ' ' HA ' ' A' ' 147' ' ' PHE . 0.3 OUTLIER -36.25 -25.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.992 -1.299 . . . . 0.0 109.408 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.672 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER -178.36 34.22 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -162.79 83.89 0.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.628 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.645 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -61.62 51.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 109.874 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.697 ' CG ' ' OE1' ' A' ' 107' ' ' GLN . 7.5 mt-10 -105.49 175.28 5.55 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.435 -0.791 . . . . 0.0 110.38 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 1.165 ' CG2' HD12 ' A' ' 232' ' ' ILE . 2.2 t -154.45 131.41 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 110.211 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.669 ' HB3' ' HZ ' ' A' ' 233' ' ' PHE . . . -145.09 125.01 13.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.799 ' N ' HD12 ' A' ' 230' ' ' LEU . . . -169.74 -150.53 6.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.3 p -158.48 -176.73 6.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -1.118 . . . . 0.0 109.89 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.139 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -159.33 171.25 20.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.56 ' HG3' ' C ' ' A' ' 244' ' ' ALA . 38.8 mt-10 -143.47 137.34 28.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 1.01 HG21 ' HG2' ' A' ' 224' ' ' GLU . 6.3 p -150.44 156.89 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.969 -1.082 . . . . 0.0 111.575 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.478 ' CG ' HG13 ' A' ' 252' ' ' ILE . 1.5 mp0 -112.82 154.37 26.38 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.629 -0.669 . . . . 0.0 109.959 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 249' ' ' ALA . 3.6 m -106.27 -170.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 110.021 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.747 ' H ' HG22 ' A' ' 248' ' ' THR . . . -63.62 -3.36 2.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.524 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 39.3 t-20 179.75 49.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.359 -0.838 . . . . 0.0 110.298 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.932 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -169.33 -171.4 34.96 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.932 HD12 ' C ' ' A' ' 251' ' ' GLY . 2.3 mp -162.55 137.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.34 -1.094 . . . . 0.0 109.936 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.657 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.0 OUTLIER -159.87 161.18 34.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.138 -0.976 . . . . 0.0 110.538 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.83 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.0 OUTLIER -118.69 144.37 46.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.695 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.139 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.5 OUTLIER -122.57 122.03 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -0.951 . . . . 0.0 110.741 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.855 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.74 154.5 28.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.721 HD13 ' HE2' ' A' ' 228' ' ' TYR . 2.7 mt -133.48 147.64 51.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.347 . . . . 0.0 111.187 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -152.41 111.9 3.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.465 -0.772 . . . . 0.0 108.942 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.722 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -143.9 162.22 36.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 111.586 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.709 ' HG2' ' CE1' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -126.08 165.35 19.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.978 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.617 ' O ' ' HE2' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.366 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.212 0.53 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.28 68.71 0.33 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 t -151.66 100.91 2.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -1.128 . . . . 0.0 110.263 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.5 t -158.23 33.41 0.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.891 . . . . 0.0 110.237 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.92 -154.48 6.18 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.29 137.75 6.08 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.95 21.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.19 90.33 1.31 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.1 p -153.26 154.39 34.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -1.114 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.86 -144.62 3.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.77 60.25 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.11 49.84 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -113.59 -42.56 0.87 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.1 m -58.93 169.92 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.225 -1.162 . . . . 0.0 110.395 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.722 HG21 HG12 ' A' ' 18' ' ' ILE . 8.5 m -69.99 153.58 43.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.336 -0.852 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.57 1.01 24.0 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.261 -0.9 . . . . 0.0 110.623 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.5 46.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.111 -0.993 . . . . 0.0 110.641 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.94 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.58 -79.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.151 -0.968 . . . . 0.0 109.942 179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.94 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -120.25 -46.54 0.37 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.076 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.3 -1.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -1.189 . . . . 0.0 110.427 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' THR . . . -43.18 -36.17 2.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.687 ' CD2' ' O ' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -56.65 -33.83 66.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.183 -1.186 . . . . 0.0 110.229 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.685 ' HB1' ' HA3' ' A' ' 58' ' ' GLY . . . -54.47 -11.31 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.73 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 10.0 m-20 -93.81 -8.85 39.35 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 110.191 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.728 ' HB1' HG22 ' A' ' 71' ' ' THR . . . -87.76 -16.52 33.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.423 -0.798 . . . . 0.0 110.246 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.305 HD23 ' CD1' ' A' ' 54' ' ' LEU . 1.7 mp -106.37 -14.91 14.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.87 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -112.52 -8.49 13.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -103.07 88.3 1.52 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.773 . . . . 0.0 110.243 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' THR . 45.9 Cg_endo -72.99 -173.61 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.945 1.498 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 29' ' ' PRO . 5.3 tp -39.02 120.16 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.204 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -160.06 133.68 7.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 10.6 m170 -70.9 -2.3 14.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -66.62 -2.04 4.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.318 -0.864 . . . . 0.0 110.221 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' OD2' ' O ' ' A' ' 31' ' ' ASP . 25.4 m-20 -88.24 148.69 24.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.422 -0.799 . . . . 0.0 110.211 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -60.51 -28.2 68.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.173 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.78 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.677 ' O ' ' CA ' ' A' ' 72' ' ' GLY . 4.4 mm? -71.7 139.56 49.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -1.144 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 32' ' ' HIS . 74.6 mttt -94.48 -31.54 13.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.611 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 12.4 p -172.77 -174.33 1.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.244 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 39' ' ' SER . 1.6 tp -147.52 133.18 18.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.175 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 m -108.94 121.56 45.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.127 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.052 HD21 ' CB ' ' A' ' 67' ' ' ASP . 2.1 pp -77.15 162.01 27.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.31 -0.869 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.76 ' O ' HD12 ' A' ' 42' ' ' LEU . 22.3 tt0 -40.73 173.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.244 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 46' ' ' ILE . 3.8 p-10 -86.47 30.62 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.571 ' C ' ' O ' ' A' ' 44' ' ' ASP . 80.1 p -29.8 -37.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.691 HD11 ' OD2' ' A' ' 67' ' ' ASP . 1.7 mt -97.96 -155.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.343 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.688 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.2 OUTLIER 179.93 -159.9 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.527 -0.733 . . . . 0.0 109.944 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -4.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -0.824 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.899 ' HB2' HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -119.99 64.21 0.82 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.304 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.459 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.91 91.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.1 p -115.45 135.54 54.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.218 -1.166 . . . . 0.0 110.245 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . 1.7 pp -161.91 134.55 5.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 0.0 110.193 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -103.02 154.07 19.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.23 -0.919 . . . . 0.0 110.253 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.305 ' CD1' HD23 ' A' ' 26' ' ' LEU . 1.4 pp -131.71 131.64 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 26.8 p -109.67 146.33 35.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.331 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.656 ' HB2' HD22 ' A' ' 26' ' ' LEU . . . -120.46 -170.39 1.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 110.207 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 1.076 ' O ' HG22 ' A' ' 20' ' ' THR . 4.1 tt0 -74.65 42.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.246 -0.909 . . . . 0.0 110.257 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . 179.71 -45.8 0.08 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.87 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.5 177.4 11.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.255 -1.144 . . . . 0.0 110.321 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 15.6 pt-20 -127.58 155.09 44.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.25 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.621 ' HB3' HD11 ' A' ' 54' ' ' LEU . 37.0 tptt -123.14 129.38 51.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.291 -0.881 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 62' ' ' THR . 1.2 t -71.48 113.72 8.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.707 ' CD1' ' CD2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -103.14 112.94 26.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.116 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.54 -154.11 8.76 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.617 ' HA ' ' HB ' ' A' ' 46' ' ' ILE . 1.3 t-20 -48.87 132.06 18.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -1.136 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.612 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 88.7 -14.11 60.86 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 1.052 ' CB ' HD21 ' A' ' 42' ' ' LEU . 6.0 m-20 28.34 98.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -1.105 . . . . 0.0 110.339 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.609 ' O ' ' CE1' ' A' ' 63' ' ' TYR . 8.1 t -97.62 128.57 44.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 110.151 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 HG23 ' A' ' 71' ' ' THR . 0.2 OUTLIER -102.59 107.76 18.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.634 ' ND2' ' HA ' ' A' ' 29' ' ' PRO . 10.6 m120 -79.63 77.07 6.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.206 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.832 ' HB ' HD12 ' A' ' 74' ' ' LEU . 10.3 p -127.72 64.9 1.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.152 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.677 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -80.88 28.64 2.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.609 ' O ' ' O ' ' A' ' 74' ' ' LEU . 65.6 mttt -137.45 -0.37 2.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.832 HD12 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.9 163.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 110.711 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' LYS . 1.7 ttpt -144.51 -153.84 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 110.243 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -61.1 -68.43 0.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.241 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.681 ' CG ' ' CB ' ' A' ' 260' ' ' LYS . 1.2 m-20 -116.64 61.43 0.73 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 110.072 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 75' ' ' LYS . 7.5 mmmt -79.72 147.17 32.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.151 HG13 ' CD2' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -108.31 164.33 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.68 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.6 OUTLIER -151.53 72.33 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 110.043 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -111.24 136.18 50.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 110.238 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 2.6 p90 -159.38 153.02 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.186 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.04 129.9 35.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.713 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 2.9 p90 -138.15 -170.65 2.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.898 . . . . 0.0 110.212 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 85' ' ' ILE . 19.7 tt -148.01 113.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.651 ' NH2' ' OG1' ' A' ' 117' ' ' THR . 3.0 ptt180 -84.68 101.08 11.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.131 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.694 ' OE1' ' CD1' ' A' ' 85' ' ' ILE . 8.8 mt-30 -121.29 119.09 31.21 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.899 HD11 ' HB2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.64 112.44 40.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.6 tt0 -141.3 132.04 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 110.397 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.89 HG11 ' CD ' ' A' ' 93' ' ' GLN . 95.4 t -115.72 169.85 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.439 -0.788 . . . . 0.0 109.907 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 90' ' ' VAL . 15.6 m-20 -64.07 -1.57 1.59 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.338 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.628 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.5 46.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 95' ' ' ILE . 5.3 mt-30 -156.75 -138.5 0.06 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -1.187 . . . . 0.0 110.717 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 49.6 mt -45.25 165.07 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.361 0.601 . . . . 0.0 110.627 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.105 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -164.96 18.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.427 -0.796 . . . . 0.0 109.858 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.649 ' O ' HD12 ' A' ' 97' ' ' LEU . 21.9 m -51.69 160.92 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.288 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.105 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.37 103.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.596 ' HG2' ' CB ' ' A' ' 120' ' ' GLU . 17.3 mt-10 -145.56 150.65 36.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.201 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 39.1 m -112.32 147.78 35.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.201 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.676 ' HA2' ' CG ' ' A' ' 118' ' ' GLU . . . -158.65 -159.62 9.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' GLN . 6.1 tt0 -123.58 159.67 28.71 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -1.152 . . . . 0.0 110.219 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.713 ' CD2' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -120.54 143.6 48.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.962 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 3.1 tp60 -137.65 98.32 3.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.925 . . . . 0.0 110.049 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.808 HG22 HG23 ' A' ' 113' ' ' THR . 42.1 t -115.43 156.62 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 110.244 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.151 ' CD2' HG13 ' A' ' 79' ' ' VAL . 1.1 t80 -156.71 143.46 18.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 5.5 tmtt? -128.26 128.35 44.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 110.267 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -95.99 -132.77 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.226 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.584 ' OG ' ' OE1' ' A' ' 107' ' ' GLN . 5.3 p -76.89 -64.51 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.508 ' H ' ' HG ' ' A' ' 108' ' ' SER . 7.7 m80 -117.48 -22.11 8.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.163 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -164.07 1.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 110.155 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.738 ' O ' HG23 ' A' ' 140' ' ' ILE . . . -172.57 179.34 2.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.707 ' CD1' ' HB3' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -149.95 127.66 11.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.808 HG23 HG22 ' A' ' 104' ' ' VAL . 7.7 m -107.81 173.84 6.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 103' ' ' GLN . . . -169.13 120.58 0.74 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.425 HD12 ' HE ' ' A' ' 136' ' ' ARG . 12.3 mt -104.99 140.16 38.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.098 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.891 ' OE1' ' HB1' ' A' ' 168' ' ' ALA . 15.8 tt0 -131.99 147.7 52.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 110.236 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.651 ' OG1' ' NH2' ' A' ' 86' ' ' ARG . 4.4 m -110.49 169.93 8.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.179 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.676 ' CG ' ' HA2' ' A' ' 100' ' ' GLY . 7.0 mm-40 -140.5 -63.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.59 155.01 50.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 110.278 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 130' ' ' VAL . 9.8 tt0 -135.08 177.16 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.7 ' HA ' ' CA ' ' A' ' 129' ' ' MET . 2.1 pt20 -160.01 151.95 20.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 0.0 110.153 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.775 ' N ' ' HA ' ' A' ' 128' ' ' LYS . 24.3 m-20 -122.34 104.37 37.63 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.006 -1.059 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.689 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 42.8 Cg_endo -70.11 104.06 1.32 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.197 1.63 . . . . 0.0 111.41 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.772 ' HB3' ' CE1' ' A' ' 125' ' ' HIS . 35.7 mt-10 -163.24 -34.94 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.071 0.938 . . . . 0.0 108.945 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.772 ' CE1' ' HB3' ' A' ' 124' ' ' GLU . 0.8 OUTLIER -178.27 -77.46 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.858 0.837 . . . . 0.0 108.795 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.591 ' H ' ' CD2' ' A' ' 125' ' ' HIS . 7.9 t -122.64 17.66 10.36 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.748 ' HG3' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -103.26 -6.99 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.402 -0.811 . . . . 0.0 111.068 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.775 ' HA ' ' N ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -57.49 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.333 -0.854 . . . . 0.0 111.71 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.7 ' CA ' ' HA ' ' A' ' 121' ' ' GLN . 0.1 OUTLIER -157.0 137.54 13.09 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.12 -0.988 . . . . 0.0 110.246 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 120' ' ' GLU . 16.6 t -151.45 177.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.123 -0.986 . . . . 0.0 110.115 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' O ' ' CG ' ' A' ' 132' ' ' LYS . . . -153.38 115.28 4.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.696 ' CG ' ' O ' ' A' ' 131' ' ' ALA . 54.5 mttt -162.95 129.41 3.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -85.88 106.59 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' H ' ' HB ' ' A' ' 117' ' ' THR . 10.2 ttt85 -116.47 130.08 56.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.743 ' O ' ' CG ' ' A' ' 135' ' ' PHE . 2.6 p90 -129.69 114.01 15.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.227 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 ' HE ' HD12 ' A' ' 115' ' ' LEU . 6.5 ttp180 -104.74 107.82 18.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.0 110.163 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 137' ' ' ILE . 6.3 tp -79.66 113.64 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.93 35.58 4.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.644 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 3.9 p-10 -62.56 148.27 46.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -1.117 . . . . 0.0 110.263 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.827 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -134.08 45.66 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 0.0 110.061 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.061 ' HB1' ' CE1' ' A' ' 233' ' ' PHE . . . -68.22 131.9 46.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 110.153 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 233' ' ' PHE . . . -177.84 34.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.728 ' O ' HG22 ' A' ' 145' ' ' THR . 2.4 tt0 -79.77 145.07 33.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -1.153 . . . . 0.0 110.043 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.662 ' N ' ' CD2' ' A' ' 144' ' ' HIS . 8.2 m170 -57.18 71.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.884 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.804 HG23 ' CB ' ' A' ' 211' ' ' HIS . 2.8 t -106.76 36.74 2.54 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.354 -0.841 . . . . 0.0 110.962 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.716 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 2.1 m -58.68 73.25 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.058 -1.026 . . . . 0.0 109.087 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.069 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 2.4 m-85 -30.46 -32.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.917 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 146' ' ' SER . 2.7 t0 -54.99 -13.41 1.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.333 -0.855 . . . . 0.0 109.925 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 1.061 ' CD ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -74.35 -0.89 18.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.472 -0.767 . . . . 0.0 109.725 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.061 HD23 ' CD ' ' A' ' 149' ' ' LYS . 1.1 pp -175.58 55.03 0.13 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.483 -0.761 . . . . 0.0 109.607 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 1.005 ' CB ' ' HB2' ' A' ' 179' ' ' ALA . 45.7 Cg_endo -87.27 103.27 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.047 1.551 . . . . 0.0 110.657 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.581 ' HG3' ' C ' ' A' ' 151' ' ' PRO . 20.8 mtpt -141.52 -80.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.439 -0.788 . . . . 0.0 109.889 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.93 45.27 0.83 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.738 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 85.8 t -92.54 109.21 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.267 -0.896 . . . . 0.0 110.408 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.1 OUTLIER -100.36 101.46 12.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 110.065 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' O ' ' CE1' ' A' ' 158' ' ' TYR . . . -111.39 118.55 36.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 175' ' ' THR . 99.9 m -70.91 156.29 39.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.968 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 1.057 ' CE2' HD13 ' A' ' 232' ' ' ILE . 77.5 m-85 -134.83 121.39 20.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.147 -0.971 . . . . 0.0 110.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.894 ' C ' ' HB1' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -142.28 143.57 32.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -171.4 -138.56 2.56 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.077 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.714 ' C ' HD21 ' A' ' 172' ' ' LEU . 54.9 m -124.92 155.46 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.622 -0.928 . . . . 0.0 110.6 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -149.85 -179.63 7.29 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.518 0.675 . . . . 0.0 110.365 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.746 ' O ' ' CD1' ' A' ' 163' ' ' PHE . 13.9 p90 -146.83 132.73 19.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.883 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.65 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -83.27 135.03 13.38 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.592 -1.289 . . . . 0.0 110.012 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 254' ' ' HIS . 0.4 OUTLIER -24.38 -96.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.483 -1.01 . . . . 0.0 110.532 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.661 ' N ' ' OG ' ' A' ' 165' ' ' SER . 0.4 OUTLIER -54.48 -9.8 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 109.934 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.645 ' HB3' ' CB ' ' A' ' 191' ' ' LYS . 24.6 m-20 -99.4 172.28 7.43 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.533 -0.729 . . . . 0.0 109.656 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.891 ' HB1' ' OE1' ' A' ' 116' ' ' GLN . . . -131.69 18.5 4.71 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 108.666 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.679 ' N ' ' HD2' ' A' ' 191' ' ' LYS . . . -148.48 149.18 21.18 Favored Glycine 0 C--N 1.298 -1.571 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.827 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 178.93 108.35 0.23 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.616 ' HB2' ' CB ' ' A' ' 188' ' ' GLU . 76.2 mttt -90.98 140.99 29.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.515 -1.58 . . . . 0.0 110.007 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.06 HD13 ' HB3' ' A' ' 257' ' ' LEU . 1.0 OUTLIER -128.43 120.37 26.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.319 -0.863 . . . . 0.0 110.9 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 15.8 m -139.79 100.68 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.423 -0.798 . . . . 0.0 108.982 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.699 ' CD1' ' N ' ' A' ' 174' ' ' TYR . 2.4 p90 -137.09 159.62 41.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 111.112 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 18.2 m -93.99 133.66 37.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.377 -0.827 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.12 HD13 ' CA ' ' A' ' 183' ' ' GLY . 28.3 mm -119.36 166.16 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.054 -1.029 . . . . 0.0 110.728 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.858 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 46.2 t0 -137.86 132.39 32.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.738 ' CD2' ' HB ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -49.91 -144.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.705 0.764 . . . . 0.0 111.52 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.005 ' HB2' ' CB ' ' A' ' 151' ' ' PRO . . . -32.4 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 109.646 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.858 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.73 56.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 25.2 mttp -16.45 74.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.746 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 180' ' ' ALA . 2.6 tt0 -130.76 138.18 49.83 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.208 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 1.12 ' CA ' HD13 ' A' ' 176' ' ' ILE . . . -171.5 101.28 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' C ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER -154.22 140.84 18.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.864 -1.374 . . . . 0.0 110.895 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 174' ' ' TYR . . . -161.18 -140.65 2.93 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 19.4 mttp -144.04 151.85 40.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -1.228 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.695 HG21 ' CG2' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -87.31 133.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.967 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.681 ' O ' ' N ' ' A' ' 190' ' ' LEU . 2.1 mt-10 -101.62 -173.55 2.38 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.921 0.867 . . . . 0.0 112.0 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.54 ' C ' ' O ' ' A' ' 188' ' ' GLU . 4.4 t-80 -19.42 76.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.417 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -95.23 150.41 20.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.199 -0.938 . . . . 0.0 109.021 178.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.735 ' N ' HD12 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -45.83 -72.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.534 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.697 ' HB2' HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -37.85 171.57 0.02 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 121.816 -0.552 . . . . 0.0 110.918 -179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.603 ' HG2' ' OE2' ' A' ' 194' ' ' GLU . 44.9 Cg_endo -71.79 -14.48 29.85 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.98 1.516 . . . . 0.0 110.199 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.658 ' O ' HD23 ' A' ' 190' ' ' LEU . 56.1 mp0 -87.88 30.69 0.82 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 109.244 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.94 HD12 ' N ' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -46.89 -13.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.609 -0.682 . . . . 0.0 111.364 -179.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.514 ' H ' HD12 ' A' ' 195' ' ' LEU . 2.9 m-80 -135.21 112.64 10.62 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 109.766 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 220' ' ' TYR . 2.8 t -138.24 168.79 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 220' ' ' TYR . 0.4 OUTLIER -91.47 106.38 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.433 -0.792 . . . . 0.0 109.983 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.087 ' CD2' HG22 ' A' ' 218' ' ' VAL . 3.8 mt -88.34 129.78 35.3 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 111.305 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.631 ' HA ' ' ND1' ' A' ' 184' ' ' HIS . . . -139.47 119.41 13.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 0.0 108.916 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.119 HG13 ' C ' ' A' ' 215' ' ' SER . 54.5 t -143.15 156.84 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.037 . . . . 0.0 111.366 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -111.21 131.68 54.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.91 ' HE1' ' HB1' ' A' ' 212' ' ' ALA . 74.9 t80 -81.99 163.43 22.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.987 . . . . 0.0 110.962 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.613 ' HB ' ' HB ' ' A' ' 213' ' ' VAL . 4.1 mt -142.09 167.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.563 -0.711 . . . . 0.0 109.631 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.775 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 15.6 mtpt -81.88 -72.75 0.1 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 0.0 110.591 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.775 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.47 112.59 3.5 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.842 1.443 . . . . 0.0 110.905 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 213' ' ' VAL . 49.2 t0 -86.0 -110.46 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.0 109.872 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.592 ' O ' ' HD2' ' A' ' 209' ' ' LYS . 12.2 mt-10 -93.25 -11.21 33.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.75 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -163.28 -51.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 109.984 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.796 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 6.0 p80 -170.06 38.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.165 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.804 ' CB ' HG23 ' A' ' 145' ' ' THR . 60.0 m170 -126.84 166.68 17.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 0.0 110.183 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.069 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -62.38 148.03 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.917 -1.114 . . . . 0.0 109.367 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.746 ' O ' ' CD1' ' A' ' 203' ' ' TYR . 0.1 OUTLIER -120.8 159.37 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.966 -1.084 . . . . 0.0 110.922 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -151.67 102.01 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 0.0 109.841 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 1.119 ' C ' HG13 ' A' ' 201' ' ' VAL . 1.1 t -124.47 123.45 40.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.398 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.954 ' N ' HG13 ' A' ' 201' ' ' VAL . . . -154.8 -158.01 8.49 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 16.0 p -137.01 142.08 42.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -1.143 . . . . 0.0 110.633 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.087 HG22 ' CD2' ' A' ' 199' ' ' LEU . 6.3 t -97.05 126.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.29 -0.881 . . . . 0.0 109.646 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.666 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -140.83 132.66 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.515 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.989 ' HB2' HG13 ' A' ' 197' ' ' VAL . 5.5 t80 -97.76 155.46 17.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.883 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -4.37 24.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 110.284 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.686 ' HB2' ' CD2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -83.38 -64.68 1.12 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.17 34.23 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.875 -0.515 . . . . 0.0 110.292 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.601 ' OE1' ' HB3' ' A' ' 194' ' ' GLU . 6.0 tt0 -91.94 151.73 20.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.001 . . . . 0.0 110.94 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.597 ' HG3' ' C ' ' A' ' 224' ' ' GLU . 1.6 mtpm? -143.34 75.91 1.5 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.504 -0.748 . . . . 0.0 109.334 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 246' ' ' VAL . . . -106.55 173.93 19.86 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.575 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.708 ' CB ' ' HB2' ' A' ' 245' ' ' GLU . 0.3 OUTLIER -113.68 -178.6 3.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.52 -0.988 . . . . 0.0 109.804 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.066 ' CD2' HG21 ' A' ' 201' ' ' VAL . 14.9 t80 -149.9 124.5 9.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.962 -1.086 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.637 ' C ' HD12 ' A' ' 230' ' ' LEU . 38.2 m -148.69 125.91 11.47 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.275 -0.891 . . . . 0.0 109.674 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.042 HD23 ' N ' ' A' ' 242' ' ' GLY . 1.4 mp -159.13 170.55 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.849 -1.157 . . . . 0.0 110.971 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.88 134.57 11.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.057 HD13 ' CE2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.39 135.23 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -1.204 . . . . 0.0 111.273 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 1.061 ' CE1' ' HB1' ' A' ' 141' ' ' ALA . 28.6 m-85 -111.45 151.93 27.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.65 . . . . 0.0 109.557 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.551 ' H ' ' CB ' ' A' ' 145' ' ' THR . . . -155.79 5.36 0.23 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.859 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 144' ' ' HIS . 8.3 tt0 -47.17 -21.41 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.675 -1.485 . . . . 0.0 108.811 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.479 ' N ' ' C ' ' A' ' 234' ' ' GLY . 13.9 tttp 179.25 35.06 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.07 86.41 0.13 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.811 -177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.597 ' O ' ' CA ' ' A' ' 261' ' ' GLN . 1.2 mt-30 -62.5 50.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 109.749 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.88 ' O ' HD12 ' A' ' 232' ' ' ILE . 1.0 OUTLIER -105.18 171.59 7.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.526 -0.734 . . . . 0.0 110.383 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.696 ' CG1' ' OH ' ' A' ' 174' ' ' TYR . 14.9 p -163.38 123.52 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -0.895 . . . . 0.0 110.111 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.463 ' C ' HD23 ' A' ' 230' ' ' LEU . . . -134.8 150.58 50.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.089 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 1.042 ' N ' HD23 ' A' ' 230' ' ' LEU . . . 179.6 -138.96 3.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.66 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 1.6 m -158.35 130.3 6.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.429 -1.042 . . . . 0.0 109.346 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.059 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -105.71 171.23 7.44 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.133 -0.98 . . . . 0.0 110.082 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.708 ' HB2' ' CB ' ' A' ' 227' ' ' SER . 2.8 mt-10 -97.07 159.89 14.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.837 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 253' ' ' HIS . 4.3 t -149.79 112.65 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.453 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 6.6 mt-10 -114.52 121.78 44.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.923 . . . . 0.0 110.171 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 249' ' ' ALA . 2.2 m -103.64 -171.02 1.86 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.691 ' H ' HG22 ' A' ' 248' ' ' THR . . . -69.46 -2.37 10.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 249' ' ' ALA . 4.9 t-20 179.69 53.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.269 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.738 ' O ' ' CE1' ' A' ' 253' ' ' HIS . . . -177.35 98.1 0.12 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 252' ' ' ILE . 4.9 mp -89.62 125.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.268 -1.136 . . . . 0.0 110.301 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.86 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -156.11 161.29 40.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.226 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.672 ' O ' ' N ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -112.31 154.47 25.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.032 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.059 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.1 OUTLIER -113.96 122.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.144 -0.972 . . . . 0.0 110.526 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.67 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.36 123.73 6.47 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.06 ' HB3' HD13 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -113.83 153.96 28.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.296 . . . . 0.0 111.654 -178.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.57 108.84 3.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.894 ' HB1' ' C ' ' A' ' 159' ' ' ARG . . . -141.54 166.16 25.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.795 -1.19 . . . . 0.0 111.573 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.681 ' CB ' ' CG ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -119.19 165.68 13.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.863 -0.523 . . . . 0.0 110.171 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.613 ' C ' ' O ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.446 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.63 -115.15 0.51 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -99.52 94.29 6.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -1.172 . . . . 0.0 110.171 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -120.65 -170.18 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.32 -130.05 1.14 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.24 -172.73 49.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 67.07 3.8 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.16 78.63 1.86 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.5 t -94.52 151.72 19.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -1.14 . . . . 0.0 110.196 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.42 94.4 1.55 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.77 145.23 20.8 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.17 178.71 20.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.48 -169.99 3.62 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' H ' HG22 ' A' ' 14' ' ' VAL . 2.1 m -58.97 -179.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.231 -1.158 . . . . 0.0 110.293 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.7 ' CB ' HG12 ' A' ' 18' ' ' ILE . 11.1 m -72.2 156.28 39.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.12 0.14 29.3 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.252 -0.905 . . . . 0.0 110.621 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 17' ' ' ASP . 16.4 t70 -162.47 46.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.063 -1.023 . . . . 0.0 110.729 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.92 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.01 -79.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.147 -0.971 . . . . 0.0 109.982 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.92 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -107.46 -45.71 1.12 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.096 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -64.27 -1.29 1.57 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -1.171 . . . . 0.0 110.369 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -60.19 -23.87 60.31 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.883 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -61.91 -38.76 89.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 0.0 110.227 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.23 -11.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 110.049 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -94.55 -8.78 37.25 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.431 -0.793 . . . . 0.0 110.254 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.69 ' O ' ' CB ' ' A' ' 70' ' ' ASN . . . -76.53 -22.52 54.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.391 -0.818 . . . . 0.0 110.249 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.1 ' CD2' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -106.3 -27.16 11.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.744 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 5.8 m -90.46 -6.06 55.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.664 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -103.12 88.85 1.7 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.158 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 27' ' ' THR . 46.8 Cg_endo -72.9 169.16 22.79 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.053 1.554 . . . . 0.0 110.458 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' CD1' ' HG3' ' A' ' 38' ' ' LYS . 1.2 mp -29.75 141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.211 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -169.42 132.83 1.28 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.335 -0.853 . . . . 0.0 110.171 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -69.53 -2.13 10.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 110.114 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -2.7 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.386 -0.822 . . . . 0.0 110.174 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.585 ' HA ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 m-20 -94.36 -171.39 2.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -111.61 -8.42 14.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.69 ' C ' HD22 ' A' ' 37' ' ' LEU . . . -176.73 -57.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -99.85 133.57 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' CA ' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -113.36 -11.88 13.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.847 ' O ' HD22 ' A' ' 40' ' ' LEU . 64.7 p -177.34 177.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.135 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 39' ' ' SER . 0.3 OUTLIER -154.78 119.45 4.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.958 . . . . 0.0 110.32 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 98.6 m -108.48 136.58 47.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 110.113 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -116.34 92.7 3.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' LEU . 26.5 mt-10 -36.18 163.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.568 ' CB ' ' ND2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -146.37 167.24 24.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 110.354 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 t -56.44 -9.65 0.76 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 110.036 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.786 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -87.01 -154.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 0.0 110.469 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -179.48 -159.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -48.26 -16.41 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 109.783 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -97.1 53.91 1.21 Allowed 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.608 0.718 . . . . 0.0 110.39 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 46' ' ' ILE . . . -164.38 85.64 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 48.5 p -98.62 134.95 40.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -1.126 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.6 pp -154.9 110.55 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 110.077 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -84.99 150.78 24.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.286 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.1 HD11 ' CD2' ' A' ' 26' ' ' LEU . 1.6 pp -141.37 129.56 22.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.356 -0.84 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 34.8 t -106.96 132.59 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.884 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.789 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -100.04 -176.55 3.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 1.096 ' O ' HG22 ' A' ' 20' ' ' THR . 54.3 mt-30 -74.46 43.54 0.18 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 23' ' ' ALA . . . -176.76 -41.72 0.06 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.744 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.52 177.42 11.21 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.248 -1.148 . . . . 0.0 110.261 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 10.9 pt-20 -141.58 150.43 42.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.214 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.588 ' HD2' ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -145.35 143.46 30.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.1 t -64.52 154.63 35.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.772 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -133.45 112.72 11.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.327 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.97 179.41 49.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.677 ' HB2' ' N ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -48.62 137.25 12.17 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.968 -1.313 . . . . 0.0 109.793 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 90.6 -18.43 49.89 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.713 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.6 m-20 46.16 110.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -1.13 . . . . 0.0 110.467 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 57.3 p -91.6 118.03 30.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.115 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -90.78 140.84 29.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -111.62 61.17 0.62 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 110.139 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 73' ' ' LYS . 11.2 p -104.98 54.85 0.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.11 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.688 ' CA ' ' O ' ' A' ' 37' ' ' LEU . . . -30.29 -33.94 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.682 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 13.3 pttt -176.6 97.82 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.177 . . . . 0.0 110.301 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.678 ' CD2' ' HD2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -83.72 -162.73 0.67 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -0.902 . . . . 0.0 110.187 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 78' ' ' LYS . 12.6 mttm -108.73 177.22 4.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 73.7 m-20 -80.24 14.69 1.82 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.196 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 260' ' ' LYS . 1.8 p-10 -166.54 74.1 0.16 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mmmp? -142.61 137.66 30.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -0.932 . . . . 0.0 109.994 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.118 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.4 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.191 -0.943 . . . . 0.0 110.422 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.679 ' CB ' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -130.15 78.62 1.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.142 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HD2' ' NE2' ' A' ' 103' ' ' GLN . 5.1 ptm180 -116.73 136.13 53.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.406 -0.809 . . . . 0.0 110.498 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.874 ' CG ' HD13 ' A' ' 54' ' ' LEU . 1.1 p90 -160.86 155.07 23.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.451 -0.78 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 7.1 p-10 -81.81 141.39 33.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.983 . . . . 0.0 110.242 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.709 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 3.2 p90 -153.75 170.5 20.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.181 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 1.018 HG22 ' CG ' ' A' ' 87' ' ' GLN . 48.1 mt -138.82 114.12 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.657 ' NE ' ' HB3' ' A' ' 98' ' ' GLU . 0.3 OUTLIER -84.48 102.68 13.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 110.092 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 1.018 ' CG ' HG22 ' A' ' 85' ' ' ILE . 2.0 mt-30 -135.65 142.72 45.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.893 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.639 HG21 ' O ' ' A' ' 49' ' ' ASN . 1.3 mp -125.02 112.49 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.971 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' CG ' HG13 ' A' ' 95' ' ' ILE . 4.7 tt0 -137.67 115.51 11.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.333 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 93' ' ' GLN . 97.4 t -102.44 171.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.574 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -67.85 3.45 1.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 110.557 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.615 ' O ' ' OE1' ' A' ' 93' ' ' GLN . . . 179.64 36.95 0.07 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.122 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.9 mm100 -148.69 -138.38 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.162 -1.199 . . . . 0.0 110.731 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 2.1 mt -45.51 163.47 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.378 0.609 . . . . 0.0 110.552 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.122 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -166.3 18.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.453 -0.779 . . . . 0.0 110.094 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.833 ' C ' HD12 ' A' ' 97' ' ' LEU . 2.0 m -60.66 162.21 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.164 -0.96 . . . . 0.0 110.533 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 96' ' ' THR . 3.8 mp -148.05 120.71 8.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.143 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.805 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.8 mt-10 -136.6 140.95 43.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.607 ' CB ' HG12 ' A' ' 85' ' ' ILE . 54.8 p -125.42 154.11 42.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . 176.96 -179.48 47.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -116.8 159.7 21.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -1.153 . . . . 0.0 110.191 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.781 ' CE1' ' CD2' ' A' ' 115' ' ' LEU . 0.1 OUTLIER -117.86 137.17 52.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.88 . . . . 0.0 110.273 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.717 ' NE2' HG21 ' A' ' 161' ' ' THR . 1.6 mm-40 -122.51 102.33 8.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.313 -0.867 . . . . 0.0 109.954 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.955 ' O ' HG12 ' A' ' 79' ' ' VAL . 5.2 t -114.44 147.6 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.562 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -139.21 120.01 14.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.678 ' HD2' ' CD2' ' A' ' 74' ' ' LEU . 25.2 mmtt -103.27 140.24 37.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.178 -0.951 . . . . 0.0 110.305 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.851 ' OE1' ' HB1' ' A' ' 237' ' ' ALA . 6.4 pt20 -110.99 -131.85 0.32 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.621 ' HA ' ' OD1' ' A' ' 76' ' ' ASN . 5.3 m -81.81 -63.7 1.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -124.77 32.23 5.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.746 ' CB ' ' N ' ' A' ' 142' ' ' GLY . 0.9 OUTLIER -151.1 -165.77 2.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.161 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.018 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -172.37 125.89 0.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 139' ' ' ASP . 0.3 OUTLIER -114.64 135.26 54.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.89 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.3 OUTLIER -129.92 173.72 10.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.021 -1.049 . . . . 0.0 110.981 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.745 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -154.59 123.51 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.585 -0.697 . . . . 0.0 109.458 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.781 ' CD2' ' CE1' ' A' ' 102' ' ' PHE . 3.3 mt -82.96 141.54 32.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 36.9 tt0 -138.29 89.45 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 110.02 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.681 HG22 ' N ' ' A' ' 118' ' ' GLU . 7.8 m -64.75 176.78 1.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.681 ' N ' HG22 ' A' ' 117' ' ' THR . 0.5 OUTLIER -142.64 -35.74 0.41 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 110.183 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.605 ' CG ' ' O ' ' A' ' 118' ' ' GLU . 30.1 mt-30 -161.0 155.07 22.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -125.84 160.44 29.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 6.2 tt0 -159.86 90.44 0.92 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.978 -1.076 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 128' ' ' LYS . 0.3 OUTLIER -119.96 -171.84 0.22 Allowed Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.937 -1.102 . . . . 0.0 109.753 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.61 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 53.2 Cg_endo -92.94 23.11 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.593 1.529 . . . . 0.0 114.376 -177.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.742 ' HB3' ' CD2' ' A' ' 125' ' ' HIS . 6.2 mt-10 -150.63 -102.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 119.652 -1.905 . . . . 0.0 112.16 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 124' ' ' GLU . 0.3 OUTLIER -131.28 -97.02 0.33 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.65 ' C ' ' O ' ' A' ' 125' ' ' HIS . 3.7 m -36.32 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 176.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.696 ' C ' ' CB ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -115.36 74.14 0.87 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.039 176.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.754 ' CE ' HG21 ' A' ' 130' ' ' VAL . 7.2 pttt -135.39 -149.17 0.33 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.448 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.688 ' CE ' ' O ' ' A' ' 129' ' ' MET . 0.0 OUTLIER -121.77 110.74 16.29 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.043 -1.035 . . . . 0.0 110.131 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.754 HG21 ' CE ' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -152.59 174.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.247 0.546 . . . . 0.0 109.993 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -125.27 114.84 19.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.055 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.61 ' O ' ' HG3' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -144.73 -162.59 1.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -143.5 108.0 4.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.3 111.05 21.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 109.952 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.87 ' CE2' ' CD2' ' A' ' 163' ' ' PHE . 24.1 t80 -105.36 116.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.538 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.694 ' CZ ' ' O ' ' A' ' 137' ' ' ILE . 1.2 ttp85 -97.49 167.75 10.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.299 -0.876 . . . . 0.0 109.724 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.769 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.73 134.52 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.594 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.713 ' O ' HG23 ' A' ' 113' ' ' THR . . . -160.11 84.39 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 112' ' ' LEU . 51.4 m-20 -110.86 144.04 40.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -1.205 . . . . 0.0 110.557 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.018 HG22 ' O ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -119.87 76.66 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 0.0 109.56 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.321 ' HB3' ' CD2' ' A' ' 144' ' ' HIS . . . -51.48 136.54 25.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.95 . . . . 0.0 110.118 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.746 ' N ' ' CB ' ' A' ' 110' ' ' SER . . . -46.5 -53.02 10.14 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -151.4 40.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -1.092 . . . . 0.0 110.141 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 1.321 ' CD2' ' HB3' ' A' ' 141' ' ' ALA . 7.1 p80 -48.07 80.92 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.507 0.67 . . . . 0.0 110.549 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.668 ' N ' ' O ' ' A' ' 143' ' ' GLU . 0.2 OUTLIER -107.33 -166.42 1.15 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 110.19 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.714 ' CA ' ' O ' ' A' ' 210' ' ' HIS . 0.1 OUTLIER -72.16 120.62 18.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.977 ' CD1' ' HB2' ' A' ' 212' ' ' ALA . 1.6 m-85 -42.03 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 0.0 109.568 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.626 ' HB2' ' OG ' ' A' ' 146' ' ' SER . 5.8 t70 -40.2 -24.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.947 . . . . 0.0 109.261 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.732 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 0.5 OUTLIER -83.16 21.9 1.04 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.671 0.748 . . . . 0.0 109.058 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.783 ' O ' HD23 ' A' ' 150' ' ' LEU . 0.2 OUTLIER 179.73 57.92 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 43.3 Cg_endo -86.56 96.02 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.293 1.681 . . . . 0.0 110.326 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.956 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -144.73 81.34 1.65 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.505 ' C ' ' O ' ' A' ' 152' ' ' LYS . 4.7 m-20 -26.54 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.486 1.136 . . . . 0.0 110.36 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.956 ' N ' ' O ' ' A' ' 152' ' ' LYS . 7.1 t -120.34 159.92 21.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.295 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -102.08 135.25 44.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.045 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.858 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -122.19 103.46 8.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.867 . . . . 0.0 110.35 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.609 ' O ' ' O ' ' A' ' 261' ' ' GLN . 4.8 t -46.28 152.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 109.985 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.745 ' CD1' ' O ' ' A' ' 261' ' ' GLN . 1.8 m-85 -133.24 137.96 46.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 11.4 ptp180 -149.6 127.24 11.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.606 ' HA2' ' OH ' ' A' ' 105' ' ' TYR . . . -169.87 -132.29 1.43 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 170' ' ' GLY . 0.9 OUTLIER -138.65 137.6 37.03 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.182 -1.187 . . . . 0.0 110.94 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 172' ' ' LEU . . . -123.61 117.0 24.04 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.87 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -101.63 145.4 29.12 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.592 -1.243 . . . . 0.0 112.105 -177.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 255' ' ' ILE . . . -112.76 135.51 12.74 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.81 ' CB ' ' CD2' ' A' ' 254' ' ' HIS . 0.9 OUTLIER -67.3 -10.35 50.01 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.076 -1.249 . . . . 0.0 110.241 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 253' ' ' HIS . 13.4 t70 -147.75 9.88 0.92 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.479 -0.763 . . . . 0.0 109.961 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 169' ' ' GLY . 0.3 OUTLIER -124.9 172.37 9.43 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.408 -0.808 . . . . 0.0 109.261 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 1.069 ' HB3' HD23 ' A' ' 190' ' ' LEU . . . -70.85 1.57 5.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.113 -0.992 . . . . 0.0 108.741 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.912 ' HA2' HD11 ' A' ' 187' ' ' ILE . . . -26.88 116.01 0.03 OUTLIER Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.908 ' O ' HG23 ' A' ' 161' ' ' THR . . . -156.86 -56.84 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.711 ' HG3' ' CE1' ' A' ' 189' ' ' HIS . 18.4 mtpt -119.77 137.52 53.9 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.919 -1.342 . . . . 0.0 109.663 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.938 HD13 ' HB2' ' A' ' 162' ' ' ALA . 1.2 pt? -148.75 141.29 24.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.777 -1.202 . . . . 0.0 111.42 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 29.4 m -105.51 136.15 45.61 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.994 ' CE2' HD21 ' A' ' 199' ' ' LEU . 0.4 OUTLIER -125.79 159.91 31.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.861 -1.15 . . . . 0.0 111.172 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 175' ' ' THR . 0.8 OUTLIER -141.35 102.46 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 1.056 HG23 ' O ' ' A' ' 182' ' ' GLN . 8.1 mt -128.07 150.54 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 110.975 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.946 ' OD1' ' HB3' ' A' ' 180' ' ' ALA . 9.4 t0 -104.84 139.94 38.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.437 -0.789 . . . . 0.0 109.764 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.858 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 81.0 m-85 -51.91 -139.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.612 0.72 . . . . 0.0 111.274 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 181' ' ' LYS . . . -33.38 -33.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.484 -0.76 . . . . 0.0 109.928 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.946 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . . . -67.56 57.48 0.06 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 179' ' ' ALA . 14.7 mttp -16.11 75.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.498 0.666 . . . . 0.0 111.43 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 1.056 ' O ' HG23 ' A' ' 176' ' ' ILE . 5.5 tt0 -127.16 137.05 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.574 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.692 ' HA2' ' CG1' ' A' ' 176' ' ' ILE . . . -153.56 148.07 18.29 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.306 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 2.8 t-160 178.82 122.84 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.176 -1.19 . . . . 0.0 109.98 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 174' ' ' TYR . . . -160.23 -178.75 34.5 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.011 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 172' ' ' LEU . 13.0 mtmt -143.11 158.15 43.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -1.074 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.144 HD12 ' N ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -115.03 138.2 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 1.144 ' N ' HD12 ' A' ' 187' ' ' ILE . 11.4 pt-20 -162.66 143.03 9.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.458 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.761 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 6.5 t60 -160.72 -34.83 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.893 . . . . 0.0 109.976 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.069 HD23 ' HB3' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -41.23 178.51 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.566 0.698 . . . . 0.0 111.183 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -60.6 0.57 0.19 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.464 -0.773 . . . . 0.0 111.953 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 195' ' ' LEU . 3.2 m -151.16 125.74 4.59 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.801 -1.187 . . . . 0.0 110.967 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.676 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 48.9 Cg_endo -74.47 11.59 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.947 1.498 . . . . 0.0 110.16 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.98 -26.79 12.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.369 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.835 HD12 ' N ' ' A' ' 195' ' ' LEU . 5.5 mp -86.12 10.62 13.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.849 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.698 ' CB ' ' HB3' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -78.79 -162.56 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 110.173 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.997 HG13 ' O ' ' A' ' 219' ' ' LEU . 74.4 t -135.06 145.88 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.954 . . . . 0.0 110.516 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.535 ' C ' ' OD1' ' A' ' 198' ' ' ASP . 8.8 t0 -93.88 133.2 37.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 109.576 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.056 HD22 ' CD2' ' A' ' 228' ' ' TYR . 0.1 OUTLIER -121.42 158.7 27.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.111 -0.993 . . . . 0.0 110.938 -179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.989 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -136.14 130.93 34.04 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.942 HG11 HG23 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -135.62 159.94 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.881 -1.137 . . . . 0.0 111.756 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.29 128.43 55.56 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.439 -0.788 . . . . 0.0 109.287 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.805 ' CD1' ' N ' ' A' ' 204' ' ' ILE . 0.6 OUTLIER -82.67 158.34 22.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.093 -1.004 . . . . 0.0 110.83 -179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.826 HG22 HG21 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -144.46 167.83 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.495 -0.753 . . . . 0.0 109.786 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.742 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.57 -69.97 0.16 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.742 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 46.7 Cg_endo -72.78 111.73 3.32 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.934 1.492 . . . . 0.0 110.517 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.788 ' CA ' HG22 ' A' ' 213' ' ' VAL . 56.5 t0 -88.49 -118.87 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.584 ' C ' ' HG3' ' A' ' 209' ' ' LYS . 3.0 mt-10 -81.27 -26.95 35.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 109.94 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB3' ' CD2' ' A' ' 210' ' ' HIS . 16.6 mtpp -140.43 -52.88 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.467 -0.771 . . . . 0.0 109.932 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.798 ' CE1' ' NE2' ' A' ' 211' ' ' HIS . 1.1 p80 -170.18 37.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.223 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.798 ' NE2' ' CE1' ' A' ' 210' ' ' HIS . 5.8 m170 -126.63 -175.76 3.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.264 -0.898 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.005 ' HB3' ' O ' ' A' ' 232' ' ' ILE . . . -66.75 154.88 39.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.207 -0.933 . . . . 0.0 110.049 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.826 HG21 HG22 ' A' ' 204' ' ' ILE . 0.2 OUTLIER -128.81 157.73 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.0 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.942 HG23 HG11 ' A' ' 201' ' ' VAL . 3.5 mm -149.48 123.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 109.91 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.698 ' C ' HG22 ' A' ' 201' ' ' VAL . 63.7 m -147.49 143.51 27.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.098 -1.001 . . . . 0.0 110.365 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . 179.87 -167.18 36.77 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.75 175.51 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -1.041 . . . . 0.0 110.126 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 199' ' ' LEU . 6.2 t -137.98 159.75 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.208 -0.932 . . . . 0.0 110.556 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.997 ' O ' HG13 ' A' ' 197' ' ' VAL . 0.2 OUTLIER -156.66 172.22 18.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.843 . . . . 0.0 109.734 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.947 ' HB2' HG22 ' A' ' 197' ' ' VAL . 11.5 t80 -158.18 155.95 29.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.04 -1.037 . . . . 0.0 110.589 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.52 ' C ' ' O ' ' A' ' 220' ' ' TYR . 0.1 OUTLIER -36.71 -25.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.234 -0.917 . . . . 0.0 109.849 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.711 ' O ' ' N ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -88.69 59.9 5.32 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.66 ' C ' ' O ' ' A' ' 222' ' ' GLN . 20.1 t70 4.25 61.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.561 0.696 . . . . 0.0 111.247 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 222' ' ' GLN . 7.5 tt0 -92.04 -174.16 3.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.621 -0.675 . . . . 0.0 109.403 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.626 ' CD ' ' O ' ' A' ' 224' ' ' GLU . 1.5 mmmt -158.24 81.89 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.838 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 246' ' ' VAL . . . -101.08 158.19 19.03 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 245' ' ' GLU . 0.6 OUTLIER -104.05 159.84 15.34 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.355 -1.085 . . . . 0.0 109.943 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.056 ' CD2' HD22 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -145.53 124.61 12.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.084 -1.01 . . . . 0.0 110.978 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 1.189 ' C ' HD12 ' A' ' 230' ' ' LEU . 78.9 p -147.96 122.86 10.01 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.435 -0.791 . . . . 0.0 109.56 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.189 HD12 ' C ' ' A' ' 229' ' ' SER . 7.5 mp -139.81 173.67 11.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.939 -1.1 . . . . 0.0 110.959 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -118.4 128.58 7.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 1.013 HG13 HG23 ' A' ' 240' ' ' VAL . 9.4 mt -106.58 160.69 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.031 -1.276 . . . . 0.0 111.289 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.718 ' N ' ' CD1' ' A' ' 233' ' ' PHE . 0.1 OUTLIER -148.88 144.74 27.08 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . -147.55 1.65 0.73 Allowed Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.656 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.661 ' CG ' ' OG1' ' A' ' 145' ' ' THR . 1.4 tt0 -40.08 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.791 -1.417 . . . . 0.0 109.105 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 234' ' ' GLY . 2.3 tptt -179.24 35.19 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.851 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -168.42 79.99 0.15 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.031 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.465 ' OE1' ' HB1' ' A' ' 156' ' ' ALA . 2.8 mt-30 -61.92 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 109.391 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 237' ' ' ALA . 1.4 tp10 -110.38 156.68 20.44 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.601 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 1.013 HG23 HG13 ' A' ' 232' ' ' ILE . 12.1 p -135.98 122.91 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.735 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -143.72 143.5 31.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.962 . . . . 0.0 110.478 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -176.67 -131.55 1.5 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.63 ' O ' ' O ' ' A' ' 229' ' ' SER . 64.0 p -158.46 -179.11 7.79 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.387 -1.066 . . . . 0.0 108.963 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 1.11 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -166.8 171.18 11.64 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.663 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.3 tt0 -112.51 155.61 24.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.951 HG12 ' CD2' ' A' ' 253' ' ' HIS . 29.5 t -141.55 117.56 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.79 136.29 54.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.123 -0.986 . . . . 0.0 110.201 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 249' ' ' ALA . 1.5 m -108.47 -176.48 3.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.575 ' H ' HG22 ' A' ' 248' ' ' THR . . . -68.11 2.23 2.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.217 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -175.87 25.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.282 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 252' ' ' ILE . . . -143.45 -177.83 18.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 251' ' ' GLY . 0.6 OUTLIER -166.65 121.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.307 -1.114 . . . . 0.0 110.269 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.951 ' CD2' HG12 ' A' ' 246' ' ' VAL . 0.0 OUTLIER -152.84 161.54 42.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.81 ' CD2' ' CB ' ' A' ' 165' ' ' SER . 0.1 OUTLIER -110.95 157.9 19.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 110.006 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 1.11 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -127.3 127.45 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 110.554 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.73 ' HA3' ' CE2' ' A' ' 163' ' ' PHE . . . -85.16 142.41 19.75 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.051 ' CD1' HD11 ' A' ' 230' ' ' LEU . 5.6 mt -127.77 134.5 49.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.373 . . . . 0.0 111.741 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -152.9 109.17 3.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.673 -0.642 . . . . 0.0 109.288 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 239' ' ' GLU . . . -143.36 157.08 44.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.884 -1.135 . . . . 0.0 110.916 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.684 ' CB ' ' OE1' ' A' ' 239' ' ' GLU . 0.3 OUTLIER -112.81 165.26 12.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 110.187 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 13.9 mm-40 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.186 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.3 mtt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.296 0.569 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.22 121.15 5.34 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -153.79 174.03 15.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.135 . . . . 0.0 110.272 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -153.97 105.05 2.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.281 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.34 -144.54 10.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.43 149.61 20.28 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.39 154.13 27.04 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.23 -107.86 0.33 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.8 p -149.59 -60.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -1.132 . . . . 0.0 110.21 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.41 70.24 2.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.16 56.21 0.31 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.53 176.71 0.63 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.94 165.03 38.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 18' ' ' ILE . 2.3 m -58.94 153.93 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.313 -1.11 . . . . 0.0 110.338 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.896 HG23 ' H ' ' A' ' 17' ' ' ASP . 14.8 t -84.03 174.25 10.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.212 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.08 6.38 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 0.0 110.69 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.896 ' H ' HG23 ' A' ' 15' ' ' THR . 12.7 m-20 -133.47 42.94 2.95 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.116 -0.99 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 1.2 mt -115.62 -79.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 0.0 109.996 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -140.64 16.09 2.88 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -4.91 1.62 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -1.208 . . . . 0.0 110.316 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.6 -8.71 85.72 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.749 ' CD2' ' N ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -68.86 -39.0 80.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -1.128 . . . . 0.0 110.219 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.919 ' HB1' ' N ' ' A' ' 59' ' ' ALA . . . -55.48 -11.12 0.76 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.069 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.899 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.8 m-20 -94.79 -8.8 36.46 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.465 -0.772 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.77 -20.63 45.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.828 . . . . 0.0 110.264 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -106.16 -42.15 5.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.796 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 18.0 m -77.98 -5.64 51.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.135 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.899 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -115.87 89.12 23.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.481 -0.762 . . . . 0.0 110.212 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.571 ' O ' ' C ' ' A' ' 30' ' ' LEU . 45.9 Cg_endo -73.18 171.61 17.25 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.013 1.533 . . . . 0.0 110.397 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 38' ' ' LYS . 5.8 tp -29.82 146.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 110.199 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.593 ' CG ' ' HE2' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -155.57 -174.27 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 110.222 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -113.47 48.16 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HE2' ' CG ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -156.63 13.39 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.227 -0.921 . . . . 0.0 110.469 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -76.37 174.97 9.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -118.85 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.03 -114.61 0.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 37' ' ' LEU . 4.5 mm? -83.49 127.43 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HB3' HD12 ' A' ' 30' ' ' LEU . 42.8 mtmt -64.01 -43.19 96.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.753 ' O ' HD22 ' A' ' 40' ' ' LEU . 56.8 p 175.49 -174.97 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 110.172 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.753 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -151.88 117.87 5.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 110.171 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.9 HG23 ' HB2' ' A' ' 68' ' ' SER . 54.3 m -90.85 154.27 19.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 68' ' ' SER . 5.4 mp -96.61 124.77 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.861 . . . . 0.0 110.185 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.667 ' O ' ' N ' ' A' ' 45' ' ' SER . 3.6 pt-20 -48.39 -168.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.01 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.667 ' N ' ' O ' ' A' ' 43' ' ' GLU . 13.3 p -73.92 -45.17 52.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.787 HG22 ' H ' ' A' ' 47' ' ' SER . 1.6 mt -107.82 -157.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.457 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.787 ' H ' HG22 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.5 -174.19 0.46 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.592 -0.693 . . . . 0.0 109.83 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.55 -12.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.666 ' CA ' HG13 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.34 1.83 54.48 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.563 -0.711 . . . . 0.0 110.37 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -135.84 70.71 0.5 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 37.1 p -103.37 135.44 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -1.141 . . . . 0.0 110.193 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 63' ' ' TYR . 1.2 pp -161.17 159.39 28.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.293 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 1.1 m -117.2 154.63 30.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.199 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 26' ' ' LEU . 2.0 pp -134.99 129.22 33.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.228 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HA ' ' CB ' ' A' ' 60' ' ' GLU . 28.7 t -116.53 129.04 55.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.856 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -94.53 -178.01 4.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.515 HE22 ' NH1' ' A' ' 81' ' ' ARG . 30.5 mt-30 -74.5 43.62 0.19 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.599 ' CA ' ' CB ' ' A' ' 23' ' ' ALA . . . -179.98 -35.8 0.07 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.919 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -154.55 177.32 11.33 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.241 -1.152 . . . . 0.0 110.272 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.612 ' CB ' ' HA ' ' A' ' 55' ' ' SER . 12.6 pt-20 -142.72 165.6 26.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.886 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 2.5 tptm -147.64 124.94 11.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.214 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.7 t -59.06 117.09 4.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 0.0 110.184 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.74 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -103.02 112.95 26.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.23 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.79 -162.01 10.1 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.662 ' HB2' ' CA ' ' A' ' 47' ' ' SER . 4.6 t-20 -48.94 127.79 14.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.187 . . . . 0.0 109.982 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.586 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.68 -5.27 84.79 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' C ' ' O ' ' A' ' 66' ' ' GLY . 13.4 p-10 -29.16 136.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -1.055 . . . . 0.0 110.202 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.9 ' HB2' HG23 ' A' ' 41' ' ' THR . 20.7 t -130.17 156.88 43.85 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.327 -0.858 . . . . 0.0 110.206 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 39' ' ' SER . 0.3 OUTLIER -117.88 156.85 27.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.896 . . . . 0.0 110.27 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.64 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 2.9 t-20 -147.62 115.73 6.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.073 ' CB ' HD21 ' A' ' 74' ' ' LEU . 8.2 p -119.69 39.08 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.56 0.15 10.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.15 -27.55 13.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -1.172 . . . . 0.0 110.212 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.073 HD21 ' CB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -102.32 -162.64 0.94 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 110.203 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -121.49 -140.28 0.33 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.319 -0.863 . . . . 0.0 110.229 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 107' ' ' GLN . 7.9 m-80 -114.57 20.37 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 110.218 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.7 ' CA ' ' HD3' ' A' ' 260' ' ' LYS . 6.8 m-20 -137.65 62.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -154.02 -166.8 2.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 105' ' ' TYR . 2.3 t -130.99 169.01 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.192 -0.943 . . . . 0.0 110.415 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 31.7 m -135.03 94.64 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.41 -0.806 . . . . 0.0 109.699 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -109.51 125.15 52.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 110.364 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.737 ' CD1' ' HB2' ' A' ' 54' ' ' LEU . 29.4 p90 -148.47 143.19 26.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 110.112 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 4.0 p30 -81.14 139.02 35.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.805 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 21.2 p90 -153.43 176.5 11.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 1.061 HG23 ' O ' ' A' ' 98' ' ' GLU . 2.6 mp -142.14 122.63 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 110.393 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' CZ ' ' CE1' ' A' ' 84' ' ' PHE . 2.5 mtm-85 -85.13 112.4 20.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.356 -0.84 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' A' ' 85' ' ' ILE . 33.3 mt-30 -127.55 126.45 42.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.351 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.91 ' CD1' HD22 ' A' ' 94' ' ' LEU . 3.2 tt -114.41 112.02 38.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.255 -0.903 . . . . 0.0 110.099 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 2.4 tt0 -141.08 128.09 20.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 110.403 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.673 HG11 ' CD ' ' A' ' 93' ' ' GLN . 98.6 t -114.27 170.76 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.326 -0.859 . . . . 0.0 109.899 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -65.05 -0.9 1.78 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 110.555 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.54 42.02 0.07 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.145 ' O ' HD12 ' A' ' 95' ' ' ILE . 16.5 mt-30 -151.55 -139.08 0.09 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.253 -1.145 . . . . 0.0 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.91 HD22 ' CD1' ' A' ' 88' ' ' ILE . 1.1 mt -45.3 163.16 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.309 0.576 . . . . 0.0 110.675 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.145 HD12 ' O ' ' A' ' 93' ' ' GLN . 0.7 OUTLIER -167.57 18.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.53 -0.731 . . . . 0.0 109.906 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 97' ' ' LEU . 87.6 m -59.45 172.5 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 110.528 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -167.96 115.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 110.095 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.061 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.4 tt0 -135.77 157.15 47.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.945 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.608 ' OG ' HG13 ' A' ' 85' ' ' ILE . 30.6 t -129.41 159.6 35.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -0.886 . . . . 0.0 110.169 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 117' ' ' THR . . . -179.89 -159.24 23.39 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.546 ' OE1' ' CZ ' ' A' ' 163' ' ' PHE . 4.9 tm-20 -120.56 159.94 24.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.145 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.893 ' CZ ' HD21 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -124.67 135.92 53.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.947 . . . . 0.0 110.383 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.925 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 1.4 mm-40 -128.05 102.89 6.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 113' ' ' THR . 24.9 t -117.58 112.91 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 110.721 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.91 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -89.17 141.62 28.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.039 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -120.89 136.35 54.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 110.336 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.707 ' NE2' HD21 ' A' ' 112' ' ' LEU . 2.8 mt-30 -116.41 -138.98 0.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 76' ' ' ASN . 13.3 p -89.96 -57.19 2.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.208 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -114.91 -25.3 8.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.045 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.653 ' CB ' ' HA ' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -108.31 -164.02 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . . . -172.64 162.78 5.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.218 -0.926 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.91 HD12 ' HB3' ' A' ' 105' ' ' TYR . 1.5 mt -119.99 161.66 20.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.613 ' O ' ' O ' ' A' ' 138' ' ' GLY . 10.2 m -136.63 171.7 14.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.148 -0.97 . . . . 0.0 110.8 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.925 ' HB3' ' CB ' ' A' ' 103' ' ' GLN . . . -171.14 120.62 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.541 -0.724 . . . . 0.0 109.609 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.893 HD21 ' CZ ' ' A' ' 102' ' ' PHE . 4.3 mt -114.62 108.16 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.582 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 135' ' ' PHE . 30.3 tt0 -102.83 132.81 48.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.502 HG22 ' N ' ' A' ' 118' ' ' GLU . 78.9 m -103.28 167.09 10.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.385 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HG3' ' HG3' ' A' ' 119' ' ' GLN . 2.7 tp10 -143.04 -41.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.845 . . . . 0.0 110.121 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.689 ' O ' ' CG ' ' A' ' 98' ' ' GLU . 11.8 mt-30 -133.18 154.95 50.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.214 -0.929 . . . . 0.0 110.155 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -152.17 143.11 23.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.333 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.615 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 1.5 mt-30 -120.0 142.35 48.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -0.941 . . . . 0.0 110.031 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.741 ' N ' ' O ' ' A' ' 127' ' ' GLU . 0.6 OUTLIER -142.11 104.69 5.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.016 -1.052 . . . . 0.0 110.997 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 122' ' ' ASP . 48.1 Cg_endo -74.7 48.08 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.238 1.652 . . . . 0.0 111.414 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.757 ' O ' ' CD2' ' A' ' 125' ' ' HIS . 0.6 OUTLIER -88.0 -40.27 14.01 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.384 1.088 . . . . 0.0 108.353 178.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.757 ' CD2' ' O ' ' A' ' 124' ' ' GLU . 13.0 m80 -164.35 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.24 17.07 9.11 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.741 ' O ' ' N ' ' A' ' 122' ' ' ASP . 1.6 mt-10 -106.2 9.57 32.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 111.595 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -57.14 -0.57 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.121 -0.987 . . . . 0.0 111.17 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.601 ' HA ' ' HG3' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -156.77 125.44 5.82 Favored 'General case' 0 C--N 1.284 -2.257 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.233 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -151.4 160.94 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 110.193 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -139.8 114.94 9.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -145.08 -162.83 1.58 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 134' ' ' ARG . 4.5 mtm-85 -125.69 111.65 15.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' ARG . 0.2 OUTLIER -143.78 110.92 5.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.086 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.797 ' CE1' ' NE2' ' A' ' 254' ' ' HIS . 11.2 p90 -117.84 129.92 55.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.5 ttp85 -102.82 107.41 18.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.9 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 1.045 HD12 ' O ' ' A' ' 137' ' ' ILE . 2.7 pp -77.68 117.13 22.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.214 -0.929 . . . . 0.0 110.751 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 113' ' ' THR . . . -136.07 152.0 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' A' ' 112' ' ' LEU . 3.0 p30 -166.77 158.95 13.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.263 . . . . 0.0 110.552 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.906 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -130.37 81.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.259 -0.901 . . . . 0.0 109.674 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.653 ' HA ' ' CB ' ' A' ' 110' ' ' SER . . . -112.64 141.59 46.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.951 . . . . 0.0 110.106 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.58 65.63 1.72 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.742 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 2.5 tt0 -77.26 41.14 0.29 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.413 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.6 ' HA ' ' CD2' ' A' ' 211' ' ' HIS . 61.2 m-70 -98.87 5.72 47.2 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.37 -0.831 . . . . 0.0 110.107 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.237 HG21 ' N ' ' A' ' 235' ' ' GLU . 1.8 t -106.8 108.38 19.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 111.207 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 210' ' ' HIS . 0.2 OUTLIER -63.53 123.44 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.438 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 1.02 ' CG ' ' HB2' ' A' ' 212' ' ' ALA . 1.0 OUTLIER -60.21 -4.14 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.256 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' CG ' ' HG2' ' A' ' 205' ' ' LYS . 35.8 t70 -97.44 13.37 30.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.61 ' CD ' ' C ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -124.59 -1.45 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.842 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.098 HD23 ' CD ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER -123.0 -50.39 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.033 -1.042 . . . . 0.0 110.508 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 1.098 ' CD ' HD23 ' A' ' 150' ' ' LEU . 48.8 Cg_endo -91.88 -162.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.809 1.426 . . . . 0.0 110.144 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 1.21 ' O ' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -149.29 -68.98 0.21 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.765 . . . . 0.0 109.699 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -150.81 38.37 0.67 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.562 -0.711 . . . . 0.0 109.389 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.746 ' HB ' ' CD2' ' A' ' 178' ' ' PHE . 71.2 t -96.29 166.26 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.327 -0.858 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.669 ' HA ' ' O ' ' A' ' 176' ' ' ILE . 1.3 mtm -111.05 102.69 11.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 110.225 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.981 ' HB2' ' CZ ' ' A' ' 178' ' ' PHE . . . -90.58 103.37 16.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.577 ' O ' ' OXT' ' A' ' 261' ' ' GLN . 91.5 m -42.96 142.04 1.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.746 ' CE2' ' OH ' ' A' ' 203' ' ' TYR . 4.1 m-85 -132.53 125.52 30.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.61 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.0 ptp85 -140.12 142.18 36.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.514 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 259' ' ' ALA . . . -163.8 -158.05 9.75 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.924 -1.608 . . . . 0.0 111.054 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.924 ' C ' HD21 ' A' ' 172' ' ' LEU . 53.2 m -128.72 156.0 44.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.894 -0.768 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.895 ' HB2' HD22 ' A' ' 172' ' ' LEU . . . -140.62 -178.87 5.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 110.691 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.731 ' CE1' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -142.88 141.4 31.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.959 179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 255' ' ' ILE . . . -124.78 141.4 13.15 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.106 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -67.6 -10.85 55.79 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -1.089 . . . . 0.0 109.841 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -121.32 1.09 10.18 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.718 0.771 . . . . 0.0 109.683 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.65 171.32 10.16 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.653 -0.654 . . . . 0.0 109.238 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.54 60.56 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.041 -1.037 . . . . 0.0 110.377 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.02 -119.21 0.66 Allowed Glycine 0 C--N 1.284 -2.312 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.71 ' HA3' ' HB3' ' A' ' 162' ' ' ALA . . . 177.18 153.96 11.5 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 188' ' ' GLU . 7.9 mttp -139.5 119.77 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -1.116 . . . . 0.0 108.982 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.924 HD21 ' C ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -117.51 130.94 56.75 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.105 -0.997 . . . . 0.0 110.94 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 159' ' ' ARG . 5.6 m -150.18 99.16 2.77 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.143 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 1.249 ' CE1' HD23 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.35 160.1 40.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.076 -1.015 . . . . 0.0 111.239 -179.25 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 157' ' ' THR . 86.2 m -99.25 114.41 27.21 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.996 HG21 ' CE1' ' A' ' 203' ' ' TYR . 1.5 mt -103.75 163.19 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.1 -1.0 . . . . 0.0 111.298 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.753 ' CG ' ' HB3' ' A' ' 180' ' ' ALA . 68.5 t0 -121.3 127.5 51.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 0.0 109.783 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.981 ' CZ ' ' HB2' ' A' ' 156' ' ' ALA . 90.6 m-85 -48.21 -141.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.964 0.887 . . . . 0.0 112.226 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 1.21 ' HB3' ' O ' ' A' ' 152' ' ' LYS . . . -33.28 -39.23 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.726 -0.609 . . . . 0.0 110.175 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.753 ' HB3' ' CG ' ' A' ' 177' ' ' ASP . . . -67.67 52.38 0.06 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.709 ' CB ' ' O ' ' A' ' 203' ' ' TYR . 3.1 pttm -17.94 75.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.223 0.535 . . . . 0.0 111.195 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.753 ' N ' ' O ' ' A' ' 180' ' ' ALA . 0.9 OUTLIER -147.59 114.93 6.27 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.049 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 176' ' ' ILE . . . -155.77 159.52 29.33 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.082 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.61 ' CE1' ' O ' ' A' ' 199' ' ' LEU . 4.3 t60 179.76 148.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -1.001 . . . . 0.0 109.717 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.652 ' N ' ' HB3' ' A' ' 174' ' ' TYR . . . -162.06 -136.1 1.94 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.006 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.542 ' N ' ' HD1' ' A' ' 174' ' ' TYR . 9.4 mttt -135.19 120.88 19.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -1.113 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.142 HD13 ' OH ' ' A' ' 228' ' ' TYR . 0.4 OUTLIER -92.95 130.15 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.131 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 0.4 OUTLIER -123.1 91.4 3.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.296 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.645 ' HA ' ' HA2' ' A' ' 170' ' ' GLY . 41.2 m-70 -44.16 -49.33 9.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 0.0 109.951 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.126 HD11 ' HB2' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.16 -103.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 110.162 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.613 ' HG3' ' O ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -164.88 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.49 -0.756 . . . . 0.0 110.74 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.627 ' OG ' ' CD1' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -53.02 132.88 49.76 Favored Pre-proline 0 C--N 1.294 -1.818 0 O-C-N 121.599 -0.688 . . . . 0.0 110.045 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.466 ' HA ' ' OD1' ' A' ' 196' ' ' ASN . 44.0 Cg_endo -71.37 46.12 0.71 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.958 1.504 . . . . 0.0 110.004 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.417 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.0 mt-10 -149.86 -32.3 0.2 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.302 -0.874 . . . . 0.0 110.334 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HB2' HD11 ' A' ' 190' ' ' LEU . 5.1 mp -91.08 6.93 42.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.313 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.715 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -79.59 170.87 15.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.304 -0.872 . . . . 0.0 109.682 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.943 ' CG2' HG23 ' A' ' 187' ' ' ILE . 27.7 m -139.96 154.34 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 110.542 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 219' ' ' LEU . 1.7 m-20 -73.67 116.81 14.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.53 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.249 HD23 ' CE1' ' A' ' 174' ' ' TYR . 0.1 OUTLIER -110.28 158.01 18.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.166 -0.959 . . . . 0.0 110.521 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.013 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -129.73 122.03 28.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.623 -0.673 . . . . 0.0 109.405 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.934 ' CG1' HG23 ' A' ' 214' ' ' ILE . 20.1 t -110.02 136.02 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.981 . . . . 0.0 111.003 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 214' ' ' ILE . . . -110.84 122.97 49.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.369 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.996 ' CE1' HG21 ' A' ' 176' ' ' ILE . 0.1 OUTLIER -85.23 102.94 13.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.906 -179.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.685 ' HB ' ' CG2' ' A' ' 213' ' ' VAL . 98.3 mt -83.97 153.44 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.543 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.768 ' CB ' ' CD ' ' A' ' 206' ' ' PRO . 1.5 mtpp -81.74 -74.59 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.422 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.768 ' CD ' ' CB ' ' A' ' 205' ' ' LYS . 48.1 Cg_endo -73.64 94.15 0.86 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.685 1.361 . . . . 0.0 110.631 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.665 ' CB ' HG22 ' A' ' 213' ' ' VAL . 30.8 t0 -67.93 -134.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.999 . . . . 0.0 109.927 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.593 ' HA ' ' OE1' ' A' ' 208' ' ' GLU . 1.3 mm-40 -63.2 -10.81 16.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.961 . . . . 0.0 109.841 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 208' ' ' GLU . 3.9 mptt -166.29 -66.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.821 . . . . 0.0 109.881 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.8 ' CD2' ' NE2' ' A' ' 211' ' ' HIS . 10.3 p-80 -147.88 42.05 1.03 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 109.963 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.8 ' NE2' ' CD2' ' A' ' 210' ' ' HIS . 3.3 m170 -126.13 -176.62 3.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.959 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 1.02 ' HB2' ' CG ' ' A' ' 147' ' ' PHE . . . -93.47 156.09 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.751 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.685 ' CG2' ' HB ' ' A' ' 204' ' ' ILE . 0.1 OUTLIER -132.65 169.89 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.01 -1.056 . . . . 0.0 110.491 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.973 HD12 HG21 ' A' ' 240' ' ' VAL . 8.0 mt -145.96 104.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.873 . . . . 0.0 110.137 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.559 ' O ' ' HB3' ' A' ' 202' ' ' ALA . 32.9 t -131.0 140.44 50.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 0.0 110.23 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.598 ' HA3' ' O ' ' A' ' 200' ' ' ALA . . . -175.1 -153.86 10.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 2.9 p -129.32 175.43 8.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -1.121 . . . . 0.0 110.384 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 1.051 HG22 ' HB2' ' A' ' 199' ' ' LEU . 31.5 t -144.82 149.4 17.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.379 -0.825 . . . . 0.0 109.929 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 218' ' ' VAL . 0.3 OUTLIER -147.72 145.94 29.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.051 -1.031 . . . . 0.0 110.661 -179.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.777 ' CB ' HG12 ' A' ' 197' ' ' VAL . 3.6 t80 -97.56 154.38 17.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.735 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.432 ' N ' ' CD1' ' A' ' 220' ' ' TYR . 4.0 m120 -74.81 -12.7 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 110.469 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 1.0 OUTLIER -82.03 -63.61 1.35 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.793 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.75 26.81 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 121.182 0.515 . . . . 0.0 110.362 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 8.5 tt0 -86.46 171.76 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 0.0 111.214 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 224' ' ' GLU . 2.3 mttp -151.45 81.35 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.568 ' O ' ' O ' ' A' ' 218' ' ' VAL . . . -108.13 174.59 19.17 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.431 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 217' ' ' SER . 18.9 t -132.47 174.08 10.64 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.588 -0.948 . . . . 0.0 109.997 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.142 ' OH ' HD13 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -136.44 134.01 37.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.166 -0.959 . . . . 0.0 110.75 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.926 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -147.75 119.95 8.33 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.329 -0.857 . . . . 0.0 109.884 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.059 HD23 ' N ' ' A' ' 242' ' ' GLY . 4.8 mp -158.04 174.37 15.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.129 -0.982 . . . . 0.0 110.573 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.79 ' O ' HG23 ' A' ' 240' ' ' VAL . . . -119.9 136.88 11.97 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -109.44 137.1 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.246 . . . . 0.0 110.808 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.669 ' CB ' ' HA ' ' A' ' 143' ' ' GLU . 1.1 p90 -131.38 158.09 41.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.733 -0.604 . . . . 0.0 109.509 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.77 ' C ' HG21 ' A' ' 145' ' ' THR . . . 179.83 55.37 0.08 OUTLIER Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.827 -1.654 . . . . 0.0 110.974 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 1.237 ' N ' HG21 ' A' ' 145' ' ' THR . 5.5 pt-20 -60.45 -11.88 8.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.819 -1.4 . . . . 0.0 107.699 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 14.2 tptt -176.86 33.54 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.672 ' O ' ' N ' ' A' ' 239' ' ' GLU . . . -170.48 90.23 0.16 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.361 -177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.746 ' O ' ' CE1' ' A' ' 158' ' ' TYR . 3.3 mp0 -60.28 53.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.504 -0.748 . . . . 0.0 110.141 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.674 ' CD ' ' CB ' ' A' ' 260' ' ' LYS . 5.6 mt-10 -105.14 157.97 16.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.591 -0.693 . . . . 0.0 110.353 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.973 HG21 HD12 ' A' ' 214' ' ' ILE . 0.9 OUTLIER -152.96 146.92 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.919 . . . . 0.0 110.246 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -145.34 155.62 43.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 0.0 110.284 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 1.059 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.8 -146.88 7.1 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 13.3 t -152.33 134.08 14.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -1.094 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.992 ' HB3' ' CD1' ' A' ' 255' ' ' ILE . . . -106.13 171.32 7.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -127.8 128.67 45.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.607 HG21 ' NE2' ' A' ' 189' ' ' HIS . 0.9 OUTLIER -117.77 128.45 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 110.745 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -105.69 132.66 51.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.404 -0.81 . . . . 0.0 110.053 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.718 ' OG1' ' CE1' ' A' ' 253' ' ' HIS . 40.2 m -95.76 -117.85 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 110.231 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.599 ' N ' HG22 ' A' ' 248' ' ' THR . . . -131.98 2.07 3.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.82 . . . . 0.0 110.015 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' A' ' 249' ' ' ALA . 0.6 OUTLIER -154.9 14.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.221 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 252' ' ' ILE . . . -178.11 -168.34 37.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.706 HD12 ' C ' ' A' ' 251' ' ' GLY . 4.0 mp -146.29 140.52 20.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.302 -1.116 . . . . 0.0 110.116 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.718 ' CE1' ' OG1' ' A' ' 248' ' ' THR . 0.9 OUTLIER -116.41 161.09 19.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.131 -0.981 . . . . 0.0 110.466 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.797 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -125.52 134.27 52.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.594 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.992 ' CD1' ' HB3' ' A' ' 244' ' ' ALA . 0.4 OUTLIER -124.98 126.52 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.024 -1.047 . . . . 0.0 110.914 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 163' ' ' PHE . . . -85.4 128.22 8.64 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.814 HD23 ' CB ' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -113.08 155.12 25.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.866 -1.373 . . . . 0.0 111.982 -178.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -153.06 118.44 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.791 ' HB2' HD12 ' A' ' 172' ' ' LEU . . . -144.36 155.39 43.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.635 -1.29 . . . . 0.0 111.804 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.7 ' HD3' ' CA ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -114.17 165.35 12.75 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.213 0.53 . . . . 0.0 109.846 179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.745 ' OXT' ' CD1' ' A' ' 158' ' ' TYR . 39.2 mm-40 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.373 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.238 0.542 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.03 -128.93 2.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.4 t -153.31 115.2 4.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -1.104 . . . . 0.0 110.205 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -101.04 148.33 25.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.05 -94.66 0.1 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.25 -142.81 5.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.96 -54.48 3.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.39 -69.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -102.26 -51.11 3.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -1.163 . . . . 0.0 110.187 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 43.07 0.26 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.94 140.93 4.43 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.43 112.35 0.52 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.16 157.66 35.38 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG12 ' H ' ' A' ' 15' ' ' THR . 6.1 t -58.91 -172.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -1.167 . . . . 0.0 110.21 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.835 ' H ' HG12 ' A' ' 14' ' ' VAL . 9.1 m -105.15 154.34 20.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.8 0.74 25.78 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.308 -0.87 . . . . 0.0 110.577 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -162.4 46.34 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -0.999 . . . . 0.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.968 HG22 ' N ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -100.3 -79.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.161 -0.962 . . . . 0.0 109.946 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.968 ' N ' HG22 ' A' ' 18' ' ' ILE . . . -91.44 -60.82 1.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -64.08 -1.45 1.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 110.348 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' O ' ' HB2' ' A' ' 24' ' ' ASP . . . -58.65 -24.8 57.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -58.16 -37.91 75.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -1.147 . . . . 0.0 110.21 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.25 -11.19 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.067 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.122 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -94.32 -8.85 37.75 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 110.273 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' A' ' 70' ' ' ASN . . . -69.03 -32.1 71.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.35 -34.32 7.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.244 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.998 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 8.0 m -86.06 -5.86 59.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 110.261 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 1.122 ' HB3' ' O ' ' A' ' 24' ' ' ASP . . . -119.53 92.86 46.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.334 -0.854 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.606 ' O ' ' O ' ' A' ' 30' ' ' LEU . 46.0 Cg_endo -73.19 -162.36 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.979 1.516 . . . . 0.0 110.422 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -41.92 175.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.16 -161.04 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.64 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 14.6 m-70 -128.86 47.02 2.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 110.213 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.64 ' CG ' ' O ' ' A' ' 32' ' ' HIS . 2.0 mtpt 179.81 28.03 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 110.214 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.75 145.21 38.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.242 -0.912 . . . . 0.0 110.218 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -47.32 -61.36 1.94 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.168 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.6 -47.45 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.617 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 1.7 mm? -94.47 133.51 37.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -1.177 . . . . 0.0 110.209 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.695 ' HB3' ' CD1' ' A' ' 30' ' ' LEU . 26.4 mtmt -94.76 -21.82 18.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.17 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.629 ' CB ' ' HA ' ' A' ' 70' ' ' ASN . 13.3 p 175.73 -176.11 0.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.927 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 ' O ' ' A' ' 39' ' ' SER . 0.2 OUTLIER -154.42 110.83 3.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 110.224 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.843 HG23 ' HB2' ' A' ' 68' ' ' SER . 28.7 m -90.3 157.17 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' CD1' ' O ' ' A' ' 67' ' ' ASP . 4.8 mp -93.47 139.53 30.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 110.179 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 42' ' ' LEU . 1.3 pt-20 -54.59 -134.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 0.0 110.18 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 45' ' ' SER . 1.5 m-20 -83.69 16.97 2.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 110.197 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.585 ' C ' ' O ' ' A' ' 44' ' ' ASP . 2.8 m -29.85 -64.0 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 110.114 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -94.94 -157.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -0.833 . . . . 0.0 110.298 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.619 ' HA ' ' CG ' ' A' ' 65' ' ' ASN . 0.6 OUTLIER 179.79 -161.46 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.483 -0.76 . . . . 0.0 109.934 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.75 -5.42 0.91 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.203 -0.936 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 1.008 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -120.06 63.79 0.83 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 110.329 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . 179.83 91.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.603 ' OG1' ' O ' ' A' ' 87' ' ' GLN . 55.0 p -118.96 134.94 54.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -1.126 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.9 pp -162.65 161.81 26.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.145 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 0.8 OUTLIER -121.27 150.07 41.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.36 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.774 ' HB3' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.66 140.8 38.17 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.135 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 58.5 m -134.69 120.96 20.14 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.21 0.529 . . . . 0.0 110.224 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 22' ' ' LEU . . . -115.76 -177.05 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.184 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.71 ' O ' HG22 ' A' ' 20' ' ' THR . 38.8 mt-30 -74.49 43.57 0.18 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.291 -0.881 . . . . 0.0 110.201 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -170.91 -49.7 0.04 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB3' ' OG1' ' A' ' 27' ' ' THR . . . -154.71 177.38 11.3 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.253 -1.145 . . . . 0.0 110.32 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.669 ' CB ' ' O ' ' A' ' 54' ' ' LEU . 1.8 pm0 -128.68 170.27 13.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.172 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.688 ' CD ' ' O ' ' A' ' 26' ' ' LEU . 1.6 mttt -148.43 126.94 12.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.95 . . . . 0.0 110.231 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 62' ' ' THR . 1.2 t -69.92 126.9 31.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.687 ' CZ ' ' O ' ' A' ' 68' ' ' SER . 2.7 m-85 -117.82 112.89 21.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.256 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.07 -157.9 10.13 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 47' ' ' SER . 1.5 t-20 -48.82 125.36 10.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -1.178 . . . . 0.0 110.111 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . 88.6 0.38 82.0 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.69 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.2 p-10 -26.85 129.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -1.008 . . . . 0.0 110.4 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.843 ' HB2' HG23 ' A' ' 41' ' ' THR . 1.7 t -123.2 165.06 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 8.3 mt -127.12 121.07 30.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.629 ' HA ' ' CB ' ' A' ' 39' ' ' SER . 5.0 m120 -99.41 104.5 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.83 ' HB ' HD13 ' A' ' 74' ' ' LEU . 40.0 p -132.61 50.18 2.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.326 -0.859 . . . . 0.0 110.188 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 37' ' ' LEU . . . -57.06 -41.04 92.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.626 ' O ' ' O ' ' A' ' 74' ' ' LEU . 3.9 mmpt? -61.36 -50.22 73.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -1.115 . . . . 0.0 110.197 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.83 HD13 ' HB ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -34.77 162.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.359 -0.838 . . . . 0.0 110.721 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -139.52 -158.95 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.456 -0.778 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 108' ' ' SER . 4.3 m-20 -76.65 12.96 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 110.19 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.669 ' HB2' ' CD ' ' A' ' 260' ' ' LYS . 8.1 p-10 -157.73 79.04 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.665 ' HB2' HD23 ' A' ' 74' ' ' LEU . 8.9 mttt -153.58 154.99 35.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.24 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 105' ' ' TYR . 2.0 t -125.02 168.93 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -145.65 94.34 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.105 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 81' ' ' ARG . 0.1 OUTLIER -101.3 125.25 47.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.22 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.776 ' CZ ' ' CD2' ' A' ' 102' ' ' PHE . 44.2 p90 -156.95 175.05 14.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.945 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 101' ' ' GLU . 8.1 t70 -118.8 147.74 43.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 102' ' ' PHE . 3.0 p90 -145.66 157.08 44.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' A' ' 87' ' ' GLN . 2.7 mp -106.48 110.36 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 87' ' ' GLN . 12.1 ptp180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' A' ' 85' ' ' ILE . 15.7 mt-30 -145.88 119.06 8.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.3 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.008 HD11 ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -114.63 112.34 39.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.249 -0.907 . . . . 0.0 110.34 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -141.25 133.04 27.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.92 . . . . 0.0 110.324 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.902 HG11 ' CD ' ' A' ' 93' ' ' GLN . 97.6 t -116.7 169.84 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.875 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.522 ' N ' HG12 ' A' ' 90' ' ' VAL . 18.8 m-20 -64.0 -1.53 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.385 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLN . . . 179.6 46.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 1.067 ' O ' HD12 ' A' ' 95' ' ' ILE . 17.0 mt-30 -156.84 -138.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -1.148 . . . . 0.0 110.671 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 27.7 mt -45.23 165.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.357 0.599 . . . . 0.0 110.645 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.095 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -163.88 18.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.471 -0.768 . . . . 0.0 109.858 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.631 ' O ' HD12 ' A' ' 97' ' ' LEU . 41.0 m -50.41 158.73 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 0.0 110.268 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.095 HD12 ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -170.56 109.84 0.36 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 0.0 110.122 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.688 ' CG ' ' HA ' ' A' ' 120' ' ' GLU . 15.3 mp0 -156.4 172.77 17.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.169 -0.957 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 t -121.09 163.6 18.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 110.124 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.58 ' HA3' ' NH2' ' A' ' 86' ' ' ARG . . . -173.12 -176.23 41.5 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.68 ' CB ' ' HB3' ' A' ' 116' ' ' GLN . 4.0 tt0 -112.03 159.78 18.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.328 -1.101 . . . . 0.0 110.27 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.776 ' CD2' ' CZ ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -130.31 125.12 33.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.876 . . . . 0.0 110.236 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' O ' ' A' ' 103' ' ' GLN . 13.6 tm0? -124.72 115.4 20.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 79' ' ' VAL . 46.0 t -120.89 147.78 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.739 ' CE1' ' OE1' ' A' ' 107' ' ' GLN . 1.7 t80 -142.61 125.51 16.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.918 . . . . 0.0 110.149 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.37 142.83 36.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 110.238 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.739 ' OE1' ' CE1' ' A' ' 105' ' ' TYR . 3.6 mm100 -107.58 -139.22 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.241 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' ' CB ' ' A' ' 76' ' ' ASN . 17.1 m -86.26 -47.08 9.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.238 -0.914 . . . . 0.0 110.288 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' NE2' ' A' ' 144' ' ' HIS . 0.3 OUTLIER -128.23 -21.45 3.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.028 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.3 p -103.71 -162.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.128 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.843 ' C ' HD23 ' A' ' 112' ' ' LEU . . . -172.36 171.46 4.73 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.312 -0.867 . . . . 0.0 110.255 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.03 ' CD1' ' HB1' ' A' ' 258' ' ' ALA . 0.0 OUTLIER -161.13 161.51 31.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 110.123 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -156.04 173.5 16.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.399 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 103' ' ' GLN . . . -156.56 125.2 5.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.441 -0.787 . . . . 0.0 109.931 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD12 ' NH1' ' A' ' 136' ' ' ARG . 6.8 mt -95.65 141.09 29.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.337 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.713 ' HG2' ' CD2' ' A' ' 135' ' ' PHE . 1.5 tm0? -125.55 152.15 45.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.498 ' OG1' ' HB3' ' A' ' 134' ' ' ARG . 26.2 m -117.58 164.85 14.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.321 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HB2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -132.94 -63.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.693 ' CG ' ' O ' ' A' ' 130' ' ' VAL . 5.0 tt0 -135.69 155.04 51.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' VAL . 5.7 mt-10 -131.16 178.6 6.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.89 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.638 ' CB ' ' O ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -160.99 151.93 18.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.107 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' CB ' ' HG2' ' A' ' 127' ' ' GLU . 0.5 OUTLIER -117.27 -171.36 0.2 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.0 111.228 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.711 ' O ' ' CG ' ' A' ' 124' ' ' GLU . 53.1 Cg_endo -89.93 35.98 0.34 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.67 1.58 . . . . 0.0 110.917 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.713 ' O ' ' N ' ' A' ' 127' ' ' GLU . 35.1 mt-10 -164.09 96.86 0.81 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.114 -0.991 . . . . 0.0 110.006 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.756 ' N ' ' HB3' ' A' ' 128' ' ' LYS . 70.3 m-70 -12.78 -52.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 121.744 0.783 . . . . 0.0 111.158 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 124' ' ' GLU . 34.2 t -51.59 -41.51 61.26 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 121.394 -0.817 . . . . 0.0 109.51 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.725 ' HG2' ' CB ' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -117.09 -3.8 11.51 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.984 0.897 . . . . 0.0 109.272 179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.756 ' HB3' ' N ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -56.99 8.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.712 . . . . 0.0 112.244 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.721 ' CB ' ' HD3' ' A' ' 128' ' ' LYS . 3.7 ttp -155.89 152.54 28.43 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.578 -0.701 . . . . 0.0 109.584 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -151.87 174.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.91 114.84 3.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.882 . . . . 0.0 110.222 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -161.31 -171.89 3.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.915 . . . . 0.0 110.17 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 135' ' ' PHE . 5.0 mmt-85 -126.4 106.36 9.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 110.29 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.498 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 2.8 ttt85 -117.19 147.21 42.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.713 ' CD2' ' HG2' ' A' ' 116' ' ' GLN . 15.6 m-85 -147.6 115.46 6.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.975 . . . . 0.0 110.312 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.557 ' NH1' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -102.15 107.64 18.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.024 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.596 HD13 ' CE2' ' A' ' 163' ' ' PHE . 7.5 tp -76.81 141.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.671 ' O ' HG23 ' A' ' 113' ' ' THR . . . -145.86 58.48 0.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.622 ' HA ' ' HA ' ' A' ' 112' ' ' LEU . 80.2 m-20 -92.38 152.54 19.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.837 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -135.38 48.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.167 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.944 ' HB1' ' CE2' ' A' ' 233' ' ' PHE . . . -86.59 119.85 27.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.6 29.18 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.649 ' O ' ' N ' ' A' ' 145' ' ' THR . 1.7 tt0 -88.73 -161.29 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -1.194 . . . . 0.0 110.298 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.751 ' CE1' ' HB2' ' A' ' 235' ' ' GLU . 0.0 OUTLIER -47.92 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 110.069 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.044 HG23 ' CG ' ' A' ' 211' ' ' HIS . 1.0 OUTLIER -98.38 -0.9 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.773 . . . . 0.0 110.054 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 210' ' ' HIS . 10.3 p -60.19 101.53 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.388 -0.82 . . . . 0.0 109.909 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.878 ' CE2' ' CE2' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -39.51 -22.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.097 -1.002 . . . . 0.0 109.774 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.633 ' N ' ' O ' ' A' ' 146' ' ' SER . 1.7 m-20 -40.84 -36.09 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.467 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.734 ' N ' ' CD ' ' A' ' 149' ' ' LYS . 6.8 mptt -83.24 25.31 0.73 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.71 0.766 . . . . 0.0 109.049 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 150' ' ' LEU . 1.1 pp 179.27 58.7 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 150' ' ' LEU . 42.7 Cg_endo -84.89 111.7 1.44 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 124.303 1.686 . . . . 0.0 110.612 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' O ' ' N ' ' A' ' 154' ' ' VAL . 0.0 OUTLIER -168.23 90.37 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.67 ' OD1' ' N ' ' A' ' 180' ' ' ALA . 8.9 m-20 -59.72 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.777 ' N ' ' O ' ' A' ' 152' ' ' LYS 0.259 5.6 t -129.04 108.99 17.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.292 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 177' ' ' ASP . 21.0 ptt? -31.43 140.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.121 -0.987 . . . . 0.0 110.056 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.115 ' HB2' ' CE2' ' A' ' 178' ' ' PHE . . . -133.8 129.87 37.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 0.0 110.258 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -65.86 146.94 54.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 110.165 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.733 ' CE1' ' HG2' ' A' ' 238' ' ' GLN . 5.5 m-85 -141.4 142.87 33.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 110.321 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.448 ' O ' ' CG ' ' A' ' 159' ' ' ARG . 8.9 ptp180 -139.25 131.69 28.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 108.972 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.711 ' HA3' ' CB ' ' A' ' 259' ' ' ALA . . . -151.72 -179.83 27.71 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 258' ' ' ALA . 91.9 m -117.78 155.39 30.13 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.989 ' HB3' ' O ' ' A' ' 170' ' ' GLY . . . -148.7 179.55 7.74 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 121.097 -1.002 . . . . 0.0 110.358 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.663 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 0.2 OUTLIER -141.04 142.8 34.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.372 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.41 ' CA ' HG23 ' A' ' 255' ' ' ILE . . . -122.7 146.56 16.67 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.915 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.601 ' OG ' ' CD2' ' A' ' 254' ' ' HIS . 1.5 p -70.97 -5.72 33.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.298 -1.119 . . . . 0.0 110.242 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -128.97 2.25 5.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.858 . . . . 0.0 109.965 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.742 ' OD2' ' CD2' ' A' ' 189' ' ' HIS . 13.9 m-20 -124.94 171.18 10.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.624 -0.672 . . . . 0.0 109.362 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.38 -10.46 59.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.965 -1.085 . . . . 0.0 110.344 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 163' ' ' PHE . . . 178.03 -126.6 1.09 Allowed Glycine 0 C--N 1.284 -2.338 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.989 ' O ' ' HB3' ' A' ' 162' ' ' ALA . . . 175.11 82.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 188' ' ' GLU . 14.7 mtmt -91.57 127.2 36.93 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.407 -1.643 . . . . 0.0 108.857 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 1.118 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.7 pp -145.49 134.25 22.32 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.769 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 26.0 m -96.26 125.87 41.08 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.832 ' HD1' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -112.09 154.32 25.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.763 -1.211 . . . . 0.0 112.263 -177.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.565 ' HB ' ' NE2' ' A' ' 184' ' ' HIS . 1.9 m -130.18 97.54 4.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.858 HG23 ' CA ' ' A' ' 183' ' ' GLY . 28.9 mt -111.41 131.83 61.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.186 -0.946 . . . . 0.0 112.204 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.775 ' CB ' ' CB ' ' A' ' 182' ' ' GLN . 53.5 t0 -82.48 117.9 22.84 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 1.115 ' CE2' ' HB2' ' A' ' 156' ' ' ALA . 99.3 m-85 -43.48 -152.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.355 1.074 . . . . 0.0 112.513 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 203' ' ' TYR . . . -43.72 -6.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.412 -0.805 . . . . 0.0 112.111 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.67 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . -66.12 -95.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.497 -1.377 . . . . 0.0 108.776 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -164.46 44.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.857 -1.137 . . . . 0.0 112.297 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.775 ' CB ' ' CB ' ' A' ' 177' ' ' ASP . 1.0 OUTLIER -150.31 148.91 29.42 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 117.237 -1.785 . . . . 0.0 112.319 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.858 ' CA ' HG23 ' A' ' 176' ' ' ILE . . . -170.2 87.4 0.09 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.741 ' O ' ' CD2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -142.37 177.5 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.036 -1.273 . . . . 0.0 110.705 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.742 ' HA3' ' CD1' ' A' ' 174' ' ' TYR . . . -172.68 -157.27 14.07 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.15 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 199' ' ' LEU . 11.0 mtmm -138.48 127.46 23.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -1.073 . . . . 0.0 109.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.089 HG23 HG23 ' A' ' 197' ' ' VAL . 1.0 OUTLIER -87.49 137.68 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.355 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.678 ' CG ' ' O ' ' A' ' 171' ' ' LYS . 4.3 mt-10 -132.72 74.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.971 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.742 ' CD2' ' OD2' ' A' ' 167' ' ' ASP . 10.8 m-70 -28.11 -61.0 0.11 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.566 -0.709 . . . . 0.0 109.936 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.251 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -94.62 -106.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.546 ' CG ' ' HE2' ' A' ' 171' ' ' LYS . 1.6 mtpt -155.52 -30.81 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 110.674 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.761 ' HB3' HD13 ' A' ' 195' ' ' LEU . 0.9 OUTLIER -45.93 134.41 6.74 Favored Pre-proline 0 C--N 1.295 -1.765 0 O-C-N 121.52 -0.737 . . . . 0.0 110.043 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.54 46.2 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.087 1.572 . . . . 0.0 110.171 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.597 ' O ' ' OH ' ' A' ' 220' ' ' TYR . 2.5 mt-10 -153.79 -31.12 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 110.416 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.251 HD22 ' CD1' ' A' ' 190' ' ' LEU . 5.8 mp -84.84 2.79 40.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.132 -0.98 . . . . 0.0 110.225 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.692 ' N ' ' ND2' ' A' ' 196' ' ' ASN . 0.2 OUTLIER -80.49 166.91 20.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.863 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 1.089 HG23 HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -122.15 144.32 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.939 . . . . 0.0 110.509 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 219' ' ' LEU . 5.2 t70 -70.11 91.57 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.674 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.951 ' CD2' HG13 ' A' ' 218' ' ' VAL . 2.7 mt -75.9 128.61 35.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.314 -0.866 . . . . 0.0 111.02 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . . . -129.22 119.86 24.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.435 -0.79 . . . . 0.0 109.524 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.002 HG11 ' CG2' ' A' ' 214' ' ' ILE . 37.4 t -146.47 158.6 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -110.8 136.62 49.58 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.878 ' CE2' ' CE2' ' A' ' 147' ' ' PHE . 0.2 OUTLIER -82.34 157.99 23.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 0.0 110.391 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ILE . . . . . 0.652 HD13 ' HB ' ' A' ' 213' ' ' VAL . 4.5 mp -133.38 128.23 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 110.017 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.679 ' N ' ' CD ' ' A' ' 206' ' ' PRO . 0.0 OUTLIER -81.45 -40.24 1.03 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 110.731 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 205' ' ' LYS . 49.0 Cg_endo -77.45 61.52 7.42 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.86 1.453 . . . . 0.0 110.971 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.707 ' CG ' HG22 ' A' ' 213' ' ' VAL . 29.5 t0 -75.14 -154.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.032 -1.042 . . . . 0.0 109.515 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.606 ' O ' ' CD ' ' A' ' 209' ' ' LYS . 12.7 mt-10 -40.92 -23.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.927 -1.108 . . . . 0.0 109.301 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.606 ' CD ' ' O ' ' A' ' 208' ' ' GLU . 0.4 OUTLIER -165.34 -60.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 109.293 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 146' ' ' SER . 0.2 OUTLIER -149.58 9.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.47 -0.769 . . . . 0.0 109.931 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 1.044 ' CG ' HG23 ' A' ' 145' ' ' THR . 2.4 m170 -75.66 173.01 11.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.381 -0.825 . . . . 0.0 110.15 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 147' ' ' PHE . . . -99.61 147.13 25.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.061 -1.024 . . . . 0.0 110.02 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.707 HG22 ' CG ' ' A' ' 207' ' ' ASP . 1.1 t -127.34 165.04 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.252 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.002 ' CG2' HG11 ' A' ' 201' ' ' VAL . 5.5 mt -147.86 109.98 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.196 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.877 ' C ' HG13 ' A' ' 201' ' ' VAL . 0.3 OUTLIER -132.39 132.21 42.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.282 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 201' ' ' VAL . . . -169.94 -153.14 8.4 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 227' ' ' SER . 0.4 OUTLIER -136.36 140.69 43.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -1.213 . . . . 0.0 110.481 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.951 HG13 ' CD2' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -93.95 141.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.297 -0.877 . . . . 0.0 110.173 179.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.917 ' C ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 132.25 28.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.084 -1.01 . . . . 0.0 110.605 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.747 ' CE2' ' HB2' ' A' ' 222' ' ' GLN . 3.1 t80 -97.69 154.17 17.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.359 -0.838 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 0.3 OUTLIER -78.0 -15.17 59.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.428 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.747 ' HB2' ' CE2' ' A' ' 220' ' ' TYR . 0.0 OUTLIER -78.31 -64.23 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.365 -0.834 . . . . 0.0 109.807 179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.84 27.45 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.902 -0.499 . . . . 0.0 110.215 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 220' ' ' TYR . 5.2 tt0 -88.55 162.6 16.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 111.088 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 224' ' ' GLU . 1.2 mmmp? -148.35 78.72 1.43 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.575 -0.703 . . . . 0.0 109.24 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' A' ' 246' ' ' VAL . . . -104.05 174.07 22.05 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.454 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.743 ' O ' ' HB1' ' A' ' 244' ' ' ALA . 0.2 OUTLIER -121.1 173.05 7.52 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.486 -1.008 . . . . 0.0 109.727 179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 1.199 ' CE2' HD13 ' A' ' 230' ' ' LEU . 31.0 t80 -144.19 126.87 16.11 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.888 -1.133 . . . . 0.0 111.15 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.899 ' C ' HD12 ' A' ' 230' ' ' LEU . 46.7 m -147.71 117.44 7.11 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.501 -0.749 . . . . 0.0 109.442 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.199 HD13 ' CE2' ' A' ' 228' ' ' TYR . 5.5 mp -152.19 170.62 19.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 110.87 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -116.95 131.03 9.24 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.819 HG22 HD12 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -105.2 133.36 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.963 -1.316 . . . . 0.0 111.069 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.944 ' CE2' ' HB1' ' A' ' 141' ' ' ALA . 0.6 OUTLIER -113.44 -176.73 2.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.783 -0.573 . . . . 0.0 109.52 179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.683 ' O ' ' N ' ' A' ' 236' ' ' LYS . . . 179.8 61.59 0.08 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.751 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . 6.4 pt-20 -32.33 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.281 -1.129 . . . . 0.0 109.268 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 234' ' ' GLY . 0.0 OUTLIER 178.39 35.35 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.548 ' HB1' ' NE2' ' A' ' 261' ' ' GLN . . . -157.29 -140.26 0.08 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.658 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.733 ' HG2' ' CE1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -130.92 69.27 1.47 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.619 -0.676 . . . . 0.0 110.675 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 233' ' ' PHE . 10.4 pt-20 -104.81 142.6 34.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.844 -1.16 . . . . 0.0 110.321 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.688 ' CG2' ' HB ' ' A' ' 232' ' ' ILE . 1.4 p -163.76 131.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.204 -0.935 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 258' ' ' ALA . . . -145.35 158.81 43.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.857 ' N ' HD23 ' A' ' 230' ' ' LEU . . . -179.47 -147.79 7.47 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.659 -1.257 . . . . 0.0 109.99 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 36.9 p -151.87 127.38 10.05 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.326 -1.103 . . . . 0.0 109.356 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.964 ' HB3' HD13 ' A' ' 255' ' ' ILE . . . -106.11 171.3 7.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.421 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 227' ' ' SER . 1.0 OUTLIER -107.68 153.41 22.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 109.576 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.711 ' O ' HG12 ' A' ' 246' ' ' VAL . 1.2 t -141.22 107.1 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.052 -1.03 . . . . 0.0 110.633 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.47 ' HG3' ' CG1' ' A' ' 252' ' ' ILE . 2.2 tt0 -99.52 126.86 45.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 110.154 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 250' ' ' ASN . 4.8 t -90.32 -116.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.19 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.65 ' N ' HG23 ' A' ' 248' ' ' THR . . . -116.2 1.2 13.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.752 ' H ' HG23 ' A' ' 248' ' ' THR . 3.5 m-80 179.85 28.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.243 -0.91 . . . . 0.0 110.237 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.739 ' O ' HG22 ' A' ' 248' ' ' THR . . . -166.45 116.02 0.66 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.47 ' CG1' ' HG3' ' A' ' 247' ' ' GLU . 2.6 mp -81.43 129.48 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.331 -1.099 . . . . 0.0 110.368 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.676 ' NE2' ' O ' ' A' ' 251' ' ' GLY . 1.9 m170 -118.15 161.26 20.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.892 . . . . 0.0 110.227 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.607 ' H ' ' CD2' ' A' ' 254' ' ' HIS . 0.1 OUTLIER -123.99 141.25 52.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 109.934 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.964 HD13 ' HB3' ' A' ' 244' ' ' ALA . 0.3 OUTLIER -124.35 125.26 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.099 -1.0 . . . . 0.0 110.575 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.566 ' O ' ' HB1' ' A' ' 162' ' ' ALA . . . -85.54 132.91 11.41 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 1.069 HD12 HD21 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -122.28 153.34 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.769 -1.43 . . . . 0.0 111.942 -178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 1.03 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -152.78 121.57 6.49 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.711 ' CB ' ' HA3' ' A' ' 160' ' ' GLY . . . -139.92 161.53 37.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.482 -1.386 . . . . 0.0 112.085 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.692 ' CE ' ' OH ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -132.38 165.84 23.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.259 0.552 . . . . 0.0 109.634 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 238' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.183 -179.804 . . . . . . . . 2 2 . 1 stop_ save_